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CHAPTER ONE: 
 Introduction 
The body is the world’s greatest storyteller. Inside each of us, throughout the course 
of our lives, our cells work together to paint a picture of who we are; every cell growing and 
responding in time to both internal and external stimuli. When confronted with abnormal 
stimuli, such as those brought on by disease or trauma, the body begins a new chapter--our 
cells and systems incorporating the physiological changes and stress responses into the 
overall narrative. In this way, disease has the ability to shape and reshape the human body, 
our tissues acting as the manuscript upon which our fluctuating states of health are recorded. 
While cuts and bruises eventually heal, erased from our bodies as our tissues replenish 
themselves over a lifetime, certain experiences of disease last much longer, altering not only 
our physical selves, but transforming our individual, social and evolutionary trajectories as 
well. This is precisely why the story of disease, and the ways in which it articulates with 
human systems and societies, is a crucial aspect of holistically understanding our past, 
present, and potentially, our future. Fortunately, although aspects of our physical and social 
selves may disappear along with our flesh and blood, the structural and biochemical 
alterations made to our skeletal systems during times of stress last much longer; our bones 
and teeth steadfastly remembering many of the disease processes we may have faced while 
alive.  
            Despite the skeleton’s ability to inscribe certain aspects of disease however, a 
complete life history is only made possible when chapters are pieced back together through 
literate diagnoses. As such, the development of novel and more accurate diagnostic 
techniques remains an essential objective of disciplines like bioarchaeology, which seeks to 
investigate the complex and dynamic nature of human ‘health’ through multi and 
interdisciplinary research. The purpose of this thesis, therefore, is to investigate whether the 
biochemical alterations made to the skeletal system (osteological and dental tissues) during 
periods of stress can be used as an aid for diagnosing chronic diseases in archaeological 
, O81δpopulations. Specifically, this research seeks to determine if the isotopic composition (
of the organic (bone collagen) and inorganic (enamel apatite) matrices of  1N)15δand  C13δ
human skeletal tissues differs between individuals with and without the genes responsible for 
                                                          
1 Formalized method of representing the ratio of heavier to lighter stable isotopes (in this case, stable oxygen, carbon and nitrogen isotopes) in any 
given sample, compared to the universal standard. See Chapter 2 for more information on stable isotopes and isotopic analyses. 
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ssemia; genetically homozygotic or heterozygotic expressions of sickle cell and/or thala
blood disorders characterized by phenotypically and functionally  2inherited hemolytic
abnormal hemoglobin molecules and red blood cells (RBCs) (Cao et al. 2000; Origa et al. 
2005; Yochum and Rowe 2005) (see Chapter 3). Consequently, if the pathophysiological 
do significantly alter inter (between) and intra  3mechanisms of sickle cell and/or thalassemia
(within)-individual stable isotope values, this thesis will determine whether stable isotopic 
analyses is a viable method of diagnosing the conditions within archaeological populations, 
when interpreting stable  4and whether bioarchaeologist should consider the role of disease
isotope data. 
1. Brief History of Archaeological Research 
Until the inception and development of bioarchaeology as an academic discipline the 
complex interplay between individual and social responses to illness, and the 
demographic/evolutionary significance(s) of disease-host relationships in archaeological 
populations were often overlooked (Aufderheide and Rodriguez-Martin 1998; Roberts and 
Manchester 2005). Now, with the proliferation of research investigating the spectrum of 
ancient human ‘health’, and the engagement of multi and interdisciplinary analyses, 
bioarchaeology is beginning to shed light on aspects of disease which were previously 
considered unknowable. For instance, histological and radiographic investigations, 
parasitology and aDNA studies have all proven successful in elucidating the presence and 
evolution of various disease vectors5 and pathophysiological processes, enabled a more 
comprehensive understanding of osteological responses to various stressors, and called for a 
more holistic approach to palaeopathological research (Katzenberg and Saunders 2008; 
Roberts and Manchester 2005). Regardless of the successes afforded by these advances 
however, it remains challenging to fully assess and diagnose diseases which primarily affect 
the soft tissues, those which do not leave osteological signatures (either due to the 
physiological processes themselves, or because death occurs prior to osteological 
involvement), those which produce non-pathognomonic6 lesions, and/or those which are 
comorbid in nature (Aufderheide and Rodriguez-Martin 1998; Roberts and Manchester 
                                                          
2 Conditions characterized by the premature destruction (lysis) of red blood cells (Yochum and Rowe 2005). 
3 The terms ‘sickle cell’ and ‘thalassemia’ are hereby considered to be generic terms for all sicklic and thalassemic mutations, and does not denote 
or specify the exact genetic nature of the condition. 
4 With specific reference to all conditions which may chronically interfere with the diffusion, fixation and metabolization of stable isotopes 
throughout the body. 
5 Disease vector is understood as any person, animal (mammal, reptile, arthropods etc…) or microorganism (viral, bacterial, fungal etc.) that 
carries and transmits infectious pathogens to another organism (Tortora and Derrickson 2012). 
6Pathognomonic refers to signs or symptoms which are unique to a particular disease, and that permits a firm diagnosis of that disease (Hillson 
2008). 
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2005). To complicate matters further, inter and intra-individual variation in the timing and 
presentation of disease(s) and sequelae, the osteological paradox7 (Wood et al. 1992) and 
taphonomic8 processes ablating diagnostic features further confounds palaeopathological 
investigations, often forcing researchers to present a range of differential diagnoses which 
may have vastly different physical, social and/or evolutionary consequences (Aufderheide 
and Rodriguez-Martin 1998; Roberts and Manchester 2005).  
The complex relationship between advancing technology and the limits posed to 
bioarchaeologists is explicitly demonstrated by the anemias, a multifactorial and 
pathophysiologically varied class of acquired and genetic blood disorders (fig.1) (see Chapter 
3). 
1.1. The Anemias in Archaeology: 
Contemporary epidemiological 
investigations indicate that over 800 million 
individuals worldwide9 are ‘anemic’ (WHO 2008); 
the global burden of which exceeds that of major 
depressive disorders and chronic respiratory 
diseases (Kassebaum et al. 2014; WHO 2008). It is 
estimated that comparable rates of ‘anemia’ may 
have occurred in the archaeological past, possibly 
precipitated by certain subsistence strategies, the 
increased inhabitation of low altitude/equatorial 
regions where anemia-inducing disease vectors (e.g. 
malaria, hookworm, schistosomiasis) may have 
been more prevalent/endemic, and the exchange of 
‘anemic’ loci due to genetic admixture (Cohen and 
Armelagos 1984; Roberts and Cox 2003; Roberts 
and Manchester 2007; Steckel and Rose 2002). This 
                                                          
7 The paradox initially developed by Wood et al. 1992 which states that, due to the time required to develop an osteological response to any 
disease/disease process, skeletons exhibiting osteological lesions may represent ‘healthier’ and more resilient individuals/populations since they 
survived long enough to develop bony response/s. Individuals without hard-tissue lesions may  therefore represent ‘healthy’ individuals (free from 
disease), or they may represent the least resilient individuals in the population as they may have died early on in the disease process.  
8 The term taphonomic refers to any and all processes which affect plant and animal/human remains after they have died. This includes 
decomposition, diagenesis (recombinations of constituent chemical/molecular remains after death), bioturbation process (the restructuring of the 
sediments within which an organism is buried), fossilization and damage caused by animal or human activities (gnawing, burning etc.) 
(Behrensmeyer 1978; Lyman 1994). 
9 Between 1993-2005 (WHO 2008). 
Fig. 1. Global cause-specific anemia prevalence 
in men and women for 1990 and 2010. 
G6PD=glucose-6-phosphate dehydrogenase; 
hemog= hemoglobinemia; NTD=neglected 
tropical diseases; CKD= chronic kidney disease 
(Kassebaum et al. 2014, 616). 
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suggests that, within each archaeological population, there is a significant possibility that 
multiple individuals will have had (at some point in their lives) one or more anemic 
conditions.  
The multi-etiological, multi-pathophysiological nature of ‘anemia’ complicates 
bioarchaeological investigations since not only does it have numerous origins/risk factors 
(fig. 1), but it is intrinsically linked to all of the aforementioned barriers presented to 
palaeopathologists; it is first and foremost a soft tissue disorder; it may be a primary or 
comorbid condition, it may be chronic or acute in nature, it may be mediated by social or 
individual responses to illness and disease, and it may affect both soft and hard tissues 
differently depending on the individual and the origins/severity/chronicity of the condition 
(Chui and Waye 1998; Clarke and Higgins 2000; Kassebaum et al. 2014; 
Mahachoklertwattana et al. 2003; Morabito et al. 2004; Origa et al. 2005; Perisano et al. 
2012; Voskaridou 2009; Yochum and Rowe 2005). Similarly, osteological manifestations of 
‘anemia’ are non-pathognomonic and occur only in a subset of ‘resilient’ or stressed (see the 
osteological paradox; Wood et al. 1992) individuals, regardless of the objective or subjective 
severity of the condition(s) (Chui and Waye 1998; Clarke and Higgins 2000; 
Mahachoklertwattana et al. 2003; Morabito et al. 2004; Origa et al. 2005; Perisano et al. 
2012; Voskaridou 2009; Yochum and Rowe 2005). This leaves a portion of the ‘anemic’ 
population invisible to the naked eye, since either osteological signatures did not have time to 
develop prior to death, or the individual did not compensate/respond osteologically to the 
underlying pathophysiology of their ‘anemic’ condition(s).  
The overall preservation of archaeological ‘anemics’ may also be reduced compared 
to their non-anemic cohorts, since the characteristics of anemic bone matrices (e.g. increased 
porosity) may predispose them to certain forms of diagenetic or taphonomic alterations 
(Baxter 2004; Cox and Mays 2000; Jans et al. 2004). This may ablate certain diagnostic 
lesions or distribution patterns making it difficult, if not impossible, to concretely diagnose 
‘anemia’ as an underlying cause or condition. Last, but certainly not least, ‘anemics’ may not 
be visible in certain archaeological populations if perceptions of personhood and/or socio-
cultural illness narratives dictated ‘non-normative’ burial practices (e.g. different burial 
placements and/or preparation rituals/customs for those designated as ill when compared to 
otherwise analogous age/gender/socio-economic cohorts) for deceased neonates10/infants11, 
                                                          
10 All those who are born, and are aged less than 30 days.     
11 All those who are between the ages of 30 days and four years old. 
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for those who could not contribute to the group, or for those seen as ‘other’ as a result of 
severe, chronic illness(es) (Chidester 2001; Sullivan 2003). This, again, may leave a subset of 
the population ‘hidden’ or removed from bioarchaeological investigations, making it difficult 
to comprehend or appreciate the spectrum and influence of ‘anemia’ in the past.  
Accompanying the difficulties associated with locating archaeological ‘anemics’ is 
the struggle to differentiate between genetic and acquired ‘anemias’. Despite the fact that 
‘anemia’ is etiologically and pathophysiologically variable, the skeletal system’s ability to 
respond to and compensate for hemoglobinopathic and RBC disorders is somewhat limited 
(Aufderheide and Rodriguez-Martin 1998; Roberts and Manchester 2005). As such, both 
genetic and acquired ‘anemias’ produce similar types and patterns of lesions, often forcing 
palaeopathologists to clump both classes together (Angel 1977; Ascenzi and Balistreri 1977; 
Aufderheide and Rodriguez-Martin 1998; Stuart-Macadam 1989, 1992). This not only dilutes 
the social, environmental and evolutionary significance of each etiologically distinct 
condition, but also leads to a misconception of ‘anemia’ in the past, with the grossly 
simplified umbrella term being used to contextualize multiple, physiologically distinct, blood 
and hemoglobinopathic disorders.   
As a consequence of the over-application of the word ‘anemia’, genetic 
hemoglobinopathic disorders like sickle cell and thalassemia are often mis/underdiagnosed in 
the archaeological record (Roberts and Manchester 2007). Prior to the advent of modern 
medicine, individuals with homozygotic expressions of hemolytic anemias are likely to have 
died in-utero or during early infancy/childhood12 due to acute and/or systemic complications 
(fig. 2) (Chui and Waye 1998; Clarke and Higgins 2000; Mahachoklertwattana et al. 2003ab; 
Morabito et al. 2004; Origa et al. 2005; Perisano et al. 2012; Platt et al. 1994; Voskaridou 
2009). Given the aforementioned issues with identifying and differentiating between 
‘anemias’, as well as the non-pathognomonic nature of the conditions, neonate and infant 
remains may be misdiagnosed as having diarrheal disorders, nutritional disturbances, or other 
preterm, intra-partum or post-partum complications; especially if sickle cell and thalassemia 
are not considered as possible differentials even within the adult population, or the genetic 
distribution of sicklic and thalassemic alleles is unknown.  
 
                                                          
12 Any individual aged between four years and one day, and 12 years old.  
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Finally, but certainly not lastly, the difficulties associated with conclusively 
differentiating and diagnosing sickle cell and/or thalassemia in the archaeological record is 
not always alleviated by the presence of characteristic lesions (fig. 2), as numerous 
nutritional, metabolic, inflammatory and viral/bacterial infections produce near analogous 
osteological responses (Aksoy et al. 1966; Coben and Paeglow 2000; Diez-Ewald  and 
Layrisse 1968; Gandapur et al. 1995; Noordin et al. 2012; Roberts and Manchester 2007; 
Rollot et al. 2005; Thornton 1968; Walker et al. 2009; Wright 1999; Yochum and Rowe 
2005) (fig. 3). As previously mentioned, this is complicated by the presence of comorbidities 
and/or sequelae, which may create atypical physiological responses (thereby disrupting the 
distribution and/or appearance of anemia-type lesions), destroy areas of the skeleton which 
are most diagnostic, and/or become the focus of the investigation. Additionally, since the 
distribution and severity of sicklic and thalassemic lesions may differ from individual to 
individual, and between homo and heterozygotes (i.e. not all people with the same condition 
will produce the same types of lesions, in the same place, to the same degree), it is difficult to 
accurately estimate morbidity and mortality rates of sickle cell and thalassemia in the 
archaeological past, further supporting misinterpretations and diluting our understanding of 
both conditions within any given society (Palkovich 1987, Stuart-MacAdams 1987; Walker 
Fig. 2. Chronic and acute manifestations of sickle cell and/or thalassemia anemia (Carroll 2015; after Chui and Waye 1998; 
Clarke and Higgins 2000; Mahachoklertwattana et al. 2003ab; Morabito et al. 2004; Origa et al. 2005; Perisano et al. 2012; 
Voskaridou 2009; Yochum and Rowe 2005). 
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et al. 2009; Wright 1999). 
Overall, the macroscopic diagnosis of sickle cell and thalassemia has proven to be a 
difficult endeavor within archaeological populations, given the range of exogenous and 
internal factors mediating the appearance of lesions, and the discovery of those affected. This 
necessitates the development of methods which may assist in illuminating the presence, and 
role, of the various ‘anemias’ in the archaeological record. The use of stable isotope analyses 
may provide such a mechanism. 
1.2. The Application of Stable Isotopes in Palaeopathology:  
Within the past quarter century, researchers have taken steps to more accurately 
understand isotopic fractionation (see Chapter 2), and how internal and external stimuli may 
affect the relative abundances of stable isotopes within and throughout the body (Epstein and 
Fig. 3. Possible differential diagnoses for sickle cell and/or thalassemia based on the presence and distribution of 
characteristic osteological lesions (Carroll 2015; after Aksoy et al. 1966; Coben and Paeglow 2000; Diez-Ewald and 
Layrisse 1968; Gandapur et al. 1995; Rollot et al. 2005; Thornton 1968; Yochum and Rowe 2005). 
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Zeiri 1987; Luijendijk et al. 2007; Panteleev et al. 1999; Reitsema 2013; Reitsema and Crews 
2011; Schuster and Pflug 1989; van Dam et al. 2004; Widory 2004; Zanconato et al. 1992). 
Investigations on living populations have demonstrated that rates of metabolism, pulmonary 
function, osteological lesions, organ function/failure etc. all affect rates of isotopic 
fractionation, and therefore, the isotopic composition of tissues and tissue by-products (e.g. 
Barstow et al. 1989; Buchowski et al. 2000; Butz et al. 2014; Dam et al. 2004; Epstein and 
Zeiri 1988; Feldman et al. 1959; Heller et al. 1994; Katzenberg and Lovell 1999; Lane and 
Dole 1956; Olsen et al. 2014; Reitsema and Crews 2011; Salman et al. 1996; Schoeller et al. 
1984; Schuster et al.  1994; Wolfe et al. 1984; Zanconato et al. 1992).  
The aforementioned research, among others, demonstrates a clear and indisputable 
relationship between human (patho)physiology and stable isotope biochemistry. 
Archaeologically, the majority of these (non-osteological) factors are overlooked since it is 
difficult (if not impossible) to determine an individual’s soft-tissue/biochemical status 
(pulmonary/organic function, metabolic rate etc.) based on dental and/or osteological 
elements alone. The negation of these factors, however, may significantly alter the 
conclusions garnered from archaeological stable isotopic analyses, since significant increases 
or decreases in isotopic fractionation may be interpreted as different trophic levels, 
dietary/breastfeeding practices and/or migratory histories, as opposed to alterations in 
physiology.  
2. Hypothesis                
In individual’s experiencing an optimal state of health, whereby physical and mental 
stressors are at a minimum, all systems and structures are at a dynamic, but homeostatic 
equilibrium (Tortora and Derrickson 2012). In other words, the body of a healthy individual 
is capable of regulating itself such that it remains within its physiological limits, and has the 
capacity to re-stabilize itself if internal or external stressors occur (Tortora and Derrickson 
2012). In individuals with sickle cell and/or thalassemia however, equilibrium is more 
difficult to achieve and maintain since the hemoglobin molecules of individuals with 
either/both condition(s) are functionally and phenotypically abnormal (see Chapter 3). This 
creates multi-systemic issues since diseased RBCs are incapable of assimilating and 
transporting adequate levels of oxygen, disrupting the pulmonary, cardiovascular, metabolic 
and hematopoietic systems and inducing a number of compensatory and pathological 
responses throughout the body and its tissues (see Chapter 3 to 5).  
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It is therefore hypothesized that individuals with the mutations responsible for sickle 
cell and/or thalassemia anemia (i.e. homozygotes) will incorporate significantly different 
ratios of stable isotopes into their organic and inorganic tissues, since the physiological 
responses and biochemical reactions (in this case, the rate of isotopic fractionation) of 
severely, chronically ill individuals are non-analogous to those of healthy, non-anemic 
individuals. More specifically it is hypothesized that anemic homozygotes, who clinically 
exhibit increased episodes of multi-systemic stress as well as reduced physiological re-
stabilization times (Hebbel et al. 2010; Platt et al. 1994), will have the heaviest δ15N values, 
the lightest δ18O values, and comparable δ13C values when compared to healthy, non-anemic 
individuals and heterozygotic anemics.  
The aforementioned hypothesis is formulated around the supposition that 
homozygotes will experience increased stable oxygen isotope fractionation as a result of 
decreased exercise, cardiorespiratory compensations leading to co-morbid complications, and 
more selective oxygen fractionation mechanisms (see Chapter 3 and 4). Combined, or in 
isolation, it is thought that these factors will contribute to overall lighter stable oxygen 
isotope ratios, when compared to their non-homozygotic cohorts13. In addition to the 
aforementioned pathophysiological responses, it is also hypothesized that homozygotes will 
be at an increased risk for developing organ failure, severe infections, hypermetabolism, 
increased bone turnover and/or muscle atrophy, causing an increase in stable nitrogen 
isotopes within the body, and a decrease in fractionation as a result of processes such as 
catabolism and increased metabolic rate. It is thought that, if protein catabolism and/or 
hypermetabolic responses are chronic, or occurring during the time of enamel formation, a 
trophic level shift in nitrogen will occur, leading to heavier δ15N values in the organic and 
inorganic matrices of the skeletal system. Unlike stable nitrogen and oxygen isotope values 
however, stable carbon ratios are expected to be within range of healthy individuals. This is 
due to the fact that bone collagen and enamel are considered to be more representative of 
dietary carbon (DeNiro 1985; DeNiro and Epstein 1978; Schoeninger 1985; Schoeninger and 
DeNiro 1984; van der Merwe and Vogel 1978; Vogel and van de Merwe 1977), than the 
dissolved and gaseous carbon circulating throughout the pulmonary and venous systems. It is 
thought that if δ13C values are significantly different from healthy individuals this would 
reflect socio-cultural mores and customs (i.e. an illness narrative as opposed to a diseased 
response), whereby the chronically ill are expected to consume different types or quantities of 
                                                          
13 Non-anemics and those with heterozygotic expressions of sickle cell and/or thalassemia anemia.  
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foodstuffs in an effort to resolve the illness and/or separate the diseased from the rest of the 
community.  
Finally, it is hypothesized that heterozygotes will be indistinguishable from healthy 
individuals since clinical research indicates that heterozygotes generally experience more acute 
symptoms, or are asymptomatic (Cao and Galanello 2010; Origa et al. 2005; Yochum and 
Rowe 2005) (see Chapter 3). Due to the slow turnover rates of bone collagen and the static 
nature of enamel apatite (Hillson 1996; Larsen 1997; Price 1989; White and Folkens 2005), 
short-term fractionation differences are unlikely to be incorporated into either tissues in 
significant enough quantities, over significant enough time, to induce definitive fractionation 
effects or trophic level changes (within these tissues). As such, it is expected that only homo 
and heterozygotic anemics experiencing chronic complications of the disease will be visible 
using stable isotope analysis.  
3. Definitions and Boundaries 
In order to garner a more complete understanding of the material presented within 
this chapter, and throughout this thesis, a set of cursory definitions, principles and boundaries 
are provided. More in-depth definitions will be provided at the start of certain chapter in 
order to lay down the appropriate foundations and to emphasize key concepts.  
             For the purposes of this research, stress will be defined as any environmental, 
cognitive, physiological or emotional factor(s) that causes bodily and/or mental tension, and 
which may contribute to acquiring, maintaining, or increasing the severity of a disease 
(Schneiderman et al. 2008) (fig. 4). Disease is 
considered to be a category of un-wellness 
which includes injuries, disorders, syndromes, 
infections and disabilities resulting from 
pathogens, deficiencies, abnormal physiology, 
and/or hereditary/genetic conditions (Hudson 
1993). Disease is known to disrupt 
internal/external stability, and leads to a state 
of non-homeostasis at one, or multiple sites, 
throughout the body (Hudson 1993). The term 
chronic refers either to being in a persistent 
state of disease, or to having a 
Fig. 4. Physical and mental stressors which may 
contribute to acquiring, maintaining, or increasing the 
severity of a disease (Carroll 2015, after U.S. 
Department of Veterans Affairs 2014). 
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disease(s)/symptom(s) which re-occur(s) repeatedly over the course of several months or 
years (Mullner and Mullner 2009). The National Center for Health Statistics (NCHS) defines 
any disease or symptom which lasts longer than three months to be a chronic condition 
(2008). The term acute refers to diseases or symptoms which last less than three months, 
which generally have more rapid onsets, and which may or may not be more severe (i.e. 
result in a higher mortality rate) than chronic conditions (Mullner and Mullner 2009). Illness 
is defined as the culturally subjective experience of suffering, constructed as a result of both 
personal and social customs, mores and ideologies (Sisti et al. 2013; Sussman 2004). It is 
how individuals and societies perceive, experience, cope and respond to disease conditions 
and those that host them (Sisti et al. 2013; Sussman 2004). In this way, disease is the physical 
embodiment of stress/unwellness, while illness is the social and/or emotional actualization of 
stress/unwellness.  Health refers to a state of complete physical, mental and social well-being, 
whereby all internal and external processes are functioning efficiently, and without distress 
(McWhinney 1987; WHO 1946). It is recognized that individuals are in a constant flux 
between states of health, illness and disease (fig. 5), and that it may not always be possible to 
differentiate between these gradients in certain individuals. As such, they are recognized as a 
spectrum, with individuals oscillating between gradients of physical and social wellness 
throughout their lifetime.  
Fig. 5. The human health spectrum (Carroll 2015). 
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           The term pathophysiology refers to any abnormal alteration (functional, 
chemical etc.) associated with, or resulting from, disease or stress (McPhee et al. 2007; 
Miller-Keane and O’Toole 2003). In other words, it is how the body physiologically responds 
to, or regulates, a particular disease/stressor. Comorbid(ity) indicates the presence of one or 
more conditions co-occurring with a primary disease (Valderas et al. 2009). Comorbid 
conditions may occur simultaneously but independently of each other, may or may not have 
the same risk factors, and may be chronic or acute in nature (Valderas et al. 2009) (fig. 6). 
Sequelae refers to pathological conditions which are a direct complication/consequence of a 
single disease (fig. 6). In other words, they are co-morbid conditions which are different to, 
but a consequence of, the primary/first condition (Yochum and Rowe 2005). 
 
 
 
 
 
 
 
 
       While this thesis focuses solely on sickle cell and thalassemia, it is acknowledged 
that other anemias (and blood disorders) are likely to have been present in the sample 
population, and that stable isotopes may be alternatively fractionated as a result of numerous 
pathological processes (including various metabolic, gastrointestinal and/or osteological 
conditions). As a consequence, it is recognized that more research into the pathophysiological 
mechanisms of stable isotope fractionation is required, and that in the interim, 
bioarchaeologists should recognize the potential for disease-related inter and intra-individual 
variation in isotopic values within skeletal matrices (Katzenberg and Lovell 1999; Olsen et 
al. 2014; White and Armelagos 1997). Additionally, while only stable oxygen, nitrogen and 
carbon isotopes are analyzed within this thesis, it is suggested that future researchers evaluate 
variations in stable iron isotopes if/when attempting to use stable isotopes as a diagnostic 
Fig. 6. Simplified schematic of the complex etiology of 
comorbid conditions and sequelae within the human body 
(Carroll 2015). 
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tool,  as it is possible that these ratios may be similarly affected by the pathophysiology of 
anemia (especially iron-deficiency anemia, or anemia induced hyperchromatosis).  
4. Biomedical Approaches to Archaeology: Sickle Cell and Thalassemia 
 
Over the years isotopic analyses have become an increasingly important and common 
aspect of archaeological analyses. The use of stable carbon, nitrogen and oxygen isotopes 
(among others) has been an invaluable tool for elucidating past subsistence strategies (e.g. 
Ambrose et al. 1997; Katzenberg et al. 1995; Lee-Thorp et al. 1989; Richards and Hedges 
1999), breast feeding/weaning practices (e.g. Dupras and Tocheri 2007; Fuller et al. 2006; 
Schurr 1998), and widespread migration/transhumance patterns (e.g. Dupras and Schwartz 
2001; Hodell et al. 2004; Price et al. 2000). Despite the many benefits afforded by the current 
state of isotopic analyses, however, limited archaeological research has been conducted on 
the ways in which chronic disease/disrupted metabolism may influence how tissues 
incorporate molecules and elements, like stable isotopes, into their overall structure. As such, 
the role of disease has often been overlooked as a mechanism for both intra and inter-
individual variation in isotopic values. This oversight is problematic since, if disease plays a 
significant role in the way stable isotopes are partitioned throughout the body (particularly in 
the skeletal tissues which form the crux of archaeological analyses), then it may be necessary 
to re-evaluate how isotopic data are interpreted. This may be especially relevant in cases 
where there are outlier or non-typical stable isotope values (which are generally assumed to 
be due to a procedural error or contamination issues), and in individuals and populations 
where severe and/or chronic diseases may be endemic. 
4.1. The Disease Model: 
 As previously stated, the purpose of this thesis is to evaluate the role chronic disease, 
and diseased mechanisms, may have in the partitioning of stable isotopes throughout the 
body. Given the nature of archaeological stable isotope analyses, which primarily investigates 
the isotopic values of skeletal tissues, it was deemed necessary to find a disease model that; 
(1) was chronic in nature; (2) induced a systemic response; (3) was (preferably) a congenital, 
life-long condition; (4) was present in multiple individuals from the same population; (5) left 
multiple individuals from the same population unaffected; and (6) occurred in a population 
with more or less analogous diets and migration histories. These factors are crucial, since, in 
order for the isotopic signature of bone collagen to be representative of a pathophysiological 
response, and not dietary or migratory differences between individuals and/or socio-
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economic classes (etc.), the disease process(es) must alter the ‘normal’ rate of fractionation 
over a significant enough time period (~seven years) (Larsen 1997; Schweissing and Grupe 
2003; White and Folkens 2005) (see Chapter 2), and induce enough of a fractionation effect, 
to not only be visible in bone collagen, but to produce significantly different isotopic values 
when compared to those without the disease. Similarly, in order to be visible within dental 
enamel, which is an inert tissue after mineralization (see Chapter 2), the disease process(es) 
must be present during sub-adulthood (<25 years old), since dental enamel reflects the 
isotopic values imbibed during its formation (Budd et al. 2000; Hillson 2005; Koch et al. 
1997). Perhaps most importantly, however, is the fact that the disease model must be present 
in a population with statistically analogous dietary and migratory histories, since both diet 
and migration are known to significantly alter the isotopic signature of dental enamel and 
bone collagen (DeNiro 1985; DeNiro and Epstein 1978; Schoeninger 1985; Schoeninger and 
DeNiro 1984; van der Merwe and Vogel 1978; Vogel and van de Merwe 1977). In other 
words, without comparable dietary/migration histories, any inter or intra-individual variation 
in isotopic values cannot be definitively linked to the pathophysiological fractionation of 
stable isotopes, since too many additional/exogenous fractionation factors are present.  
4.2. The Anemia Model: 
As mentioned, sickle cell and thalassemia are genetically inherited, congenital 
conditions which produce and proliferate diseased hemoglobin molecules, and RBCs 
incapable of functioning as efficiently or effectively as healthy RBCs (Epstein and Hsia 
1998; Matora et al. 1993; Weed et al. 1963) (see Chapter 3 and 4). As a result, both 
conditions induce multi-systemic, chronic complications associated with the ineffectual 
fixation and transport of oxygen (and other diatomic gases), and the resultant compensations 
and sequelae (Epstein and Hsia 1998; Matora et al. 1993; Weed et al. 1963) (see Chapter 3 
and 4). Therefore, if the pathophysiology of sickle cell and thalassemia affects the overall 
fractionation of stable oxygen, carbon and nitrogen isotopes, it should be visible within 
either/both bone collagen and enamel apatite.  
Sickle cell and thalassemia are widely regarded as an evolutionary response to 
malaria, and as such both conditions are endemic to certain populations and regions (Enevold 
et al. 2007; Luzzatto 2012). This is of crucial importance, since, as mentioned, it is necessary 
to have access to a disease model which is both prevalent and chronic enough to induce 
osteological and biochemical responses in multiple individuals, while leaving others 
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unaffected. Genetic models dictate that, in areas like the Mediterranean where the conditions 
are endemic, the population should exist on an “anemia gradient.” In other words certain 
individuals should be homozygotic for sickle cell and thalassemia (anemia), and should 
produce the types of severe, chronic physiological responses required to test the hypothesis, 
while others would be heterozygotic (diseased) or non-anemic, thereby providing  access to a 
subset of the population which could feasibly act as a control (i.e. individuals who are socio-
culturally similar enough that non-disease factors should not be significant enough to be the 
cause of the isotopic variation), or as a comparative model.  
While it is acknowledged that other diseases fit this model, and should similarly be 
tested in future research , this thesis will concentrate solely on sickle cell and thalassemia 
anemia at a single site in Spain, where malaria is endemic and where osteological features 
suggest both conditions were present (see Chapter 3; section 5). 
4.3. Sample Selection: 
In order to critically evaluate the affects of sickle cell and thalassemia on stable 
isotope fractionation, individuals from Écija, Spain (see Chapter 7) were examined 
macroscopically for indicators of sickle cell and thalassemia anemia (see Chapters 3 and 8). 
Osteological and/or dental samples from 45 individuals expressing various states of ‘health’ 
(Anemic, Possibly Anemic/Heterozygotic (Pos. A./H.), Diseased and Control) were taken for 
isotopic analyses, in order to determine whether isotopic values were significantly affected by 
cohort (‘health’) status. Bone collagen was used to examine ante-mortem ratios of stable 
carbon and nitrogen, while enamel apatite was used to examine sub-adult ratios of stable 
carbon and oxygen. All samples were obtained from individuals unearthed from an 8th-12th 
century Islamic cemetery, and are hypothesized to have had similar dietary practices and 
migratory life-histories, theoretically precluding socio-cultural factors from significantly 
affecting isotopic values between individuals (see Chapter 2, section 4.1) 
5. Research goals 
       The primary purpose of this research is to critically evaluate the role sickle cell and 
thalassemia have on the fractionation of stable oxygen, nitrogen and carbon isotopes in the 
organic (bone collagen) and inorganic (enamel apatite and bone carbonate) matrices of 
human skeletal tissues. Consequently, this research also seeks to determine whether stable 
isotope analyses is a valid tool for diagnosing (or assisting in diagnosing) sickle cell and/or 
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thalassemia in archaeological populations. The research questions are as follows: 
● Does functionally abnormal hemoglobin and/or the secondary effects (clotting, 
infection etc.) of sickle cell and/or thalassemia significantly affect how stable 
oxygen, carbon and nitrogen isotopes are incorporated into skeletal and dental 
tissues?  
● If the pathophysiology of sickle cell and thalassemia does affect the fractionation of 
stable oxygen, carbon and nitrogen isotopes, is it significant enough to differentiate 
sicklic and/or thalassemic individuals from healthy non-anemics?  
● If stable isotope values between individuals with sickle cell and/or thalassemia 
anemia are significantly different from those of the non-affected population, is it 
possible to differentiate between individuals who are homozygotic and those who are 
heterozygotic?  
● Is stable isotope analyses a viable method for diagnosing and/or differentiating sickle 
cell and thalassemia in the archaeological record? 
● If this proves to be a viable method for diagnosing genetic anemias in skeletal 
populations, is it necessary to re-evaluate current dietary, weaning, and migration 
studies in populations where sickle cell and thalassemia anemia are endemic. 
6. Chapter Outline 
6.1. Chapter 2: Introduction to Stable Oxygen, Carbon and Nitrogen Isotopes: 
This chapter provides a comprehensive overview of stable oxygen, carbon and 
nitrogen isotopes, and their application within archaeological sciences. Its primary purpose is 
to elucidate the basic principles and concepts associated with the isotopic analyses of human 
skeletal tissues, as well as to detail how shifts in isotopic fractionation can lead to significant 
inter and intra-individual variations in isotopic values. 
6.2. Chapter 3: Introduction to the Genetic and Pathophysiological Mechanisms of 
Sickle Cell and Thalassemia: 
This chapter provides a thorough introduction to, and overview of, the genetic and 
pathophysiological mechanisms of homo and heterozygotic sickle cell and thalassemia, with 
specific regards to how the skeletal system responds to sicklic and thalassemic disease 
processes. This chapter also discusses the likelihood of sickle cell and thalassemia existing 
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within the Écijan population, using osteological signatures, contemporary distribution of 
sicklic and thalassemic alleles, and the geographic distribution of malaria as indicators.  
6.3. Chapter 4: Physiological Mechanisms of Stable Isotope Diffusion, Fixation and 
Fractionation during Total Respiration:  
This chapter focuses on the physiological mechanisms of stable nitrogen, oxygen and 
carbon isotope diffusion, fixation and metabolization during the process of Total Respiration 
(TR); the multi-systemic, multi-fractionating process whereby oxygen is conveyed to cells 
and tissues, and cellular waste products are removed.  
6.4. Chapter 5: Literature Review: Metabolic Fractionation of Stable Oxygen and 
Carbon Molecules in Chronic Anemias: 
This chapter investigates the validity and constraints of using stable isotope analyses 
as a tool for identifying genetic anemias in human skeletal remains, by addressing whether 
previous biomedical studies have been successful in identifying chronic shifts in 
metabolism/physiology using inter and intra-individual variations in δ18O and δ13C values. Its 
primary purpose is to elucidate how alterations in the diffusion, fixation and/or 
metabolization of stable oxygen and blood carbon molecules during TR affects the isotopic 
values of tissues and tissue by-products. In doing so, this chapter seeks to provide 
archaeologists with a more comprehensive understanding of the complex nature of metabolic 
stable isotopic fractionation in humans, and provide the frameworks with which to approach 
seemingly anomalous isotopic values in individuals from the same communities (with or 
without obvious osteological lesions).   
6.5. Chapter 6: Pathophysiological Fractionation of Stable Isotopes Associated with 
Rates of Protein Turnover and Energy Expenditure:  
This chapter investigates the validity and constraints of using stable isotope analyses 
as a tool for identifying genetic anemias in human skeletal remains, by addressing whether 
previous biomedical studies have been successful in identifying chronic shifts in 
metabolism/physiology using inter and intra-individual variations in δ13C and δ15N values. Its 
primary purpose is to elucidate how states of hypermetabolism, and increases in bone and 
whole-body protein turnover alter isotopic fractionation, and consequently, the isotopic 
signature of associated tissues.  
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6.6. Chapter 7: The Socio-Religious History of Écija, Spain: Islam and Isotopes: 
      This chapter focuses on the historical and religious history of Écija, Spain, from 
which all skeletal samples analysed here were obtained, in order to garner a more 
comprehensive understanding of the socio-religious factors which may have influenced the 
isotopic values of the inhabitants bone collagen and dental enamel. 
6.7. Chapter 8: Methods and Materials: 
This chapter addresses the context and suitability of the samples used within this 
thesis, and outlines the methodological approaches applied. The first section details the 
criteria used for sampling, focusing specifically on the pathological traits used to classify 
individuals as ‘Anemics’ (sicklic and/or thalassemic), ‘Pos. A./H.’, ‘Diseased’ or ‘Control’. 
Methods for ageing and sexing the skeletal samples, as well as their overall state of 
preservation, are noted in section 2. The third and final section provides a detailed account of 
the analytical methods employed in order to prepare the samples for isotopic analyses.   
6.8. Chapter 9: Results: 
This chapter presents the results obtained throughout the course of this study, and 
discusses the quality control indicators used to ensure their validity. Inter-individual, intra-
individual and inter-group variations in the isotopic composition of bone collagen and enamel 
apatite are presented as a whole, and briefly discussed in terms of the various exogenous and 
internal factors which may have affected their ratios.  
6.9. Chapter 10: Discussion  
This chapter interprets and discusses the results showcased in the previous chapter, 
and addresses the research questions set forth within this chapter. Namely, it examines 
whether the bone collagen and/or enamel apatite results conclusively demonstrate non-
analogous rates of isotopic fractionation between those with sickle cell and/or thalassemia, 
and those without, and examines the validity of using stable isotope analyses as a diagnostic 
aid. It also presents a critical review of this research, and the protocols and procedures used 
here-within, while outlining future avenues of research. Finally, the information presented 
throughout this thesis is summarized, and concluding remarks presented.  
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6.10. Chapter 11: Summary and Conclusion:  
This chapter summarizes the information presented throughout this thesis and 
presents the final conclusions. Its primary purpose is to answer the five research questions set 
forth in Chapter 1, and to discuss them in terms of present and future archaeological 
frameworks. Final thoughts, directions and implications are also elucidated.  
  All supplementary information, including the list of figures, tables, and 
abbreviations, as well as the appendices, are located after the references cited section.  
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CHAPTER TWO: 
 
Introduction to Stable Oxygen, Carbon, and Nitrogen Isotopes 
 
 
This chapter provides a comprehensive overview of stable oxygen, carbon and 
nitrogen isotopes, and their application within archaeological sciences. Its primary purpose is 
to elucidate the basic principles and concepts associated with the isotopic analyses of human 
skeletal tissues, as well as to detail how shifts in isotopic fractionation can lead to significant 
inter and intra-individual variations in isotopic signatures. The first section provides an 
introduction to atomic theory, focusing specifically on the properties of stable oxygen, carbon 
and nitrogen isotopes. The following section details the science behind stable isotope 
fractionation, as well as tissue enrichment and depletion. The third section illustrates how the 
in-vivo assimilation of stable carbon, nitrogen and oxygen isotopes can be ascertained by 
analysing the osteological reservoir, and discusses how these tissues may be useful in 
diagnosing sickle cell and thalassemia anemia in the archaeological record. The information 
presented within this chapter is summarized, and conclusions presented, in the fourth and 
final section. 
 
1. Introduction to Atomic Theory: Radioactive and Stable Isotopes   
 
All matter as we know it is composed of various combinations of atoms. Structurally, 
all atoms contain a nucleus of positively charged protons and neutral neutrons, surrounded by 
a cloud of negatively changed electrons (fig. 7) (Tortora and Derrickson 2012). The number 
of protons within the nucleus determines an atom’s chemical element (e.g. O, C and N)14, 
with specific combinations of elements creating molecules (e.g. O2, N2, CO2)15 (Tortora and 
Derrickson 2012). While the number of protons in any given atom is static (i.e. does not 
change), the total number of neutrons within the nucleus may 
vary (Allegre 2008; Faure and Mensing 2004; Hoefs 2004). 
Atoms which have the same number of protons (i.e. are the 
same element), but a different number of neutrons are known as 
isotopes (Allegre 2008; Faure and Mensing 2004; Hoefs 2004; 
Zeebe and Wolf-Gladrow 2001).  
 
                                                          
14 Elemental oxygen, carbon and nitrogen 
15 Molecular oxygen, nitrogen and carbon dioxide 
Fig. 7. Structure of an atom 
(after Sharp 2006). 
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Certain elements (like gold), are monoisotopic, while others (like oxygen, carbon and 
nitrogen) are multi-isotopic (Zeebe and Wolf-Gladrow 2001). As such, oxygen isotopes will 
always have 8 protons, but they may have 8, 9, or 10 neutrons; carbon isotopes will always 
have 6 protons, but they may have 6, 7, or 8 neutrons and so forth (fig. 8). In order to 
differentiate between isotopes of the same element, they are labelled according to their 
atomic mass, which a representation of the total number of protons and neutrons within their 
nucleus (Zeebe and Wolf-Gladrow 2001). Therefore, oxygen isotopes will be labelled as 16O 
(8 protons + 8 neutrons), 17O (8 protons + 9 neutrons) or 18O (8 protons + 10 neutrons), 
carbon isotopes as 12C, 13C or 14C and nitrogen isotopes as 14N or 15N.   
 
 
 
 
 
 
 
 
 
 
 
 
Isotopes may be radioactive or stable, depending on the nature of their nucleus.  
Radioactive isotopes contain combinations of protons and neutrons that generate an unstable 
nuclear force, and excess internal energy (Dickin 2005; Tortora and Derrickson 2012). In an 
attempt to reach stability, the nucleus of radioactive isotopes will eject protons and neutrons, 
convert one to the other, and/or release additional energy in the form of radiation (Dickin 
2005; Tortora and Derrickson 2012). As a result, radioactive isotopes will decay over time, 
transforming from their original unstable atomic state (parent radioisotope) to another, more 
stable form (i.e. a daughter radioisotope) (Dickin 2005; Tortora and Derrickson 2012). Stable 
isotopes are, as their name dictates, isotopes which contain combinations of protons and 
neutrons which make their nucleus stable (Allegre 2008; Faure and Mensing 2004; Hoefs 
2004). As such, they do not undergo radioactive decay and their nucleus will remain the 
same, no matter how long the atom has existed (Allegre 2008; Faure and Mensing 2004; 
Hoefs 2004). In other words, 13C will always be 13C, and 18O will always be 18O. This is a 
crucial principal in stable isotope analyses, since, unlike radioactive isotopes, stable isotopes 
will not convert to, or create, daughter isotopes. As such, they will exist within whichever 
material they were assimilated into, in the same quantity, until they are removed/replaced via 
Fig. 8.  Representation of the atomic structure of stable carbon isotopes 
(Carroll 2015; original image after ScienceBlogs LLC 2014). 
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various physical, chemical and/or metabolic processes (Allegre 2008; Faure and Mensing 
2004; Hoefs 2004). Archaeologically, this allows ex-vivo tissues to act as direct proxies for 
in-vivo stable isotope values, since the ratio of stable isotopes trapped within osteological 
reservoirs (see section 3) will be analogous to those assimilated therein while alive.  
 
1.1. Chemical and Molecular Properties of Stable Isotopes: 
 
While stable isotopes of the same elements have different numbers of neutrons 
within their nucleus, for all intents and purposes they are “chemically interchangeable and the 
organic compounds of which they are constituents are ostensibly indistinguishable.” (Butz et 
al. 2014:1) In other words, heavier and lighter stable isotopes will have nearly identical 
chemical properties and atomic behaviors (i.e. bonding behavior, electromagnetic force, 
quantum mechanics etc.), since the properties of atoms and isotopes are dictated primarily by 
the number of electrons within their valence shells, not by the number of neutrons within 
their nucleus (Butz et al. 2014; Faure and Mensing 2004). This is an important factor, since, 
as mentioned previously, combinations of elements (or isotopes) will create molecules. Since 
heavier and lighter isotopes have the same bonding behavior, they will have the same 
capacity to bond to other elements in order to create molecules (Butz et al. 2014; Faure and 
Mensing 2004). As such, any molecule of oxygen (O2) can be in the form of 16O2 (i.e. made 
from two isotopes of 16O) 16O18O (i.e. made from one isotopes of 16O and one of 18O) or 18O2 
(i.e. made from two isotopes of 18O), and any molecule of nitrogen (N2) can be in the form of 
14N2, 14N15N, or 15N2 16. Similarly, any molecule of carbon dioxide can be in the form of 
12C16O2, 12C16O18O, 13C16O18O, 13C18O2 (etc.), depending on which stable isotopes have bonded 
to another. Since they have the same chemical properties, organic and inorganic materials 
(like human blood and bones) can incorporate molecules made of any given combination of 
stable isotopes interchangeably (Butz et al. 2014; Faure and Mensing 2004).  
1.2. Primary and Secondary Stable Isotopes:  
As previously elucidated, oxygen, carbon and nitrogen are all multi-isotopic. Despite 
the existence of multiple stable isotopes for the same element, however, certain combinations 
of protons and neutrons are more common than others (Zeebe and Wolf-Gladrow 2001). As a 
direct result, certain isotopes (of the same element) are naturally more abundant than others. 
                                                          
16 Formed from two isotopes of 14N, one isotope of 14N and one of 15N, or two isotopes of 15N, respectively  
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For example, while oxygen has three naturally occurring stable isotopes (16O, 17O, 18O), 
99.8% of all oxygen atoms in the earth’s atmosphere are in form of 16O, making it the 
primary stable oxygen isotope. Other oxygen isotopes (e.g. 17O and 18O) are considered 
secondary isotopes, with 18O representing 0.2% of all stable oxygen isotopes in earth’s 
atmosphere, and 17O representing 0.0037% (Zeebe and Wolf-Gladrow 2001). Similar 
abundance disparities are also found between the stable carbon and nitrogen isotopes, with 
approximately 99% of all stable carbon isotopes in the universe nucleosynthesising as 12C 
(Zeebe and Wolf-Gladrow 2001), and 99.6% of all stable nitrogen isotopes forming as 14N 
(Hranicky 2013). As such, molecules made exclusively out of primary stable isotopes (i.e. 
12C32O and 32O2) will be naturally more abundant than those made exclusively of secondary 
ones (i.e. 13C36O2 and 36O2).  
On earth, the proportion of heavier, secondary stable isotopes (and molecules) to 
lighter, primary stable isotopes (and molecules) is affected by a number of physical and 
chemical processes, including (but certainly not limited to) distance from the sea, altitude, 
underlying geology, trophic level, diet and basal metabolic rate (DeNiro and Epstein 1978; 
Faure and Mensing 2004; Hoefs 2004; Katzenberg 2008; Sharp 2006; van der Merwe 1982). 
Therefore, while primary stable isotopes will always be more naturally abundant than their 
secondary isotopes, the ratio between secondary and primary isotopes will differ as a result 
of any and/or all of the aforementioned factors. 
2. Stable Isotopic Fractionation   
 
Stable isotope fractionation refers to the chemical, physical and metabolic 
phenomena which affect the relative abundance of heavier to lighter stable isotopes (of the 
same element) in the atmosphere, and in any given material/tissue (Butz et al. 2014; Faure 
and Mensing 2004; Hoefs 2004; Sharp 2006). As mentioned previously, stable isotopes of the 
same element have different atomic masses as a consequence of having more or less neutrons 
in their nucleus; for example, while 13C has only one additional neutron, it is 8% heavier than 
12C (Butz et al. 2014). This weight difference is enough to affect the rate at which stable 
isotopes or molecules participate in chemical or metabolic reactions, since molecules 
composed exclusively of heavier stable isotopes (i.e. 13C36O2 and 36O2) require more energy to 
breakdown17 than those made exclusively of lighter stable isotopes (i.e. 12C32O and 32O2) 
                                                          
17 The nucleus of stable isotopes are held together by nuclear forces. Stable isotopes with more neutrons (i.e. heavier isotopes) will generate more 
nuclear forces than those with fewer neutrons (i.e. lighter isotopes)  
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(Butz 2014; Faure and Mensing 2004; Heller et al. 1994; Hoefs 2004; Sharp 2006; van Dam 
et al. 2004). Similarly, smaller (lighter) isotopes and molecules are diffused more rapidly 
than larger (heavier) isotopes and molecules, and as such they are preferentially utilized 
during most chemical and metabolic reactions (Butz et al. 2014; Heller et al. 1994; van Dam 
et al. 2004). This is perfectly exemplified by Graham’s law18, which states that the rate of 
diffusion and metabolization for 16O is ~3% and ~1.3% (respectively) greater than the rate of 
diffusion and metabolization of the heavier 18O isotope (Heller et al. 1994; Klots and Benson 
1963).  
The preferential diffusion and metabolization of lighter stable isotopes and molecules 
causes the isotopic ratios on one side of a chemical or metabolic reaction to be different from 
that on the other side, even at equilibrium (Butz et al. 2014; Epstein and Zeiri 1988; Feldman 
et al. 1959; Heller et al. 1994; Heller et al. 1996; Lane and Dole 1956; Pflug and Schuster 
1989; Schuster et al. 1994; Zanconato et al. 1992). As a result, certain tissues will be 
depleted in heavier isotopes (enriched with lighter isotopes), while others will be enriched 
with them.  
An example to illustrate the basic mechanics of isotopic fractionation is the transfer 
of mice from one bin to another (fig. 9). Let us suppose that the hairless mice represent 
heavier stable isotopes, while the brown 
mice represent lighter stable isotopes. 
Although both mice exist within the bin, 
the hairless mice are slightly larger than 
the brown mice—corresponding to the 
mass difference between heavier and 
lighter stable isotopes. Now, the mice are 
transferred into a second bind, which was 
initially empty. This empty bin represents 
the other side of a chemical reaction, 
which cannot be completed without the 
appropriate reagents (in this case, 
molecules made of stable isotopes). Since 
the hairless mice are slightly heavier, they 
                                                          
18 The rate of effusion of a gas is inversely proportional to the square root of the mass of its particles 
Fig. 9. An example of fractionation and tissue depletion and 
enrichment; the transfer of mice from one bin to another 
(Carroll 2015; Images after dreamstime.com/stock-photo-
hairlessmouse 2015; dreasmstime.com/stock-photo-
brownmourse 2015). 
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are harder to lift and transfer over. This results in more hairless mice remaining in the 
original bin, and more brown mice being placed in the second bin. This corresponds to the 
probability of lighter stable isotopes (and molecules) being preferentially utilized during 
chemical reactions, since the activation energy needed to metabolize heavier isotopes is 
greater than that required of lighter isotopes.  After a certain time, enough mice have been 
transferred over to fill the second bin. In other words, enough reagents have been provided to 
allow the chemical reaction to take place. Since the second bin is full, no more mice will be 
transferred over. When looking at the bins, we can tell that both of them have less mice than 
what was originally in the first bin.  They have been fractionated as a result of their transfer. 
Upon closer inspection, we see that the first bin has many more hairless mice than the second 
bin, making the weight of the first bin heavier than that of the second bin. This corresponds to 
the enrichment of heavier isotopes (and the depletion of lighter isotopes) in one tissue, and 
the depletion of heavier isotopes (and the enrichment of lighter isotopes) in another. 
Therefore, we can say that the first bin has a heavier isotopic signature than the second bin, 
which has a lighter isotopic signature.  
 
             2.1. Isotopic Fractionation and the Archaeological Record:  
 
In the aforementioned example, the first and second bins represented the starting and 
end-points of a chemical reaction (respectively), as well as two separate tissues. In the end, 
one tissue was depleted in heavier stable isotopes while the other was enriched in it. This 
same ‘mice in a bin’ concept can be applied to virtually all chemical processes, both within 
the human body and outside of it. This is one of the main principles appropriated by 
archaeological stable isotope analyses. Simply put, stable oxygen, carbon and nitrogen 
isotopes are fractionated during processes like photosynthesis, digestion, evaporation, 
condensation etc. (DeNiro and Epstein 1978; Faure and Mensing 2004; Hoefs 2004; 
Katzenberg 2008; Sharp 2006; van der Merwe 1982). These processes fractionate stable 
isotopes differently, leaving distinct isotopic signatures; for example, plants with C3  
photosynthetic (e.g. wheat, rice, barley) pathways will incorporate less 13C isotopes into their 
tissues than those with C4 photosynthetic pathways (e.g. Maize, sugar cane) causing 
individuals who eat exclusively/primarily C3 diets to have a lighter isotopic signature than 
those eating mostly C4 diets (Fig. 10) (Faure and Mensing 2004; Hoefs 2004; Katzenberg 
2008; Pollard 1993; Schoeninger et al. 1983; Sharp 2006). The same fractionation effect is 
seen between marine and terrestrial diets, weaned and un-weaned children, and between eco-
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regions and climes (fig. 11) (Ehleringer and Rundell 1988; Pollard 1993; Saurer et al. 1997; 
Schulting 1998; Schoeninger et al. 1983; Vogel 1993).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Examples of the isotopic 
values of populations eating 
various diets (after Pollard 1993; 
Schoeninger et al. 1983).  
 
Fig. 11. Simplified summary of stable carbon, nitrogen and oxygen fractionation in marine and terrestrial ecosystems 
(Carroll 2015; after Ehleringer and Rundell 1988; Saurer et al. 1997; Schulting 1998; Vogel 1993). 
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2.2 The Isotopic Composition of Tissues: Understanding Delta (δ) Values  
The isotopic composition of any material must be compared to an accepted standard, 
and expressed in terms of delta values (δ) per mil (‰) (i.e.- the difference between the 
sample and the standard, minus one), using  
 
δX= [(Rsample/Rstandard) – 1] x 103 
where δ represents the isotopic (oxygen, carbon, nitrogen etc.) composition of the substance 
relative to the standard, and R represents the ratio of heavier to lighter stable isotopes (i.e. 
18O/16O) within the sample (Zeebe and Wolf-Gladrow 2001). More positive δ values 
correspond to an isotopically heavy sample (compared to the standard), while more negative 
δ values correspond to an isotopically light sample (compared to the standard) (Zeebe and 
Wolf-Gladrow 2001).  
       2.3. Standards: 
      As mentioned, δ values represent the isotopic composition of a sample compared to 
an accepted standard. While standards are chosen arbitrarily, their isotopic composition is 
well known and it becomes the basis of comparison for all other samples (Zeebe and Wolf-
Gladrow 2001). Standards can be ‘in house’, meaning they are specific to a certain lab or 
study, or ‘universal’. Universal standards provide a way to compare the isotopic signature of 
any sample to any other sample using the same standard (Zeebe and Wolf-Gladrow 2001). 
For instance, all stable oxygen isotope ratios (for inter-lab comparison) are measured relative 
to either Vienna Standard Mean Ocean Water (VSMOW), or Vienna Pee Dee Belemnite 
(VPDB) standards, while all stable nitrogen isotope ratios are measured relative to the 
International nitrogen standard, AIR (Zeebe and Wolf-Gladrow 2001). 
3.  Stable Isotope Assimilation into Biological Tissues: The Osteological Reservoir  
Stable isotopes and molecules are incorporated into the organic and inorganic 
matrices of biological organisms through various physical, chemical and metabolic processes. 
In humans, most stable carbon, nitrogen and oxygen isotopes are ingested, either through the 
consumption of water and foodstuffs (DeNiro 1985; DeNiro and Epstein 1978; Schoeninger 
1985; Schoeninger and DeNiro 1984; van der Merwe and Vogel 1978; Vogel and van de 
Merwe 1977), or through the inspiration of atmospheric air (Epstein and Zeiri 1988; Keeling 
1995; Luijendijk et al. 2006; Panteleeve et al. 1999; Pflug and Schuster 1989; van Dam et al. 
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2004). Once inside the body, stable isotopes may become imbibed within the organic (i.e. 
bone collagen, hair, skin etc.) or inorganic (hydroxyapatite) matrices of human skeletal 
tissues, as well as within tissue by-products (i.e. urine, breast milk, sweat, expired air etc.) 
(DeNiro 1985; DeNiro and Epstein 1978; Epstein and Zeiri 1988; Luijendijk et al. 2006; 
Panteleeve et al. 1999; Pflug and Schuster 1989). Tissues and tissue by-products which 
replace/excrete molecules and cells at a relatively rapid pace (e.g. hair, skin, expired air, 
urine) will be representative of more recent isotopic signatures, while tissues which have a 
slower or static turnover rate (e.g. bone collagen/hydroxyapatite, dental enamel) will be 
representative of the average accumulation of stable isotopes over several years, or (in the 
case of dental enamel) the average isotopic signature imbibed prior to mineralization. 
Skeletal tissues, therefore, act as a natural reservoir for stable isotopes, and can therefore be 
used to assess in-vivo isotopic values post-humously.    
 
3,1. The Osteological Reservoirs: Hydroxyapatite and Bone Collagen:  
            Bones and teeth are composed of various inorganic and organic materials, including      
(but not limited to) hydroxyapatite and collagen. Hydroxyapatite (Ca10(PO4)6(OH)2), a type  
of bioapatite (Ca5(PO4)3(OH))19, is a naturally occurring calcium phosphate, and the primary 
mineral component of human bones and teeth (Burton 2008). Collagen is an organic 
structural protein, which intertwines to form elastic-like, flexible, fibers. Dental enamel, 
located at the surface of the dental crown, is composed of ~97-99% hydroxyapatite and has 
no collagenous proteins (Burton 2008; White and Folkens 2005). Bone, however, is 
composed of ~65-70% hydroxyapatite (inorganic component), and has a relatively high 
organic (~90%) collagen component (Norman and Litwack 1987; White and Folkens 2005; 
Zimmerli 2015). 
           The structural and molecular differences between bones and teeth give them different 
properties; one of the major differences being the rate of tissue remodelling and turnover. 
Given the nature and composition of bones, cells must be cyclically remodelled in order to 
support growth, general maintenance, and repair (Larsen 1997; White and Folkens 2005). As 
such, over time, collagen fibers are resorbed and replaced. The rate at which this occurs 
varies between osteological tissues (i.e. cancellous vs. cortical bone; ribs vs. crania etc.), as 
well as between life-stages (i.e. childhood vs. adulthood vs. late adulthood) (Hedges et al. 
2007; Schweissing and Grupe 2003; White and Folkens 2005). Generally speaking however, 
                                                          
19 Formula written in this fashion t denote the fact that the crystal component comprises of two entities, as opposed to one.   
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bone remodelling occurs more rapidly in cancellous bone, with collagen being replaced (in 
adult tissues) approximately every seven years (Larsen 1997; Price 1989; White and Folkens 
2005). Cortical bone, which is denser, has a longer turnover rate, taking between seven years 
and several decades20 (age and element dependant) before its cells are completely replaced by 
new ones (Hedges et al. 2007; Larsen 1997; Price 1989; White and Folkens 2005). 
Throughout this time, stable carbon, nitrogen and oxygen isotopes and molecules are 
delivered to tissues via the bloodstream, ‘feeding’ the cells the molecules they need to 
survive (Tortora and Derrickson 2012). In this way, bone collagen and hydroxyapatite 
interact with the metabolic and vascular systems, imbibing the stable isotopes that are 
delivered to them and acting as a natural reservoir (Tortora and Derrickson 2012; White and 
Folkens 2005). In terms of archaeological stable isotope analyses, this means that bone 
collagen is representative of the average accumulation of stable isotopes (a process dictated 
by isotopic fractionation) over the course of several years, making the isotopic value of bones 
representative of ante-mortem values (i.e. within the last few years of life).  
                 Unlike bone, enamel does not undergo regenerative remodeling after maturation 
(Budd et al. 2000; Hillson 2005; Koch et al. 1997). As such, once the enamel is fully 
mineralized, it will preserve (and therefore represent) the isotopic signature assimilated 
during its formation and development (Budd et al. 2000; Koch et al. 1997; Montgomery et al. 
2000). This is a benefit for archaeologists on numerous fronts; firstly, since dental enamel has 
a high hydroxyapatite component, it is highly resistant to both diagenetic alteration and 
contamination, and it is generally well preserved in the archaeological record (Budd et al. 
2000; Kohn et al. 1999; Lee-Thorp 2002; Montgomery et al. 2000). Dental enamel, therefore, 
is relatively common within skeletal assemblages and can reliably be used as a proxy for in-
vivo stable isotope signatures, since the risk of post-mortem chemical alterations (which may 
contaminate the original isotopic signature) is low (Budd et al. 2000; Kohn et al. 1999; Lee-
Thorp 2002; Montgomery et al. 2000).  
                                                          
20 Healthy adult collagen is replaced at a rate of ~1.5 to 4% per year, while healthy child/adolescent collagen is replaced more rapidly, averaging 
between ~10 to 30% per year (Hedges et al. 2007).   
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                  Secondly, the age at which dentition forms, erupts and matures is well known for 
both primary (deciduous) and secondary (permanent) dentition (Hillson 2005; Reid and Dean 
2006). Since enamel apatite assimilates stable isotopes 
from the time of its formation to the time of its 
maturation, specific teeth will provide the isotopic 
signature(s) for specific age ranges (fig 12). For instance, 
first permanent incisor crowns begin to develop around 
1.1 years, and finish mineralizing between 4.2 and five 
years (Reid and Dean 2006) (fig. 12). Therefore, its 
isotopic signature will only be representative of the 
isotopic signature assimilated during that time. If 
sampled incrementally, matching the rate at which 
enamel is formed and mineralized, the isotopic 
signature for more precise age ranges can be achieved 
(fig. 12). As such, dental enamel provides archaeologists with a way to investigate the 
isotopic values imbibed during sub-adulthood, even if that individual died as an adult. 
Similarly, since every tooth-type mineralizes at different times (Hillson 2005; Reid and Dean 
2006), the isotopic signature of an individual can be garnered over a wide age range, enabling 
archeologists to elucidate intra and inter-individual changes in stable isotope assimilation and 
fractionation.  
3.2. Stable Isotope Analyses and Anemia:  
          As mentioned in sections 1.3 and 2, the isotopic values of individuals vary as a result 
of numerous fractionation factors, including basal metabolic rate and tissue turnover. Other 
factors, such as the diffusion, fixation and metabolization of stable isotopic oxygen, carbon 
dioxide and bicarbonates (see chapter 4), as well as the catabolization of tissues (see chapter 
6), will also affect the relative abundance of stable isotopes in and between tissues (Barstow 
et al. 1989; Butz 2014; Epstein and Zeiri 1988; Heller et al. 1994; Kohn 1996; Pflug and 
Schuster 1989; Schoeller et al. 1984; Widory 2004; Wolfe 1984; Zonconato et al. 1992). The 
premise of this thesis is that the pathophysiology of sickle cell and thalassemia will alter the 
rate at which these processes occur, causing a distinctive fractionation effect between 
anemics and non-anemics. As mentioned in Chapter 1, it is hypothesized that significant 
differences between individuals (with analogous dietary and migratory backgrounds) will be 
reflective of chronic differences in physiology and metabolism, such as those brought on by 
Fig. 12. Mean estimates for chronological 
ages of enamel formation in anterior teeth 
for each decile of crown length rounded up 
or down to 0.1 years. Both cuspal enamel 
formation times and initiation times are 
included in these estimates (Reid and 
Dean 2007, 343). 
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sickle cell and thalassemia anemia. Chapters 4 through 6 discusses these principles and 
hypotheses in more detail.  
4. Summary and Conclusions  
The purpose of this chapter was to elucidate the basic concepts and principles behind 
stable isotope analyses in order to provide a more comprehensive understanding of how and 
why isotopic values may vary within and between individuals. The first part of this chapter 
provided an overview of atomic theory, concentrating specifically on the properties of stable 
isotopes and molecules. The second portion introduced the concept of isotopic fractionation; 
the chemical, physical and metabolic phenomena which affect the relative abundance of 
heavier to lighter stable isotopes in the atmosphere, and in any given material or tissue (Butz 
et al. 2014). It was highlighted that lighter stable isotopes (i.e. those with fewer neutrons) are 
generally preferentially utilized during chemical reactions, owing to the comparative ease 
with which lighter isotopes are diffused and catabolized (Butz et al. 2014; Epstein and Zeiri 
1988; Faure and Mensing 2004; Heller et al. 1994; Hoefs 2004; Sharp 2006; van Dam et al. 
2004). This preferential utilization of lighter isotopes causes the aforementioned fractionation 
effect, leaving certain tissues depleted, and others enriched, with heavier isotopes. This 
depletion and enrichment of tissues creates a distinct isotopic signature, which is measured 
relative to a standard and expressed in terms of delta values (δ) in percent per mil (‰) (Zeebe 
and Gladrow 2001). The third section reviewed how stable isotopes are assimilated into 
human systems, and how isotopic values can be assessed by analysing dental enamel and 
bone collagen. Since both tissues have a long, or inert, turnover rate, they act as stable 
isotope reservoirs (Hillson 2005; Larsen 1997; Schweissing and Grupe 2003; White and 
Folkens 2005). These reservoirs represent the average accumulation of stable isotopes over 
the first, or last, several years of life, depending on which tissue is sampled and analysed 
(Hillson 2005; Larsen 1997; White and Folkens 2005; Schweissing and Grupe 2003). Finally, 
it was hypothesized that bone collagen and dental enamel can be used to assess chronic 
alterations in metabolism and physiology, such as those brought on by sickle cell and 
thalassemia anemia, given the nature of isotopic fractionation and tissue turnover.  
             4.1 Notes: 
This thesis concerns itself only with the pathophysiological fractionation of stable 
isotopes as a result of sickle cell and thalassemia, however, it is acknowledged that isotopic 
fractionation is a complex, multifarious chemical process which is affected by numerous 
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factors. As mentioned previously (see section 1.2), the relative abundance of stable isotopes 
is affected by environmental conditions, as well as by dietary metabolism. These are the 
fundamental principles of archaeological stable isotope analyses, and one that cannot be 
ignored. In short, because stable isotope ratios are affected by the types of foods (i.e. marine 
vs. terrestrial; CAM vs. C4 vs. C3 plants etc.), breastfeeding  (which is related to differences 
in δ18O, δ13C and δ15N values in breastmilk compared to those in other foods and drinking 
water), and water sources (ground water vs. surface water etc.) consumed, as well as by 
location (altitude, levels of precipitation, distance from the sea etc.), individuals who are from 
different biomes or eco-regions, and/or who are eating non-analogous diets will have 
significantly different stable isotope signatures. As such, in order to evaluate the fractionation 
of stable isotopes as a result of abnormal physiology and/or metabolism, all individuals must 
be from the same area, and must also be consuming the same types of foods. If these controls 
are not set in place, it is impossible to determine if differences in and between individuals are 
the result of dietary, migratory and/or physiological factors, unless obviously pathological 
bone is compared to non-pathological bone in and between individuals. This research 
attempts to circumvent these issues by comparing the isotopic values of suspected anemic 
and non-anemics from a (hypothetically) socio-culturally homogenous group, with strict 
dietary customs (see Chapter 7). The validity of such a practice is explored in Chapter 10 (see 
pages 175-191). 
 Please see the following literature on more information on isotopic fractionation 
related to diet, breastfeeding and weaning practices, and migration:  
DeNiro 1985; DeNiro and Epstein 1978; Ehleringer and Rundell 1988; Katzenberg 
2000; Fogel et al., 1989; Fuller et al. 2006; Millard 2000; Pollard 1993; Saurer et al. 1997; 
Schoeller et al. 1986; Schoeninger 1985; Schoeninger et al. 1983; Schoeninger and DeNiro 
1984; ; Schulting 1998; Tsutaya and Yoneda 2015; van der Merwe and Vogel 1978; Vogel 
1993; Vogel and van de Merwe 1977 
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CHAPTER THREE:  
 
Introduction to the Genetic and Pathophysiological Mechanisms of 
Sickle Cell and Thalassemia 
 
 This chapter provides a thorough introduction to, and overview of, the genetic and 
pathophysiological mechanisms of homo and heterozygotic sickle cell and thalassemia, with 
specific regards to how the skeletal system responds to sicklic and thalassemic disease 
processes. The first section describes the functional and phenotypic characteristics of healthy 
(fetal and adult) hemoglobin polypeptide chains, concentrating primarily on their role as 
inherited oxygen transport molecules. The information elucidated within section one is 
expanded upon in sections two and three, both of which discuss the mutations responsible for 
the various expressions of thalassemia and sickle cell (respectively), and describes their 
resultant pathophysiologies. Section four describes some of the genetic factors which are 
known to moderate the expression (severity, chronicity, pathophysiology) of sicklic and 
thalassemic mutations, and discusses these factors in terms of the perimeters set forth in this 
thesis. Section five discusses the probability that sickle cell and/or thalassemia existed in 
Écija during the 8th-12th centuries, the period from which the individuals sampled for this 
thesis originated. Information is summarized, and concluding remarks provided, in the sixth 
and final section.   
1. Hemoglobin 
Sickle cell and thalassemia are genetically inherited hemolytic blood disorders 
characterized by phenotypical and functional abnormalities in RBC hemoglobin. 
Hemoglobin, the tetrameric globular-metalloprotein found within all mammalian RBCs, is 
primarily responsible for the fixation, transport and release 
of oxygen (and other gases) during the process of Total 
Respiration (TR) (Clarke and Higgins 2000; Sarnaik 2005). 
Essentially, each healthy mammalian hemoglobin molecule 
is composed of specific combinations of amino acids 
arranged into four polypeptide chains, each of which 
contains a ferrous iron (Fe2+) heme group (metalloprotein) 
which acts as the fixation site for oxygen and other 
diatomic gases (Clarke and Higgins 2000; Sarnaik 2005) 
Fig. 13: The quaternary structure of 
healthy adult hemoglobin (HbA) 
(Carroll 2015; image after 
proteopedia.org 2015). 
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(fig 13).  Genetic mutations and/or internal mechanisms that alter one or more of the 
polypeptide chains, induces the transformation of the Fe2+ metalloprotein to a non-oxygen 
fixating heme group (see Chapter 4), or pathologically accelerates RBC lysis will result in 
hemoglobin which is ineffectually synthesized, or which has an inhibited or disabled ability 
to fixate, transport and/or release oxygen (Clarke and Higgins 2000; Sarnaik 2005). This, in 
turn, alters the overall capabilities of affected RBCs, hindering tissue oxygenation and waste 
detoxification (Clarke and Higgins 2000; Sarnaik 2005). This, in turn, affects the rate at 
which stable isotopes are brought into, and removed from, the system (see Chapter 4).  
1.1. Globin Chains:  
Approximately 97% of all healthy adult hemoglobin (HbA) is composed of two alpha 
(α) and two beta (β) polypeptide chains (Chui and Waye 1998; Clarke and Higgins 2000; 
Sarnaik 2005) (fig. 13). The structure and properties of the chains, and their Fe2+ heme 
groups, allows HbA to efficiently transition between states of oxygenation (R-state) and 
deoxygenation (T-state), enabling the effective fixation and release of oxygen when and 
where required (Marden et al. 1988; Sarnaik 2005). The amino acid composition of each 
chain, and therefore their structural and functional properties, is dictated by a set of 
transcription genes which are genetically inherited from each parent (Cao et al. 2000; Origa 
et al. 2005; Sarnaik 2005). All α-chains are encoded by the HBA1 and HBA2 genes located 
chromosome 16, while all β and β-like chains (e.g. gamma (ɣ) and delta chains (δ)) are 
controlled by the HBB complex located on chromosome 11 (Cao et al. 2000; Origa et al. 
2005; Sarnaik 2005). All diploid cells have four α and two β alleles which control the amino 
acid sequence of their respective globin chains (Cao et al. 2000; Origa et al. 2005; Sarnaik 
2005). In this way, each individual inherits two copies of the α-gene, and one copy of the β-
gene from each parent (Cao et al. 2000; Origa et al. 2005; Sarnaik 2005).  
1.2. HbF and HbA2 Hemoglobin: ɣ and δ Polypeptides:  
Approximately ten to 12 weeks after embryogenesis, fetuses begin to produce 
hemoglobin composed of α and ɣ dimers (two polypeptide chains), which react with one 
another to form the α-ɣ tetramer known as Fetal Hemoglobin (HbF) (Chui and Wayne 1998; 
Thein et al. 2009). While similar in many ways to HbA, the amino acid sequence of the ɣ-
chains increases HbF’s affinity for oxygen, allowing for increased oxygen saturation in low 
oxygen-tension environments (e.g. the placenta/chorion) (Chui and Wayne 1998; Thein et al. 
2009). In this way, fetuses are able to effectively obtain oxygen despite the presence of 
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maternal HbA in the chorion because oxygen preferentially binds to deoxygenated HbF over 
deoxygenated HbA. In other words, HbF effectively ensures adequate oxygenation to tissues, 
even when oxygen levels are non-optimal. 
From the third trimester (27 weeks in-utero) on, levels of HbF steadily decline until ~ 
six to 12 months postpartum, when ~99% of all ɣ-chains are replaced by β-chains (Oliverier 
and Weatherall 1998; Sarnaik 2005; Thein et al. 2009). In certain circumstances (Charache 
1990; Conley et al. 1963; Edoh et al. 2006; Powers et al. 1984), however, HbF production 
persists inside specialized RBCs well into child and/or adulthood (Galanello and Origa 2010; 
Ngo et al. 2011; Steinberg et al. 2001). When this occurs, HbF-persistent RBCs retain their 
embryonic propensity for increased oxygen fixation, thereby increasing the overall oxygen 
saturation capacity of affected RBCs, even in states of low oxygen availability or when 
coupled with inhibited non-ɣ polypeptides (Charache 1990; Conley et al. 1963; Edoh et al. 
2006; Galanello and Origa 2010; Ngo et al. 2011; Powers et al. 1984; Steinberg et al. 2001).  
 In addition to HbA and HbF, a small fraction (~2-3%) of hemoglobin is composed of 
α-δ chains (HbA2) (Drakoulakou et al. 1997; Moi et al. 1992). As with other forms of 
hemoglobin, the amino acid composition, and therefore the structural and functional 
properties of HbA2 is dictated by a set of genes inherited from each parent (Drakoulakou et 
al. 1997; Moi et al. 1992). Given that the amino acid composition of hemoglobin’s 
polypeptide chains are essential to its structure and function, inherited alterations in even one 
nucleotide or transcription gene is capable of modifying the behavior of the entire molecule, 
and the RBCs within which they are housed. While many transcription anomalies, 
substitutions and/or deletions are benign, several produce adverse hemoglobinopathic 
disorders, such as sickle cell and thalassemia (Sarnaik 2005).  
2. Thalassemia  
Thalassemia is an overarching class of genetic, microcytic, hypochromic, hemolytic21 
RBC disorders primarily caused by deactivations/deletions in the HBB, HBA1 and/or HBA2 
complexes (Cao et al. 2000; Galanello and Origa 2010; Origa et al. 2005; Sarnaik 2005). 
This inhibits and/or arrests the synthesis of one or all of the α and/or β-globin chains, 
depending on the mutation. Since each diploid cell contains four copies of the α-complex and 
two copies of the β-complex, the expression/severity of α and/or β-thalassemias are directly 
                                                          
21 Characterized by the production of small, iron-deficient RBCs which are prone to premature membrane destruction and cellular death 
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related to how many copies of the transcription genes have been deleted/deactivated, a factor 
which is determined though patterns of autosomal recessive inheritance (Cao et al. 2000; 
Galanello and Origa 2010; Origa et al. 2005; Sarnaik 2005) (fig. 14). Given that α and β 
transcription complexes are on separate chromosomes, individuals may co-inherit any 
manifestation of either condition, depending on the nature of their parent’s genetics (Sarnaik 
2005).  
2.1. Alpha (α)-Thalassemias:  
While several forms of α-thalassemia exist (some caused by non-HBA1 and/or HBA2 
mutations) (Steinberg et al. 2009), only four will be discussed within the context of this 
thesis. The most severe form of α-thalassemia, hydrops fetalis (aka α-thalassemia major; Hb 
Bart syndrome), is characterized by the deletion/deactivation of all four α-genes (Chui and 
Waye 1998; Clarke and Higgins 2000; Origa et al. 2005) (fig. 15). As such, affected fetuses 
are incapable of producing efficiently functioning α-globin polypeptides (Chui and Waye 
1998; Clarke and Higgins 2000; Origa et al. 2005). In these circumstances (i.e. the complete 
absence/deactivation of all α-globin), HbF is transformed into Bart’s hemoglobin (Hb Bart), a 
ɣ-tetramer (fig. 15). As mentioned, in their HbF form, ɣ-chains encourage the fixation of 
oxygen in-utero by increasing HbF’s affinity for oxygen. When ɣ-chains are in tetramer 
form, however, oxygen is ineffectively disassociated (released) as a result of its high affinity 
towards the ɣ-chains (Agosti and Duke 2008; Orkin et al. 2015; Provan 2010). As such, 
Fig. 14. Pattern of inheritance for α-thalassemia, if one parent is a silent carrier and the other has the thalassemia trait 
(Carroll 2015; Images after medicaldictionary.com 2015). 
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while oxygen is rapidly fixated to Hb Bart hemoglobin, fetal tissues are less effectively 
oxygenated since the molecule ‘struggles’ to transition between states of oxygenation and 
deoxygenation (Agosti and Duke 2008; Orkin et al. 2015; Provan 2010) (fig 15). This 
induces fetal hypoxia and hypoxemia, and is largely incompatible with fetal or neonate life 
(Chui and Waye 1998; Clarke and Higgins 2000; Origa et al. 2005). In terms of this thesis, it 
is unlikely that any of the individuals selected for analyses expressed this mutation, since no 
fetal/neonate remains were sampled (see Chapter 8).  
The second form of α-thalassemia anemia is HbH disease, which results when three 
of the four α-globin genes are deleted/inactivated (Chui and Waye 1998; Clarke and Higgins 
2000; Origa et al. 2005; Sarnaik 2005) (fig. 15). As a result of the inactivation of the α-genes, 
and therefore, the underproduction of α-polypeptides, unstable HbH tetramers (formed from 
four ɣ or β-polypeptides) are congenitally, chronically synthesized (Agosti and Duke 2008; 
Orkin et al. 2015; Provan 2010; Steinberg 2009) (fig. 15). As mentioned, these tetramers 
have anomalous oxygen dissociation curves caused by the molecules’ propensity to fixate, 
but not release, oxygen (Agosti and Duke 2008; Orkin et al. 2015; Provan 2010). This causes 
RBCs to maintain their state of oxygenation, while inhibiting their ability to effectively 
release oxygen to surrounding tissues (Agosti and Duke 2008; Orkin et al. 2015; Provan 
2010). This leads to (among other complications) systemic hypoxemia and tissue 
hypoxia/anoxia similar to, but not as severe as, hydrops fetalis.  
In addition to their inability to effectively release oxygen, unstable α-thalassemic 
Fig. 15. The functional and phenotypic characteristics of HbF and Hb Bart’s hemoglobin (Carroll 2015; Images after 
fetalfacts.net 2015; healthmad.com 2015; lumen.luc.edu; medicaldictionary.com 2015; seplessons.ucsf.edu 2015). 
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tetramers precipitate Heinz bodies, which are small, round inclusions composed of 
irreversibly denatured hemoglobin (Agosti and Duke 2008; Orkin et al. 2015; Provan 2010). 
These inclusions aggregate within affected RBCs, causing severe membrane damage and 
eventually, premature RBC death (Agosti and Duke 2008; Orkin et al. 2015; Provan 2010).  
Since hemoglobin cannot function outside of the RBC, chronic hemolysis exacerbates states 
of hypoxemia and hypoxia (Shawky and Kamai 2012; Yochum and Rowe 2005), stimulating 
the secretion of erythropoietin; the hormone responsible for proliferating RBCs (Sherwood et 
al. 2005). Despite the increase in RBC production, however, α-globin chains are still 
ineffectually synthesized, since their characteristics are genetically predetermined. As such, 
HbH disease initiates a cascade of pathophysiological responses (see Chapter 4) in an attempt 
to compensate for the low oxygenation potential of HbH hemoglobin. 
 Osteologically, HbH disease may manifest as hematopoietic marrow hyperplasia; the 
pathological reconversion of yellow (fatty/cartilaginous) marrow to red (blood cell 
producing) marrow, in response to the increased demand for RBCs and the exhaustion of 
existing red marrow stores (Lukens 1993; Shawky and Kamai 2012; Siegel 2005). Initially, 
bones which are affected showcase signs of medullary expansion and osteoporosis, mainly 
visible upon radiographic examination (Glader 1999; Shawky and Kamai 2012; Yochum and 
Rowe 2005). As hyperplastic marrow responses become increasingly chronic/severe 
however, intramedullary pressure causes progressive cortical thinning, medullary expansion, 
biconvexation of the diaphyses and metaphyses, and severe granular osteoporosis (which 
may or may not result in pathological fracturing) (Glader 1999; Shawky and Kamai 2012; 
Yochum and Rowe 2005). The development of coarsened, erratically oriented trabeculae 
(hair-on-end) is also common (Glader 1999; Shawky and Kamai 2012; Yochum and Rowe 
2005), and is a direct result of marrow extension through the cortex of the Harversian canals 
and consequent elevation of the periosteum (Lawson 1984).  
While HbH does not produce pathognomonic lesions, it is primarily characterized by 
cranio-facial marrow hyperplasia. The skull, a major site of erythropoiesis and therefore 
particularly sensitive to hematopoietic marrow hyperplasia, becomes increasingly thickened 
as the inner table and diploic space expands, and the outer table thins (Galanello and Cao 
2011; Kharsa 1996; Origa et al. 2005; Riyanti 2010; Yochum and Rowe 1996) (fig. 16). This 
results in frontal and/or parietal bossing, osteoporosis and porotic hyperostosis (and cribra 
orbitalia), increased meningeal and vascular channels, and/or a reduction in the 
pneumatisation of the frontal, maxillary, sphenoid and mastoid bones (Galanello and Cao 
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2011; Kharsa 1996; Origa et al. 2005; Riyanti 2010; Yochum and Rowe 1996) (fig. 16). 
Maxillary marrow hyperplasia may result in the hyper-expansion of the facial bones, the 
protrusion of the premaxilla, and depressing of the nasal bridge (Galanello and Cao 2011; 
Kharsa 1996; Origa et al. 2005; Riyanti 2010; Yochum and Rowe 1996) (fig 16). This may 
result in dental defects, such as diastemas and rodentia facilies malocclusion (Galanello and 
Cao 2011; Kharsa 1996; Origa et al. 2005; Riyanti 2010; Yochum and Rowe 1996). Linear 
enamel hypoplasia and erratically oriented hair-on-end trabeculae may also be present. 
Despite the range of cranio-facial responses, skeletal manifestations of HbH disease only 
occur in approximately one third of affected individuals (Origa et al. 2005), making it 
difficult to diagnose using macroscopic techniques alone. 
Less severe forms of α-thalassemia include silent α-thalassemia, whereby individuals 
have one mutated α-gene and develop few to no signs or symptoms, and α-thalassemia minor 
(α-thalassemia trait), whereby two of the four α-genes are deleted/deactivated (Chui and 
Waye 1998; Clarke and Higgins 2000; Origa et al. 2005). α-thalassemia minor is 
characterized by mild hypochromic microcytosis, with symptoms commonly resembling 
either those of iron deficiency anemia or iron overload (Chui and Waye 1998; Clarke and 
Fig. 16. Craniofacial manifestations of hemolytic anemias. Top left, cranial porotic hyperostosis; top center, suspected 
thalassemic; top right, cribra orbitalia; bottom left, expansion of the cranial diploe; center left, erratically oriented trabeculae 
on the endocranium; center right, maxillary gnathopathy; right, linear enamel hypoplasia (Carroll 2015, taken with 
permission from the Municipal Museum of Écija Spain; radiographs after Camerlinck et al. 2009; Kharsa 1996).  
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Higgins 2000; Galanello and Cao 2011; Origa et al. 2005). It is not uncommon for 
individuals with α-thalassemia minor to be completely asymptomatic, however, and therefore 
they are less likely to be diagnosable in the archaeological record (Chui and Waye 1998; 
Clarke and Higgins 2000). 
2.2. Betal (β)-Thalassemias: 
As with α-thalassemias, there are several forms of deletional and non-deletional β 
and β-like thalassemias, all characterized by the ineffectual/absent synthesis of non-α-globin 
chains (Cao and Galanello 2010; Galanello and Origa 2010; Perisano et al. 2012; Yochum 
and Rowe 2005). Of the genetically and phenotypically heterogeneous class of β-complex 
disorders, only three will be discussed; β-thalassemia major, β-thalassemia intermedia and β-
thalassemia minor. 
  
Fig. 17. Functional and phenotypic characteristics of HbF and β-thalassemic (major) hemoglobin (Carroll 2015; Images 
after fetalfacts.net 2015; lumen.luc.edu 2015; medicaldictionary.com 2015; seplessons.ucsf.edu 2015; Photograph by Marie 
Carroll, 1992). 
   52 
 
The most severe expression of the β-thalassemia family is β-thalassemia major 
(HbB0), commonly referred to as Cooley’s, erythroblastic and/or Mediterranean anemia (Cao 
and Galanello 2010; Galanello and Origa 2010; Perisano et al. 2012; Yochum and Rowe 
2005). β-thalassemia major is characterized by the deletion/deactivation of both HBB genes, 
resulting in severely reduced, or completely absent β-globin production (Cao and Galanello 
2010; Galanello and Origa 2010; Perisano et al. 2012; Yochum and Rowe 2005) (fig.17). As 
a result, unbound α-globin chains precipitate in RBC precursors (located in red marrow), 
inducing hemolysis, ineffectual erythropoiesis and marrow hyperplasia (Cao and Galanello 
2010; Galanello and Origa 2010; Perisano et al. 2012; Yochum and Rowe 2005).  
Osteological complications of β-thalassemia major include (but are not limited to) 
growth retardation (premature epiphyseal fusion, delayed osteoid maturation and 
mineralization), ulcerations and pseudo-tumors, focal osteomalacia, extra-medullary 
hematopoiesis and marrow/erythroid hyperplasia (with associated complications), unbalanced 
bone turnover, characteristic cranial-facial abnormalities (fig 16, fig. 18), osteomyelitis 
(infection of the bone marrow), osteitis (non-specific bone infection/inflammation), 
periostosis (non-specific periosteal inflammation), septic arthrosis (as a result of decreased 
immune function, ischemia and infarction (Table 1) and systemic osteopenia/porosis (with or 
without porotic hyperostosis and/or cribra orbitalia) (DeLong and Burkhart 2013; 
Mahachoklertwattana et al. 2003; Morabito et al. 2004; Perisano et al. 2012; Voskaridou 
2009; Yochum and Rowe 2005). Given that the initiation of β-globin synthesis is linked to 
the decline of ɣ-chain transcription, symptoms are more or less supressed until six to 24 
months of age, when HbF production drops to ~1% (Cao and Galanello 2010; Galanello and 
Origa 2010; Oliverier and Weatherall 1998; Perisano et al. 2012; Sarnaik 2005; Yochum and 
Rowe 2005). As such, 
infants with β-
thalassemia major may 
not be visible using 
stable isotope 
analyses, since their 
isotopic values will be 
at least partially 
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representative of ‘healthy’ levels of oxygenation.  
 
 
 
 
 
 
 
 
 
 
 
 As with α-thalassemia major, osteological complications mirror the body’s (and 
skeletal system’s) attempt(s) to re-achieve homeostasis in face of chronically 
inactivated/ineffective β-globin synthesis and decreased tissue oxygenation (DeLong and 
Burkhart 2013; Mahachoklertwattana et al. 2003; Morabito et al. 2004; Perisano et al. 2012; 
Voskaridou 2009; Yochum and Rowe 2005). While β-thalassemia major also does not 
produce pathognomonic lesions, clinical literature suggests that severe cranial 
erythroid/marrow hyperplasia (i.e. hair-on-end trabeculae) (fig.18) is more indicative of β-
thalassemia major than other hemolytic conditions, including sickle cell anemia (Baker 1964; 
Hollar 2001; Moseley 1974). It has, however, been noted in confirmed cases of sickle cell 
anemia and β-thalassemia intermedia (see below) (Balikar et al. 2012; Diggs 1973; 
Lagundoye 1970; Sebes and Diggs 1979; Song 1971; Williams et al. 1975), as well as in iron 
deficiency anemia, cyanotic congenital heart disease, and certain cancers (Britton et al. 1960; 
Burko et al. 1961; Walor et al. 2005). 
β-thalassemia intermedia and minor are the carrier, heterozygotic, states (HbB+) 
(Figure 4) of the β-globin mutation (Cao and Galanello 2010; Galanello and Origa 2010; 
Fig. 18. Macroscopic (bottom) and radiographic (top) comparisons between a 
healthy, non-anemic crania (left) and a hemolytic anemia with hair-on-end 
trabeculae (Carroll 2015, taken with permission from the Municipal Museum 
of Écija Spain; radiographs after Azam and Bhatti 2006; www.thebody.com 
2015). 
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Perisano et al. 2012). In both cases, one of the two β-genes is deleted/deactivated, leading to 
the anomalous synthesis of β-polypeptides (Cao and Galanello 2010; Galanello and Origa 
2010; Perisano et al. 2012). In the less severe form, β-thalassemia minor, the 
ineffectual/arrested synthesis of the affected polypeptide is mediated by the remaining 
(functioning) gene, which compensates by producing more β-globin (Cao and Galanello 
2010; Galanello and Origa 2010; Perisano et al. 2012). While this still results in a net 
decrease of β-globin synthesis, enough is produced to leave RBCs only mildly anemic (Cao 
and Galanello 2010; Galanello and Origa 2010; Perisano et al. 2012). Archaeologically, 
individuals with β-thalassemia minor may masquerade as iron-deficient, and are likely 
commonly misdiagnosed.  
The second carrier trait, β-thalassemia intermedia, is more genetically heterogeneous. 
As such, the degree to which β-globin synthesis is inhibited/arrested depends on the exact 
nature of the mutation, which ranges from mild to severe. Regardless, fewer β-globin chains 
are proliferated than in the minor form, causing a greater imbalance in α and β-polypeptides 
(Cao and Galanello 2010; Galanello and Origa 2010; Perisano et al. 2012). This, in turn, 
increases the number of unpaired α-globins within the RBC, leading to a cascade of 
pathophysiological responses including hemolysis, ineffectual erythropoiesis and marrow 
hyperplasia, and their sequalae Cao and Galanello 2010; Galanello and Origa 2010; Perisano 
et al. 2012). As with β-thalassemia major, however, symptoms only begin to manifest once ɣ-
synthesis declines, suggesting that they may only be diagnosable after infancy (Cao and 
Galanello 2010; Galanello and Origa 2010; Perisano et al. 2012).   
3. Sickle Cell  
 
As with the thalassemias, sickle cell is a category of autosomal recessive hemolytic 
blood disorders characterized by phenotypical and functional abnormalities in the 
hemoglobin molecule and RBC membrane (Barabino et al. 2010; Nagel 1993; Serjeant 
1993). Unlike the thalassemias, however, sickle cell is primarily caused by an inherited 
substitution mutation in the amino acid sequence of β-globin polypeptides, and not by the 
deletion/deactivation of the β-globin complex (Barabino et al. 2010; Serjeant 1993). As such, 
individuals may inherit both sickle cell and α/β-thalassemia, depending on the nature of their 
parent’s genetics.  
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3.1. Homozygotic Sickle Cell:  
 
In those with sickle cell anemia (HbSS), thymine replaces adenine at the sixth amino 
acid position in both β-globin chains, causing glutamic acid to transcribe as valine (HbSS) 
(Barabino et al. 2010; Serjeant 1993) (fig.19). Unlike glutamic acid, valine is a non-polar 
hydrophobic amino acid and as such, it repels water and preferentially bonds to other neutral 
and/or non-polar molecules (Totora and Derrickson 2012). Since the intracellular RBC 
environment is similar to water, sicklic β-globin chains polymerize (react/bond) with 
themselves and/or the α-chains causing the entire hemoglobin molecule to aggregate and 
form insoluble fibrous precipitates (Barabino et al. 2010; 
Embury 1986; Horne 1981; Serjeant 1993).  This distorts 
the RBC membrane into the characteristic crescent, or 
sickle-like shape (Barabino et al. 2010; Embury 1986; 
Serjeant 1993) (fig.20). These deformed, dehydrated 
cells lack the plasticity and rheological properties of 
healthy RBCs, increasing the rate at which they are 
lysed, and increasing their propensity for adhering to one 
another, the vascular endothelium and other blood 
cells (vaso-occlusion) (Barabino et al. 2010; Horne 
1981). 
 
 
 
 
 
As valine is only located on the surface of the deoxygenated HbSS structure, young 
sickle cells will revert back to their non-aggregated, toroidal form when oxygenated 
(Barabino et al. 2010; Embury 1986; Horne 1981; Serjeant 1993). In cases where blood 
oxygen concentrations are chronically low (thereby decreasing oxygen saturation), 
deoxygenation is prolonged, and/or the Fe2+ heme group is modified to a ferric iron (Fe3+) 
heme group (which does not bind oxygen) (see Chapter 4), HbS RBCs will continuously self-
Fig. 19. Differences in the nucleotide sequence 
and amino acid composition of normal and 
sicklic β-globin chains, where sicklic 
polypeptides substitute thymine for adenine, 
causing glutamic acid to transcribe as valine 
(Carroll 2015). 
Fig. 20. Morphological changes of HbS RBCs upon complete deoxygenation 
(left and right) and partial deoxygenation (center) (Obata et al. 2006, 29). 
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polymerize/crystalize, and eventually become irreversibly sickled even when oxygenated 
(Barabino et al. 2010; Embury 1986; Horne 1981; Serjeant 1993). As a result of sickled cell’s 
chronically inhibited ability to fixate and/or transport oxygen, as well as the obstruction of 
circulation (which decreases/arrests the oxygenation of tissues downstream of the occlusion), 
states of hypoxemia and hypoxia are common; mediated only by the rate at which cells 
become sickled and the rate at which vaso-occlusion occurs (Barabino et al. 2010; Embury 
1986; Horne 1981; Serjeant 1993) (see Chapter 4). Since the sicklic substitution of glutamic 
acid for valine only occurs on the β-globin polypeptides, symptoms of sickle cell anemia 
become increasingly pronounced as HbF production declines, and ineffectual β-globin 
synthesis increases.   
Osteologically, sickle cell anemia produces many of the same responses as 
homozygotic thalassemias (α and β-thalassemia major), or more severe expressions of the 
thalassemia trait (e.g. β-thalassemia intermedia) since they all induce moderate to severe, 
chronic, hemolysis and marrow hyperplasia (Barabino et al. 2010; Embury 1986; Horne 
1981; Serjeant 1993). Unlike α-thalassemia major, compensations for sicklic hemolysis is 
noted systemically; with the long bones, pelvis and vertebral column (in addition to the 
cranial diploe) experiencing characteristic marrow expansion, osteoporosis, and cortical 
thinning (etc.) (Anand and Giatt 1994; Angel 1964, 1966, 1967, 1971, 1977; Hershkovitz et 
al. 1997; Onwubalili 1983; Serjeant 1993; Yochum and Rowe 2005). As with the 
thalassemias, maxillary expansion may occur in response to chronic marrow hyperplasia. 
This may affect the morphology of the sinuses, the angulation of the dentition and overall 
prognathic profile of the cranio-facial skeleton, often resulting in maxillary gnathopathy 
and/or malocclusion (Costa et al. 2012; Fernandez et al. 1995; Maia et al. 2011; Pithon 2011; 
Serjeant 1993; Yochum and Rowe 2005). Granular osteoporosis, porotic hyperostosis (and 
cribra orbitaliaa), coarsened trabeculae, avascular necrosis of the femoral and humeral heads, 
tibia, radius and ulnae, and degenerative spinal changes (kyphosis, H-shaped vertebrae) are 
also common osteological expressions of homozygotic sickle cell (Anand and Giatt 1994; 
Angel 1964, 1966, 1967, 1971, 1977; Hershkovitz et al. 1997; Onwubalili 1983; Serjeant 
1993; Yochum and Rowe 2005).  
As mentioned, sickle cell anemia is characterized by the aggregation of RBCs, which 
in turn forms blood clots and reduces/prohibits the flow of oxygen to areas downstream of the 
obstruction (Barabino et al. 2010; Nagel 1993). This induces tissue anoxia, and if left 
unresolved, ischemia and cellular necrosis (Barabino et al. 2010; Serjeant 1993). As such, 
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those with sickle cell anemia tend to exhibit more necrotic, ischemic and/or infarctic lesions 
(Table 1) than those with thalassemia (which is not characterized by severe clot formation), 
and have a higher propensity for developing osteomyeltitis (especially osteomyelitic 
Salmonella, which is 100 times more prevalent in those with sickle cell anemia than those 
without), periostosis (generalized inflammation of the periosteum), periostitis (infection of 
the periosteum) and septic arthrosis (Anand and Giatt 1994; Angel 1964, 1966, 1967, 
1971,1977; Embury 1986; Hershkovitz et al. 1997; Onwubalili 1983; Serjeant 1993; Yochum 
and Rowe 2005). The presence of systemic inflammatory/infective lesions may therefore 
provide a way to distinguish sickle cell anemia from the thalassemia; however, these 
responses are non-pathognomonic and are not reliable as the only method of differentiation 
(Anand and Giatt 1994; Angel 1964, 1966, 1967, 1971, 1977; Hershkovitz et al. 1997; 
Onwubalili 1983; Serjeant 1993; Yochum and Rowe 2005). Dactylitis, the inflammation of 
the hands and/or toes, is also more common in those with sickle cell anemia than those with 
thalassemia (Serjeant 1993; Yochum and Rowe 2005).  
3.2. Heterozygotic Sickle Cell:  
In the heterozygotic state, only one copy of the β-mutation (HbS) is inherited, 
causing one of the two β-globin chains to manifest the characteristic valine substitution (CDC 
2015; Kavanagh et al. 2011; Serjeant 2010; Yawn et al. 2014). Two heterozygotic states 
exist; sickle cell disease (HbS-) and sickle cell trait (HbAS). In individuals with sickle cell 
disease, the other β-globin chain is replaced by a hemoglobin variant, such as hemoglobin C 
(HbSC), δ-hemoglobin (HbSD; Hb Lepore), hemoglobin O (HbSO), or hemoglobin E 
(HbSE) (CDC 2015; Kavanagh et al. 2011; Serjeant 2010; Yawn et al. 2014). These variants 
are all caused by specific mutations in the β-globin amino acid sequence, and will not be 
discussed. Given the heterogeneous nature of sickle cell disease, the severity and chronicity 
of (osteological and non-osteological) complications depends on the exact nature of the 
mutation (CDC 2015; Kavanagh et al. 2011; Serjeant 2010; Yawn et al. 2014). In most cases 
however, self-polymerization/crystallization of the hemoglobin molecule is decreased 
(compared to HbSS), reducing the overall number of irreversibly sickle cells and improving 
rates of vaso-occlusion and tissue oxygenation (CDC 2015; Kavanagh et al. 2011; Serjeant 
2010; Yawn et al. 2014).  
As with sickle cell disease, sickle cell trait is characterized by the inheritance of a 
single abnormal β-globin gene. Unlike sickle cell disease, however, the other β-globin chain 
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is unaffected, enabling that chain to retain its functional and phenotypic properties. As such, 
those with sickle cell trait are generally mildly anemic or asymptomatic, reducing the 
likelihood of skeletal manifestation of the disease (CDC 2015; Kavanagh et al. 2011; 
Serjeant 2010; Yawn et al. 2014; Yochum and Rowe 2005) and making them more difficult 
to identify using macroscopic analyses alone.  
4. Modifying Influences: HbF Persistence, HBA2 and Sickling-Thalassemias  
While the expression of thalassemia and sickle cell depends on a range of factors, the 
degree to which symptoms are expressed may be modulated by a number of factors, 
including HbF persistence (Charache 1990; Clarke and Higgins 2000; Conley et al. 1963; 
Edoh et al. 2006; Olivieri and Weatherall 1998; Powers et al. 1984), increased HBA2 
production (Higgins et al. 2009; Verhovsek et al. 2012) and/or the co-inheritance of sicklic 
and thalassemic mutations (Embury et al. 1984; Saleh-Gohan and Mohammadi-Anaie 2012; 
Rahim et al. 2013; Rumaney et al. 2014; Wambua et al. 2006). Clinical research has 
repeatedly demonstrated that a significant subset of individuals with sickle cell and/or 
thalassemia anemia develop persistent HbF and/or have elevated concentrations of HbA2 
(≥3.5%) (Craver et al. 1997; Embury et al. 1986; Ou et al. 2011; Verhovsek et al. 2012). In 
fact, the presence/elevation of HbF and/or HbA2 is currently a widely accepted technique for 
screening and diagnosing sicklic and/or thalassemic mutations, since non-mutated HBB, 
HBA1 and HBA2 complexes rarely enable the continued/increased synthesis of either 
polypeptide (Craver et al. 1997; Ou et al. 2011; Verhovsek et al. 2012).  
The presence of HbF and/or HbA2 polypeptides reduces the polymerization of sicklic 
and/or thalassemic hemoglobin, decreasing the rates at which sickling, vaso-occlusion and 
lysis occurs (Bookchin et al. 1974). Clinically, it has been demonstrated that individuals with 
more than 10% (of total hemoglobin concentration) HbF have less frequent vascular and 
osteonecrotic complications, and those with more than 20% HbF have less frequent vaso-
occlusive episodes and pulmonary syndromes (Powers et al. 1984).  This has major 
implications for this research, since the presence of HbA2 and HbF is known to ameliorate 
the deleterious (including osteological) effects of sickle cell and/or thalassemia anemia by 
increasing the overall concentration of functioning (high affinity) hemoglobin (Bookchin et 
al. 1974). Given that it was not possible to genetically/haematologically screen the 
individuals used in this study, it is unknown whether certain (or all) individuals inherited the 
capacity to produce HbA2 and/or persistent HbF. As such, it is possible that; (a) 
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homozygotic/heterozyogtic anemics with HbF and/or HBA2 will not present with 
characteristic osteological lesions and will therefore be miscategorised, skewing the results; 
(b) homozygotics/heterozygotic anemics with HbA2 and/or HbF will present with 
characteristic osteological lesions, but will not exhibit significant differences in isotopic 
fractionation; and (c) that certain homozygotes/heterozygotes will have increased/persistent 
HbF and/or HbA2 while others will not, and therefore they will dilute the statistical 
significance of the results.  
In addition to increased concentrations of HbA2 and/or HbF, clinical research has 
also shown that the co-occurrence of sicklic and thalassemic mutations also reduces/retards 
the polymerization of sicklic RBCs, decreases the number of irreversibly sickled RBCs, 
improves hematological indices and therefore, rates of survival, and delays the age at which 
symptoms of either disease manifest (Embury et al. 1984; Rahim et al. 2013; Rumaney et al. 
2014; Saleh-Gohari and Mohammadi-Anaie 2012; Wambua et al. 2006). Since the exact 
mutation of each individual used in this study is unknown, it is unknown which, if any, 
individuals co-inherited sicklic and thalassemic mutations, and therefore the ameliorating 
effects. As with the aforementioned factors, this presents a major obstacle in this, and future 
studies since it is impossible to predict the exact mutation(s) (and many of their 
pathophysiological effects) based on macroscopic analyses alone.  
5. Sickle Cell and Thalassemia in Écija  
        Archaeologically the diagnosis of, and differentiation between, sickle cell and/or 
thalassemia is difficult since there is a significant amount of inter-individual variation in the 
timing and presentation of each condition, their (direct and indirect) complications, and the 
body’s compensatory responses. This is confounded by the fact that, as mentioned, 
thalassemic and sicklic mutations do not produce pathognomonic skeletal lesions, making it 
difficult to distinguish one from the other, as well as from other hemolytic, cardiovascular or 
anemic conditions. In order to determine which condition most likely affected the Écijan 
population under investigation a combination of factors, including the presence and 
distribution of characteristic skeleton lesions, the contemporary distribution of sicklic and 
thalassemic alleles, and geographic distribution of malaria were employed.    
5.1. Skeletal Signatures:  
        Currently, the primary diagnostic feature associated with identifying sickle cell and 
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thalassemia in the archaeological record is the presence and severity of ‘hair-on-end’ 
trabeculae; a feature which has been linked to sickle cell and thalassemia anemia both 
clinically (Aksoy et al. 1966; Britton et al. 1960; Burko et al. 1961; Eng 1958; Jelliffe and 
Blackman 1962; Mosley 1974) and archaeologically (Angel 1964, 1966, 1967, 1984) since at 
least the 1950’s. According to the clinical literature, ‘hair-on-end’ trabeculae is most 
indicative of β-thalassemia major (Baker 1964; Hollar 2001; Moseley 1974), with α-
thalassemia major, β-thalassemia intermedia and sickle cell anemia (among select other 
conditions) possible differentials (Balikar et al 2012; Diggs 1973; Lagundoye 1970; Sebes 
and Diggs 1979; Song 1971; Williams et al. 1975). To the best of the author’s knowledge, 
these lesions are rare in those with α-thalassemia minor, silent α-thalassemia, β-thalassemia 
minor, sickle cell disease, and sickle cell trait, as well as within those which co-inherit 
thalassemic and sicklic mutations.  
        In the skeletons analysed, a total of nine (infant) individuals exhibited evidence of 
active ‘hair-on-end’ trabeculae (see Chapter 8, section 1.1) as defined by the literature 
(Aksoy et al. 1966; Angel 1964, 1966, 1967, 1984; Britton et al. 1960; Burko et al. 1961; 
Eng 1958; Jelliffe and Blackman 1962; Mosley 1974) (Table 1, Appendix). All nine 
individuals manifested lesions which could be viewed macroscopically on one or more of the 
cranial-facial elements/surfaces. This suggests that these nine individuals had either β-
thalassemia major, β-thalassemia intermedia, α-thalassemia major, or sickle cell anemia, with 
β-thalassemia major being the most likely diagnosis (Baker 1964; Hollar 2001; Moseley 
1974). The overall distribution and severity of additional skeletal lesions (Pathology Reports; 
Appendix) supports the hypothesis that these nine individuals had either β-thalassemia major, 
β-thalassemia intermedia, or sickle cell anemia since all nine exhibited extensive, systemic 
osteological lesions (e.g. marrow hyperplasia, porosity etc.). As previously mentioned, the α-
thalassemias, β-thalassemia minor, sickle cell disease, sickle cell trait, and the co-inheritance 
of sickle cell and thalassemia do not regularly induce severe, systemic osteological responses 
and are thus unlikely diagnoses within this ‘Anemic’ cohort.  
       Pathologies generally considered more characteristic of sickle cell anemia, such as 
dactylitis, osteomyelitis and H-shaped vertebrae (Anand and Giatt 1994; Embury 1986; 
Onwubalili 1983; Serjeant 1993; Yochum and Rowe 2005) were not noted in any of the nine 
Anemic individuals, however this may have been a consequence of their age at death, which 
ranged from two years +/- 8 months to ~four years old (Table 1; Appendix). A total of 14 
individuals were designated as Possibly Anemic/Heterozygotic (see Chapter 8, section 1.1) 
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however, as with the Anemic infants, none of these individuals exhibited lesions which could 
conclusively differentiate β-thalassemia from sickle cell. As such, the osteological evidence 
can only support a diagnosis of sickle cell and/or β-thalassemia over that of α-thalassemia, 
but cannot determine which mutation is responsible for the osteological lesions noted, and 
does not indicate whether less severely affected individuals (a) co-inherited the conditions; 
(b) were heterozygotic for one or both; or (c) were homozygotics which exhibited less 
skeletal compensations than those noted in the Anemic infants.  
         Differential diagnoses include malaria, iron imbalances and anemia, scurvy 
(vitamin C deficiency), polycythemia vera, vitamin B12 deficiency, folic acid (vitamin B9) 
deficiency, megaloblastic anemia, unspecified gastrointestinal disorders/infections, 
unspecified parasitic infection(s), cyanotic congenital heart disease, and leukemia (Aksoy et 
al. 1966; Aufderheide and Rodriguez-Martin 1998; Coben and Paeglow 2000; Diez-Ewald 
and Layrisse 1968; Gandapur et al. 1995; Roberts and Manchester 2005; Rollot et al. 2005; 
Thornton 1968; Walker et al. 2009; Yochum and Rowe 2005).  
5.2. Contemporary Genetic Distribution: 
        More explicit evidence for sickle cell and thalassemia in 8th-12th century Spain comes 
from contemporary DNA research, which has mapped the evolution and distribution of 
sicklic and thalassemic mutations around the world. As mentioned previously, several genetic 
mutations/deletions/deactivations are responsible for the development of thalassemia, all of 
which affect the synthesis of β-globin. In recent years, advances in DNA technology have 
allowed researchers to calculate the frequency of these mutations in contemporary 
populations, and to make estimations as to their prevalence in the archaeological past. Several 
studies have concluded that one of the most common β-thalassemia mutations, the Codon 39 
(CD39) nonsense mutation, evolved in the Levant or North Africa between 6500 and 2000 
B.C., and was spread to Spain (and elsewhere) by the Phoenicians (Western Mediterranean) 
and the North Africans during the first millennium B.C.E (Agouti et al. 2008; Cao et al. 
1989; Sallares et al. 2004; Tadmouri et al. 2001). As such, genetic evidence explicitly 
advocates for the presence of this, and other, β-thalassaemic mutations in the Iberian 
Peninsula (and surrounding areas) before and during the 8th-12th centuries. To the best of the 
author’s knowledge, no publicized information exists as to the past (i.e. 8th-12th centuries) or 
present prevalence of β-thalassemia in Écija itself. The incidence of heterozygotic β-
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thalassemia in contemporary Spain, however, is reported to be 0-5%; with a total of 83 cases 
of β-thalassemia major recorded in Spain in 1986 (Mdel et al. 2009; Wegner et al. 1996).  
            Historically, the ‘racial’ characteristic of Spain and Andalusia has been formed by 
centuries of emigration and colonization. This was especially true during the 8th-12th 
centuries, when the country experienced the influx of non-indigenous Muslims and North 
Africans, and became a part of the Umayyad Caliphate (see Chapter 7) (Hitti 2002; Kennedy 
2007; Lapidus 2002; Samso 1998). As such, 8th-12th century Spain was both a cultural and 
genetic melting pot. Both archaeological and contemporary genetic evidence supports the 
presence of β-thalassemia throughout North Africa, as well as within the Middle East (Agouti 
et al. 2008; Amselem et al. 1988; Bennani et al. 1994; Cao et al. 1989; Fattoum et al. 1991; 
Rosatelli et al. 1992); areas where not only individuals emigrated to Spain from, but also 
which served as possible routes Écijan Islamic pilgrims may have undertaken to get to 
Mecca--an Islamic Holy site and Pillar of the Faith (see Chapter 7) (fig 21). While this, again, 
does not conclusively confirm the presence of β-thalassemia in 8th-12th century Écijan 
Muslims, it does suggest that genetic admixture and the inheritance of β-thalassemia was not 
only possible, but probable during the 8th-12th centuries--at least for certain Écijan 
individuals/families.  
      Unlike β-thalassemia, Spain does have a contemporary official registry for those with 
sickle cell, with a total of 138 individuals registered from across Spain. To the best of the 
author’s knowledge, no publicized information exists as to the suspected prevalence of sickle 
cell in 8th-12th century Écija. As with β-thalassemia, contemporary genetic evidence suggests 
that ~76% (n=138) of sickle cell mutations are consistent with haplotypes originating in 
Africa. Despite this, sickle cell is only present in ~0-2% of the (contemporary) population, 
despite the significant increase in (reported) cases between 2000 and 2004 (Arias et al. 2006; 
Mdel et al. 2009). It is unknown whether the current frequency of sicklic mutations is 
reflective of those from 8th-12th century Écija however, it is possible to hypothesize that 
sickle cell mutations were likely insignificant in Écija prior to the influx of North Africans 
during the 10th-11th centuries (see Chapter 7).  
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          Deletional and non-deletional α-thalassemic mutations also exist in Spain today (Ayala 
et al. 1996; Villegas et al. 1990; Villegas et al. 1994), and therefore must also be considered 
as a differential diagnosis despite the fact that the osteological lesions do not fully support its 
presence in the individuals sampled. Overall, the genetic evidence strongly advocates for the 
presence of β-thalassemia in Spain during the 8th-12th centuries, with sickle cell and α-
thalassemia being possible, but less likely differentials. Without aDNA examination, 
however, it is not possible to conclusively determine which genetic anemia is responsible for 
the osteological lesions noted and as such all three must be considered.  
5.3. Malaria and Genetic Anemias:  
It is now well established that the presence and prevalence of malaria (Plasmodium 
falciparum, P. vivax, P. ovale and P. malariae) is related to the presence and prevalence of 
sicklic and thalassemic mutations, since the latter provides a type of genetic resistance to the 
former (Mockenhaupt et al. 2004; Wegner et al. 1996). In other words, the geographic 
distribution of sickle cell and thalassemia is strongly linked to the geographic distribution of 
endemic malaria. It is therefore possible to hypothesize that malarial rich regions will support 
a number of sicklic and/or thalassemic individuals, since heterozygotes have a genetic 
advantage over those with healthy RBCs and phenotypically normal HbA (Mockenhaupt et 
al. 2004; Wegner et al. 1996).  
Fig. 21. Contemporary frequency distribution of the most common β-thalassemia mutations in Spain, and along possible 
8th-12th century Islamic pilgrimage routes. (Carroll 2015; after Agouti et al. 2008 and googlemaps.com 2015).  
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          Until 1964 malaria was extremely prevalent in Andalusia, with between 401 and 725 
reported malaria infections occurring per year in the Province of Seville alone (fig. 22) 
(Sousa et al. 2009). This led to a prodigious number of hospitalizations and deaths, reiterating 
the aforementioned evolutionary advantage of having genetic malarial immunity (Sousa et al. 
2009). While these reports are reflective of modern prevalence rates one can easily 
hypothesize that similar, if not higher rates of infection occurred during the 8th-12th centuries, 
given the number of wetlands in Southwestern Spain, the climate, the number of historical 
documents describing malaria and malaria-like symptoms, and the fact that Spain was one of 
the last countries in Western Europe to be declared malaria-free (Betran 2006; Sousa et al. 
2009; Sousa 2014). This suggests that, even if sickle cell and thalassemia originally existed 
solely in pocket population, their prevalence could have increased over time as more and 
more individuals with malarial immunity survived to pass on their genes, and more and more 
individuals without died. As such, if thalassemia or sickle cell existed within the Écijan 
population during the 8th-12th centuries, as genetic and osteological data seem to suggest, 
certain forms (i.e. heterozygotic) would have been genetically advantageous and thus selected 
for—increasing the overall number of affected individuals.    
 Given that α and β-thalassemias, as well as sickle cell anemia are known to protect against 
malaria, it is possible to hypothesize that one or more sicklic and/or thalassemic mutations 
existed within the population, but it is not possible to conclusively determine which.   
 
 
 
 
 
 
 
 
 
Fig. 22. Mean number of malaria patients per province in Spain during 
the 1949-1964 period. Andalusia is demarcated in red, with Écija 
marked by a star (Carroll 2015; after Sousa et al. 2009) 
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6. Summary and Conclusions  
    Sickle cell and thalassemia are both autosomal recessive hemolytic blood disorders 
characterized by deletions, deactivations and/or mutations to one or more of the polypeptide 
chains which form the structural basis of the hemoglobin molecule (Yochum and Rowe 
2005). Since hemoglobin is required for the fixatation and transport of oxygen and other 
diatomic gases, functional and phenotypical alterations to one or more of the polypeptide 
chains will result in RBCs which have a reduced capacity to oxygenate and/or deoxygenate 
tissues (Clarke and Higgins 2006; Sarnaik 2005) This induces an array of pathophysiological 
responses (fig.23, fig. 24, fig. 25), which are moderated by the exact nature of the 
mutation/deactivation, and can be ameliorated by factors such as persistent HbF, elevated 
HbA2, and or the co-inheritance of other hemoglobinopathies (Charache 1990; Embury et al. 
1982; Embury et al. 1984; Embury et al. 1986; Powers et al. 1984). The presence and 
distribution of skeletal lesions will therefore depend on an array of internal and exogenous 
factors, including but not limited to the degree of marrow hyperplasia, the presence of 
secondary infection(s), and age at death (Charache 1990; Powers et al. 1984).  
 
 
Fig. 23. Summary of the genetic and pathophysiological changes associated with α-thalassemia (Carroll 2015; after Agosti 
2008, 71). 
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While it is not possible to determine which genetic anemia existed within the Écijan 
population during the 8th-12th centuries, osteological, genetic and malarial data all suggest 
that it is highly likely that one or more sicklic and/or thalassemic mutation existed within the 
population.  Using these lines of evidence, it seems most likely that β-thalassemia is 
responsible for the osteological lesions noted within the samples; however, sickle cell, α-
thalassemia, malaria, iron imbalances, scurvy (vitamin C deficiency), polycythemia vera, 
vitamin B12 deficiency, folic acid (vitamin B9) deficiency, megaloblastic anemia, unspecified 
Fig. 24. Summary of the genetic and pathophysiological changes associated with β-thalassemia (Carroll 2015; after Agosti 
2008, 72). 
 
Fig. 25. Summary of the genetic and pathophysiological changes associated with sickle cell (Carroll 2015; after 
Agosti 2008, 51). 
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gastrointestinal disorders/infections, and unspecified parasitic infection(s), cyanotic 
congenital heart disease and certain cancers must also be considered as possible differential 
diagnoses. 
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CHAPTER FOUR:  
 
Physiological Mechanisms of Stable Isotope Diffusion, Fixation and 
Fractionation during Total Respiration  
 
This chapter focuses on the physiological mechanisms of stable nitrogen, oxygen and 
carbon isotope diffusion, fixation and metabolization during the process of Total Respiration 
(TR); the multi-systemic, multi-fractionating process whereby oxygen is conveyed to cells 
and tissues, and cellular waste products are removed. This chapter has three purposes; (1) to 
elucidate the pathophysiological mechanisms of TR in sickle cell and thalassemia anemia in 
order to provide a more comprehensive understanding of differences in the supply, 
consumption and elimination of stable oxygen22, nitrogen23 and carbon24 molecules between 
severe anemics and healthy non-anemics; (2) to explore how the anomalous rates of TR 
experienced by sicklic and thalassemic individiauls may induce a fractionation effect, thereby 
significantly altering average (population based; non-anemic) δ18O; δ13C, and/or δ15N values 
and; (3) to determine whether the fractionation of stable isotopes during sicklic and 
thalassemic TR is chronic, and significant enough to be incorporated into the organic and 
inorganic matrices of human skeletal tissues, and whether these values can distinguish 
anemics from non-anemics in the archaeological record.  
Section one provides a review of essential definitions and concepts, while section 
two concentrates on the physiological mechanisms of stable oxygen, nitrogen and carbon 
isotope diffusion, fixation and metabolization during TR--known points of isotopic 
fractionation. The third section discusses the contribution of fractionation factors to isotopic 
values (associated with TR), and discusses how rates of fixation, diffusion and 
metabolization enrich or deplete tissues and tissue by-products. Section four and five 
discusses how the pathophysiology of sickle cell and thalassemia anemia induce altered rates 
of TR, while section six discusses how these factors affect the isotopic values of anemics, 
both within living populations and archaeological ones. Concepts are summarized and 
conclusions presented at the end of the seventh, and final section.  
 
                                                          
22 Primarily in the form of oxygen (O2) 
23 Primarily in the form of nitrogen (N2), nitric oxide (NO), nitrite (NO2-), and nitrate (NO3-) 
24 Primarily in the form of carbon dioxide (CO2) and bicarbonate (HCO3-) 
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1.  Definitions and Concepts 
For the purposes of this research, metabolism will refer to the set of life-sustaining 
chemical and cellular reactions responsible for the growth, reproduction, maintenance and 
response capabilities of cells and tissues (Brand 1997; Cannon 1926). Metabolic processes 
rely on both anabolic (construction of molecules like proteins and nucleic acids) and 
catabolic (breakdown of molecules) reactions to support, regulate and maintain the body’s 
internal and external conditions, such that they remain stable and relatively constant (Brand 
1997; Cannon 1926). Metabolic fractionation will refer to the anabolic and catabolic 
processes which affect the relative abundance of stable isotopes within the body (Bucheister 
and Latour 2010; Butz et al. 2014; Focken and Becker 1998). In other words, it refers to the 
mechanism(s) whereby stable isotopes are separated (see Chapter 2) during/after metabolic 
reactions like cellular respiration (CR), the diffusion of gaseous oxygen, nitrogen and carbon 
dioxide across pulmonary membranes, and the fixation of stable oxygen, nitrogens and blood 
carbon molecules to red blood cell (RBC) hemoglobin. Oxyhemoglobin will refer to any 
hemoglobin molecule (HbA, HbF, HbA2) which has fixated oxygen to one or more of its 
heme groups, while deoxyhemoglobin will refer to any hemoglobin molecule which has not.  
For the purposes of this chapter, specific stable molecules (two or more stable 
isotopes bonded together) will be denoted according to their chemical, isotopic formula. As 
such, heavier stable oxygen isotopes will be expressed as 18O16O, lighter stable oxygen 
isotopes as 16O16O, and so on. Since carbon dioxide, bicarbonate and nitric oxide are formed 
from combinations of stable carbon, oxygen and/or nitrogen isotopes, only the isotope of 
interest will be denoted. As such, H13CO3- will denote the bicarbonate molecule (HCO3-), 
with a specific focus on the (heavier) stable carbon isotope (13C), 14N16O will denote nitric 
oxide, with a specific focus on the (lighter) stable nitrogen isotope etc.  
It is acknowledged that TR is a multi-fractionating process, and that stable isotopes 
may be additionally/alternatively fractionated during this, and other, metabolic processes. 
This chapter, however, will concern itself only with the fractionation of stable oxygen, 
nitrogen and carbon isotopes as a result of these three factors;  
1) The diffusion of stable isotopes and molecules across pulmonary membranes 
(inhalation and exhalation)  
2) The affinity of stable isotopes and molecules towards hemoglobin  
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3) The anabolism or catabolism of stable isotopes and molecules during processes 
like CR, and the transformation of one stable molecule to another (i.e. 
bicarbonate to carbon dioxide, nitrogen and oxygen to nitric oxide etc.)  
 
2. Physiological Mechanisms of Stable Oxygen, Nitrogen and Carbon Isotope 
Diffusion, Fixation and Metabolization During Total Respiration 
The air that we breathe is composed of a mixture of gases, including nitrogen (~78% 
of atmospheric air, by volume), oxygen (~21% of atmospheric air, by volume) and carbon 
dioxide (~0.03% of atmospheric air, by volume) (Tans and Keeling 2014; Wallace and Hobbs 
2006). While every human has a direct, intimate relationship with the air around them, 
breathing it in thousands of times per day, most people do not consider the fact that, with 
each breath, they are consuming, assimilating, and eliminating stable isotopes and molecules. 
Therefore, while the isotopic value of tissues and tissue by-products represent the average 
accumulation of stable isotopes from the foods and water sources consumed (DeNiro 1985; 
DeNiro and Epstein 1978; Schoeller et al. 1986; Schoeninger 1985; Schoeninger and DeNiro 
1984; van der Merwe and Vogel 1978; Vogel and van de Merwe 1977),  isotopic values are 
also a representation of the average accumulation of stable isotopes assimilated during the 
process of TR (Epstein and Zeiri 1988; Keeling 1995; Luijendijk et al. 2006; Panteleeve et al. 
1999; Pflug and Schuster 1989; Widory 1999; van Dam et al. 2004). As such, we ‘are what 
we eat’, but we are also what we breathe.  
2.1. Total Respiration and Stable Oxygen Fractionation: 
Oxygen is one of the most essential elements known to life on earth; without it, 
organic tissues begin to die, poisoned by waste gases as they are asphyxiated and starved of 
vital energy (Maton et al. 1993; Tortora and Derrickson 2012). The majority of multicellular 
organisms, like humans, obtain most of their oxygen from the inspiration of atmospheric air 
(Maton et al. 1993; Tortora and Derrickson 2012). While oxygen makes up ~21% (by 
volume) of the atmospheric gas pool (Tans and Keeling 2014; Wallace and Hobbs 2006), 
only ~0.2% of that is composed of the heavier 18O16O molecule (Zeebe and Wolf-Gladrow 
2001). As such, there is a significant abundance disparity between 18O16O, and the more 
common 16O16O isotope. Despite this, however, both are chemically indistinguishable from 
one another (see Chapter 2), and will be used by the body for the same purposes—
maintaining homeostasis and enabling cellular function.   
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In order to obtain sufficient quantities of oxygen to survive and thrive, vertebrates 
have developed a multi-step, multi-systemic, respiratory process. This process, known as TR, 
involves inhaling atmospheric air into the pulmonary system where stable 16O16O and 18O16O 
molecules diffuse through the alveolar membranes and into the pulmonary capillaries (Maton 
et al. 1993; Nilsson 2010; Tortora and Derrickson 2012; West 2011) (fig. 26). The diffusion 
of stable oxygen molecules across pulmonary/alveolar membranes represents the first point 
of 18O16O/16O16O fractionation, since the rate of 16O16O diffusion is ~3% greater than the rate 
of 18O16O diffusion (Heller et al. 1994; Klots and Benson 1963). As such, more stable 16O16O 
molecules will diffuse through pulmonary membranes and into the blood stream than 18O16O, 
enriching the vascular system with stable 16O isotopes (Heller et al. 1994; Klots and Benson 
1963).  
Once in the vascular system, stable 16O16O and 18O16O molecules are fixated to the 
ferrous iron heme sites on the hemoglobin molecule, saturating RBCs cell with oxygen 
(Maton et al. 1993; Nilsson 2010; Tortora and Derrickson 2012; West 2011) (fig. 26). This 
represents the second point of atmospheric stable oxygen fractionation, as stable 16O16O 
molecules are more readily fixated to hemoglobin than stable 18O16O molecules (Epstein and 
Zeiri 1988; Pflug and Schuster 1989). As such, oxygen bound to hemoglobin is ~0.35% 
lighter (isotopically) than atmospheric oxygen (Pflug and Schuster 1988). Hemoglobin’s 
affinity towards oxygen is also a known fractionating factor, as a reduction in binding 
potential decreases the overall rate of 18O16O and 16O16O fixation (increasing the diffusion of 
oxygen molecules back and forth through pulmonary membranes), while an increase in 
binding potential increases the overall fixation rate of oxygen (Epstein and Zeiri 1988; Heller 
et al. 1994; Widory 1999).  
Once oxygen is fixated, oxyhemoglobin is circulated throughout the body via the 
arteries and arterioles, releasing oxygen to the body’s various tissues and becoming 
deoxyhemoglobin. This highlights two essential characteristics of healthy hemoglobin; the 
ability to fixate oxygen, and the ability to release it (Maton et al. 1993; Nilsson 2010; Tortora 
and Derrickson 2012; West 2011). Once released from hemoglobin, stable 16O16O and 18O16O 
molecules diffuse through the RBC membrane and into the membrane of its target cell (i.e. 
muscle cells, skin cells etc.) (Maton et al. 1993; Nilsson 2010; Tortora and Derrickson 2012; 
West 2011). Once inside the cell, oxygen is catabolised by the mitochondria for CR 
(Campbell et al. 1999; Lubert 1995; Maton et al. 1993; Nilsson 2010; Tortora and Derrickson 
2012; West 2011). The catabolism of oxygen molecules represents the third point of isotopic 
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fractionation for inhaled stable oxygen molecules, since, as with the processes of diffusion 
and fixation, 16O16O is metabolized more rapidly (~1.3% faster) than 18O16O (Feldman et al. 
1959; Heller et al. 1994).  
While stable oxygen molecules are fractionated throughout the TR process, the rate 
at which heavier and lighter isotopes are fractionated depends on numerous factors including 
metabolic rate, (patho)physiology, and the overall rate of TR  (determined by cardiac output, 
respiratory rate and blood pressure) (Tortora and Derrickson 2012). For example, research 
has demonstrated that at rest, and in those with pulmonary complications (i.e. comparatively 
decreased rates of TR) 16O16O is transported throughout the entire system 0.72-0.9% faster 
than 18O16O (Heller et al. 1994). As such, inhibited rates of TR (diffusion, fixation or 
metabolization) increases isotopic fractionation, leading to lighter overall δ18O values 
(Epstein and Zeiri 1988; Reistema and Crews 2011). During periods of physical exertion (i.e. 
comparatively increased rates of TR) however, there is a significant decrease in oxygen 
isotope fractionation, enriching the entire process with 18O16O molecules, causing heavier 
δ18O values (Epstein and Zeiri 1988; Widory 1999; Zanconato et al. 1992). As such, the 
rate/degree of oxygen diffusion, fixation and metabolization will have a direct, and 
significant effect on stable oxygen isotope fractionation and, therefore δ18O value (of certain 
tissues and tissue by-products); inhibited processes leading to lighter isotopic values and 
accelerated processes leading to heavier isotopic values.  
2.2. Cellular Respiration and Stable Carbon Fractionation 
Like TR, CR is an essential multi-step metabolic process (Campbell et al. 1999; 
Lubert 1995, Tortora and Derrickson 2012). As the name so aptly states, CR occurs within 
each cell, and relies on the import of oxygen and the export of carbon dioxide to function 
efficiently (Campbell et al. 1999; Lubert 1995; Tortora and Derrickson 2012). Simply put, 
cells must catabolize food products and stable oxygen molecules in order to form adenosine 
triphosphate (ATP), a vital source of cellular energy needed to fuel all energy-requiring 
reactions/processes in the body (Campbell et al. 1999; Lubert 1995; Tortora and Derrickson 
2012) (fig. 26).  
Carbon dioxide, an end product of CR (fig. 26) and ‘source’25 of stable carbon 
isotopes during TR, is diffused into the blood plasma where it is fixated to hemoglobin in the 
                                                          
25 Synthesised primarily from sources of dietary carbon, which were catabolized during the process of CR.  
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form of dissolved carbon dioxide (~10% of blood carbon) or bicarbonate (~85% of blood 
carbon)26 (Campbell et al. 1999; Lubert 1995; Tortora and Derrickson 2012).  As with 
oxygen, hemoglobin’s affinity towards carbon dioxide is a point of fractionation since the 
lighter stable 12CO2 molecule is more rapidly fixated than 13CO2. .Carbon-saturated 
hemoglobin, known as carbaminohemoglobin, then travels back through the capillary beds 
and into the venous system, where it is circulated to the pulmonary system. Once in the 
pulmonary system, bicarbonates are converted back into carbon dioxide, and exhaled as a gas 
(Maton et al. 1993; Nilsson 2010; Tortora and Derrickson 2012; West 2011) (fig. 26). The 
conversion of bicarbonate to carbon dioxide, as well as diffusion of carbon dioxide across 
pulmonary membranes are points of isotopic fractionation, analogous to that of oxygen 
diffusion and CR.  
                                                          
26 The remaining ~5% does not fixate to hemoglobin, and is therefore not overtly affected by changes to the hemoglobin molecule, as in sickle cell 
and thalassemia anemia (Campbell et al. 1999; Lubert 1995; Tortora and Derrickson 2012).  
Fig. 26: The process of Total Respiration in humans (Carroll 2015; Images after Encyclopaedia Britannica, Inc. 2014; 
Encyclopaedia of Alternative Energy 2014; Hale 2014; PennMedicine.org 2014; Prenhall.com 2014). 
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2.3. Total Respiration, Inflammation and Stable Nitrogen Fractionation: 
Despite the fact that nitrogen (N2) makes up ~78% of atmospheric air (Tans and 
Keeling 2014; Wallace and Hobbs 2006), it plays a very small role in TR. This is due, in part, 
to the low energy availability of nitrogen, and the strong chemical bonds between nitrogen 
atoms (Tortora and Derrickson 2012). Therefore, unlike oxygen, human hemoglobin will not 
fixate atmospheric nitrogen and it will not be used during CR (Tortora and Derrickson 2012). 
This negates its discussion in this chapter, since even if rates of atmospheric nitrogen 
fractionation are non-analogous between anemics and non-anemics, it will never affect the 
isotopic values of human skeletal matrices because atmospheric nitrogen is never used by, or 
assimilated into, bodily tissues (Widory 1999).  
Unlike atmospheric nitrogen, however, the human body does respond to/assimilate 
other nitrogenous molecules and compounds. One of these is nitric oxide (NO). In humans, 
nitric oxide is primarily synthesized as an immune response to inflammation (Cirino et al. 
2006; Elmasri et al. 2014; Rassaf et al. 2002). Despite its anti-inflammatory 
immunosuppressive characteristics, however, in certain circumstances nitric oxide may be 
pro-inflammatory, thereby stimulating the overproduction of nitric oxide at certain sites in the 
body (Cirino et al. 2006). This may be toxic, as concentrations of nitric oxide have a direct 
affect on rates of oxygen fixation (Asadi et al. 2015; Poli de Figueiredo et al. 1997; Rimar 
and Gillis 1993).  
As with oxygen, once nitric oxide is produced it must be metabolized by the body. 
This may occur in the blood plasma, where molecules of nitric oxide react to produce nitrite 
(NO2– ), or it may occur inside RBCs (Gladwin et al. 2000; Gross and Lane 1999; Rassaf et 
al. 2002). The metabolization of nitric oxide inside RBCs primarily occurs as a result of one 
of three reactions. Firstly, nitric oxide is known to rapidly react with oxyhemoglobin to form 
methemoglobin and nitrate (NO3−) (Gladwin et al. 2000; Gross and Lane 1999; Rassaf et al. 
2002). Nitric oxide may additionally/alternatively bind to the FE II heme group of 
deoxyhemoglobin to form nitrosylhemoglobin, or it may react with cysteine-93 of the β-
globin forming S-nitrosohemoglobin (SNO-Hb) (Gladwin et al. 2000; Gross and Lane 1999; 
Rassaf et al. 2002). If nitric oxide is fixated by hemoglobin, it will be brought back to the 
pulmonary system and exhaled as a gas (Gladwin et al. 2000; Gross and Lane 1999; Rassaf et 
al. 2002). If nitric oxide is not fixated by hemoglobin and removed as a gas, it will decay into 
nitrite, increasing blood nitrite levels and affecting blood platelet activity (Park et al. 2013). 
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As such, the overall fractionation effect of nitric oxide (and its nitrogenous metabolites27) will 
depend on the rate of nitric oxide formation, fixation, and decomposition, and according to 
the site of inflammation (i.e. pulmonary tissues vs. muscular tissues etc.) and mirco-
environmental redox conditions (Kelm 1999). 
Research conducted on rats, a proxy for human systems, demonstrated a significant 
inter-tissue fractionation effect between the stable 15N and 14N isotopes from nitric oxide, 
nitrites and nitrates; blood plasma, serum, RBCs and urine being isotopically enriched with 
15N, and the trachea, liver, lungs, kidneys and muscle tissues being comparatively depleted 
(Kelm 1999). Results conclusively demonstrated that, while nitric oxide is rapidly fixated to 
RBC hemoglobin, neither nitric oxide nor its metabolites are stored in any tissue for 
significant periods of times (Kelm 1999). As such, like with atmospheric nitrogen, it is 
unlikely that nitric oxides (and its metabolites) will significantly affect the overall δ15N value 
of enamel apatite or bone collagen, since the effects are too acute to disrupt the average 
accumulation of stable nitrogen from other sources.  
While the fractionation effect of nitric oxide is unlikely to significantly affect the 
δ15N values of skeletal tissues, the presence of nitric oxide (and its metabolites) may affect 
δ18O values. Nitric oxide, a known vasodilator, stimulates targeted increases in blood flow 
(Rimar and Gillis 1993; Weinberger et al. 1999). Despite increasing rates of oxygen 
transport, however, nitric oxide has been shown to reduce rates of cellular oxygen 
consumption by inhibiting CR (Beltran et al. 2000; Brown 2001; Brown and Borutaite 2001) 
affecting hemoglobin’s affinity towards oxygen (Stepturo and Zinchuk 2006), and decreasing 
rates of oxygen release (from methemoglobin) (Curry 1982; Gebara and Goetting 1994; 
Mansouri 1993). In both these situations, oxygen metabolization is decreased, even if oxygen 
saturation is high (Brown and Borutaite 2001). Rates of oxygen fractionation will therefore 
depend not only on rates of oxygen diffusion, fixation and metbolization, but also on rates of 
nitric oxide (and its metabolites) synthesis, decomposition, and area/chronicity of the 
inflammation.  
3. Contribution of Fractionation Factors to Isotopic Values 
        As mentioned, healthy systems preferentially diffuse, fixate and metabolize lighter 
stable isotopes since they require less energy to metabolize and because smaller isotopes 
                                                          
27 Metabolites are the intermediates and products of metabolism. In this case, nitrate, nitrite etc. are metabolites of nitric oxide.  
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diffuse more rapidly than larger ones (Epstein and Zeiri 1988; Heller et al. 1994; Heller et al. 
1996; Pflug and Schuster 1989; Schuster et al. 1994; Schuster and Pflug 1989; van Dam et al. 
2004; Zanconato et al. 1992). This creates a fractionation effect (even within healthy 
individuals), with certain tissues being depleted of lighter isotopes, and others enriched in 
them. The overall isotopic signature of any tissue, or tissue by-product, is therefore an 
average of the ratio of heavier to lighter isotopes within that sample.    
      The contribution of any given fractionation factor to the overall isotopic signature of 
tissues and tissue by-products during the process of TR can be exemplified with the formula  
 
 
where k1 (step 1) is representative of the diffusion rate of oxygen 
molecules through pulmonary membranes and k2 (step 2) is 
representative of the rate of oxygen fixation to hemoglobin (Hb) 
molecules (Epstein and Zeiri 1988) (fig. 25).  The fractionation 
factor (the degree to which fractionation of stable oxygen isotopes 
will occur) for step 1 is noted as σ1, and for step two as σ2 
(Epstein and Zeiri 1988) (fig. 27).  
According to the aforementioned equation, the overall 
fractionation of stable oxygen isotopes during TR depends on the 
relative rates of oxygen diffusion (k1) and fixation (k2) (Epstein 
and Zeiri 1998). If k1 is the inhibited process, it will dictate the 
overall fractionation of stable oxygen isotopes/molecules because 
the rate of pulmonary diffusion dictates the rate at which oxygen is 
fixated to hemoglobin (Epstein and Zeiri 1988). If k2 is the 
disrupted process, it will control the overall fractionation of stable oxygen isotopes because 
non-fixated oxygen will simply diffuse back and forth through pulmonary membranes, 
neutralizing the fractionation effect of k1 (Epstein and Zeiri 1988). The slower the reaction 
rate, the more influence it has on the overall fractionation process, and thus the isotopic 
composition of associated tissues and tissue by-products (Widory 1999).  
If rates of k1 and k2 are comparable, then the δ18O signature of the TR process will 
be the result of a combination of σ1 and σ2 (Epstein and Zeiri 1988). Thus, the overall 
Fig. 27: Pulmonary and 
Vascular Points of 
Isotopic Fractionation 
(Carroll 2015; image 
after Integrated 
Publishing Inc. 2014). 
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fractionation experienced by stable oxygen isotopes during TR will either be controlled by/be 
the result of one of three processes; (1) the relative rate of oxygen diffusion through 
pulmonary membranes; (2) the relative rate of oxygen fixation to RBC hemoglobin (i.e. 
hemoglobin’s affinity towards oxygen); or (3) the relative rates of both oxygen diffusion and 
fixation at equilibrium (Epstein and Zeiri 1988; Widory 2004). While the aforementioned 
equation does not mention the rate of oxygen metabolization during CR, the same basic 
principles apply, with slower reaction rates increasing isotopic fractionation and faster 
reactions decreasing it (Epstein and Zeiri 1988; Widory 19999; Zanconato et al. 1992).   
Using a modified Epstein and Zeiri (1988) equation for blood carbons and nitric 
oxides (instead of oxygen), it is possible to deduce that, like with stable oxygen fractionation, 
the overall fractionation of stable carbon and nitrogen isotopes during TR will be controlled 
by/be the result of; (1) the relative rate of blood carbon and nitric oxide anabolism and 
catabolism; (2) the relative rate of blood carbon and nitric oxide fixation by hemoglobin; (3) 
the relative rate of carbon dioxide and nitric oxide diffusion through pulmonary membranes; 
(4) the rate of all reactions at equilibrium.   
The probability of fractionation factors/effects being incorporated into long-term 
tissues like bone collagen and enamel apatite depends on numerous factors, including the 
chronicity and severity of the fractionation effect. Acute disturbances, such as those produced 
by nitric oxide, are unlikely to be assimilated into the organic and inorganic matrices of 
skeletal tissues, since they are not significant enough to alter the average accumulation of 
stable isotopes assimilated as a result of other processes/factors (like diet). Long term 
disturbances, such as those resulting from diseased hemoglobin, are more likely to be 
recorded since the fractionation effect is chronic and congenital.  
4. Hemoglobin: The Fixation of Oxygen, Nitrogen and Carbon Molecules in Sickle 
Cell and Thalassemia Anemia  
         The following section details how the pathophysiology of sickle cell and 
thalassemia anemia affects hemoglobin molecules, and by proxy, the diffusion, fixation, 
metabolization, and overall fractionation of stable oxygen, blood carbons and nitrogens.  
4.1 Hemolysis: Affects on Blood Oxygen, Carbon and Nitrogen Concentrations 
As mentioned throughout Chapter 3, healthy hemoglobin molecules are composed of 
four polypeptide chains, each capable of binding one molecule of oxygen, carbon dioxide or 
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nitric oxide (for a total of four oxygen, four nitric oxide, or four carbon dioxide molecules per 
hemoglobin molecule) (Berg et al. 2002; Tortora and Derrickson 2012). On average, 250-270 
million hemoglobin molecules exist within each human RBC, making every healthy RBC 
capable of carrying approximately one billion molecules of oxygen, carbon dioxide or nitric 
oxide (Berg et al. 2002; Tortora and Derrickson 2012; Sanders 2011). This allows healthy 
RBCs to efficiently deliver oxygen to, and remove blood carbons and nitric oxides from, 
every cell in the human body (Berg et al. 2002; Gnaiger et al. 1995; Lajtha et al. 2007; 
Tortora and Derrickson 2012). These blood-gas transport mechanisms are crucial, since 
without appropriate oxygenation most cells28 are incapable of producing ATP and will 
eventually die (Berg et al. 2002; Lenihan and Taylor 2013; Mazure and Pouyssegur 2010). 
Similarly, without appropriate detoxification, blood carbon and nitric oxide concentrations 
will increase, affecting blood pH, platelet activity, and inducing a number of 
cardiorespiratory complications and other sequalae (Bohr 1904; Glatte et al. 1967; 
Lambertson et al. 1971; Langford 2005; Morgan et al. 2005; Weinberger et al. 2000) 
In healthy individuals, cellular death as a result of insufficient oxygen supply and/or 
carbon dioxide and nitric oxide toxicity is rare, as those with healthy RBCs (quality and 
quantity) and functioning hemoglobin molecules are capable of effectively binding and 
transporting oxygen, blood carbons and nitric oxides throughout the body (Maton et al. 1993; 
Suresh 2006; Tomaiuolo 2014). If a state of disequilibrium does occur, the healthy body is 
able to effectively manage and mediate disturbances, and return to a state of equilibrium 
without inducing a cascade of compensations and co-morbidities. In individuals with sickle 
cell and/or thalassemia anemia, however, the hemoglobin molecule is mutated, changing the 
oxygen binding capacity and transport ability of affected RBCs (Chen et al. 2011; Perisano et 
al. 2012) (see Chapter 3). While this mutation does not affect blood carbon or nitric oxide 
fixation sites, it affects the overall morphology of the molecule and RBC, leading to, among 
other issues, easily ruptured RBC membranes (see Chapter 3).  
On average, sicklic and thalassemic RBCs lyse (rupture) approximately 90-100 days 
earlier than healthy RBCs, necessitating the formation of new RBCs (which will also lyse 
within 10-20 days of formation) (Koury 2014; Shemin and Rittenberg 1946). This type of 
chronic, frequent, hemolysis has been shown to induce inflammation and decrease RBC 
oxygen saturation and metabolization (Ahmed et al. 2005; Sison 2005; Yale et al. 2000). As 
                                                          
28 With the exception of muscle cells, which may temporarily convert to anaerobic respiration (no oxygen required) (di Prampero and Ferretti 
1999; Margaria et al. 1964; Saladin 2011) 
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a consequence, this will also affect rates of blood carbon fixation and diffusion, as per the 
Haldane29 (1895) and Bohr effects30 (1904).   
Hemolysis primarily affects blood oxygen, carbon and nitrogen concentrations in the 
following ways; firstly, RBC death reduces the overall number of hemoglobin molecules 
available for both oxygenation and detoxification, since hemoglobin does not function 
outside of the RBC (Koury 2014; Shemin and Rittenberg 1946). As sicklic and thalassemic 
hemoglobin molecules already have an inhibited ability to bind oxygen, uncompensated 
hemolysis will severely impact the rate of oxygen fixation and metabolization. This may 
result in states of hypoxemia or hypoxia, since the oxygen saturation of arterial blood (which 
‘feeds’ cells and tissues) will be reduced as a direct consequence of low/inadequate 
hemoglobin concentrations (Colledge et al. 2010; Eckman 2010; Robinson et al. 2009; West 
1977).  This may induce a range of inflammatory responses, which, in turn, elicits the 
synthesis of nitric oxide. As mentioned previously, this may increase oxygen metabolization 
by encouraging vasodilation, or it may reduce oxygen fixation and metabolization by 
monopolizing hemoglobin and inhibiting oxygen release.   
Hemolysis will also have an adverse affect on blood carbon fixation. In severe 
anemics, low concentrations of hemoglobin have been shown to cause up to a 50% reduction 
in carbon dioxide elimination, increasing the concentration of dissolved carbon dioxide and 
bicarbonates in the blood (Bidani and Crandall 1982; Hill et al. 1973). As concentrations of 
dissolved carbon dioxide are in equilibrium with carbonic acid, increases in dissolved carbon 
dioxide will drive concentrations of carbonic acid up, decreasing the pH and acidifying the 
blood (Bohr 1904; Kato et al. 2005). As hemoglobin’s affinity for oxygen is inversely related 
to the acidity of the blood (Bohr et al. 1904), high concentrations of blood carbons will 
reduce oxygen fixation. Since deoxygenated hemoglobin has a higher affinity to both carbon 
dioxide and nitric oxide than it does to oxygen, blood carbons and nitric oxides will be 
preferentially fixated, further decreasing tissue oxygenation.  
 In addition to decreasing hemoglobin concentrations, hemolysis causes an increase in 
vascular carbon monoxide concentrations (since carbon monoxide is a product of RBC lysis). 
As with nitric oxide, carbon monoxide and oxygen compete for the same binding sites on 
deoxyhemoglobin. Hemoglobin’s affinity for carbon monoxide, however, is roughly 230 
                                                          
29 Deoxygenated hemoglobin has a higher capacity to fixate carbon dioxide, while oxygenated hemoglobin has a reduced capacity for fixating 
carbon dioxide (Haldane 1895). 
30 Hemoglobin’s affinity for binding oxygen is inversely related to the acidity of the blood, and to the concentration of carbon dioxide, with 
increasing carbon dioxide concentrations causing a decrease in oxygen fixation and vice versa (Bohr et al. 1904; Ueda 1979). 
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times stronger than its affinity for oxygen, allowing carbon monoxide to monopolize oxygen 
fixation sites (Bateman 2003; Ganong 1995; Gorman 1991). Healthy systems, which shed 
RBCs every 110-120 days (Koury 2014; Shemin and Rittenberg 1946), are capable of 
removing small amounts of carbon monoxide without severely inhibiting oxygen fixation, 
since there are enough hemoglobin molecules available to compensate for the monopolization 
of oxygen binding sites. Sicklic and thalassemic RBCs, however, are less capable of 
mitigating carbon monoxide monopolization, since not only is more carbon monoxide 
released as a result of frequent hemolysis, but there are also less (quality and quantity) 
oxygen binding sites available to compensate for the preferential assimilation of carbon 
monoxide (Bateman 2003; Ganong 1995; Gorman 1991). As such, the monopolization of 
hemoglobin by carbon monoxide restricts oxygen saturation, causing an increase in 
deoxygenated RBCs, a decrease in tissue oxygenation, and acute alterations in rates of CR 
(Bateman 2003; Ganong 1995; Gorman 1991; Gorman et al. 2003) (fig. 28). Like with nitric 
oxide, even if hemoglobin is not completely monopolized by carbon monoxide, the bonds 
formed between carbon monoxide and hemoglobin are so strong that hemoglobin will retain 
oxygen molecules (Gorman et al. 2003). As such, rates of oxygen delivery and 
metabolization are altered compared to non-hemolytic individuals (Gorman et al. 2003) (fig. 
28).  
While carbon monoxide is known to monopolize hemoglobin, it has been shown to 
have a positive effect on sicklic RBs. Research on transgenically modified, sicklic mice has 
shown that carbon monoxide reduces hemoglobin polymerization (sickling) and vaso-
occlusion by preventing RBC lysis, adhesion and inflammation, and encouraging 
vasodilation (Belcher et al. 2013). Increased RBC life spans, lack of sickling, and reduced 
clotting will all have an effect on oxygen, blood carbon, and nitric oxide concentrations. As 
such, the rate/degree of isotopic fractionation (as a consequence of the presence of carbon 
monoxide) will depend on if carbon monoxide has a deleterious, or positive, effect on an 
individual’s physiology.  
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Finally, hemolysis may affect oxygen, blood carbon and nitric oxide concentrations 
by inducing a state of hypercoagulability; a condition characterized by an abnormally 
increased tendency for RBCs to adhere to one another, forming excessive, non-reparative 
clots (Ataga 2009; Ataga and Orringer 2003; Gladwin and Kato 2008; Helms et al. 2013). 
Non-hemolytic hypercoagulability has also been linked to other pathophysiological factors, 
such as the overall properties of sicklic and thalassemic RBC membranes, and the increased 
propensity for the production of tissue factors, platelets, thrombin and fibrin31 Ataga 2009; 
Ataga and Orringer 2003; Gladwin and Kato 2008; Helms et al. 2013). Regardless of the 
exact mechanisms of clot formation, clots may become mobilized within the arterial and 
venous systems, growing large enough to occlude blood vessels and restrict circulation. If the 
clot continues to restrict the flow of blood, tissues downstream of the occlusion will be 
deprived of oxygen, impairing rates of CR (Ataga 2009; Ataga and Orringer 2003; Gladwin 
                                                          
31 The enzymes, proteins and blood products which initiate coagulation, the process which changes blood from a liquid to a gel through the 
activation, adhesion and aggregation of platelets, and the formation of fibrin.  
Fig. 28: The effects of hemolysis and carbon monoxide fixation on oxygen fixation, diffusion and tissue oxygenation 
(Carroll 2015; Images after chemistryland.com 2014; dssimage.com 2014). 
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and Kato 2008; Helms et al. 2013). If clots form in, or travel to, the pulmonary system, 
oxygen saturation, as well as the rate of oxygen and blood carbon diffusion through 
pulmonary membranes may also be affected.  
4.2. Inflammation:  
 As previously mentioned, inflammation promotes the creation of nitric oxide, which 
(like with carbon monoxide) may have a deleterious or positive effect on oxygen diffusion, 
fixation and metabolization, either by increasing vaso-dilation, or monopolizing oxygen 
binding sites (Gladwin et al. 2000; Gross and Lane 1999; Rassaf et al. 2002). It was noted in 
section 2.2.3 that nitric oxide may react with oxyhemoglobin to form methemoglobin and 
nitrate. In healthy individuals, methemoglobin concentrations are usually <1%, since nitric 
oxide concentrations are low in non-inflammatory conditions (Gladwin et al. 2000; Gross and 
Lane 1999; Rassaf et al. 2002). In disorders characterized by oxidative stress (like sickle cell 
and thalassemia anemia) however, concentrations of methemoglobin are increased since 
inflammation is more common, and overwhelmed RBCs will convert ferrous ion (Fe2+ ) heme 
groups to ferric iron (Fe3+) heme groups (i.e. convert oxyhemoglobin to methemoglobin) 
(Gladwin et al. 2000; Gross and Lane 1999; Rassaf et al. 2002). As methemoglobin has a low 
affinity towards fixating and releasing oxygen, increased concentrations of methemoglobin 
will further reduce rates of oxygen fixation and metabolization, inducing a fractionation 
effect not present in healthy individuals (Gladwin et al. 2000; Gross and Lane 1999; Rassaf 
et al. 2002).   
4.3. Summary:  
Hemolysis and inflammation, as well as other pathophysiological processes inherent 
within sickle cell and thalassemia anemia may effect one, or multiple points, of stable isotope 
fractionation by altering the rates of stable oxygen, nitrogen and blood carbon diffusion and 
fixation, and metabolization. If these effects are chronic, or induce enough of a fractionation 
effect to significantly alter the average ratio of stable isotopes in bone collagen and/or non-
mineralized dental enamel, then the isotopic signatures of sicklic and thalassemic individuals 
should be significantly different compared to those without a hemolytic and/or inflammatory 
disorder  
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5.  Total Respiration: Cardiorespiratory Complications and Rates of Oxygen and 
Carbon Diffusion and Fixation:  
 
As TR involves both the cardiovascular and pulmonary systems, the rate at which 
cells become oxygenated and deoxygenated is highly dependent on cardiac output (beats per 
minute), respiration rate (breaths per minute) and blood pressure (Campbell et al. 1999; 
Lubert 1995; Tortora and Derrickson 2012). Clinically, healthy children average between 18-
40 breaths and 80-120 heart beats per minute32, with average blood pressure33 (systolic over 
diastolic) ranging between 109-127 over 72-83 in boys, and between 108-126 over 71-82 in 
girls (DeBoer 2004; Lindh et al. 2009). Healthy individuals over the age of 12 years old 
average between 12-20 breaths and 60-100 beats per minute, with blood pressure averaging 
around 120 over 80 (at rest) (Ganong 1995; Lindh et al. 2009). This means that, while inter 
and intra-individual variations in oxygen and carbon dioxide supply and consumption exists 
even within healthy individuals, the physiological processes which mediate stable isotope 
fractionation are at equilibrium, reducing chronically aberrant fractionation patterns/rates. As 
such, healthy individuals with the same relative amounts of stable oxygen and carbon isotope 
input and output should have statistically similar stable isotope values in their osteological 
tissues, since no significant internal mechanisms are chronically altering normal fractionation 
patterns.  
Due to the pathophysiology of sickle cell and thalassemia anemia (see Chapter 3), 
average rates of TR are adapted. In order to maintain equilibrium and adequately oxygenate 
and detoxify tissues, various physiological mechanisms are triggered. These include; (1) 
increasing the rate of TR in order to expedite the rate at which oxygen is brought into the 
system, and waste products are removed; (2) inciting RBC proliferation in order to increase 
the number of hemoglobin molecules available for oxygen fixation and waste transport; 
and/or (3) increasing cardiovascular output (volume of blood pumped by the heart) in order 
to maximize the rate at which RBCs are oxygenated and circulated throughout the body 
(Batra et al. 2002; Colledge et al. 2010; Liumbruno et al. 2009; van der Linden 2007). As a 
result of one or more of these compensations, sicklic and thalassemic children average over 
40 breaths per minute, with adults averaging over 23 breaths per minute, at rest (Karimi et al. 
2006; Santiago 2009). As previously mentioned (section 2.2.1), overall rates of TR will have 
                                                          
32 at rest; ages 1 to 12 yrs 
33 at rest; aged 6 to 12 years old 
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a significant effect on isotopic fractionation, with increased respiratory/metabolic rates 
reducing fractionation, and decreased respiratory/metabolic rates increasing it.   
The aforementioned compensation mechanisms (and therefore the rate/degree to 
which stable isotopes are fractionated) may be chronic or acute in nature, and may occur as a 
single or multi-systemic response depending on the nature and severity of oxygen 
deprivation, as well as the concentrations of dissolved carbon monoxide, nitric oxide and 
blood carbons (Batra et al. 2002; Colledge et al. 2010; Liumbruno et al. 2009; van der 
Linden 2007). While potentially life-saving, these compensations may induce a range of 
sequelae and co-morbid complications (Audard et al. 2010; Batra et al. 2002; Bayar et al. 
2014; Cavallaro et al. 1993; Dessap et al. 2008; Gladwin and Sachdev 2012; Kardelen et al. 
2008; Linguraru et al. 2009; Parent et al. 2011; Pegelow et al. 1997; Rao et al. 2011; Shatat 
et al. 2013), further influencing the rate at which oxygen, nitric oxide and blood carbon are 
diffused, fixated and metabolized, and stable isotopes fractionated.  
Tachycardia (increased heart rate; over 100 beats per minutes), arrhythmias (irregular 
heart beat), systemic hypotension (low blood pressure; below 90/60), and pulmonary 
hypertension (increased pressure in the pulmonary arteries) are common complications of 
sickle cell and thalassemia anemia, and result from ineffectual compensation mechanisms 
(Bayar et al. 2014; Cavallaro et al. 1993; Dessap et al. 2008; Kardelen et al. 2008; Pegelow 
et al. 1997; Rao et al. 2011). As such, not only are the average rates of stable isotope 
diffusion, fixation and metabolization affected as a result of chronic hemolysis and 
inflammation, but the overall rates of TR are adapted as a result of compensations and 
complications of those compensation. For example, chronic hypotension may contribute to 
states of hypoxemia and hypoxia, as the force with which blood is flowing to the body’s 
tissues is insufficient to allow adequate, efficient, oxygenation and detoxification (Loftus 
2011; Manley et al. 2001). Similarly, tachycardia and arrhythmias may also inhibit tissue 
oxygenation and detoxification, as blood is ineffectually pumped at such a rapid and/or 
irregular pace (Tortora and Derrickson 2012). Pulmonary hypertension (high blood pressure 
in the pulmonary arteries), a well-known complications of sickle cell and thalassemia anemia 
(Audard et al. 2010; Linguraru et al. 2009; Parent et al. 2011; Shatat et al. 2013), may further 
affect the rate at which RBCs become oxygenated and deoxygenated, as damage to the walls 
of arteries and arterioles supplying the lungs, as well as thickening and enlargement of the 
right cardiac ventricle, decreases the rate of oxygen diffusion, and inhibits the transfer of 
oxygen and waste gases to and from the blood stream (Batra et al. 2002). Other pulmonary 
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complications characteristic of sicklic crises, such as Acute Chest Syndrome, fat embolisms 
and pulmonary edemas will similarly inhibit the diffusion of oxygen and blood carbons in 
and out of the body (Barrett-Connor 1973; Johnson and Verdegem 1988; Vinchinsky et al. 
1994).  
In addition to cardiorespiratory compensations, the hematopoietic system may also 
react to chronic oxygen deficiency and the decreased life expectancy of sicklic and 
thalassemic RBCs by increasing the rate at which RBCs are formed (Gumbs et al. 1987; 
Koller et al. 1992; Travlos 2006; van der Linden 2007). If the proliferation of these new 
RBCs becomes too rapid, however, the blood will become hyper-viscous, making it difficult 
to circulate effectively or diffuse efficiently (Basseman 1977; Castro 1981; Crielaard and 
Rivella 2014; Thomas 2001). This may predispose individuals to various inflammatory 
processes, and potentially the local overproduction of nitric oxide. Therefore, as opposed to 
increasing oxygenation, the creation of too many RBCs will further reduce RBC and tissue 
oxygenation, reinforcing cyclic compensation mechanisms and co-morbidities, both of which 
alter fractionation patterns by changing the rates at which oxygen, nitrogen and carbon 
dioxide are supplied, consumed and eliminated.  
Regardless of the exact nature and degree of cardiovascular and/or respiratory 
pathophysiologies, stable oxygen, nitrogen and carbon dioxide supply, consumption and 
elimination in severely anemic individuals is non-analogous to that of non-anemic, healthy 
individuals. This is due to the fact that, while the same levels of oxygen may be inhaled, 
hypo/hypertension, altered cardiorespiratory rates, polycythemia, abnormal hemoglobin, 
aberrant RBC membranes, carbon monoxide and nitric oxide monopolization of binding sites 
(etc.) inhibits oxygen diffusion, fixation and metabolization. As oxygen saturation and 
hemolysis (etc.) have a direct effect on the rate of blood carbon supply, assimilation and 
elimination (Bohr et al. 1904; Haldane 1895; Ueda 1979), levels of blood carbon will also be 
non-analogous between severe anemics and non-anemics. This will change the rate at which 
stable oxygen and carbon isotopes are fractionated, leading to significant differences in stable 
isotope values between the two groups, at least in certain tissues/by-products (Butz et al. 
2014; Epstein and Zeiri 1988; Heller et al. 1994; Kohn 1996; Pflug and Schuster 1989; 
Reitsema and Crews 2013; van Dam et al. 2002; Widory 2004; Zonconato et al. 1992).   
 
 
 
   86 
 
6. Discussion  
 
6.1. Stable Isotope Fractionation in Anemics: Hypotheses  
     In healthy individuals, the overall fractionation of stable isotopes (during TR) is 
primarily determined by the combined fractionation effect of all reactions at equilibrium. 
This can be exemplified by the formula 
Oσ = k1 + k2 + k3 
where Oσ represents the overall fractionation factor,  k1 represents the diffusion of oxygen 
through pulmonary membranes, k2 represents the fixation of oxygen to hemoglobin and k3 
represents the metabolization of oxygen during CR. In those with sickle cell and thalassemia 
anemia, however, k1, k2 and/or k3 may be inhibited. Given the pathophysiology of 
homozyogotic anemia, the primary point of fractionation (and thus the rate controlling step) 
is likely to be K2, since anemics will always have inhibited oxygen fixation. As such, it can 
be assumed that 
Oσ = k2  
since unfixated oxygen will diffuse back and forth through the pulmonary membranes, 
neutralizing the effects of k1, and, once released from hemoglobin, cells will metabolize all 
available oxygen, neutralizing the effects of k3.  
If complications such as pulmonary hypertension, Acute Chest Syndrome and 
pulmonary vaso-occlusion occur, fractionation may be dominated by k1. This will only occur 
if the rate of diffusion into or out of the pulmonary membranes is more inhibited than the rate 
of oxygen fixation, since it is the most inhibited process which is most influential in 
determining the overall fractionation effect. Similarly, in cases of ischemia, hypoxia, 
inhibited oxygen release from hemoglobin (etc.), the overall fractionation of stable 
isotopes/molecules may be dominated by k3, since CR will be the most inhibited process. 
This is likely only to be a local and acute response, since long-term CR impairment will 
invariably cause cell/tissue death (Brown and Borutaite 2001), which will eventually prove 
fatal if not reversed. As such, the development of sequlae and degree of cardiorespiratory 
compensations are likely extraordinarily influential in determining the overall fractionation of 
stable isotopes, since certain compensations/sequelae may increase oxygen fixation (no 
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longer making it the most inhibited process), and/or decrease oxygen diffusion or 
metabolization (making them the most inhibited process). As such, it is likely that stable 
oxygen isotope values will be extremely variable within and between anemics, since the 
development and degree of sequelae/compensations vary between individuals, and 
throughout the course of a lifetime.   
The isotopic values of heterozygotes are hypothesized to be the result of relative rates 
of k2, or all reactions at equilibrium. Since heterozygotes have both pathological and healthy 
RBCs, the overall fractionation factor should depend on whether the relative rates of 
hemoglobin fixation are more inhibited than diffusion and metabolization, or whether all 
three are at equilibrium. This is likely to vary between the two, since heterozygotics may still 
experience acute and/or chronic sicklic and thalassemic complications.  
For the purposes of this research, it is hypothesized that the step which controls the 
total reaction rate for blood carbon isotope fractionation (during TR) is a modified k1 step 
(Epstein and Zeiri 1988), where k1 represents the rate of diffusion of carbon dioxide across 
pulmonary membranes. This is due to the fact that, while sicklic and thalassemic mutations 
alter the structure of the hemoglobin molecule, the binding sites for blood carbons is 
unaffected. As such, the fixation of blood carbons to hemoglobin is primarily influenced by 
blood pH, the concentration of carbon monoxide in the system, and the amount of 
hemoglobin available for fixation (determined by the rate of RBC death and formation). This 
will vary between, and even among, anemics and may not be significant enough of a factor to 
determine the overall fractionation rate of stable carbon isotopes during TR. The diffusion of 
blood carbons across pulmonary membranes, however, is likely to be a significant factor in 
individuals attempting to compensate for low blood oxygen by inducing compensations 
which ultimately decrease oxygen diffusion, as well as those experiencing pulmonary co-
morbidities. As such, the fractionation of carbon is likely to reflect (and vary between) 
decreased rates of respiration, or the decreased ability of blood carbons to diffuse through 
pulmonary membranes as a result of complications such as alveolar destruction, Acute Chest 
Syndrome, and pulmonary embolisms (etc.). This is thought to be especially relevant in cases 
of homozygotic anemia, since pulmonary complications are common, chronic, and severe 
(Audard et al. 2010; Barrett-Connor 1973; Johnson and Verdegem 1988; Linguraru et al. 
2009; Parent et al. 2011; Shatat et al. 2013; Vinchinsky et al. 1994).  
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Overall, due to the complex nature of sickle cell and thalassemia anemia/trait, it is 
hypothesized that the primary point of fractionation, as well as the rate at which stable 
oxygen and carbon isotopes are fractionated, will vary depending on the nature and severity 
of the condition, compensations and co-morbidities. In other words, since the 
pathophysiology of anemic complications are widely varied, and inter and intra-individual 
variations in compensation mechanisms exists, the stable oxygen and carbon isotope ratios of 
anemics are likely to be a mix of disturbed k1, k2, and/or k1 and K2 fractionation events. The 
contribution of each of these fractionation factors is likely to depend on the individual, the 
tissue type, and the time of sampling (e.g. in-vivo vs. ex-vivo; while experiencing 
compensation mechanisms etc.). Thus, while all anemics will have altered oxygen fixation 
patterns when compared to non-anemics, inter-individual variation between anemics may 
also exist, reflecting individual pathophysiological responses to the same disease.  
6.2. Anemia Related Stable Isotope Fractionation in Archaeological Populations: 
    In archaeological populations, it is hypothesized that the isotopic signatures of organic 
(bone collagen) and inorganic (enamel apatite) tissues will primarily reflect k2 fractionation 
rates. This is due to the fact that, without access to modern health care, severe pulmonary 
conditions are likely to have been fatal. Therefore, a k1 dominant fractionation mechanism is 
highly unlikely, since the condition would have had to be more inhibited than oxygen 
fixation, yet chronic enough to be assimilated into bone collagen and/or enamel apatite. 
Similarly, in order to appear in the enamel apatite values, the pulmonary condition would 
have had to have occurred in sub-adulthood, since enamel ratios are representative of the 
stable isotopes imbibed during the time of enamel formation (see Chapter 2). A child with 
such a condition is unlikely to have survived long enough (Fitzhugh et al. 2010) to 
incorporate diffusion dominant shifts into their enamel in sufficient enough quantities to 
replace fixation dominant effects. If inhibited diffusion processes are chronic, but not severe 
enough to prove fatal, then stable isotope values may be the result of a mixed k1/k2 
fractionation pattern. More then likely however, the primary contributor to the stable oxygen 
isotope ratios in the organic and inorganic tissues of archaeological Anemics is thought to be 
an inhibited k2 process, since reduced oxygen fixation is the primary, chronically 
pathological feature of sickle cell and thalassemia anemia. Despite which process is the most 
severely inhibited, or which is the primary contributor to stable oxygen isotope values, 
anemics should have significantly different stable isotope ratios than non-anemics, and 
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heterozygotes, since at least one or more process(es) is inhibited, thereby altering normal 
fractionation patterns.  
 In terms of stable carbon isotope analyses, it is hypothesized that genetic anemias 
will not be visible in the archaeological record, due to the fact that bone collagen and enamel 
apatite is more likely to reflect dietary stable carbons and rates of protein metabolism 
(DeNiro 1985; DeNiro and Epstein 1978; Schoeninger 1985; Schoeninger and DeNiro 1984; 
van der Merwe and Vogel 1978; Vogel and van de Merwe 1977), and not the supply, 
consumption or elimination of blood carbons. This is due to the fact that, as with oxygen, any 
mechanisms which would have severely inhibited blood carbon diffusion would have likely 
been fatal, or not chronic enough to systemically imbibe adherently fractionated stable carbon 
isotopes. Similarly, as the fixation of carbon to blood hemoglobin is not affected by the sickle 
cell and thalassemia mutation (Tortora and Derrickson 2012), blood carbons are likely only 
to experience significant fractionation differences (when compared to non-anemics) if carbon 
monoxide levels are chronically high, and/or levels of RBCs are extremely high or low. 
Without medical intervention, these conditions would have also likely proven fatal (Fitzhugh 
et al. 2010), and therefore also would not be a significant enough factor to affect stable 
carbon isotope levels in osteological tissues.  
 It is hypothesized that stable nitrogen isotope analyses will be useful for identifying 
sickle cell and thalassemia anemia in the archaeological record, not because of differences in 
the supply and elimination of atmospheric nitrogen or in the over-production of nitric oxide, 
but because sickle cell and thalassemia anemia (and their sequelae) induce a number of 
complications which are known to affect whole body turnover (see Chapter 6). As such, like 
with stable carbon, it is not expected that TR will be the primary factor motivating stable 
nitrogen fractionation in sicklic and thalassemic individuals.  
7. Summary and Conclusions 
7.1 Summary:  
      The purpose of this chapter was to elucidate the physiological mechanisms of 
molecular and stable isotope diffusion, fixation, and fractionation during the process of TR, 
and to garner a more comprehensive understanding of how and why stable isotope ratios may 
vary between those with sickle cell and thalassemia anemia, and those without.  
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      The first half of this chapter dealt with TR and CR, the multi-step, systemic processes 
which enables humans to produce the energy required to survive. The supply, consumption 
and exportation of stable oxygen, blood carbon, and nitric oxide on molecules are influenced 
by three, overarching stable isotope fractionating factors, namely; (1) the rate at which stable 
isotopes/molecules diffuse through pulmonary membranes; (2) the affinity of hemoglobin to 
stable isotopes/molecules; and (3) the catabolism and anabolism of stable isotopes/molecules. 
Processes which inhibit, or increase, the rate at which any of these steps occur will therefore 
alter the rate of stable isotope fractionation, and affect stable isotope values.  
Throughout this chapter, it has been made clear that sickle cell and thalassemia anemia 
affects the overall rate at which the TR process occurs for four main reasons; (1) both 
conditions cause hemoglobin to mutate, affecting the sites where oxygen is fixated and 
thereby inhibiting effective RBC and tissue oxygenation; (2) sickle cell and thalassemia 
anemia are both hemolytic anemias characterized by the destruction of RBCs. Hemolysis 
further reduces the number of hemoglobin molecules available for oxygenation and 
detoxification, releases poisonous carbon monoxide, and may induce a state of 
hypercoagulability (etc.), all of which affect the supply, fixation and metabolization of blood 
oxygen and carbons; (3) in order to compensate for chronically low levels of blood oxygen 
(and other pathophysiologies), the body physiologically adapts by altering cardiorespiratory 
rates and/or proliferating RBCs, changing the rate at which TR occurs; and (4) co-morbidities 
resulting from the compensatory mechanisms may further decrease the body’s ability to 
import, fixate and eliminate oxygen and blood carbons, also altering the rate at which TR 
occurs. While non-anemics may also experience altered rates of TR, healthy individuals will 
only experience acute changes, and will therefore not fractionate stable isotopes in significant 
enough quantities, over enough time, for these changes to be assimilated into tissues with 
slower or inert turnover rates, such as bone collagen or dental enamel. Given that sickle cell 
and thalassemia anemia are genetically acquired, congenital conditions, they are more likely 
to induce chronic alterations to TR, hypothetically causing significant, systemic, alterations 
to stable isotope fractionation, when compared to non-anemics.   
7.2. Conclusions:  
Sickle cell and thalassemia anemia are known to affect the rate of TR, which affects 
the fractionation of stable isotopes. This has been repeatedly demonstrated in controlled 
studies on living populations, using expired air (Epstein and Zeiri 1988; Feldman et al. 1959; 
   91 
 
Heller et al. 1994; Heller et al. 1996; Lane and Dole 1956; Pflug and Schuster 1989; Schuster 
et al. 1994; van Dam et al. 2004; Zanconato et al. 1992). The question then becomes “if 
alterations to the rate of TR significantly effects stable isotope ratios in expired air samples, 
does it also affect stable isotope ratios in the organic and inorganic matrices of human 
skeletal tissues?” Using the information available, it is possible to hypothesize that it does, 
but that archaeological specimens will likely only reflect a portion of the pathophysiological 
processes which cause these alterations, because osteological tissues reflect chronic, and not 
acute, stable isotope ratios. Additionally, it is hypothesized that only stable oxygen isotope 
analyses will be able to assist in the diagnosis of sickle cell and thalassemia anemia, because 
stable carbon isotope ratios are more likely to reflect changes in diet, and not physiology.   
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CHAPTER FIVE:  
 
Literature Review: Metabolic Fractionation of Stable Oxygen and 
Carbon Molecules in Chronic Anemia 
 
This chapter investigates the validity and constraints of using stable isotope analyses 
as a tool for identifying genetic anemias in human skeletal remains by addressing whether 
previous biomedical studies have been successful in identifying chronic shifts in 
metabolism/physiology using inter and intra-individual variations in δ18O and δ13C values.  
Its primary purpose is to elucidate how alterations in the diffusion, fixation and/or 
metabolization of stable oxygen and blood carbon molecules during TR affects the isotopic 
values of tissues and tissue by-products. In doing so, this chapter seeks to provide 
archaeologists with a more comprehensive understanding of the complex nature of metabolic 
stable isotopic fractionation in humans, and provide the frameworks with which to approach 
seemingly anomalous isotopic values in individuals from the same communities (with or 
without obvious osteological lesions).   
The first and second sections amalgamate and critically assess previous biomedical 
stable isotope research which have assessed stable oxygen and carbon isotope fractionation in 
relation to TR, and/or hemoglobin concentration. Section one concentrates on the relationship 
between δ18O values and anemia, while section two focuses on the relationship between δ13C 
values and alterations in TR and metabolism. All articles are summarized, critiqued, and 
integrated into research-specific frameworks which take into account archaeological 
populations, and osteological tissues. The third and final section provides a review of the data 
presented, and discusses the biomedical conclusions within archaeological contexts.  
1. Stable Oxygen Isotopes  
 This section presents a review and critique of previous biomedical research which 
have analysed stable oxygen fractionation in relation to hemoglobin concentration and TR.  
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1.1. Oxygen Isotopes as a Biomarker for Sickle-Cell Disease? Results from 
Transgenic Mice Expressing Human Hemoglobin S. Genes (Reitsema and Crews 
2011): 
This 2011 article by Reitsema and Crews explores the relationship between sickle 
cell anemia and the ratio of δ18O in bone bioapatite, using transgenically34 modified mice 
expressing healthy or anemic human hemoglobin genes. A total of 24 mice, divided into three 
Types (fig.29), were raised in a controlled setting and then sacrificed for stable isotopic 
analyses. Type 1 mice (n=8) were 
modified to produce normal, healthy 
human hemoglobin (HbA) and acted as 
the control for which all other values 
were assessed. The two remaining sets 
of mice were genetically modified to 
express varying levels of the sickling 
trait, with the first set (Type 2, n=9) 
expressing sickle cell disease (45-90% 
human HbS globins, 8-55% fetal Hby hemoglobin), and the second set (Type 3, n=7) 
exhibiting sickle cell anemia (almost 100%35 HbS human hemoglobin) (Fig. Fancy face 
mice). It was hypothesized that mice suffering from sickle cell disease (Type 2) and sickle 
cell anemia (Type 3) would exhibit higher δ18O ratios in their bone bioapatite tissues when 
compared to the healthy mice (Type 1) due to reduced fractionation during TR (Reitsema & 
Crews 2011) (fig. 30).  Simply put, the authors hypothesized that, because the sickling trait 
inherently inhibits oxygen fixation by physiologically altering the hemoglobin molecule and 
its oxygen binding sites, the fractionation process would no longer preferentially metabolize 
the lighter 16O isotopes and would therefore incorporate more 18O isotopes into their systems, 
and tissues, than non-anemics (fig. 30).  
Upon the analysis of the bone bioapatite values from all three Types, it was 
concluded that both Type 2 (sickle cell disease) and Type 3 (sickle cell anemia) mice 
exhibited statistically lighter δ18O ratios than healthy (Type 1) mice36. It was also noted that 
                                                          
34 Transgenic refers an organism which has been artificially (i.e-by humans interference) implanted with the DNA of another, unrelated, organism 
through recombinant DNA techniques (the process of splicing genetic material from different organisms together). In this way, the genes of the 
unrelated organism are expressed within the genome of the genetically modified individual.  
35 Individuals had less than 4% Hby (fetal hemoglobin) 
36 Type 1 (healthy mice) had a value of -4.5 +/- 0.7 ‰, Type 2 (HbS + Hby) had a value of -5.5 +/- 0.5‰, and Type 3 (HbS) had a value of -5.8 +/- 
0.7‰.  
Fig. 29:  The three Types of genetically modified mice used by 
Reitsema and Crews (2011) (Carroll 2015; Images after 
dreamstime.com/stock-pictures-hairlessmouse 2014; 
faunatech.co.uk 2014). 
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mice expressing the highest percentages of the HbS hemoglobin gene (i.e. those with the 
most severe expression of sickle cell anemia) exhibited the lightest δ18O ratios (Reitsema & 
Crews 2011). In other words, those with the most inhibited oxygen fixation experienced the 
highest stable oxygen fractionation, leading to the preferential exclusion of 18O isotopes over 
16O isotopes. 
This was in sharp contrast to the author’s initial hypothesis, suggesting that the 
mechanisms for stable oxygen isotope fractionation in individuals with sickle cell 
anemia/disease may be more complex then previously ascertained. The authors’ surmised 
that the lighter δ18O values seen in the bioapatite of anemic and diseased mice may have been 
related to numerous factors, including low levels of physical activity and high levels of 
pulmonary vaso-occlusion (fig. 31). Research on stable oxygen isotope fractionation during 
and after physical stress, as well as in those with various pulmonary conditions, has clearly 
and repeatedly shown an inverse linear relationship between stable oxygen isotope 
fractionation and the level/intensity of physical activity (Epstein and Zeiri 1988; Kohn 1996; 
Fig. 30: Representation of the hypothesis originally purported by Reitsema & Crews (2011) (Carroll 2015; 
Images after dj003.k12.sd.us 2014; Encyclopaedia Britannica, Inc. 2014; fotolia.com 2014; PennMedicine.org 
2014). 
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Widory 2004; Zonconato et al. 1992). Simply put, the less exercise one engages in, or the 
more damage there is to the pulmonary alveoli the higher the rate of stable oxygen 
fractionation (Epstein and Zeiri 1988; Kohn 1996; Widory 2004; Zonconato et al. 1992).  In 
mice, as well as in humans, fatigue, cardiorespiratory distress, pain and even death are known 
complications of sickle cell anemia/disease, and contribute to a decreased desire and ability 
to engage in non-essential forms of exertion (Connes et al. 2011; Covitz et al. 1983; 
Machado et al. 2007; Paszty et al. 1997). As such, it is more then likely that the mice with the 
highest concentrations of sicklic hemoglobin (i.e-Type 3) did not engage in the same level or 
degree of physical activity as their healthy counterparts, as doing so was likely painful, 
distressing and/or unmanageable (Paszty et al. 1997). Given what is known about stable 
oxygen isotope fractionation and exercise, it is not a stretch to assume that those engaging in 
the least amount of exercise (Type 3) would have the lightest δ18O ratios, given the increased 
rate of fractionation associated with decreased activity levels.  
In addition to differences in activity levels between healthy, diseased and anemic 
mice, the authors hypothesized that the presence, and degree of pulmonary vaso-occlusion 
may have contributed to the overall fractionation effect (fig. 31). Research by Fabry et al. 
(1992) on transgenically modified mice with sickle cell anemia recorded approximately six 
times more hemoglobin (in the form of blood clots) in the lungs of anemic mice than in the 
lungs of control mice. Since increased concentrations of hemoglobin are known to increase 
isotopic fractionation (Pflug and Shuster 1989), the authors hypothesized that the coagulated 
RBCs in the pulmonary system may have provided the higher rates of hemoglobin needed to 
increase the fractionation of stable oxygen isotopes. Furthermore, while not specifically 
stated in the article, other pulmonary complications of sickle cell anemia, including 
pulmonary hypertension and pulmonary endothelial dysfunction have also been noted in 
studies on transgenically sicklic mice (Hsu et al. 2007). As described in Chapter 4, alterations 
in the way oxygen diffuses through the alveolar membranes into the capillary system will 
affect the overall rate of stable oxygen isotope fractionation. Since the mice with the highest 
ratio of sicklic hemoglobin are the most likely to experience cardiorespiratory side effects 
and/or vaso-occlusion, they are also the most likely to have inhibited oxygen diffusion, and 
thus the lowest δ18O ratios.  
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Despite the statistically significant differences in bone bioapatite δ18O ratios between 
sick and healthy Types, there were no significant differences in δ18O values between those 
expressing the HbS gene (sickle cell anemia) and those expressing the HbS + Hby genes 
(sickle cell disease). This suggests that, while sickle cell disease does appear to affect the 
assimilation of stable oxygen isotopes into skeletal tissues, it is not possible to differentiate 
between the type or the severity of the sickling trait using isotopic analysis alone (at least in 
transgenic mice). As a result of the non-linear relationship between δ18O ratios and %HbS the 
authors suggest that hemoglobin-specific fractionation is “not the only source of differences 
between the groups and that the complex etiology of [sickle cell disease] should be 
considered in greater detail.”(Reitsema & Crews 2011, 498).  As such, the authors implore a 
more comprehensive evaluation of how factors such as  “urine concentration ability, blood 
Fig. 31. Visual representation of the results set forth by Reitsema & Crews (2011) (Carroll 2015; Images after 
dj003.k12.sd.us 2014; Encyclopaedia Britannica, Inc. 2014; fotolia.com 2014; PennMedicine.org 2014). 
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pressure, oxygen dissociation of sickle cells, and other pleiotropic37 or epistatic38 effects of 
the sickle cell mutation” (Reitsema & Crews 2011, 498) alter isotopic ratios in and between 
tissues of individuals with sickle cell mutations. 
Overall, this study clearly demonstrates a relationship between sickle cell 
anemia/disease and δ18O values in the bone apatite of transgenically modified mice. The 
results suggest that, when compared to an appropriate control population, the diagnosis (but 
not differentiation) of sickle cell anemia/disease in human archaeological populations should 
be possible using stable oxygen isotope analyses. It must be remarked, however, that the 
results presented in this study are only representative of stable oxygen isotope partitioning in 
the bone bioapatie of transgenic mice, which have vastly different metabolic systems, 
exercise patterns and less diverse subsistence strategies than humans. As such, they do not 
represent a direct proxy for human subjects, and the mechanisms for stable oxygen isotope 
fractionation may not be directly comparable to those seen in humans with sickle cell 
anemia/disease.  
Additionally, while the mice in this study have been transgenically altered, it is 
important to recognize that the mouse’s own hemoglobin (which is produced in addition to its 
genetically modified hemoglobin) may have had an effect on the overall fractionation 
patterns seen. This is especially significant if the RBCs containing the mouse’s own 
hemoglobin (presumably unaffected by the sickling gene and able to efficiently bind oxygen) 
clotted alongside the sickled cells, since hypothetically this would lead to an increase in the 
quantity and quality of blood hemoglobin aggregates in the clot, thereby leading to an even 
more significant increase in stable oxygen fractionation.  
Finally, it is not known how long the mice were allowed to live prior to sacrifice, and 
therefore the results may be slightly skewed in favor of less statistically significant values 
between Type 2 and 3. It is possible that, if Type 2 and 3 mice were assessed upon a natural 
death (i.e-not sacrificed), they may have in fact had more significant differences in δ18O 
values due to the more chronic nature of the disease, and the increased rate at which Type 3 
mice would have had sickling crises leading to blood clots, pulmonary hypertension and 
other conditions. As such, while the results of the transgenic mouse model suggest that the 
                                                          
37 When a single gene controls or influences multiple, potentially unrelated, phenotypic traits. More information can be found in Chang, B. et al. 
2002. Retinal degeneration mutants in the mouse. Vision Research 42, 517–525 (2002) and; Lobo, I.. 2008. Pleiotropy: One Gene Can Affect 
Multiple Traits.Nature Education 1(1):10.  
38 When the effect/expression of one gene depends on the presence of one or more modifier genes. More information can be found in Cordell, 
Heather J. 2002. Epistasis: What it means, what it doesn't mean, and statistical methods to detect it in humans. Human Molecular Genetics 11 (20): 
2463–8. 
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severity of the sickling mutation cannot be ascertained isotopically, this does not necessarily 
hold true for a human model. Theoretically, if individuals suffering from severe sickling 
anemia (analogous to Type 3 mice) had multiple, non-fatal, clotting episodes and/or other 
chronic cardiorespiratory or hematopoietic pathophysiologies, it is possible that they would 
have significantly different stable isotope ratios than individuals who had no clotting 
episodes and/or only minor/acute symptoms (i.e.-heterozygotes). Additionally, since the 
article does not mention whether or not Type 2 or 3 mice developed osteological lesions, it is 
difficult to assess whether the sampling strategy used in this thesis (which sampled both 
pathological and non-pathological tissues) (see Chapter 6) will produce the same types of 
results afforded by Reitsema and Crews.   
1,2, Dependency of Overall Fractionation Effect of Respiration on Hemoglobin 
Concentration within Blood at Rest (Heller et al. 1994): 
Heller et al. (1994) examines the link between stable oxygen isotope fractionation 
and soft tissue pathophysiology, concentrating specifically on how δ18O varies between 
healthy individuals (i.e.-no medical conditions existing at the time of experimentation) (n=6) 
and those with anemia (of varying aetiologies) (n=6). The aim of the study was to elucidate 
the overall fractionation effect of various blood hemoglobin concentrations within blood at 
rest, by analysing inter-individual variations in the isotopic composition of expiratory air. 
Expired gases were considered to act as a proxy for δ18O values found within the blood, since 
they contain the end-products of the entire TR process. Therefore, any significant differences 
in δ18O values between and among groups would be representative of differences in the 
diffusion, fixation and/or metabolization of oxygen and blood carbons, one of the major 
physiological differences between anemics and healthy subjects.  
The expiratory gases from twelve individuals of known hemoglobin concentration 
were assessed in order to determine the overall fractionation effect associated with the 
diffusion, transport and metabolization of blood oxygen. Healthy and anemic patients were 
instructed to inhale air while in a seated position, hold their breath for a short period of time, 
and then exhale the resultant gases into a bag. The physiological (respiratory and circulatory) 
conditions of each subject were assessed in order to correct for non-hemoglobin related 
differences, which are known to affect rates of TR (see Chapter 4), and therefore stable 
isotope values. Samples of inhaled air (the control) and the expiratory gases from all twelve 
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subject were analysed, and the rate of fractionation associated with the fixation and 
metabolization of oxygen assessed by plotting δ18O values against hemoglobin concentration.  
Based on the results, the authors’ found a linear relationship (r=0.79) between overall 
hemoglobin concentration and the fractionation of stable oxygen isotopes, with the “values of 
[the] overall fractionation effect decreas[ing] with respect to a drop in hemoglobin 
concentration from 17.6 [(healthy)] to 6.6 [(anemic)] g/100mL…provided that values of 
overall fractionation effect were normalized as to exclude the influence of varying ventilator 
conditions.” (Heller et al. 1994, 760).  In other words, 16O was preferentially fixated over 18O 
in those with reduced hemoglobin concentration, leading to lighter δ18O values. These results 
are in line with the results achieved by the aforementioned Reitsema and Crews (2011) study.   
As with the Reistsema and Crews (2011) study, the authors remark on the complex 
nature of metabolic stable isotope fractionation, especially in regard to individual responses 
to anemia and changes in hemoglobin concentration. The authors note that chronic anemics 
compensate for the reduced oxygen carrying capacity through various mechanisms which 
alter the rate at which oxygen is diffused, fixated and metabolized (Chapter 4). In this study, 
anemic participants showcased increased cardiac rates (96.6 min-1) and output compared to 
healthy subjects (84.7 min-1), a way to compensate for reduced oxygen transport. Increased 
cardiac output and/or enhanced oxygen release from RBCs to tissues, as well as 
cardiorespiratory co-morbidities such as tachycardia (initiated once hemoglobin 
concentrations drop below 8 g/100 mL), initiates an increase in blood flow resistance and/or a 
concentration difference between arterial and venous blood. While both blood flow resistance 
and arterial-venous concentration differences are known to be non-fractionating, they 
nonetheless affect the rate perfusion39, and therefore the rate of oxygen transport to tissues (a 
fractionating process). As such, in addition to the already complex array of factors 
influencing the fractionation of stable oxygen isotopes in anemics, non-fractionating factors 
such as differences in blood flow, blood flow redistribution, and the rate of perfusion (etc.) 
must also be taken into consideration when comparing the isotopic values of anemics to other 
anemics, and to healthy individuals. Despite this complexity, however, it does appear that 
anemics will preferentially assimilate 16O over 18O, and that they will do so at higher rates 
than healthy individuals, causing anemics to have lighter δ18O values in comparison.  
                                                          
39 The process of delivering blood to a capillary bed 
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While this research focuses specifically on stable oxygen fractionation within the 
expiratory gases of healthy and anemic subjects (at rest), the authors clearly demonstrate that 
reduced hemoglobin concentration correlates to lighter δ18O values, and that alterations at one 
or more points of fractionation will have an effect on the isotopic composition of the entire 
TR process. While the article does not specifically state this, it is possible to hypothesize that, 
like with the Reitsema and Crews (2011) study, the effect of chronically reduced oxygen 
diffusion, fixation and/or transport will be visible within the inorganic and organic matrices 
of skeletal tissues. This is due to the fact that, if the body’s tissues are continually receiving 
higher quantities of the lighter 16O isotopes, they will become enriched with 16O. If this is the 
case, anemia may be visible in the archaeological record using stable isotope analyses, so 
long as appropriate controls are in place. Additionally, it may be possible to determine which 
individuals had the lowest concentrations of hemoglobin based on δ18O values (i.e. highest 
vs. lightest), and use other archaeological methods to determine the cause and physical/social 
effects of such a condition. More research into this avenue of investigation is required. 
1.3. Oxygen and Carbon Isotopic Compositions of Gases Respired by Humans 
(Epstein and Zeiri 1988): 
This article by Epstein and Zeiri (1988) presents a comprehensive overview of stable 
oxygen isotope fractionation within healthy and diseased human systems. Primarily, the 
article details the respiratory mechanisms responsible for the partitioning of stable oxygen 
isotopes throughout the human body, focusing on the two key points of fractionation 
associated with TR--the diffusion of gaseous oxygen throughout pulmonary membranes and 
the transport of dissolved oxygen via the hemoglobin molecules found within RBCs. The aim 
of the study was to evaluate how hemoglobin concentration alters δ18O ratios in individuals 
of various sexes, ages, and weights, as well as in those with anemia (of various aetiologies). 
In this way, the authors hoped to elucidate the mechanisms of oxygen isotope fractionation 
within and between individuals of various backgrounds, and physiologies.  
 Breath samples from 14 healthy individuals, aged six to 64 years of age (both sexes) 
were taken for stable isotope analyses and compared to the respired air samples obtained 
from 25 individuals with anemias of various aetiologies and severities. Subjects were asked 
to inhale an aliquot of atmospheric air (of known isotopic and chemical composition), and 
exhale the resulting gases at specified time intervals. The exhaled gases were then analysed 
via mass spectrometry, and inter and intra-individual variations in δ18O values were assessed. 
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Results indicated a dramatic decrease in δ18O values (~12‰ to 3‰) in individuals with 
reduced hemoglobin concentrations, indicating that subjects with anemia preferentially 
utilized 16O during TR. Results likewise indicated significant variations between individuals, 
which the author’s hypothesized to be related to differences in hemoglobin count and/or the 
rate of tissue oxidation40. In other words, both the rate of oxygen fixation and the rate of 
oxygen utilization during cellular respiration were posited as possible factors for inter-
individual variation of δ18O values in the expired air of both healthy and anemic subjects.  
In addition to variations among anemic and non-anemics, Epstein and Zeiri (1988) 
also noted higher rates of fractionation in smokers, when compared to non-smokers. As such, 
smokers exhibited lighter δ18O values, which signifies the preferential consumption of 16O 
over 18O. As mentioned throughout Chapter 4, oxygen diffusion through the pulmonary 
membranes is a point of fractionation, analogous to that of oxygen fixation. Thus, just as 
anemics have inhibited oxygen fixation capabilities leading to lighter δ18O values, smokers 
(who are clinically shown to have more damage to their airways than non-smokers) will have 
inhibited oxygen diffusion rates, leading to lighter δ18O values.  
Epstein and Zeiri (1988) conclusively showcase that oxygen isotope fractionation 
associated with TR varies significantly as a result of factors such as hemoglobin 
concentration in the lungs.  In spite of the foundational principles and conclusions associated 
with this article, however, it remains to be said that the authors did not specify which anemic 
conditions were assessed, nor did they indicate whether age, sex, weight or other co-
morbidities may have played a role in the values seen. This means that, while the authors 
reveal that ‘anemia’ does affect stable oxygen fractionation, they do not specify which 
pathophysiologies have the most effect on δ18O values, nor whether additional factors (like 
weight, which is difficult to assess archaeologically) contributes to the overall rate of 
fractionation.  This is of particular importance to this thesis, and future research, since as 
Heller et al. (1994) showcased, non-fractionating factors/mechanisms will influence 
fractionating ones, and understanding these factors may help elucidate the degree of stable 
isotope fractionation, and may help differentiate anemia from other pathological conditions 
(like leukemia, chronic obstructive pulmonary disease, malaria etc.) which likewise affect 
oxygen diffusion and fixation,  may produce similar osteological lesions, and may have been 
present in the sample population. Therefore, while this article is crucial for showcasing that 
                                                          
40 The loss of electrons during the metabolism of oxygen 
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hemoglobin and lung disorders are visible using stable oxygen isotope analyses, at least in 
respired air, it remains unclear whether this technique is feasible in archaeological 
populations, given the vast amount of pathological unknowns and the potential inability to 
differentiate between cardiorespiratory and vascular pathologies based on osteological lesions 
alone.   
In regards to the results concerning smokers and non-smokers, the authors indicate 
that smokers (N=3) preferentially consumed 16O, giving them lighter δ18O values. Despite 
this, however, three non-smokers had values within range of the smokers (-5.7, -6.1 and -6.4), 
two had lighter isotope values (-4.3, -4.9) and only one had heavier values (n=-7.4). This 
suggests that while differences are noted, they are not as significant as purported and may be 
due to individual variation or other factors, such as weight or differences in food/water 
consumption prior to experimentation. Since macromolecules like proteins, lipids and 
carbohydrates, as well as water, are all sources of oxygen isotopes, it is possible that the 
ingestion of different sources/quantities of these products prior to experimentation may have 
contaminated the results. This is especially relevant, given that store-bought foods are 
delivered from a variety of global locations, and those locations have different δ18O values 
depending on altitude, distance from the sea, and level of precipitation. Additionally, given 
the trophic level affect, those ingesting meat products prior to experimentation may have 
alternative δ18O values than those that consumed mainly vegetable products. Since no 
(mentioned) protocols were set in place to control for these variations, it is difficult to ensure 
that the values seen are truly the result of alternative lung function, or merely the result of 
differences in δ18O values from ingested macromolecules/water sources prior to 
experimentation. These factors, are of course, also an issue in archaeological populations, 
since differences in diet and migration will alter δ18O values in the organic and inorganic 
matrices of osteological tissues, making it difficult to determine which factors (diet, 
migration, anemia) are primarily influencing stable oxygen isotope fractionation, and 
therefore the overall δ18O values.    
Overall, this article highlights many factors foundational to stable oxygen isotope 
fractionation as a result of TR, and showcases that disruptions in oxygen diffusion, fixation 
and metabolization alters δ18O values in both anemics, and non-anemics. In specific regards 
to this thesis, it is clear that anemics do have lighter δ18O values than healthy non-anemics, as 
a result of inhibited fixation and metabolization processes, however it remains unclear 
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whether anemias may be differentiated from one another, or from other pathological 
conditions which also affect oxygen diffusion and fixation. 
2. Stable Carbon Isotopes  
This section presents a review and critique of previous biomedical research which 
have analysed stable carbon isotope fractionation in relation to hemoglobin concentration 
and/or TR. 
2.1. Carbon Isotope Fractionation between Blood and Expired CO2 at Rest and 
Exercise: (Panteleev et al. 1999): 
Panteleev et al. (1999) investigates the relationship between stable carbon isotope 
fractionation and levels of acute physical exertion, by examining how changes in activity 
levels enriches or depletes the δ13C values of blood and expiratory gases. The author’s 
hypothesized that, since the fractionation of stable carbon isotopes is known to occur between 
dissolved carbon dioxide and bicarbonate (which occurs after CR, when carbon dioxide is 
converted to bicarbonate for RBC transport) and between bicarbonate and gaseous carbon 
dioxide (for exhalation) (Mook et al. 1974), and that these processes discriminate against the 
heavier 13C isotope, a “reduction in this fractionation could contribute to the increase in 
13C/12C in expired air in response to prolonged moderate exercise.” (Panteleev et al. 1999, 
76). The authors also hypothesized that, since the majority (~90%) of dissolved carbon 
dioxide is fixated to RBC hemoglobin in the form of bicarbonate (Severinghaus 1965), the 
aforementioned fractionation effect would be visible in both the blood stream, and in aliquots 
of expired air.  
 In order to test this hypothesis, tests were conducted on six active, healthy, males 
between 22 and 24 years of age, with healthy BMIs. Subjects were asked to perform three 90 
minute exercise routes at 1 week intervals in a humidity and temperature controlled setting. 
Three days prior to the experiment, participants abstained from C4 plant carbohydrates, since 
the C4 photosynthetic pathway is a source of naturally enriched 13C (which could contaminate 
the δ13C values found within the blood). The evening prior to the test, subjects ingested a 
standardized meal of known carbohydrate, lipid, protein and energy content. After 30 minutes 
of exercise, participants ingested either 30 g of glucose in 300 mL of water, or 300 ml of 
water without glucose. In one trial, glucose was enriched (13C) with corn glucose (δ13C = -
10.9‰ PBD-1), while in the second trial it was enriched with 13C-glucose (δ13C = + 2.5‰ 
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PBD-1). Certain dietary controls were set in place in order to minimize the contribution of 
dietary stable carbon isotopes in the samples. The isotopic composition of blood and 
expiratory air samples from all six participants were assessed before and after each trial 
(n=3), in order to determine the overall fractionation of stable carbon isotopes before and 
after physical activity.  
 Results indicated that, at rest and during exercise, as well as over a range of 13C 
enrichment, all six participants exhibited significant differences between the isotopic 
composition of their blood and their expiratory gases41¸with expiratory gases being enriched 
with 12C and blood being comparatively depleted (i.e. heavier δ13C values). This suggests that 
carbon dioxide release from the blood in the pulmonary system discriminates against the 
heavier 13C isotope, causing the aforementioned fractionation effect.  The fractionation of 
stable carbon isotopes between blood and expiratory air was not significantly modified 
during exercise, however. As mentioned previously, the authors hypothesized that the 
difference between the isotopic composition of blood and expiratory air may be the results of 
the fact that the majority of carbon dioxide is transported in the blood under the form of 
bicarbonates (Severinghaus 1965), and that this is a known point of fractionation, which 
heavily discriminates against 13CO2 (Mook et al. 1974). The authors also suggested, however, 
that the degree of isotopic fractionation seen between blood and expired gas cannot be 
predicated solely on the basis of the fractionation of bicarbonates to gaseous carbon dioxide. 
As such, they hypothesized that, during exercise, δ13C values of expiratory air are also 
influenced by the “increased contribution of carbohydrate oxidation to the energy yield, since 
[δ13C values] are higher in carbohydrates than fat.” (Panteleev et al. 1999: 81). In other 
words, during moderate to intense exercise, the metabolization of carbohydrates is increased 
in order to support the heightened need for energy, increasing δ13C values (Barstow et al. 
1989; Schoeller et al. 1984; Wolfe 1984). However, once carbohydrate oxidation to energy 
yield declines, so too will the δ13C value of in expired air (Massicotte et al. 1992; Romijn et 
al. 1992; Schoeller et al. 1984).  As such, both the fractionation of bicarbonates to gaseous 
carbon dioxide, as well as the metabolization of carbohydrates, are likely to contribute to the 
isotopic composition of the blood and expired air, and contribute to the overall differences 
between them.  
                                                          
41 A difference of approximately 4.6‰ 
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While this article is not directly applicable to anemia-related studies, it nonetheless 
highlights two key points essential to this thesis; 1) that there is a significant fractionation 
affect associated with the conversion of bicarbonate to gaseous carbon dioxide; and 2) that 
the metabolization of carbohydrates has more of an effect on δ13C values than the type or 
degree of exercise, at least in expired air. As mentioned throughout Chapter 4, the 
pathophysiology of sickle cell and thalassemia anemia, as well as many of the resulting co-
morbidities, may affect the amount of carbon dioxide produced by CR, and therefore the 
concentration of both dissolved carbon dioxide and bicarbonate within the blood stream. As 
such, individuals with conditions such as hypercapnia, ischemia, polycythemia and/or low 
concentrations of hemoglobin will produce and convert bicarbonate to gaseous carbon 
dioxide at different rates than those without, showcasing an alternative fractionation effect. 
Similarly, as severe anemics are less capable of physically exerting themselves, they are 
theoretically less likely to metabolize carbohydrates in an attempt to maintain prolonged 
and/or moderate to intense activity. As such, they will have non-analogous fractionation 
patterns when compared to healthy individuals who regularly engage in exercise which 
requires carbohydrate oxidation. With these factors in mind however, it must be recalled that, 
while sickle cell and thalassemia anemia may predispose individuals to conditions which 
alter the concentration of bicarbonates, and/or the rate at which bicarbonates are released as 
carbon dioxide, not all anemics will develop those conditions. Of those that do, the degree 
and severity of the condition may vary between and even among individuals. Similarly, 
certain conditions may inhibit the fractionation of stable carbon isotopes between bicarbonate 
and carbon dioxide, while others may accelerate it.  As such, it is difficult to assess, let alone 
diagnose, sickle cell and thalassemia anemia in the archaeological record based on 
statistically different δ13C alone, as it is not a consistent marker of either condition.  
In terms of carbohydrate oxidation, severe anemia reduces the capacity for strenuous 
activity, thereby reducing exercise-related carbohydrate oxidation and decreasing δ13C values 
(Barstow et al. 1989; Schoeller et al. 1984; Wolfe et al. 1984). However, carbohydrate 
oxidation during exercise is an acute process, which declines after a certain point (Massicotte 
et al. 1986; Schoeller et al. 1984). Therefore, while exercise may affect δ13C values in the 
short-term, the process is not chronic enough to be registered in the osteological tissues. On 
the other hand, however, sickle cell and thalassemia anemia have been shown to affect rates 
of carbohydrate oxidation by inducing changes in basal nutrient metabolism (Borel et al. 
2014; Costin et al. 1977; Gozashti et al. 2014; Myfanwy et al. 1998). This shift may be 
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chronic enough to affect the isotopic composition of the inorganic and organic matrices of 
human skeletal tissues, and may be significant enough to differentiate severe anemics from 
non-anemics. This may be especially relevant in cases where individuals are known to have 
statistically analogous diets, since any major differences could be attributable to 
changes/differences in basal metabolic rates. In terms of archaeological contexts, however, it 
would be faulty to attribute statistically different δ13C values to sickle cell and thalassemia 
anemia, since numerous pathological and non-pathological conditions are known to alter the 
rate at which carbohydrates (etc.) are metabolised. As such, relying solely on differences in 
δ13C values between individuals to diagnose either sickle cell or thalassemia anemia in the 
archaeological record is not supported by biomedical research, and would be tenuous at best.  
3. Summary and Conclusion 
The purpose of this chapter was to determine the validity, and constraints, of using 
δ18O and δ13C values to diagnose sickle cell and thalassemia in the archaeological record. 
Based on biomedical research conducted by Reitsema and Crews (2011), Heller et al.. (1994) 
and Epstein and Zeiri (1988), among others, it appears as though the pathophysiology, co-
morbidities and compensatory mechanisms associated with anemia (of various aetiologies) 
does increase stable oxygen isotope fractionation, causing lighter δ18O values in certain 
tissues and tissue by-products (when compared to healthy, non-anemic, individuals). In 
addition to those factors mentioned throughout Chapter 4, other factors such as urea 
concentration, blow flow resistance, rates of perfusion (etc.) are also hypothesized to 
influence stable oxygen isotope fractionation, both in anemics and in individuals with other 
acute or chronic conditions. As such, it appears as though the δ18O composition of tissues and 
tissue by-products are the result of a multitude of fractionating and non-fractionating factors, 
including but certainly not limited to the diffusion, fixation and metabolization of oxygen 
during TR.  
According to research by Panteleev et al. (1999) and others, during TR, δ13C values 
are primarily affected by carbohydrate oxidation and the fractionation of stable carbon 
isotopes between bicarbonate and gaseous carbon dioxide. Alterations to basal metabolic 
rates, as well as various co-morbid conditions which alter the rate at which bicarbonates are 
converted to carbon dioxide (and vice versa) are expected to alter the overall fractionation of 
stable carbon isotopes, and thus the δ13C values of tissues (when compared to healthy, non-
anemic individuals). Given the complex pathophysiology of sickle cell and thalassemia 
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anemia and its co-morbidities, however, it is difficult to ascertain whether anemics will 
consistently have the heaviest or the lightest δ13C values. Similarly, it is unknown whether 
other metabolic or gastrointestinal disorders will induce the same type of fractionation affect 
expected of severe anemics, since they too may have chronically altered carbohydrate 
oxidation (etc.). In order for stable carbon isotope analyses to function as an accurate 
biogeochemical marker for diagnosing sickle cell and thalassemia in the archaeological 
record, these factors must be addressed and further researched.  
While biomedical stable isotope studies indicate that anemia does reliably alter stable 
oxygen isotope fractionation in certain tissues and tissue by-products, it remains unclear 
whether these values will be visible in the organic and inorganic matrices of human skeletal 
tissues from the archaeological record. It must be recalled that, despite anemics always 
showcasing lighter δ18O values, the aforementioned studies were conducted with strict 
controls set in place. This means that both diet, a known contributor to δ18O and δ13C values, 
as well as other disease factors which may also influence the isotopic composition of tissues, 
were known and corrected for. These factors are difficult, if not impossible, to control in 
archaeological collections. Even if dietary factors and noticeable disease processes were 
controlled and/or corrected for in archaeological populations, it remains almost impossible to 
amass a suitable control cohort with which to compare anemic samples. This is due to the fact 
that numerous cardiorespiratory, pulmonary, vascular, gastrointestinal and metabolic 
conditions do not leave clear osteological signatures, but may produce the same type of 
fractionation affect. Similarly, given the osteological paradox, it is possible that individuals 
with sickle cell and thalassemia anemia died prior to the development of skeletal lesions. As 
such, any given ‘control’ group may contain severely diseased, and even sicklic and 
thalassemic, individuals. If these types of individuals are in the control group, then the 
statistical differences between controls and anemics will be reduced, making it appear as 
though anemia does not significantly alter δ18O values, as shown in the preceding studies.   
Overall, it is clear that metabolic stable isotope fraction in chronic, severe, anemia is 
a complex, multi-factorial process which may produce a range of values, between and even 
among anemics. As elucidated in Chapters 2 and 4, the severity, compensatory mechanisms 
and co-morbidities of sickle cell and thalassemia anemia varies between individuals, and 
throughout the course of a lifetime. As such, points of stable isotope fractionation may be in 
constant flux, with different tissues/by-products representing different points in the disease 
/process. Current research suggests that stable oxygen isotope analyses may be a more 
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suitable diagnostic tool than stable carbon isotope analyses, however, the nature of the 
archaeological record makes the diagnosis of either condition a more complex matter than 
currently seen in biomedical analyses. More concerted research is required.  
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CHAPTER SIX:  
 
Pathophysiological Fractionation of Stable Isotopes Associated with 
Rates of Protein Turnover and Energy Expenditure.  
 
This chapter investigates the validity and constraints of using stable isotope analyses 
as a tool for identifying genetic anemias in human skeletal remains, by addressing whether 
previous biomedical studies have been successful in identifying chronic shifts in 
metabolism/physiology using inter and intra-individual variations in δ13C and δ15N 
signatures. Its primary purpose is to elucidate how states of hypermetabolism, and increases 
in bone and whole-body protein turnover alter isotopic fractionation, and consequently, the 
isotopic signature of associated tissues.  
As prefaced in chapters 4 and 5, the fractionation of stable isotopes is controlled by 
multiple physiological processes including the rate at which stable molecules are diffused, 
fixated and metabolised during the process of TR (Barstow et al. 1989; Butz 2013; Epstein 
and Zeiri 1988; Heller et al. 1994; Kohn 1996; Pflug and Schuster 1989; Reitsema and Crews 
2011; Schoeller et al. 1984; Widory 2004; Wolfe 1984; Zonconato et al. 1992). In sickle cell 
and thalassemia anemia many of these processes are inhibited, leading to a decrease in 
isotopic fractionation and therefore lighter isotopic (oxygen) signatures (Epstein and Zeiri 
1988; Reitsema and Crews 2013). Despite certain inhibitory TR processes, however, 
individuals with sickle cell and thalassemia anemia are also known to have abnormally 
increased energy expenditures (i.e. basal and active metabolic rates), as well as significantly 
increased bone and whole-body protein turnover (compared to healthy non-anemics) 
(Badaloo et al. 1989; Barden et al. 2000; Borel et al. 1998ab; Buchowski et al. 2000; 
Gozashti et al. 2014; Myfanwy et al. 1998; Salman et al. 1996). As elucidated in Chapter 3, 
they are also more likely to develop various osteological lesions, which will also have an 
effect on rates metabolism and protein turnover; known points of isotopic fractionation 
(Katzenberg and Lovell 1999; Olsen et al. 2014). As such, the overall pathophysiology of 
sickle cell and thalassemia anemia induces both systemic increases (i.e. bone turnover) and 
decreases (i.e. oxygen fixation) in stable isotopic/molecular fractionation, which are in-turn 
mediated by other, inter-individual, processes such as the development of compensatory 
mechanisms and/or co-morbid conditions. One of the purposes of this chapter, therefore, is to 
determine which process(es) will control the overall rate of isotopic fractionation for specific 
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stable isotopes, and whether these processes are consistent enough to conclusively, and 
consistently, differentiate sicklic and thalassemic individuals from non-anemics.  
Sections one through three discuss these factors in-depth, with section one concentrating 
on differences in protein and amino-acid metabolism between sicklic and/or thalassemic 
individuals and healthy individuals, and section two discussing previous biomedical research 
which has evaluated how states of sicklic hypermetabolism affects bone/whole-body protein 
turnover, and therefore, ratios of stable nitrogen isotopes within bone collagen. Section three 
discusses how osteological lesions such as osteomyelitis and periostitis, common 
complications of sickle cell and thalassemia  anemia, affects the relative abundance of stable 
nitrogen and carbon isotopes within bone collagen.  Two bioarchaeological studies are 
presented, critiqued, and placed within the frameworks of this thesis. The fourth and final 
section summarizes and discusses the preceding information, and concludes the chapter.  
1. Bone Proteins and Protein Metabolism  
      Proteins are macromolecules which consist of one or more amino acid42 polypeptide 
chains chemically bound together (Tortora and Derrickson 2012). The organization of amino 
acids within the polypeptide chain determines the protein’s chemical, functional and 
phenotypic properties and distinguishes one type of protein from another (i.e. antibodies vs. 
enzymes vs. transport molecules vs. structural proteins etc.) (Ahern and Rajagopal 2015; 
Murray et al. 2006; Tortora and Derrickson 2012). While humans can synthesize certain 
amino acids themselves (i.e. non-essential amino acids), many (i.e. essential amino acids) 
must be obtained from dietary sources (carbohydrates, lipids, and plant/animal proteins) or 
from tissue recycling (tissue metabolism) (Katzenberg and Lovell 1999; Olsen et al. 2014; 
Tortora and Derrickson 2012). In this way, all essential amino acids are produced using the 
stable nitrogen, oxygen and carbon isotopes within food and/or within our own tissues as 
substrates (i.e. building blocks). As such, rates of tissue turnover (amino acid/protein 
synthesis and breakdown) and overall metabolism (which dictates the rate at which dietary 
amino acids are metabolized) will play a key role in isotopic fractionation and therefore, the 
isotopic signatures of osteological tissues (Jim et al. 2005; Katzenberg and Lovell 1999; 
Olsen et al. 2014).  
 
                                                          
42 Amino acids are organic compounds that contain at least one amino group (-NH2), and one carboxyl group (COOH), with amino-acid specific 
side chains composed of various combinations of atomic/isotopic nitrogen, carbon, oxygen and/or hydrogen.  
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1.1. Bone Collagen:  
One of the most important structural proteins in the human body is collagen, a 
fibrous, flexible connective tissue which makes up ~25-35% of whole-body protein, and 
~90% of the organic matrix of bone (Bolarin et al.. 1998; Di Lullo et al. 2002; White and 
Folkens 2005). As with all proteins, collagen is composed of combinations of essential and 
non-essential amino acids43, which are themselves created from various combinations of 
ingested and recycled stable carbon, nitrogen and oxygen isotopes (DeNiro and Epstein 1978; 
DeNiro and Schoeniger 1983; Katzenberg and Lovell 1999; Olsen et al. 2014; van der Merwe 
and Vogel 1977).   
The δ13C signature of bone collagen is primarily reflective of dietary (proteins, 
carbohydrates, lipids and water) sources of carbon, with tissue recycling playing only a minor 
role in the overall δ13C signature (Ambrose and Norr 1993; DeNiro and Epstein 1978; 
DeNiro and Schoeniger 1983; Katzenberg and Lovell 1999; Olsen et al. 2014; Tieszen and 
Fagre 1993; van der Merwe and Vogel 1977). Conditions affecting the absorption or 
metabolization of amino acids can therefore significantly affect the overall δ13C signature, 
especially if minimum dietary requirements (for particular amino acids) are not met (Jim et 
al. 1995). Simply put, amino acid deficiencies will cause more non-protein carbon to be 
synthesized and assimilated into the bone collagen, causing the bone collagen δ13C signatures 
of deficient individuals to be reflective of protein and non-protein carbons, as opposed to a 
primarily protein carbon signature generally seen within non-deficient individuals (Jim et al. 
1995).  
The δ15N signature of bone collagen, while also primarily reflective of dietary 
nitrogens, is significantly more influenced by anabolic and catabolic processes than δ13C 
signatures (Ambrose and Norr 1993; Jim et al. 1995; Katzenberg and Lovell 1999; Olsen et 
al.  2014; White and Armelagos 1997). In other words, unbalanced tissue metabolism will 
have a greater effect on δ15N signatures than on δ13C signatures; anabolic processes enriching 
bone collagen δ15N signatures and catabolic processes depleting it (with δ13C and δ18O 
signatures remaining relatively unchanged) (Katzenberg and Lovell 1999; Olsen et al. 2014; 
White and Armelagos 1997). As such, pathological rates of tissue metabolism will affect 
overall δ15N signatures of bone collagen, while pathological basal metabolic rates and amino 
                                                          
43 The most common amino acid arrangement is glycine-proline-X, and glycine-X-hydroxyproline, where X is any other amino acid than the 
aforementioned amino acids (Szpak 2011).  
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acid oxidation (which influences the metabolism of dietary amino acids) will have more of a 
role in determining δ13C (Barstow et al. 1989; Butz et al. 2013; Katzenberg and Lovell 1999; 
Massicotte et al. 1986; Schoeller et al. 1984; Olsen et al. 2014; White and Armelagos 1997; 
Wolfe et al. 1984).  
  
In healthy individuals, the anabolism and catabolism of bone and bone proteins are at 
an equilibrium – both functioning in tandem with one another to repair and replace old 
osteological/collagenous tissues with new tissue (White and Folkens 2005). Similarly, 
healthy individuals are generally not pathologically deficient in amino acids. Since there is no 
significant increase or decrease in tissue growth/maintenance/repair, and amino acids are not 
being synthesized by non-protein sources, bone collagen stable nitrogen and carbon 
concentrations will be balanced, primarily reflecting the isotopic composition of dietary 
proteins (Ambrose and Norr 1993; DeNiro and Epstein 1978; DeNiro and Schoeniger 1983; 
Katzenberg and Lovell 1999; Tieszen and Fagre 1993; van der Merwe and Vogel 1977). The 
pathophysiology and sequelae of sickle cell and thalassemia anemia, however, increases the 
average (healthy) rate of bone/protein/collagen metabolism (Badaloo et al. 1989; Barden et 
al. 2000; Borel et al. 1998ab; Buchowski et al. 2000; Gozashti et al. 2014; Myfanwy et al. 
1998; Salman et al. 1996), thereby shifting the isotopic nitrogen composition of bone 
collagen from a primarily dietary signature, to a dietary-recycling signature (Katzenberg and 
Lovell 1999; Olsen et al. 2014). In this way, the δ15N signatures of sicklic/thalassemic 
individuals are expected to be non-analogous to those of healthy individuals, with heavier 
nitrogen signatures suggesting an increase in protein catabolism, and lighter signatures 
suggesting an increase in protein anabolism. Similarly, since sickle cell and thalassemia 
anemia induces states of hypermetabolism (Badaloo et al. 1989; Barden et al. 2000; Borel et 
al. 1998ab; Buchowski et al. 2000; Gozashti et al. 2014; Myfanwy et al. 1998; Salman et al. 
1996) and can affect the gastrointestinal tract and hepatic system (Lee and Thirumalai 1989; 
Serjeant et al. 1986; Serjeant and Patrick 1989; Rao et al. 1990) the metabolism/oxidation of 
dietary amino acids will be non-analogous to non-anemics, shifting the δ13 C signatures away 
from healthy individuals.  
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1.2.  Macro and Micronutrient Deficiencies: Amino Acid, Vitamin and Mineral Status of 
Sicklic and Thalassemic Patients: 
 
 While rates of whole-body/bone protein turnover are known to influence the isotopic 
signature of osteological tissues, the quality and quantity of amino acids, vitamins and 
minerals, as well as the rate at which these nutrients are catabolized and re-synthesized into 
useable products for the body will also affect the rate of stable isotope fractionation. 
 
1.2.1. Nutritional Status: Vitamins and Minerals:  
     Several studies have demonstrated that sicklic and thalassemic individuals are prone 
to developing a variety of macro and micronutrient deficiencies including, but not limited to, 
abnormally low levels of cellular (e.g. RBC) and intercellular (e.g. plasma) zinc (Clark et al. 
1981; Mankad et al. 1982; Russell et al. 1981; Vinchinsky et al. 1984), iron (Okechealain 
and Obi 1982; Rao and Sur 1981; Serjeant et al. 1980), vitamin E (Mankid et al. 1982; 
Melhorn et al. 1971; Muskiet and Muskiet 1984) and vitamin B6  (pyridoxine) (Natta and 
Reynolds 1984). The deficiency of these micronutrients may play a significant role in stable 
isotope fractionation within sicklic and thalassemic individuals, not only because their dietary 
status is no longer directly comparable to their healthy cohorts, but also because many 
vitamins and minerals play a role in RBC function, which, as noted in Chapters 3 and 4, is an 
essential factor in stable isotope fractionation.  
 In addition to acting as a cofactor for amino acid, glucose and lipid metabolism, 
vitamin B6  (and its derivatives) is known to increase oxygen’s affinity towards hemoglobin 
(Kark et al. 1979, 1983; Solomon 1982; Zaugg et al. 1977), inhibit the gelation of 
deoxyhemoglobin, and support hemoglobin synthesis and RBC metabolism (Combs 2008). 
Vitamin B6 deficiency is therefore especially detrimental in sicklic and thalassemic 
individuals, since a pathological lack of vitamin B6 may impair hemoglobin synthesis (a 
detriment to an already actively hemolytic system), and may passively encourage blood 
clotting and sickling by not being present in sufficient quantities to inhibit/reduce 
deoxyhemoglobin gelation. As seen throughout Chapter 3 and 4, this will have a direct effect 
on the rate of stable isotope diffusion, fixation and metabolization and therefore, the isotopic 
signatures of associated tissues and tissue by-products.  
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 As with vitamin B6,   concentrations of vitamin E also directly affect RBC function. 
Among other properties, vitamin E protects RBCs against oxidative stress (Reed et al. 1987). 
As elucidated in Chapter 3, oxidative stress encourages the formation of methemoglobin and 
decreases oxygen fixation and metabolization through various pathophysiological processes 
(Gladwin et al. 2000; Gross and Lane 1999; Rassaf et al. 2002). Individuals who are 
pathologically deficient in vitamin E will therefore have comparatively limited protection 
against oxidative RBC injury and hemolysis (Reed et al. 1987). Since sicklic and thalassemic 
RBCs inherently “generate excessive oxidation products and are more sensitive to oxidant 
stress” (Reed et al. 1987, 449), this lack of RBC protection may further encourage 
irreversibly sickled cells and increased hemolysis, which will have a direct effect on rates of 
stable isotope fractionation, as per Chapter 3  
  Iron has several vital biological functions and is a key component of hemoglobin. 
Each heme group within the hemoglobin molecule contains an iron ion, which acts as an 
oxygen binding site (Maton 1993). Since iron is vital to both the structure and function of 
hemoglobin, severe iron deficiency will inhibit hemoglobin synthesis and reduce oxygen 
fixation and transport (Maton 1993). Zinc, another mineral, is vital to carbon dioxide 
regulation, the digestion of proteins (Greenwood 1997), and is thought to discourage 
irreversibly sickled cells and increase the oxygen affinity of sickled RBCs (Reed et al. 1987). 
A deficiency in either, or both of these elements will have an effect on stable isotope 
fractionation by altering healthy rates of hemoglobin synthesis and RBC destruction, and/or 
by affecting concentrations of oxygen and/or carbon dioxide within the vascular system (etc.) 
(see Chapter 4). 
 The development of nutrient deficiencies is highly variable between anemics, and is 
heavily influenced by other factors such as rates of metabolism, appetite, and dietary 
adequacy (Reed et al. 1987). As such, the type of nutrient deficiency(ies), as well as 
associated symptoms, will vary between and even among anemics from the same population, 
and may also be present in non-sicklic/thalassemic individuals (especially if they are all 
consuming a restricted and/or nutritionally deficient diet). This is an important factor for this 
thesis, since the presence of severe micro/macronutrient deficiencies in archaeological 
populations may actively encourage premature mortality within sicklic and thalassemic 
children, reducing the overall window within which stable isotope fractionation may occur in 
significant enough proportions to induce significant alterations to bone collagen and/or 
enamel apatite values. Additionally, micro/macronutrient deficiencies which severely affect 
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RBC function may isotopically masquerade as sickle cell or thalassemia anemia, making it 
difficult to distinguish the two vastly different disease categories based on stable isotope 
analyses alone (particularly stable oxygen isotope analyses).  
1.2.2. Amino Acids: Glutamine and Glycine: 
 
Glutamine is a conditional44, proteinogenic45 amino acid which plays a significant role in 
numerous biological processes including protein synthesis, the production of ammonium 
(NH4+), and the transport of ammonia (NH3) (Aledo 2004; Brosnan 2003; Buchman 2001; 
Weast 1981; Yuneva et al. 2007). It also acts as a nitrogen and carbon donor for various 
anabolic processes such as the Citric acid (Krebs) cycle, and is the preferential fuel for tissues 
with rapid replication rates (e.g. hemolytic RBCs) (Aledo 2004; Buchman 2001; Weast 1981; 
Yuneva et al. 2007).  
 
As expounded in Chapter 3, sickle cell anemia is caused by a genetic mutation which 
replaces glutamine with valine, another essential amino acid. As such, sicklic RBCs are 
inherently depleted in glutamine, a factor which deregulates the biosynthesis of other amino 
acids and affects rates of protein anabolism (Morris et al. 2008; Morris et al. 2011; Niihara et 
al. 1998; Salman et al. 1996). The same type of glutamine impoverishment has been noted in 
those with thalassemia anemia (Abdulrazzaq et al. 2005; Morris et al. 2008, 2011; 
Vinchinsky 2012). In addition to being inherently depleted in RBC glutamine, sicklic and 
thalassemic individuals also require higher levels of free glutamine (i.e. not confined to the 
hemoglobin molecule) than healthy non-anemics in order to compensate for chronic 
hemolysis and to support the production of new RBCs (Abdulrazzaq et al. 2005; Morris et al. 
2008, 2011; Vinchinsky 2012). As such, even if individuals with sickle cell and/or 
thalassemia are consuming/producing similar quantities of glutamine, their glutamine pools 
may be significantly different from one another.     
  
Glutamine depletion may affect isotopic fractionation in multiple ways. Firstly, 
research on animal models has suggested that the maintenance of cellular and intercellular 
glutamine pools is essential in the regulation of protein homeostasis (Jepson et al. 1988; 
MacLennan et al. 1987; Salman et al. 1996). In other words, glutamine is one of the essential 
                                                          
44 Can be synthesized by the human body, but only under certain pathophysiological conditions 
45 Amino acids which are precursors to proteins.  
   116 
 
amino acids that enables bone collagen to reflect ‘healthy’ (dietary) isotopic values, because 
it ensures that protein anabolism and catabolism are in equilibrium. Since sicklic and 
thalassemic individuals have less glutamine availability and/or decreased glutamine 
concentrations, rates of protein anabolism and/or catabolism are inherently non-analogous to 
those of healthy individuals. In this way, the absence of glutamine encourages a dietary-
recycling isotopic signature (as opposed to a primarily dietary isotopic signature) since 
glutamine depletion induces tissue recycling, which significantly affects stable nitrogen 
isotope fractionation. Secondly, the lysis of glutamine (glutaminolysis) plays a critical role in 
the Kreb’s cycle, a vital part of CR (McKeehan 1982; Reitzer et al. 1979). While the exact 
mechanisms of glutaminolysis are beyond the scope of this thesis, Chapters 4 and 5 have 
demonstrated that chronic alterations in the rate of CR will affect the overall isotopic values 
of related tissues, since CR is a known point of isotopic fractionation (Barstow et al. 1989; 
Butz et al. 2013; Epstein and Zeiri 1988; Widory 19999; Zanconato et al. 1992).  
 
Glycine, one of the amino acids essential to bone collagen, is also negatively 
impacted by processes such as hemolysis since, like glutamine, RBCs require increased 
levels of glycine in order to support the production of new RBCs (Jackson et al. 1987). 
Similarly, since the bone collagen of sicklic individuals has a turnover rate nearly doubled 
that of healthy individuals (Buchowski et al. 2000; Salman et al. 1996) the rate of glycine 
(and other amino acids within bone collagen) metabolism will be significantly different than 
of healthy individuals.  
 
Overall, both protein and individual amino acid metabolism are known to be non-
analogous between sicklic/thalassemic individuals, and healthy non-anemics, strongly 
suggesting that the isotopic signature between the two groups should also be significantly 
different.  
 
2. Literature Review: Protein Turn-Over and Energy Metabolism  
 
The following section provides a comprehensive overview of previous biomedical 
research that has investigated states of hypermetabolism and increases in protein/amino acid 
turnover in individuals with and without sickle cell anemia.  
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2.1. Increased Bone Turnover is Associated with Protein and Energy Metabolism in
  Adolescents with Sickle Cell Anemia (Buchowski et al. 2000): 
 
Buschowski et al. (2000) examine the relationship between bone metabolism (rates 
of bone formation and resorption), protein turnover (basal rates of whole body protein 
synthesis and catabolism), and resting energy expenditure (REE) in healthy and sicklic 
adolescents, in an attempt to quantify the “potential contribution of bone turnover to the 
hypermetabolic state observed in sickle cell anemia.” (Buchowski et al. 2000, E518). The 
authors theorized that since ~50% of the increase in sicklic REE can be attributed to the 
enhanced energy costs of protein turnover, and <20% can be attributed to hemoglobin 
synthesis (Borel et al. 1998ab), other metabolic factors such as the rate of bone remodelling, 
may also contribute to sicklic states of hypermetabolism. They hypothesized, therefore, that 
rates of bone formation and resorption (i.e. bone turnover) would be statistically different 
between sicklic and non-anemic individuals, and that increases in bone turnover would be 
associated with increases in whole-body protein turnover and REE.   
 A group of 28 African-American adolescents (14 males, 14 females; aged 14-18 
years) clinically diagnosed with sickle cell anemia, and 26 non-sicklic, non-carrier, African-
American adolescents (of comparable age and sex categories) were selected to participate in 
the study. All participants were genetically screened to determine their hemoglobin genotype 
(i.e. anemic homozygotic, heterozygotic, or non-anemic homozygotic), and evaluated for 
metabolic, skeletal, hepatic, and renal dysfunctions in order to eliminate the influence of 
other pathophysiological factors on REEand protein turnover. Female subjects were not 
menstruating or pregnant at the time of the study, and none of the sicklic volunteers had 
experienced a sickle cell crisis in the preceding 28 days.  
All volunteers were admitted to the research center for 24 hours, and placed in a 
whole-room indirect calorimeter. Subjects were asked to participate in standard daily 
activities (i.e. watching T.V., reading) and to engage in two hours of non-intensive 
(standardized) exercise (i.e. walking and stepping). Oxygen consumption, carbon dioxide 
production, barometric pressure, humidity, air flow rate, and temperature were all sampled 
repeatedly, over the course of 24 hours. In order to measure whole-body protein turnover, 
protein kinetic studies were conducted using a [15N]glycine tracer. Participants were asked to 
provide a urine sample prior to ingesting the tracer, and then every following three hours 
after the tracer was given. The rate of nitrogen entry into the metabolic pool, as well as the 
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rate of protein breakdown and synthesis, were calculated based on the δ15N value of the urine 
(under the assumption that the isotopic value of urine is equivalent to the total amino nitrogen 
entering the metabolic pool, and excreted as urea and ammonia nitrogen). Prolagen-C assays 
(PICP) were used to measure bone formation activity, and Pryilinks assays (PYD) to measure 
bone resorption. Total energy expenditure measurements were calculated based on total 
amount of oxygen used (VO2) and carbon dioxide expelled (VCO2) during the participants 
stay in the room calorimeter.  
Results demonstrated that both bone formation and bone breakdown were increased 
in those with sickle cell anemia, with sicklic patients having a 45% increase in protein 
catabolism and a 49% increase in protein synthesis, when compared to non-anemics. 
Consistent with the original hypothesis, results also indicated that increases in bone turnover 
were associated with higher rates of whole-body protein turnover and increased REE. This is 
in line with studies by Badaloo et al. (1989), and Borel et al. (1998ab), which demonstrated a 
40-100% increase in whole body protein turnover in those with sickle cell anemia, compared 
to non-anemics.  
The authors concluded that bone turnover is approximately doubled in those with 
sickle cell anemia, and that ~11% of total protein synthesis in sicklic adolescents can be 
attributed to bone metabolism, and ~20% to collagen synthesis. This increase occurred even 
in the absence of sicklic crises, suggesting that rates of protein turnover are chronically 
increased in those with sickle cell anemia.  
This is crucial to this thesis for three main reasons; firstly, if rates of bone/protein 
turnover are significantly, chronically, increased in individuals with sickle cell anemia, their 
skeletal matrices should be significantly enriched with heavier isotopes (when compared to 
healthy non-anemics), since their collagenous tissues will reflect a dietary-recycling isotopic 
signature, as opposed to a primarily dietary one. This fractionation effect should still occur, 
even if catabolic and anabolic reactions are in equilibrium, because the overall process will 
be increased compared to healthy non-anemics, decreasing the overall fractionation effect. 
Since stable nitrogen isotopes are most significantly affected by tissue recycling (Katzenberg 
and Lovell 1999; Olsen et al. 2014), it is likely that they will showcase the greatest 
fractionation effect, and the heaviest isotopic values.  
   119 
 
Secondly, this research demonstrates that rates of bone turnover and metabolism are 
chronically increased, even in the absence of complications such as sickle cell crises. This is 
an important factor when dealing with archaeological sicklic populations, who likely would 
have died during infancy/childhood, because significant isotopic fractionation will still have 
occurred even during episodes of ‘relative’ health. This means that, even if they died before 
more chronic complications had a chance to develop, sicklic individuals should exhibit the 
types of long term fractionation effects needed to significantly alter the average accumulation 
of dietary isotopes within bone collagen, making sicklic (and thalassemic) individuals 
distinguishable from healthy non-anemics (from the same socio-economic/dietary cohort). 
Thirdly, given the increased rates of bone turnover, the osteological reservoir of 
individuals with sickle cell anemia will reflect more short-term averages in stable isotope 
fractionation. As such, the skeletal matrices of sicklic/thalassemic individuals are non-
analogous to the skeletal matrices of non-anemic individuals because they reflect different 
timeframes, and therefore isotopic averages. Additionally, increased rates of bone turnover 
likely increases the impact of more acute fractionation effects, such as non-fatal sicklic crises 
and short-term compensatory mechanisms. This is important in archaeological populations 
who, as mentioned, were likely to have died before the onset of many chronic complications.  
In addition to increased rates of bone/whole-body protein turnover, the authors also 
demonstrated that individuals with sickle cell anemia have an increased REE (i.e. basal 
metabolic rate). As seen in chapters 4 and 5, alterations in metabolism will have a direct 
effect on stable isotope fractionation, with increased metabolic rates decreasing isotopic 
fractionation and vice versa. One of the proposed mechanisms for the lighter stable oxygen 
isotope values noted in sicklic mice models was a chronic decrease in exercise capacity, 
which causes a decrease in metabolic reaction rates, and therefore an increase in isotopic 
fractionation (Reistsema and Crews 2001). This, and other (Badaloo et al. 1989; Barden et al. 
2000; Borel et al. 1998ab; Buchowski et al. 2000; Gozashti et al. 2014; Myfanwy et al. 1998; 
Salman et al. 1996), studies demonstrates however, that sickle cell anemia induces a state of 
hypermetabolism, which would decrease the fractionation of stable isotopes and cause 
heavier isotopic values. Therefore, it can be hypothesized that the lighter δ18O values found 
within anemics are less reflective of decreases in energy capacity/metabolism, and more 
reflective of other pathophysiological processes (i.e. inhibited rates of TR, sequelae etc.) 
which encourages isotopic fractionation. The same logic can be applied to archaeological 
populations, with heavier isotopic values suggesting that states of hypermetabolism 
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controlled the overall fractionation effect, and lighter isotopic values suggesting more 
inhibitory processes controlled the overall rate of fractionation.  This also suggests, however, 
that if rates of bone/protein turnover and metabolism are as increased as rates of oxygen 
fixation are decreased (i.e. all processes are equally disturbed), the fractionation effect of one 
process will negate the fractionation effect of the other, causing the isotopic values of sicklic 
indiviuals to be statistically indistinguishable from healthy non-anemics and heterozygotic 
anemics.  
Finally, since REE expenditure (which is a systemic process) is chronically increased 
in individuals with sickle cell/thalassemia anemia, the isotopic values of dental enamel 
should also reflect altered rates of metabolism. This is due to the fact that metabolism and 
dietary deficiencies (common in sicklic and thalassemic individuals as a result of increased 
metabolic demands) will have a direct effect on enamel mineralization (Goepferd and Flaitz 
1981; Goodman and Rose 1990; Hillson 2008; Infante and Gillespie 1974), and therefore, 
their isotopic signature (Franz-Odendaal et al. 2003). 
 
2.2. Protein and Energy Metabolism in Prepubertal Children with Sickle Cell 
Anemia: 9Salman et al. 1996): 
 
 Salman et al. (1996) investigated whether REE and protein turnover are increased in 
pre-pubertal children with sickle cell anemia, and whether increased demands for glutamine, 
an essential amino acid which plays a significant role in protein synthesis, lead to an overall 
depletion of glutamine stores, and consequently, alterations in whole body protein 
metabolism. The authors hypothesized that sicklic hemolysis would increase protein 
demands, and therefore accelerate whole-body protein turnover, energy expenditure, 
glutamine utilization and leucine (another amino acid) disposal. These processes, in turn, 
would contribute to excess protein utilization and the states of hypermetabolism commonly 
seen in those with sickle cell anemia.  
Eight children with sickle cell anemia, and seven healthy children participated in the 
study. All subjects were free from any evidence of infection or other co-morbidities, and 
none of the sicklic children had experienced a sicklic crisis in the weeks preceding the 
experiment. Dietary histories were recorded for five to seven days prior to isotopic infusion, 
and bone density, percent body weight and lean body mass measured. All subjects were 
infused with two catheters, one for isotopic infusion, and the other for periodic arterial-
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venous blood samples. Samples were collected every 20 minutes between zero and 140 
minutes, and analysed to determine intra and inter-individual variations in the steady state 
enrichment of glutamine and plasma leucine between anemics and non-anemics. REE and 
cardiac output were measured using indirect calorimetry and echocardiography, respectively. 
Breath samples were collected prior to, and at the end of the infusion, in order to determine 
intra and inter-individual variations in 13CO2 enrichment, an indicator of leucine metabolism 
and blood-gas transport mechanisms.  
Results indicated that rates of energy expenditure, protein turnover, and glutamine 
utilization were all increased in pre-pubertal children with sickle cell anemia, with sicklic 
children using ~19% more energy, 58% more protein and ~47% more glutamine than healthy 
children. Sicklic children also evidenced a 58% increase in leucine appearance, and 65% 
increase in non-oxidative leucine disposal, when compared to healthy children. These 
increases occurred even in the absence of vaso-occlusion, sickle cell crises or other co-
mordid conditions, and were not significantly associated with differences in body 
composition, under-nutrition or stress. As such, the authors suggested that these mechanisms 
may be disease-specific (i.e. pathognomonic to hemolytic anemias like sickle cell), since 
various other metabolic disorders (like under/malnutrition) result in a decrease, as opposed to 
an increase, in energy expenditure (Shetty 1984).  
This is an important factor for this thesis. Due to the nature of the archaeological 
record, and the way disease is expressed in the skeletal system, it is often difficult to 
differentiate between specific metabolic disorders. This research suggests, however, that rates 
of isotopic fractionation should be non-analogous between those with sickle cell (and 
thalassemia anemia) and those with wasting/nutritional disorders, since sickle cell anemia 
induces states of hypermetabolism (decreasing stable isotope fractionation), while 
wasting/nutritional disorders induce states of hypometabolism (increasing stable isotope 
fractionation) (Norton et al. 1981; Shetty 1984).  
As with the preceding article, Salman et al. demonstrate that children with sickle cell 
anemia have increased metabolic rates and bone/protein turnover (when compared to healthy, 
non-anemic children), and that these mechanisms are chronic—occurring even in the absence 
of more severe sicklic complications. As such, sicklic (and thalassemic) and healthy children 
in the archaeological record should have statistically non-analogous isotopic value since they 
have significantly (chronically) different basal metabolic rates, and rates of protein/bone 
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turnover. These fractionation effects should also differentiate sickic (and presumably 
thalassemic) individuals from those with other metabolic disorders, since they are on opposite 
ends of the metabolic (fractionation) spectrum.  
3. Effects of Pathology on the Supply, Consumption and Elimination of Stable 
Carbon and Nitrogen Isotopes.  
 
The following section provides a comprehensive overview of previous bioarchaeological 
research which have investigated how various osteological lesions affect the isotopic 
signature of bone collagen.  
3.1. Intra-skeletal Isotopic Composition (δ13C, δ15N) of Bone Collagen: Nonpathological 
and Pathological Variation (Olsen et al. 2014); Skeletal Isotope Variation in Pathological 
Bone: (Katzenberg and Lovell 1999): 
The primary purpose of Olsen et al. (2014) and Katzenberg and Lovell’s (1999) 
research was to determine whether the isotopic composition (δ13C, δ15N) of bone 
protein/collagen were significantly altered by the presence of osteological lesions (of various 
aetiologies, at various stages) and/or bone wasting (atrophy, metabolic disturbances). Both 
research groups sought to evaluate which, if any, pathological conditions altered the isotopic 
composition of bone collagen, and whether δ13C and δ15N ratios varied not only between 
pathological and non-pathological bone/individuals, but between categories of disease as 
well. In both studies, traumatic (healing and healed fractures) and non-specific inflammatory 
(osteomyelitits and periostitis) lesions were sampled for inter and intra-individual variation. 
Katzenberg and Lovell (1999) also sampled bones with post-paralytic atrophy, while Olsen et 
al. (2014) also sampled individuals with evidence of metabolic (rickets/osteomalacia) and 
degenerative joint (osteoarthritis) disease. All individuals were sampled two to three times, 
and compared to an appropriate control cohort (i.e. individuals with no visible, relevant, 
skeletal pathologies).  
Katzenberg and Lovell (1999) examined seven individuals in total, three of whom 
acted as controls, and four of whom had clear evidence of periostitis, osteomyelitis, 
fracturing, or atrophy. Sample sites included the area of gross pathology (i.e. where the 
condition was most evident/severe), as well as two sites near to the affected site. The 
exception to this sampling strategy was the atrophied individual, since the entire bone 
experienced some degree of wasting.  
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Olsen et al. (2014) examined 59 individuals of various ages and of both sexes, six of 
whom showed evidence of rickets/osteomalacia, eight who showed signs of osteoarthritis, 11 
with evidence of fracture trauma, six with non-specific indicators of inflammation/infection 
and 18 with signs of periostitis. As with the aforementioned study, all individuals were 
sampled a minimum of three times, with the exception of those with osteomalacia/rickets, 
who were sampled twice (since osteomalacia is a systemic, as opposed to local, disease). 
Unlike Katzenberg and Lovell (1999), the authors sampled two distant, un-affected bones 
(i.e. unrelated to the bone showcasing the pathology) in addition to the lesion itself. Lesions 
differed between individuals and disease categories, but included fracture calluses, 
osteophytes, abnormal new bone growth (active and remodelled) and reactive (osteomyelitic) 
bone.  
Olsen et al. (2014, 603) noted “significant intra-skeletal differences in the carbon and 
nitrogen isotopic data for all lesion producing disease categories”, with the exception of the 
more systemic osteomalacia, which showcased no significant intra-individual variation 
(relative to normal intra-skeletal variation). Inflammatory lesions (periostitis) demonstrated 
the lowest level of intra-individual differences, while non-specific infections (osteomyelitis) 
demonstrated the most significant differences in carbon and nitrogen values. These results 
mirrored those achieved by Katzenberg and Lovell (1999), which demonstrated that 
osteomyelitic bone showcased the highest degree of intra-individual variation in nitrogen 
values, with periostitis showcasing the least. Similarly, both studies demonstrated that 
osteomyelitic lesions (and associated bone) produced the heaviest δ15N values, and had 
significantly different δ13C values than the other disease categories, and the control group. 
Bone atrophy (Katzenberg and Lovell 1999) also showcased significantly different δ13C 
values compared to the other disease categories and the controls, and had the lightest δ15N 
values.  
Overall, both studies clearly demonstrate that the isotopic signature of bone collagen 
is significantly affected by the presence of certain osteological lesions/disorders, with either 
or both the stable carbon and nitrogen values being affected. This is important for this thesis, 
since sickle cell and thalassemia anemia are known to induce a range of osteological lesions, 
including osteonecrosis, osteomyelitis, periostitis, and arthritis. Caution must be taken 
however, since, while sampling obviously pathological bone and comparing it to non-
pathological bone may demonstrate significant inter-individual variation, this will not 
conclusively demonstrate that the individual had a genetic, hemolytic anemia, and therefore it 
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cannot be used as a diagnostic method. In order to diagnose sickle cell and thalassemia 
anemia, it is necessary for the isotopic differences to be the result of the pathophysiological 
processes associated with the disease(s) itself, and not the sequelae, since the development of 
these conditions is not pathognomonic to sickle cell or thalassemia anemia. As such, using 
the results obtained from pathological bone may bias the results, since the isotopic values will 
reflect the mechanisms associated with the local pathology, and not the systemic fractionation 
effect associated with sickle cell and thalassemia anemia. Therefore, only significantly 
different isotopic values from non-pathological bone (which should still demonstrate the 
pathological fractionation of stable isotopes, because sickle cell and thalassemia anemia are a 
systemic disorder) should be used as a diagnostic aid.  
4. Summary and Conclusions  
 
      The purpose of this chapter was to determine the validity, and constraints, of using 
δ13C and δ15N values to diagnose sickle cell and thalassemia in the archaeological record. 
Based on biomedical research conducted by Buchowski et al. (2000) and Salman et al. 
(1996), amongst others, it appears as though sickle cell anemia will encourage a state of 
hypermetabolism, as well as increases in bone/whole-body protein (and amino acid) turnover. 
These pathophysiological responses should significantly affect the isotopic composition of 
bone collagen and enamel apatite, since they occur during childhood and continue until (at 
least) adolescence, even in the absence of more severe sicklic complications. These factors 
are expected to be more influential on overall fractionation of stable nitrogen and carbon 
isotopes than the process of TR, since they will be more chronic and will effect bone protein 
turnover, which is known to significantly affect ratios of stable nitrogen isotopes. The δ18O 
values of bone collagen, however, is hypothesized to be more reflective of pathological TR 
processes, than rates of tissue recycling. This is due to the fact that, while rates of protein 
turnover do affect the fractionation of stable oxygen isotopes, tissue recycling plays only a 
small role in the overall isotopic oxygen composition of bone collagen. Rates of oxygen 
fixation (diffusion and metabolization) however, play a significant role in stable oxygen 
fractionation, thereby providing more of a fractionation effect/influence. This overall 
fractionation effect, however, may be influenced by states of hypermetabolism and amino 
acid oxidation, since the isotopic signature of bone collagen is heavily influenced by diet (and 
therefore, the processes which affect the rate at which foodstuffs are metabolized). It is 
hypothesized, therefore, that heavier δ18O values will reflect pathologically increased dietary 
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metabolism, while lighter δ18O values will reflect pathologically decreased rates of oxygen 
fixation. As elucidated in Chapter 4, these values are likely to vary between and even among 
anemics, suggesting that the presence of sequelae and compensations are important factors in 
determining the overall isotopic values of sicklic and thalassemic individuals.  
This is supported by research from Olsen et al. (2000) and Katzenberg and Lovell (1996), 
which demonstrated that (certain) osteological lesions significantly alter the isotopic values 
of bone collagen/protein, due to alterations in rates of bone/protein synthesis and/or 
breakdown. It stands to reason, therefore, that sickle cell and thalassemia anemia, which also 
alters rates of bone/protein synthesis and breakdown will be similarly visible in the 
archaeological record, using stable isotope analyses. What is not known, however, is whether 
these alterations will be consistent enough to conclusively diagnosis sickle cell and/or 
thalassemia in the archaeological record, or whether other, highly individual, factors (i.e. 
specific sequelae and/or the presence/rate of compensation mechanisms like increased heart 
rate etc.) will create disjointed stable isotope values within anemic cohorts, making them 
appear as though they have different diseases.  
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CHAPTER SEVEN 
The Socio-Religious History of Écija, Spain: Islam and Isotopes 
 
      This chapter focuses on the historical and religious history of Écija, Spain in order to 
garner a more comprehensive understanding of the socio-religious factors which may have 
influenced the isotopic values of the inhabitant’s organic and inorganic skeletal matrices. The 
first section outlines the social and religious history of Écija, concentrating primarily on the 
socio-religious history of the city from the 8th-12th centuries. The second section provides a 
brief overview of Islam, focusing on the socio-religious practices which are known to 
influence isotopic values. Islamic breastfeeding/weaning, dietary and immigration practices 
are discussed, and set into specific research frameworks. Section three describes el Plaza de 
Espana, the cemetery from which all of the skeletal samples used for this research were 
buried. The fourth section discusses sickle cell and thalassemia anemia in Spain, with specific 
regards to the probability that the genetic conditions existed within the Iberian Peninsula, and 
in Écija during the 8th-12th century. Conclusions are provided in the fifth and final section.  
 
1. Écija: The Religious and Social History  
 
The city of Écija (formerly known as Astigi and Istichcha) is located in the 
Andalusian countryside, within the province of modern day Sevilla, Spain. Archaeologically, 
evidence of habitation dates back to at least the beginning of the 8th century B.C., when 
Iberian tribal groups settled in the area (Chapman 2009). In the second century B.C. the 
entire region was conquered by the Romans, who allowed ancient Écija to remain a 
Romanized oppidum liberum (free town) within the Imperial Roman Province of Baetica 
(Fortes and Sanchez 2012; Plinius 79). After the Battle of Munda in 45 B.C., ancient Écija 
became an official Imperial colony known historically as the Colonia lulia Augusta Firma 
Astigitana, or Astigi (Fortes and Sanchez 2012) 
 
After the decline of the Roman Empire during the 3rd through 4th centuries A.D., 
Astigi was ruled by the Germanic Suevs, and then Visigoths, who renounced Roman 
Christian Arianism in favour of Nicene Christianity in 587 A.D (Boone 2009; Christys 2002; 
Collins 1995; Garcia-Dils de la Vega et al. 2005). In 711 A.D. however, Astigi was 
conquered by the Islamic Umayyad Empire, who renamed the city Istichcha (from which its 
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current name is derived) (Hitti 2002; Kennedy 2007; Samso 1998). Despite its previously 
extensive Christian influence, the Umayyad succession of Istichcha Islamized the region, 
encouraging the influx of Persians, Berbers, Arabs, and Aramaics into the region (Díaz-
Andreu 1996; Ballard 1996; Inskip 2013). While the Muslim caliphates did not require the 
conversion of Christians, opting instead to levy a jizyah tax on all non-practicing converts 
(Alam 2003; Lane-Pool and Gilman 1893), the city of Istichcha was infamous for its large 
number of Iberio-Islamic proselytes (Baena 2006; Hitti 2002; Inskip 2013; Melville and 
Ubaydli 1992). Therefore, for just over five centuries (8th-13th) Islamic socio-religious ideals 
and codes of conduct were infused within the city’s customs and mores; individuals, 
households and communities propagating Islamic Law and ethics. Islam remained a 
predominate presence within Istichcha until 1240 A.D., when the entire peninsula was 
conquered by the Christian King of Castile, Ferdinand III during the Reconquista (O’Shea 
2006; Reilly 1993). 
 
2. Islam  
Islam is a monotheistic Abrahamic religion which is based on the theological and 
judicial teachings of the prophets of Allah (God), as articulated by the Tawrat (Torah), Injil 
(Gospels) and most importantly, the Qur’an. Muslims, adherents to the Islamic faith, believe 
that the Qur’an contains the direct, infallible revelations of Allah, which were given to the 
final prophet Muhammad by the angel Jibril (Gabriel) (Esposito 2000; Mahmutćehajić 2006). 
As the Qur’an contains the divine messages of Allah, and with them, the core tenants of 
Islam, practicing (fundamentalist) Muslims are strict adherents to the explicit and implicit 
laws and interpretations (hadiths) found therein (Esposito 2000; Mahmutćehajić 2006).  
 
As mentioned, the ancient city of Isticha experienced an influx of Islam, and Islamic 
customs, during the Umayyad Empire. As the religion began to take root in Andalusia, 
popular expressions of Islamic religiosity and jurisprudence became more institutionalized, 
and their doctrines formalized by various schools of theology and law. In Córdoba, just 
northwest of the city, the Maliki School of Law was established in 795 A.D (Campo 2009; 
Fierro 1989; Inskip 2013; Lapidus 2002). Founded by the Imam Malik ibn Anas al-Asbahi, 
the school was characterized by a strong emphasize on the hadith, a collection of sayings 
attributed to the prophet Muhammad (Cornell 2006; Fierro 1992). Under the Umayyads, 
Maliki law was promoted as the official state code of jurisprudence, further transforming 
Córdoba and surrounding areas into a type of Islamic theocracy (Maribel et al. 2005).  
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Given the fact that Córdoba was considered a preeminent center for Islamic 
Orthodoxy during the 8th-12th centuries (Campo 2009; Fierro 1989; Inskip 2013; Lapidus 
2002), it is likely that Istichan Muslims were not only keenly aware of canonical Islam, but 
also actively attempted to adhere to Qur’anic teachings and sanctioned interpretations. In 
other words, it is not improbable to assume that Istichan Muslims considered typically 
profane actions, such as food preparation, eating, and breastfeeding, a type of sacred 
communion between themselves and their god, themselves and their families, and their 
families and their communities. This may have provided them with an increased impetus for 
adhering to the dietary and parenting guidelines set forth by the Qur’an and hadiths, a crucial 
aspect for this thesis.  
 
2.1. Islamic Dietary and Migratory Laws:  
 
Both the Qur’an and prophetic, hermeneutical teachings of Islamic scholars and law-
makers are clear when it comes to halal (permissible, lawful) and haram (non-permissible, 
un-lawful) actions and objects46, placing strict socio-religious taboos and rituals on codes of 
conduct (Adamec 2009; at-Tirmidhi 1796; Qur’an n.d.). This ritualization, however, extends 
beyond modes of conduct to include a set of dietary laws prescribing and proscribing the 
types of foods and beverages allowed to be consumed (at-Tirmidhi 1796; Qur’an 2:172-173; 
2-219; 5:3; 5:90; 5:96). According to Islamic law, it is unlawful to consume wild mammals, 
birds, and insects which have fangs or eat prey with their feet, are harmful to the welfare of 
humans, are capable of pouncing, stooping or striking, are unclean, or which are otherwise 
condemned in the Tawrat and Injil (at-Tirmidhi 1796; Qur’an 2:172-173; 2-219; 5:3; 5:90; 
5:96). Additionally, all animals which are born, or live in the water are haram, with the 
exception of fish. As such, pork and pork products, shellfish, and rabbit (etc.) are forbidden, 
unless extenuating circumstances (i.e. starvation) exist (at-Tirmidhi 1796; Qur’an 2:173; 
2:219; 5:3; 5:96).  
 
In addition to the ritualization and restriction of diet, pilgrimage is a key component 
of the Islamic faith. Pilgrimage, any journey whereupon the traveler searchers for, and 
reflects upon, the moral and spiritual teachings of Allah and his prophets, is one of the Five 
Pillars of Islam (Farah 1994; Hooker 1999). While minor pilgrimages are encouraged, the 
                                                          
46 It is acknowledged that this may vary temporally, as well as between traditions and individual, social and institutionalized interpretations 
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pilgrimage to Mecca in present day Saudi Arabia is considered mandatory for all adult 
Muslims who are financially and physically capable of undertaking the journey (Farah 1994; 
Hooker 1999). Given the distance (over 5700 km) required to travel from Istichcha to Mecca 
(fig. 32), the journey likely would have lasted several months. This means that, even if the 
traveler rationed halal food obtained from their hometown, they still would have required 
additional sustenance throughout their journey. Depending on which route was undertaken, 
this may have drastically altered the normal diet of the individual.  
2.2. Islamic Diet and Migration: Archaeological Stable Isotope Implications: 
Diet and migration are factors which are known to influence the isotopic values of 
dental enamel and bone collagen (DeNiro 1985; DeNiro and Epstein 1978; Schoeninger 
1985; Schoeninger and DeNiro 1984; van der Merwe and Vogel 1978; Vogel and van de 
Merwe 1977). As all adult Muslims are ‘required’ to pilgrimage to Mecca at least once in 
their life, it is suitable to assume that the isotopic value of their bone collagen may be 
influenced by such a journey. This is especially valid if the individual chose to travel along 
the coast, or through the Mediterranean Sea (fig. 32), increasing the amount of fish in their 
diet. Since children are not required to make such a long pilgrimage, their dental enamel 
Fig. 32: Theoretical routes for pilgrimage to Mecca from Isticha (Écija) during the 8th to 12th century A.D (Carroll 2015, 
googlemaps.com 2015). 
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should theoretically be unaffected by exogenous (i.e. non-Istichchan) isotopic signatures 
related to pilgrimage.  
 
Temporary emigration out of Istichcha is only one concern, however, since as 
mentioned previously, the Islamization of Spain encouraged the immigration of Persians, 
Berbers, Arabs, Aramaics and other Iberio-Muslims into the Baetican province (and 
surrounding areas) (Ballard 1996; Díaz-Andreu 1996; Inskip 2013). Since Istichcha was a 
renowned trading city (Bridgeman 2007), and is also close to major cities like Córdoba and 
Seville, it is highly likely that Muslims traveled to/through Écija for business, to visit family 
etc. The question for this thesis, therefore, is whether there is evidence that pilgrimage was a 
common custom for Istichchan Muslims, and whether Istichcha was a common city for non-
long term/non-residential Muslim immigrants to be buried.  
 
The veracity with which any one person, or group of people, adheres to mandated 
socio-religious practices is often highly variable. The proclivity for Istichchan Muslims to go 
on pilgrimage, therefore, likely shifted through time and in accordance with various social, 
economic and physical factors. In the 8th and 9th century, the idea of ‘Muslimhood’ was likely 
quite tenuous, as Islamic and Iberio-Islamic traditions were less strictly defined; local Islamic 
spiritualties and the shadow of Arianism and Christianity likely influencing what it meant to 
be a practicing Muslim. As such, pilgrimage may have simply seemed as an ideal as opposed 
to a mandatory expression of faith and devotion. After multiple generations, however, it is 
thought that a more explicit idea of Muslimhood developed (Berkley 2003; Lewis 2001) and 
with it, the confirmation of mandatory pilgrimage. This is likely especially true in the 11th 
and 12th centuries, when Christianity became a dominate threat to the Islamic way of life 
(Glick 1999; Inskip 2013). This may have necessitated a stricter definition of Muslimhood, 
and prompted more overt expressions of faith (Inskip 2013; Schöpflin 2001) – such as 
undertaking the more then 3000 mile journey from Istichcha to Mecca. As such, the 
likelihood of pilgrimage altering the isotopic values of the individuals selected for this 
sample is likely highly variable, since it is not possible to determine which individuals went 
on pilgrimage, how many pilgrimages that individual undertook, or how close to death the 
pilgrimage was undertaken using skeletal evidence alone. What can be safely assumed 
however, is that young children (especially those who were sick enough to die in infancy and 
were subsequently sampled) were unlikely to have undertaken such a long, strenuous 
journey. As such, the dental enamel of all individuals, and the bone collagen of all subadults, 
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are likely to reflect local isotopic values. Additionally, since the bone collagen of healthy 
individuals is reflective of the final ~5-10 years of an individual’s life (see Chapter 2), any 
pilgrimage taken prior to that is unlikely to significantly affect their isotopic values.   
 
As mentioned, immigration is also a factor which must be considered. While the 
Islamization of Spain undeniably encouraged the immigration of non-Iberian Muslims, the 
city of Istichcha was well known for its high population of indigenous, non-immigrant, 
converts (Baena 2006 Hitti 2002; Inskip 2013; Melville and Ubaydli 1992). As such, it is 
likely that most Istichchan Muslims were from Istichcha itself, or from the surrounding cities 
(Baena 2006 Hitti 2002; Inskip 2013; Melville and Ubaydli 1992). In the 10th and 11th 
centuries however, two separate groups of Muslims from North Africa arrived in the 
peninsula (Lapidus 2002). It is unknown how this influx of individuals affected the city, and 
thus, the average isotopic values noted within this study. In order to avoid skewing the 
results, individuals with nasal guttering, a common African phenotype (Silver and Souviron 
2009), were selected against. Additionally, in 2010 select individuals from the site were 
chosen for strontium isotope analyses (Zakrzewski). When possible, individuals with 
strontium values consistent with the region were selected for analyses, since it was already 
evident that they had been living in the city/area for the last several years of their life 
(Zakrzewski 2010). Despite this, dental enamel values may not be entirely representative of 
Istichchan water/food supplies (if they were emigrants), and therefore may vary as a result. It 
is unlikely, however, that the dental enamel of deceased juveniles are non-indigenous, since 
traveling large distances with/as a severely, fatally ill child is improbable.  
 
The final factor that must be considered is that of diet. Given the strict food taboos 
and the ritualization associated with meal preparation, it is likely that the individuals from the 
city and surrounding areas had near analogous diets, focusing primarily on the consumption 
of halal meats and meat-by-products (e.g. milk, eggs, and farmed domesticates), C4 and C3 
cereals and pulses (e.g. wheat, rice, barley, foxtail, sorghum, broomcorn millet), honey, and 
fruits (e.g. oranges, pomegranates and olives) (Alexander et al. 2015; de Castro 1993; 
Marsilla 1993; Sanchez 2002; Tomas 2009).  
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2.2. Islam and Breastfeeding:  
Archaeological evidence suggests that, while the cemetery of el Plaza contained the 
remains of all socio-economic and age demographics, stricter notions of gender identity 
developed over time, culminating in the formation of distinct male/female burial 
arrangements (Inskip 2013).  This suggests that, as the doctrines and dogmas of Iberio-Islam 
were more formerly collated, gender and engendered activity became less fluid, and more 
rigorous male/female social expectations developed. This is supported by changes in activity-
related skeletal modifications, which demonstrate sex-related differences in physical stressors 
over time (Inskip 2013). Given the differences between males and females, especially 
throughout the later phases of the Umayyad period (Inskip 2013), it is necessary to determine 
if female and male neonates/infants were breastfed and weaned differently, as doing so would 
alter the average isotopic signature of individuals.  
According to the Qur’an all “mothers shall suckle their children for two whole years 
if they wish to complete the period of nursing.” (2: 233) This passage, and others like it 
(31:14; 46:15), explicitly recommends a breastfeeding period of at least two years, with halal 
weaning practices to follow for the next six months (i.e. until the infant was 30 months old) 
(46:15).  What is also clear, however, is the fact that the verse does not distinguish between 
male and female children, stipulating instead that each and every child be fed according to 
their physical (as opposed to engendered) needs. The Qur’an also states, however, that 
parents may wean their children prior to the expiry of two complete years, provided they seek 
counsel from their religious authority and it does not jeopardize the health and welfare of the 
child. As such, weaning any particular child younger then two years old is considered haram, 
and therefore unlikely in most circumstances. When mothers were incapable or unwilling to 
breastfeed, the child was sent to a nursemaid or ‘foster mother’, as opposed to being weaned 
haram (2:233). This suggests that, regardless of the status of the mother, most children were 
breastfed according to Qur’anic guidelines. While the Qur’an suggests a time frame for 
breastfeeding and weaning, the health of the child is prioritized. As such, mothers may have 
breastfed sick children longer then two years, and may have also extended the weaning 
period to over six months.  
              As with the tenant of pilgrimage, it is possible that the adherence to Qur’anic 
breastfeeding and weaning laws varied through time, and with the solidification of Islamic 
ideals. It is likely that, with the cohesion of Iberio-Islam in the later Umayaad periods, most 
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children were breastfed for at least two years and then weaned onto culturally appropriate, 
halal foods, following the guidelines set forth in the Qur’an. In the early periods, where 
indigenous Islamic identity may not have been as pronounced, breastfeeding and weaning 
practices may have been largely influenced by Christian ideals. While the Bible explicitly 
states the importance of breastfeeding and weaning (e.g. Exodus 2:9, Genesis 21:8, Joel 2:16, 
Luke 11:27, 1 Samuel 1:22-14), it only implicitly hints at religiously acceptable breastfeeding 
and weaning practices. Despite this, Biblical passages do hint towards a similar breastfeeding 
and weaning schedule as that of the Qur’an (i.e. around two to three years). As such, it is 
possible to hypothesize that early (8th century) Islamic breastfeeding and weaning practices 
did not significantly vary from later ones.  
3. El Plaza de Espana 
    All skeletal samples utilized in this thesis were obtained, with permission, from the 
archaeological Islamic makbara (cemetery) of el Plaza de Espana in Écija, Spain. The 
cemetery, excavated between 1997 and 2002, contained the remains of over 4500 Islamic 
individuals with no apparent age, sex or socio-economic discrimination (Inskip 2013; Romo-
Salas n.d). This makes el Plaza the largest known excavated Islamic cemetery in Europe, and 
possibly the world (Inskip 2013; Romo-Salas n.d). 
 
     The cemetery itself is stratified into seven distinct burial phases, spanning between the 
8th to 12th centuries A.D. (Inskip 2013; Romo-Salas n.d). The majority of the burials are from 
the Islamic Umayyad period (8th-11th centuries A.D), and showcase increasing organization 
as the cemetery was more commonly used over time (Inskip 2013; Romo-Salas n.d). The 
cemetery is considered definitively Islamic for four main reasons. Firstly, the individuals 
were aligned perpendicular to Mecca (Inskip 2013; Romo-Salas n.d), a commonly adhered 
burial practice which is also seen at other Islamic cemeteries in the region, and throughout 
the world (al-Misri 1994; Halevi 2007). Secondly, as per Islamic law, the graves were devoid 
of any significant personal affects and adornments, and with the exception of a few burials, 
were non-monumental (Inskip 2013; Romo-Salas n.d). Similarly, the bodies appear to have 
been wrapped in a shroud as opposed to confined in a coffin, which is typical of Islamic 
burials (Inskip 2013; Romo-Salas n.d). Thirdly, the makbara was located next to a Christian 
Visigoth cemetery (Inskip 2013; Romo-Salas n.d), which suggests that early non-Muslims 
had their own burial rituals and strategies (e.g. different orientations and burial practices), 
and did not opt for (or require) internment in communal, non-sanctified (Islamic) spaces. This 
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is further supported by the fact that Christian Visgoths are non-contemporaneous with even 
the earliest Écijan Muslims. Finally, while the Qur’an does not prohibit non-Muslims from 
being buried within Muslim cemeteries, various Islamic traditions, Hadiths and scholars (e.g. 
Al-Baihaqi (994-1066 CE); Ibn Hazm (994-1064 CE) prescribed the separation of the two. 
As such, while religious mixed burials are not haram, they are not considered normative. 
Following the aforementioned lines of evidence, which are consistent with both historical and 
modern Islamic burial customs, it is safe to assume that all the individuals in El Plaza were 
culturally Muslim.  
 
4. Summary and Conclusions     
           The purpose of this chapter was to provide a brief overview of the socio-religious and 
epidemiological background of Écija, Spain, in order to provide a more comprehensive 
understanding of the factors which may have influenced the isotopic values of those sampled. 
Given the Islamic background of the inhabitants of Écija and the Iberian Peninsula itself, it is 
likely that most individuals prescribed to Islamic codes of conduct, including appropriate 
migration (i.e. pilgrimage and immigration), dietary and breastfeeding/weaning practices. 
These practices may have changed through time, as Islamic ideals and notions of 
Muslimhood became increasingly collated, and the impact of Christianity fluctuated. As 
such, it may not be possible to compare the isotopic values of Écijans from different 
centuries, a factor which could not be taken into great consideration given the limited amount 
of time with which sampling took place. It is suggested that future studies on this, and other, 
populations take this into consideration.  
 
 
 
 
 
 
 
 
 
   135 
 
CHAPTER EIGHT   
 Methods and Materials 
This chapter addresses the context and suitability of the samples used within this 
thesis, and outlines the methodological approaches applied.  The first section details the 
criteria used for sampling, focusing specifically on the pathological traits used to classify 
individuals as ‘Anemics’, ‘Possible Anemics/Possible Heterozygotes’, ‘Diseased’ or ‘Non-
Anemic’. Methods for ageing and sexing the skeletal samples, as well as their overall state of 
preservation, are noted in section 2. The third and fourth sections provides a detailed account 
of the analytical methods employed in order to prepare the samples for isotopic analyses, 
while the fifth briefly overviews the statistical analyses used to interpret the isotopic results. 
All samples were obtained with permission from the Municipal Museum of Écija, 
Spain, and are currently housed in the Osteoarchaeological Laboratory at the University of 
Leiden, The Netherlands.   
1. Sampling Strategy  
1.1. Selection of Individuals:  
           A total of 60 osteological samples, from 45 distinct individuals (Appendix A) were 
collected for stable carbon and nitrogen isotope analyses. Given the archaeological nature of 
the skeletal collection, it was not possible to clinically diagnose sickle cell or thalassemia in 
any of the individuals. As such, the selection and categorization of individuals was based on 
the presence or absence, and severity, of the following pathological features (in order of 
importance):  
1) Active and/or healed hair-on-end trabeculae  
a. Characterized by fine, linear trabecular extensions oriented perpendicular to 
the inner cranial table, and extending through the cranial diploe into the 
marrow cavity (fig. 33);  
b. Characterized by the expansion of the diploic space, leading to asymmetrical, 
severe macropitting with erratically oriented trabeculae reticulated 
throughout (fig. 33). 
2) Active and/or healed hematopoietic (marrow) hyperplasia in at least two long bones 
and/or at least six ribs. 
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a. Characterized by epiphyseal/metaphyseal flaring, abnormally thin cortical 
bone and/or expanded marrow cavities (fig.34) 
3) Active and/or healed cribra orbitalia and/or cranial porotic hyperostosis with or 
without new bone growth 
a. Characterized by micro and/or macropitting within and along the orbital 
surfaces (uni or bilateral) (fig.35), and/or throughout one or more 
ecto/endocranial surfaces (symmetrical or asymmetrical) (fig.36)  
4) Active and/or healed porotic hyperostosis, with or without new bone growth on three 
or more skeletal elements  
a. Characterized by non-age related local or systemic micro and/or 
macropitting, as well as a decrease in bone mass and density (fig.37) 
5) Active and/or healed new bone growth on three or more skeletal elements, with or 
without porotic hyperostosis or signs of infection  
a. Characterized by local or systemic new woven, lamellar and/or waxy bone 
growth not related to age or trauma (fig. 38) 
6) Biconcavity of at least four vertebrae  
a. Characterized by non-age/trauma related H-shaped/biconcave vertebrae (fig. 
39) 
7) Active and/or healed avascular necrosis with or without osteological infarcts, 
osteomyelitis, periostitis/osis, osteosclerosis and/or dactylitis  
a. Characterized by non-trauma related osteological tissue death, infection, 
inflammation and/or septic arthritis (fig.40) 
8) Active and/or healed pathological disturbances to the epiphyseal growth plates, 
premature epiphyseal fusion and/or cupped metaphyses 
a. Characterized by inward bulging (cupping) of the metaphyses (fig.41), 
abnormally shortened bones, auricular deformities 
9) Premature polyauricular degenerative joint disease 
a. Characterized by the presence of non-age/trauma related arthrosis (e.g. 
rheumatoid, septic, osteoarthritis) and/or auricular degeneration in anyone 
under the age of 25 years old   
10) Unilateral and/or bilateral cranial bossing  
a. Characterized by the protuberance/enlargement of the frontal and/or parietal 
bones  
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11)  Maxillary gnathopathy  
a. Characterized by maxillary prominence and mandibular retrognathism  
12)  Dental enamel or alveolar bone defects   
a. Characterized by the presence of linear enamel hypoplasia (LEH) (fig. 41), 
circular enamel defects, fluorosis, diastemas and/or delayed dental 
development  
Factors such as the relative age, ethnicity47, and the presence/severity of clearly non-anemia 
related osteological lesions were also taken into consideration. Individuals/osteological 
elements with clear evidence of non-anemia related skeletal alterations (e.g. non-necrotic 
atrophy, fracture callouses, dental caries) were not sampled, as previous research by 
Katzenberg and Lovell (1999), Olsen et al. (2014) and White and Armelagos (1997) has 
demonstrated that the presence of catabolic or anabolic pathologies can affect local isotopic 
values (see Chapter 6). Given the nature of the skeletal assemblage, certain pathologies (e.g. 
porosity, new bone growth) could not be avoided. A complete description of all pathological 
and taphonomic alterations noted on each sample is noted in Table XX (Appendix). All 
multiple internments/excavations were avoided. 
             Based on the aforementioned criteria, a total of four categories—Anemic (i.e. β-
thalassemia major, sickle cell anemia, α-thalassemia major), Possible Anemics/Possible 
Heterozygotes (i.e. skeletal pathologies not severe enough to be considered genetically 
anemic, but β-thalassemia major, sickle cell anemia, and/or α-thalassemia major cannot be 
conclusively ruled out; skeletal pathologies consistent with β-thalassemia intermedia, β-
thalassemia minor, sickle cell disease, α-thalassemia minor or iron-deficiency anemia), 
Diseased (i.e. skeletal pathologies are noted, however, they cannot be conclusively linked to a 
genetic anemia) and Control (i.e. only age related degeneration noted, if skeletal pathologies 
are present)—were created. 
 
 
 
 
 
                                                          
47 Individuals with nasal guttering and other features non-typical to the sample population were not selected, as it was not possible to conclusively 
determine if the individual was a migrant – a factor which may non-pathophysiologically alter stable isotopic values.    
   138 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33: Hair-on-end trabeculae; (top left) 
trabecular extensions on the ectocranium #11321; 
(bottom left) asymmetrical macropitting and 
trabecular reticula on the ectocranium #2134; 
(bottom right) asymmetrical macropitting and 
trabecular reticula on the endocranium #2030 
(Carroll 2015, taken with permission from the 
Municipal Museum of Écija Spain). 
 
Fig. 34: Hematopoteic Marrow 
Hyperplasia: Flared metaphyses (left) 
proximal ulna #11989; (right) tibia #4776 
(Carroll 2015, taken with permission from 
the Municipal Museum of Écija Spain). 
Fig. 35: Cribra orbitalia; with 
new bone growth (left) #2030; 
and without (right) #11916 
(Carroll 2015, taken with 
permission from the Municipal 
Museum of Écija Spain). 
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Fig. 36: Cranial porotic hyperostosis; (left) micropitting on the basilar portion of the occipital bone #2030; (right) 
macropitting on the ectocranial surface of the cranium #2134 (Carroll 2015, taken with permission from the Municipal 
Museum of Écija Spain). 
 
Fig. 38: Marrow hyperplasia of the vertebral column (left); Biconcave, H-shaped 
deformities of the vertebral column (right) (neuroradiographs.com 2015). 
 
Fig. 37: Non-cranial porotic hyperostosis; (left) first sacral vertebrae #11916; (right) ventral surface of the manubrium 
#5920 (Carroll 2015, taken with permission from the Municipal Museum of Écija Spain). 
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Fig. 39: (left) Avascular necrosis of the left humeral head. Shown in comparison to the non-affected right 
humeral head from the same individual #10326; (left) healed periostosis #7968 (Carroll 2015, taken with 
permission from the Municipal Museum of Écija Spain). 
Fig. 41: Cupped metaphyses 
#11321 (Carroll 2015, taken 
with permission from the 
Municipal Museum of Écija 
Spain). 
Fig. 40: New bone growth on the cranial-facial skeleton; (left) lamellar new bone growth on the endocranium #10021; 
(center) new woven bone growth on the zygomatic #11321; (right) waxy lamellar bone growth on the ectocranium #12283 
(Carroll 2015, taken with permission from the Municipal Museum of Écija Spain). 
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             In order to most accurately differentiate sicklic and thalassemic individuals from 
non-anemics, as well as from those with various other metabolic and/or nutritional disorders, 
a set of strict criteria for cohort-inclusion were created. All subadults with indisputable 
evidence of cranial hematopoietic hyperplasia (i.e. hair-on-end trabeculae) and at least three 
of the aforementioned criteria/pathologies were considered to be ‘Anemics’. This is thought 
to reduce the likelihood that nutritional/metabolic disturbances would be mistakenly 
identified as a genetic anemia since, with the exception of iron deficiency anemia and certain 
cardiovascular conditions and osteosarcomas48 there is no strong evidence of other 
nutritional/metabolic disorders causing hair-on-end trabeculae (Aufderheide and Rodriguez-
Martin 1998, Balikar et al. 2012; Britton et al. 1960; Burko et al. 1961; Diggs 1973; 
Lagundoye 1970; Gobindrao and Ghom 2014, Hollar 2001, Ortner 2003; Sebes and Diggs 
1979; Song 1971; Walor et al. 2005; Williams et al. 1975). Similarly, since several 
nutritional/metabolic/viral disorders induce local/systemic porotic hyperostosis and/or new 
bone growth, the presence of multiple osteological lesions commonly (clinically) noted in 
sicklic and thalassemic individuals was required to further decrease the likelihood of 
misdiagnosis (Aufderheide and Rodriguez-Martin 1998, Gobindrao and Ghom 2014, Hollar 
2001, Ortner 2003). A total of nine individuals were classified as Anemic (see Appendix A, 
B).  
            All individuals (subadult and adult) with active and/or healed cribra orbitalia, porotic 
hyperostosis, linear enamel hyperplasia and/or excess amounts of new bone growth were 
                                                          
48 Osteosarcomas could be ruled out as a differential diagnoses based on the appearance of the lesion 
Fig. 42: Dental enamel defects (linear enamel hypoplasia) #7968 (Carroll 2015, taken with permission from 
the Municipal Museum of Écija Spain). 
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considered to be metabolically/nutritionally disturbed (Aufderheide and Rodriguez-Martin 
1998, Gobindrao and Ghom 2014, Ortner 2003). Those with severe porosity49, new ‘waxy’ 
bone growth (Fig. 40), and/or evidence of non-hair-on-end marrow hyperplasia, as well as at 
least one other manifestation of the aforementioned criteria were considered to be ‘Possible 
Anemics/Possible Heterozygotes’. A total of 11 individuals met these criteria (see Appendix 
A, C).  
 Individuals with fewer and/or less severe manifestations were labelled as ‘Diseased’—a 
broad category which cannot definitely differentiate between heterozygotic anemias, acquired 
anemias, malnutrition, malaria (etc.). All individuals with any non-age related new bone 
growth on the ribs were placed in this category, even if no other osteological lesions were 
present. This served to reduce the likelihood that pulmonary conditions, which also affects 
the rate of oxygen diffusion, fixation and metabolization, would bias the isotopic values of 
the control cohort. A total of 11 individuals were considered Diseased (see Appendix A).  
             Controls were selected based on the complete absence of osteological lesions, with 
two major exceptions; age-related degeneration and LEH. All non-juvenile individuals 
exhibiting LEH, but no osteological pathologies were considered controls for the collagen 
samples. A total of 14 individuals were identified as controls (see Appendix A) 
          2. Demographics and Preservation:   
          2.1. Age and Sex Estimates:  
          Due to time constraints, only a cursory estimate of the age and sex of each individual 
was conducted (Appendix A, B, C). It is suggested that these categories be more accurately 
reassessed at a later date, with special consideration afforded to the possibility of premature 
epiphyseal fusion and delayed dental development in those with sickle cell and/or 
thalassemia anemia (Hallab 2013; Hazza and Al-Jamal 2006. Mello et al. 2012; Sams et al. 
1990).  
         All age estimates were based solely on rates of epiphyseal fusion, and the degree of 
dental development, eruption and wear, as per disciplinary standards (Ash and Nelson 2003; 
Buikstra and Ubelaker 1994, Hillson 2005; Scheuer and Black 2004). When specific age 
estimates could not be garnered, individuals were labelled either as young adults (YA; 18- 35 
                                                          
49 Defined as extensive, systemic micro/macropitting, which occurs on more than one bone and which takes up 75%+ of the surface area.  
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years), middle adults (MA; 35-50 years), or old adults (OA; 50+ years). All adult sex 
estimates were based solely on the appearance of the sacrum, sciatic notch, and crania as per 
Buikstra and Ubelaker (1994). All sub-adults (<18) individuals were left unsexed. Given the 
limited sexing criteria applied, individuals were classified only as possible male (PM), 
possible female (PF) or unknown.   
2.2. Post-Mortem Alterations: 
     
           The overall (macroscopic) preservation of the 45 individuals selected for sampling 
ranged between good (50-75% of all cortical bone intact) and excellent (75-100% of all 
cortical bone intact). Taphonomic alterations were limited, but included root damage and 
sun-bleaching. Fragmentation was prevalent in the sub-adult remains, however, all 
individuals/elements could be reconstructed without issue, and their periosteal surfaces were 
not significantly altered. Glue and net-retention dressings were present on a limited number 
of (cranial) specimens. No evidence of burning, animal or other obvious bioturbation 
activities were noted on any of the individuals.  
         Completion ranged from good (50-75% complete) to excellent (75-100% complete), 
with most individuals having at least one rib and one tooth capable of being sampled. The 
vast majority of non-control samples exhibited extensive micro/macropitting, with subadults 
showcasing the most severe and widespread manifestations. While the majority of the pitting 
was determined to be non-taphonomic, its presence may have affected the overall 
preservation (protein quality, humic acid concentration, diagenetic alterations etc.) of 
severely affected samples.  
          3. Preparation Methods 
           3.1. Osteological Samples:  
           In order to analyse inter-individual variation in stable carbon and nitrogen isotope 
values, a small diaphyseal rib sample was collected from 42 of the 45 individuals (see 
Appendix A). Caution was made to select rib fragments which did not exhibit pathological 
features, however, in the majority of cases this was not possible due to excessive porosity, 
new lamellar bone growth and/or evidence of hemopoietic hyperplasia on all available ribs 
(see Appendix D)  When this occurred, ribs fragments showcasing the least amount of 
pathology were preferentially selected.  
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           In order to analyse intra-individual isotopic variation in a select number of individuals, 
samples with slower turnover rates (compared to ribs) were selected (Appendix A). These 
included non-diagnostic portions of the cranial vault (n=6), zygomatic (n=1), scapula (n=1), 
and vertebral lamina (n=5). All samples were selected based on the presence of excessive 
porosity and/or new ‘waxy’ bone growth (see Appendix D) however, individuals were 
selected at random. A total of 13 non-rib samples were selected. To reduce the amount of 
destructive analyses conducted, osteological elements which were already fragmented were 
preferentially sampled.  
          3.2. Dental Samples: 
          A total of 44 dental samples were selected for stable oxygen and carbon isotope 
analyses of enamel apatite. Given the nature of the skeletal collection50, as well as the 
permissions granted51, it was not possible to select the same dental element52 for each 
individual. A total of 24 non-pathological permanent third molars (20 mandibular, four 
maxillary), five non-pathological permanent second molars (four mandibular, one maxillary), 
10 non-pathological permanent first molars (four mandibular, six maxillary), one permanent 
mandibular canine, and three non-pathological deciduous second molars (2 mandibular, 1 
maxillary) and one non-pathological deciduous first molar (maxillary) were sampled. A 
complete list of all dental samples collected can be found within Appendix A.   
 Given the roughly isochronal developmental and mineralization timing of mandibular and 
maxillary dentition (of the same element) (Table 2), they are considered to be more or less 
analogous. As such, all stable isotope data for maxillary and mandibular dentition of the same 
element are considered comparable. As the odontogenesis and the complete mineralization of 
enamel varies between dental elements (Table 2), however, different dental elements are not 
isotopically comparable, as they represent disparate points in an individual’s 
developmental/life history. 
 
                                                          
50 Three individuals died at such a young age that no permanent dentition was available for sampling. As such, select deciduous teeth were 
sampled. Additionally, two of the individuals selected for analyses were edentulous, and therefore no dental samples could be obtained.  
51 In order to preserve the integrity of the skeletal collection, it was determined that the least destructive sampling strategies should be employed.  
As such, teeth were partially selected for ease of removal (i.e. the possibility of removing the element without severely damaging the underlying 
structures), with already unattached tooth (definitively belonging to the individual) preferentially selected over dentition firmly attached within the 
socket. 
52 The term dental element refers to a specific tooth within the dental arcade (i.e. first molar, second molar, third molar)  
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              3.3. Faunal Remains:  
              A total of seven faunal samples collected to give a non-human control baseline. 
Enamel samples included one bovine, one ovine (sheep) and two equine molars. Osteological 
samples included small, non-diagnostic mandibular fragments from one ovine and one 
bovine. It is unknown whether the dental elements belonged to the same individuals as the 
mandibular elements, as teeth were not attached to the mandibles. For the purposes of this 
research, it is assumed they are from two separate individuals. Samples were selected largely 
at random from a box of unidentified faunal remains, which all were located at the cemetery. 
Only samples which could be conclusively identified to the species level were taken for 
analyses. All samples were free of any visible pathological lesions.  
4. Analytical Methods: 
 
4.1.  Bone Collagen 
Standard collagen extraction and preparation procedures based on those purported by 
Sealy (1986, 2010) are as follows: 
Table 2: Developmental timeline for the calcification of 
select human dental elements (Carroll 2015; after Ash and 
Nelson 2003). 
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Collagen extraction procedures were conducted in the Thin Sectioning and Bone 
Processing Chemical Laboratory of the Faculty of Archaeology, Leiden University. All bone 
samples were placed in a bath of distilled water (dH2O), and cleaned ultrasonically with an 
Elma series sonicator. Large, or particularly sediment-heavy samples were fractured into 
smaller pieces in order to ensure the medullary cavities/trabeculae could be sufficiently 
rinsed of organic and inorganic contaminants. The holding containers were rinsed of 
sediments, and new dH2O added, every ten minutes. Samples were determined to be 
sufficiently cleaned when the water-bath remained clear after a minimum of ten minutes of 
sonication, or when 15 replications at five minute intervals were complete. Sonication times 
varied between 25 and 75 minutes, depending on the size and type of bone, and the amount of 
adhering sediment (Appendix E).  
 Once sonicated, all bone samples were immersed in a dilute 1% hydrochloric acid 
(HCl) solution in order to remove all inorganic hydroxyapatite crystals while minimizing 
protein loss. HCl was replaced every 24-48 hours. In one incident (ID# 12603), the 
concentration of HCl was reduced to a 0.5% solution in order to decelerate the rate of 
demineralization while preserving as much collagen as possible (Appendix E). Samples were 
considered demineralized upon the creation of a translucent, flexible collagen pseudomorph 
which could be easily pierced with a sterilized needle, and when the HCl solution was clear. 
The total decalcification process for Anemic samples varied from three to 24 days, for an 
average of seven days (Appendix E). Non-Anemic samples decalcified between three and 22 
days, for an average of nine days (Appendix E). Faunal samples decalcified between nine and 
10 days, for an average of 9.5 days (Appendix E). Relative collagen yield, based solely on the 
visual inspection of the quantity and appearance the pseudomorphs in relation to the quantity 
of the original bone sample, ranged from poor to excellent. Pseudomorph color ranged from 
translucent-milky white to translucent-dark brown, with control samples yielding the highest 
number of dark/brown pseudomorphs (Appendix E). There appeared to be no consistent 
pattern between the production of the brown vs. white pseudomorphs however, and it was 
noted that collagen color varied intra, as well as inter-individually.  
Upon their creation, all collagen pseudomorphs were removed from the 1% HCl 
solution and rinsed in dH2O for a minimum of five times. Intact pseudmorphs were then 
transferred to a 0.1M solution of sodium hydroxide (NaOH) using sterilized tweezers, for a 
minimum of 12 hours and a maximum of 23 hours (for an average of 18 hours) to remove 
humic acids from the sample (Appendix E). Post-pseudomorph NaOH solution color varied 
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between clear to dark brown, with darker collagen pseudomorphs yielding, on average, 
darker NaOH solutions (Appendix E). As the degree of demineralization varied between 
samples, it was determined that severely demineralized samples53 were to be vacuum filtered 
out of the HCl solution and placed directly into dH2O, foregoing the NaOH bath (Appendix 
E). Previous research has demonstrated that circumventing this step raises δ13C values by, on 
average, 0.3 ‰ (Jorkov et al. 2007; Sealy et al. 2014).  
 Following the NaOH bath (or the 1% HCl bath, if NaOH was not applied), all 
samples were soaked dH2O, which was changed daily until a neutral pH (7) was achieved. 
Upon neutralizing, collagen was transferred into bleach-sterilized scintillation vials with a 
small amount of fresh dH2O, and taken to the Faculty of Earth and Life Sciences at the Vrije 
Universiteit (VU) Amsterdam for freeze drying. Pre-treated, freeze-dried collagen samples 
(0.41-0.52 mgs) were encapsulated inside sterilized tinfoil capsules for combustion. The 
tinfoil capsules were then loaded into a Thermo-Scientific Flash 2000 organic elemental 
analyser, and combusted at 980-1020 degrees centigrade. The resultant gases were introduced 
into the Delta V plus isotope ratio mass spectrometer via a continuous flow (Conflo) inlet, 
using helium as the carrier gas. The results were expressed as delta values (δ) in parts per mil 
(‰) using the equation 
δRsample= {(Rsample/Rstandard) – 1} x 1000 
Where R= the ratio of the number of heavier to lighter stable isotopes 
Carbon values were reported relative to the Vienna PeeDee Belemnite (VPDB) 
marine limestone standard, and nitrogen values reported relative to international nitrogen 
standard NAir.  
4.2. Standards and Analytical Reproducibility:  
As a measure of reproducibility and quality control, USGS40, USG41, USG42, and 
glysine were used as reference standards. A total of three samples (each) of USG40, 
USG41,USG42, and four samples of glysine were combusted at the start of each bone 
collagen tray (n=6 trays). Two samples of USG42 was combusted every ten samples, 
following that. Standard deviations of repeated measurements of laboratory standards are 
                                                          
53 Characterized by amorphous globules of translucent, gelatinous fibrils which did not retain the original structure of the bone, and/or which were 
almost completely dissolved.   
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included in Appendix F. Analytical reproducibility and precision of error for each bone 
collagen sample is unknown, as the isotopic composition of every sample was only measured 
once.  
The quality (preservation; degree of contamination) of the isotopic data garnered 
from each bone collagen sample was measured according to disciplinary standards (Ambrose 
1990; Ambrose and Norr 1992; Bocherens et al. 1991; DeNiro 1985; DeNiro and Weiner 1988; 
Schoeinger et al. 1989; van Klinken 1999), and is recorded in the following chapter (see 
Chapter 9, section 1.1). All statistical analyses were conducted using IBM SPSS statistical 
software (version 22.0 for Window 8).  
4.3. Enamel Apatite:  
Standard enamel apatite extraction and preparation procedures based on those 
purported by Lee-Thorp (1997) are as follows: 
As with the aforementioned bone collagen procedures, all dental elements were 
rinsed ultrasonically in dH20 to remove organic and inorganic sediments. Prior to destructive 
sampling all teeth were photographed, and their metric and non-metric traits recorded 
following the guidelines set forth by Buikstra and Ubelaker (1994) and Hillson (2005).  
Surfaces which exhibited the following criteria were preferentially selected for 
sampling; (1) the surface was free from any visible pathologies, including linear enamel 
hypoplasia and dental caries; (2) the surface was free from macrofissures, and no had no 
visible microfissures; (3) enamel was present throughout the entire surface, from the 
cementum enamel junction (CEJ) to just below the occlusal surface; (4) the surface exhibited 
no dentin exposure; and (5) the surface had limited (less than 5%) amounts of dental calculus. 
If all surfaces exhibited the aforementioned criteria, the lingual surface was preferentially 
sampled.  
The surface of each sample site was cleaned using a variable speed diamond-tipped 
dremel, which was soaked in an ethanol solution and rinsed in clean dH20 between uses. The 
sampling site was determined sufficiently clean when the surface of the tooth exhibited a 
milky-white, homogenous color and no evidence of soil adherence, calculus and/or 
superficial staining remained. Once cleaned, the entire crown height, from just above the CEJ 
to just below the occlusal surface was harvested. This ensured that the isotopic signature 
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garnered from each sample was representative of the average accumulation of stable isotopes 
from the point of enamel formation to that of complete mineralization (i.e. the isotopic 
average of several years, as opposed to a distinct point in time). In order to avoid skewing 
δ13C and δ18O results, caution was taken not to remove any underlying dentin or cementum 
tissue. In cases where non-enamel tissues were accidentally harvested the contaminants were 
removed from the enamel sample using bleach-sterilized tweezers. When this was not 
possible the contaminated sample was stored in appropriately marked Eppendorf tubes, and a 
new sample collected. In order to avoid cross contamination the worksite was wiped down 
with a commercial bleach solution every three teeth. New pergamyn paper used for each 
enamel harvest. Approximately 10 mgs of powdered enamel apatite was collected from each 
tooth. Faunal samples were processed similarly.  
Powdered samples were loaded into marked 2 ml micro-centrifuge tubes and soaked 
in a 0.1M commercial liquid bleach solution54 for 45 minutes, in order to eliminate organic 
and biogenic contaminants. Samples were then centrifuged at 10,000 revs/minute, for one 
minute. The bleach solution was then removed from the enamel precipitate using a pipette, 
and the sample was rinsed with 0.1M of dH20. A total of three rinse-centrifuge cycles were 
conducted. The enamel was then reacted in 0.1M of acetic acid (CH3COOH) for 15 minutes 
to remove soluble diagenetic carbonates. Samples were rinse-centrifuged another three times 
with distilled water and then freeze dried.  
Pre-treated samples were analysed at the Faculty of Earth and Life Sciences at Vrije 
Universiteit (VU) Amsterdam University, using a DeltaPlus XP Therma-Finnigan stable 
isotope ratio mass spectrometer coupled with a Thermo-Scientific Flash 2000 organic 
elemental analyser with continuous flow (Conflo) inlet. Pre-treated enamel samples (0.19-2.1 
mgs) were transferred into sterilized mass spectrometry tubes, and reacted with phosphoric 
acid (H3PO4) at 72 degrees centigrade to produce gaseous carbon dioxide. Similar quantities 
of IAEA-CO1 were used as an in-house standard. The resultant gas was isolated on a 
Gasbench II universal automated interface. 
As a measure of reproducibility and quality control, IAEA-CO1 was used as a 
reference standard. Standard deviations of repeated measurements of laboratory standards 
were 0.16 and 0.07 for δ13C and δ18O respectively (Appendix G). The results were expressed 
as delta values (δ) in parts per mil (‰) using the aforementioned equation. Stable oxygen and 
                                                          
54  8% sodium hypochlorite in distilled water.  
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carbon isotope values were reported relative to the Vienna PeeDee Belemnite (VPDB) 
marine limestone standard. All statistical analyses were conducted using IBM SPSS 
statistical software (version 22.0 for Window 8). Quality control measures are outlines in 
Chapter 9, section 1.2.  
5. Statistical Analyses: 
A series of non-parametric and parametric statistical analyses are used to compare the 
isotopic values among and between groups (cohorts, tooth types, bone samples). Data which are 
normally distributed and demonstrates an equality of variance, as demonstrated by Shipiro-Wilks 
and Levene’s tests, are analysed parametrically, while data which are not are analysed non-
parametrically. One-way ANOVA (parametric) or Kruskal-Wallis (non-parametric) tests are 
employed when comparisons are made among three or more data sets. Scheffe post-hoc and 
Wilcoxon-Mann-Whitney U analyses are used determine the exact significance between groups, if 
the one-way ANOVA or Kruskal-Wallis analyses are significant. Independent t-tests (parametric) 
and Wilcoxon-Mann-Whitney U (non-parametric) analyses are used for comparison between two 
data sets. Pearson two-tailed correlation tests are employed to assess the relationship between two 
qualitative data sets. Statistical significance is set at α = ≤0.05.  
While statistical significance ensures that the null hypothesis is false, it relates only 
the probability that the results are not due to chance (Richardson 1022; Sullivan and Feinn 
2012). In order to measure the strength of the relationship between two statistically 
significant variables, a partial Eta squared test was employed (Richardson 1022; Sullivan and 
Feinn 2012). This test determines the magnitude of difference (effect size) between groups. 
In other words, it is a way to quantify the size of the difference between two groups 
(Richardson 1022; Sullivan and Feinn 2012). A value of d=0.2 is considered a small effect 
size (58th percentile, 15% of non-overlap between variables), d=0.5 is considered a medium 
effect size (69th percentile, 33% of non-overlap between variables), and d= ≥ 0.8 is 
considered a large effect size (79th percentile, 47% non-overlap of variables) (Richardson 
1022; Sullivan and Feinn 2012). 
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CHAPTER NINE 
Results 
This chapter presents the results obtained from the isotopic analysis of the bone 
collagen (δ15N; δ13C) and enamel apatite (δ18O; δ13C) samples taken from Écija, Spain. The 
first section outlines the quality control indicators used to ensure the validity of the results, 
and discusses why certain samples were omitted or retained for analyses. The second section 
discusses the correlation between isotopic values (δ18Oenamel to δ13Cenamel; δ15Ncollagen to 
δ13Ccollagen; δ13Ccollagen to δ13Cenamel), in order to more accurately elucidate the relationship 
between them. The third and fourth sections present the results obtained from the isotopic 
analysis of bone collagen and enamel apatite, respectively, and discusses intra and inter-
cohort variability. The fifth section briefly reviews the data obtained from the faunal samples, 
which acted as a set of secondary controls, and places them within broader Spanish contexts. 
Results are summarized in the sixth and final section.  
1. Quality control Indicators:  
 
1.1. Bone Collagen: 
The identification of contamination and post-mortem diagenesis in bone collagen is 
imperative to the formulation of accurate results and interpretations, since low quality 
collagen may not be a direct proxy for in-vivo stable isotope values, as is required of 
archaeological stable isotope research. In order to ensure that the isotopic values garnered 
from each sample is truly reflective of ante-mortem values, it is compulsory to ensure that 
lipids, carbonates, organic particulates, and humic acids are not significantly contributing to 
the overall isotopic signature of the sample (Ambrose and Norr 1992; van Klinken 1999). 
Similarly, it is necessary to confirm the relative integrity of the bone collagen matrix, since 
severely degraded collagen may be more significantly affected by background contamination 
than intact collagen, as per the sample size effect (Ambrose and Norr 1992; van Klinken 
1999).  
        The quality (degree of contamination, level of degradation) of each bone collagen 
sample included in this study was assessed using a combination of atomic carbon to nitrogen 
ratios (C:N mol/mol), percent carbon and nitrogen by weight (wt. % C; wt. % N) values, and 
collagen yields (% wt.) (Ambrose 1990; Ambrose and Norr 1992; Bocherens et al. 1991; 
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DeNiro 1985; DeNiro and Weiner 1988; Schoeinger et al. 1989; van Klinken 1999). A 
complete report of all quality control indicators for human and faunal bone collagen (δ13C 
and δ15N) samples is reported in Appendix H.    
A compendium of literature has been published regarding the use of C:N ratios as a 
measure of contamination and bone collagen degradation (Ambrose 1990; Ambrose and Norr 
1992; Bocherens et al. 1991; DeNiro 1985; DeNiro and Weiner 1988; Schoeinger et al. 1989; 
van Klinken 1999). Consistent with this literature, a range of 2.9-3.6 is used, with values 
above 3.3 suggesting the possible addition of organic carbons (van Klinken 1999). Of the 56 
bone collagen samples analysed (n=42 ribs; n=12 non-ribs; n=2 faunal), three fell outside of 
the acceptable range of 2.9-3.6, and were subsequently omitted from the study. An additional 
three samples were inappropriately combusted during mass spectrometry and therefore 
yielded no isotopic data or quality control data. They were also omitted. A total of 20 
samples expressed values between 3.3 and 3.6. Of those samples, 17 were retained since their 
collagen yields, wt. % C and wt. % N values were all within acceptable ranges for intact 
collagen.    
Collagen yields were used to assess the level of post-mortem collagen degradation, 
and to determine the possible impact of contaminants on the isotopic signature. Fresh bone 
contains ~22 wt. % collagen, which steadily decreases posthumously (van Klinken 1999). 
Collagen yields of <3-5 wt. % typically suggests the presence of organic or inorganic 
contaminates, however, this is known to vary between climates, regions and burial 
environments (Ambrose 1990; van Klinken 1999). Archaeological samples obtained within 
Europe have consistently demonstrated adequately preserved, non-contaminated, collagen 
with collagen yields <3-5 wt. %. As such, a cut off of <1 wt. % is typically employed, with 
yields <2wt. % necessitating the use of additional quality control measures to ensure the 
integrity of the sample (van Klinken 1999).  
Collagen yields for this study were generally low, and ranged between 10.1 to 0.1 wt. 
% for human samples. The highest collagen yield was noted in the bovine sample, which 
contained 12.4 wt % collagen. Of the 53 appropriately combusted samples, 41 contained <5 
wt % collagen. Six yielded no collagen data, either as a result of post-analysis inclusions or 
because the scintillation vial within which the sample was housed broke, and therefore 
accurate yields could not be calculated. The low collagen yields are thought to be related to 
the Spanish climate, which is hot and encourages collagen breakdown, the fact that multiple 
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skeletons were left in the sun for extended periods of time during the excavation of the 
cemetery, as well as the fact that the majority of the bones (with the exception of the Control 
cohort) were pathologically hyperporotic. Due to the amount of samples exhibiting low 
collagen yields, the less conservative cut-off of <1 wt % was deemed appropriate (Ambrose 
and Norr 1992, van Klinken 1999). A total of four samples expressed collagen yields outside 
of this range. Since low collagen yields do not necessarily reflect the presence of 
contaminants, two of the four samples were retained since their C:N ratio, wt %C and wt % N 
values were all within the acceptable range. The other two samples were omitted.    
Characteristic wt. % C and wt. % N values were used to assess the presence of 
organic and inorganic contaminants in the samples (Ambrose 1990; Ambrose and DeNiro 
1989; Ambrose and Norr 1992; van Klinken 1999). Modern collagen contains over ~43% 
carbon, and ~16% nitrogen by weight (Ambrose 1990; Ambrose and DeNiro 1989; Ambrose 
and Norr 1992). Characteristic wt % C values for intact archaeological collagen is ~35 wt. % 
C (34.8 +/- 8.8 wt. %), with lower wt. % C values suggesting the presence of peat or humic 
acid contaminants, and higher values suggesting the presence of organic carbons (van 
Klinken 1999). Of the 53 appropriately combusted samples, four fell outside of the accepted 
range of 34.8 (+/- 8.8) wt. % C. All four had previously been omitted, due to poor C:N ratios 
and/or collagen yields. Given the fact that collagen with less then 30 wt. % C is often known 
to include a small percentage of inorganic matter (van Klinken 1999), a second, more 
conservative range of 30-40 wt. % C was also included to flag possible contamination issues. 
Three samples exhibited possible peat or humic acid contamination (<30 wt. % C), while four 
exhibited the possible inclusion of additional organic carbons (>40 wt. % C). Samples which 
were flagged and had unacceptable C:N ratios or collagen yields were omitted.  
Characteristic wt % N values for intact archaeological collagens is 11-16 wt. % N, 
with values outside of that range exhibiting similar contamination issues noted in poor wt % 
C values (Ambrose 1990; Ambrose and DeNiro 1989; van Klinken 1999). A total of seven 
samples fell outside of this range, six of which were omitted due to poor C:N ratios, collagen 
yields and/or wt. % C values. Only one sample which had unacceptable wt. % N and wt. % C 
values was retained. Research by Miller et al. (1967) has shown that embryonic bone 
collagen contains more carbon rich hydroxylysine than mature lamellar bone, and since the 
sample was a cranial fragment from an infant (~3-4 years old), it was determined that the 
higher than acceptable wt. % C value (50.7) may have been reflective of increased 
concentrations of hydroxylysine in the cranial collagen, as opposed to the presence of post-
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mortem contaminants. Additionally, the sample’s C:N ratio was within acceptable range, and 
since the sample was only included as a measure of intra-individual variation, it was 
determined that it would not significantly affect the overall results, even if the sample was 
somewhat contaminated. Finally, the isotopic signature of sample was well within range of its 
cohort, reinforcing the decision to retain it.   
Overall, of the 56 samples originally selected for analyses, three were omitted due to 
improper combustion within the mass spectrometer, and seven were omitted as a result of 
poor quality control indicators (Appendix H). In total, ten Anemic (n=8 rib samples; 2 cranio-
facial samples), ten Pos. A.H. (n=9 rib samples; 1 vertebral lamina sample), 12 Diseased 
(n=10 rib samples; 2 cranial vault samples), 13 Control (n=11 rib samples; 2 vertebral lamina 
samples) and one faunal (mandible) samples were retained for analyses, for a total of 45 
human samples, 38 of which were rib collagen, and one faunal sample (Appendix H).  
1.2. Enamel Apatite:  
Unlike bone, enamel apatite is less likely to be affected by post-mortem mineral 
exchange or diagenesis (Budd et al. 2000l; Kohn et al. 1999; Lee-Thorp 2002) and as such, 
does not necessitate as strict quality control measures. Since the superficial enamel was 
removed from each dental sample prior to harvesting the apatite for analysis, and each sample 
was pre-treated, it was determined that organic particulates and other contaminants were 
sufficiently removed from the sample. As such, only samples which were flagged by the VU 
Amsterdam Earth and Life Sciences Mass Spectrometry Laboratory were omitted. Of the five 
faunal samples collected, one ovicaprid molar was rejected as possibly contaminated. The 
shell sample was also omitted, since its origins were unknown, and therefore not considered 
an appropriate control.  
2. The Statistical Correlation Between Isotopic Values 
In order to determine if and to what extent two isotopes are significantly correlated, a 
Pearson’s correlation analysis was used to assess the relationship between (a) δ13C and δ15N 
values for bone collagen; (b) δ13C and δ18O values for enamel apatite; and (c) δ13C bone 
collagen and δ13C enamel apatite values.  
The results revealed that a significant relationship exists between δ13C and δ15N 
values when all bone collagen samples (n=46) (p=0.014; R2= 0.13) are analysed. Within-
group analysis, however, demonstrate that a significant relationship between δ13C and δ15N 
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values exists only within the Control cohort. This relationship is significant when all Control 
bone samples (n=13) (p=0.007; R2 = 0.50) and just Control rib samples (n=11) (p= 0.017; R2 
= 0.49) are analysed. This indicates that Controls exhibit a strong relationship between bone 
collagen δ13C and δ15N values, and that ~50% of the variation noted in one value can be 
explained by a variation in the other. Tests also reveal that this is not the case with Anemics 
(p=0.715; R2=0.02), Pos. A./H. (p=0.061, R2= 0.41), or Diseased (p=0.268; R2=0.150) 
cohorts, suggesting that the ‘healthy’ relationship between δ13C and δ15N values is somehow 
disrupted in individuals/samples with macroscopic manifestations of pathology (Anemic or 
otherwise).  
There is no significant relationship between δ18O and δ13C enamel apatite values, 
either at a population level (p=0.114; R2 = 0.06) or between tooth-types55. This indicates that 
δ18O enamel apatite ratios are not significantly affected by shifts in δ13C values, and vice 
versa. Finally, no significant relationship exists between δ13C enamel apatite and rib bone 
collagen δ13C values, either at a population level (p=0.185; R2 =0.07) or between cohorts56.  
3. Bone Collagen: δ13C and δ15N Values 
A complete report of all isotopic data for human and faunal bone collagen (δ13C and 
δ15N) samples is reported in Appendix I.  
3.1. Population-Wide Analyses:  
Mean bone collagen composition for the entire population (n=38; ribs only) is         -
19.0‰ and 10.2‰ for carbon and nitrogen ratios, respectively (fig.43) (Appendix I). 
Standard deviations were used to assess the degree of isotopic variation between samples (i.e. 
individuals), and to identify individuals with isotopic values outside of the population mean. 
The standard deviation for mean δ13C values is +/- 0.6‰ (-18.4 to -19.6‰) (Appendix I), 
which suggests that the degree of inter-individual δ13C variation is low. The standard 
deviation for mean δ15N values is considerably higher, at +/- 1.4‰ (8.8 to 11.6‰) (Appendix 
I). This suggests a greater degree of inter-individual variation in 15N values. A total of 12 
individuals fall outside of the population mean for both δ13C and δ15N values; five Anemics 
(62.5%), three Pos. A./H.s (33.3%), two Diseased (20%), and three Controls (27%) (fig.43). 
                                                          
55 M1: p=0.147, R2 = 0.27; M2: p=0.807, R2 =0.02; M3: p= 0.255, R2 =0.06; m2: p= 0.640, R2 = 0.29 
56 Anemics: p=0.169, R2 =0.29; Pos.A/H.: p=0.546, R2 =0.10; Diseased: p=0.778, R2 = 0.01; Control: p=0.569; R2 =0.04. 
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Based on this, Anemics are roughly twice as likely to exhibit δ13C and δ15N values outside of 
the population mean. 
 
Standard group δ13C values range from -21.3 to -18.1‰, while group δ15N values 
range from 8.0 to 13.6‰ (Appendix I). Anemics exhibit the lightest δ13C values (-21.3‰) 
and the heaviest δ15N values (13.6‰), while the Pos.A./H, cohort exhibit the heaviest δ13C 
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values (-18.1‰) and the lightest δ15N values (8.0‰). In order to assess differences in the 
isotopic value of the most isotopically enriched and depleted samples the following equations 
were used: 
δ13C1-2 = δ13Cskeletal element 1 - δ13C skeletal element 2 
δ15N1-2 = δ15Nskeletal element 1 - δ15N skeletal element 2 
A difference of 5.5‰ in δ15N values is noted between the most isotopically enriched and 
depleted rib samples. Typically, an enrichment of 3.4‰ (between 2-5‰) in δ15N values is 
indicative of a trophic level shift (Caut et al. 2009; Post 2002; Tykot 2004; Vanderklift and 
Ponsard 2003) and as such, the most enriched rib (Anemic) is at least one, and possibly two, 
trophic level(s) above the most depleted (Pos. A./H.) rib sample. It is not possible to exclude 
breastfeeding as the cause of the increased δ15N value, since the most enriched sample was 
collected from an individual aged ~2 years (+/- 8 months) old, while the most depleted 
sample was collected from a middle adult (~36-50 years old) (Appendix A, I). In order to 
assess the variation in adult and infant (individuals aged <5 years old) δ15N values they were 
calculated separately. A difference of 4.7‰ is noted between the most isotopically enriched 
(Anemic; 2 years +/- 8 months; 13.6‰) and isotopically depleted (Control; ~4 years; 8.9‰) 
infants (n=12). Young adults (n=6) (~18-35 years old) exhibit a difference of 3.1‰ between 
the most isotopically enriched (Pos. A./H; 12.0‰) and depleted (Control; 8.9‰) individuals, 
middle adults (n=11) exhibit a 2.8‰ difference between the most isotopically enriched 
(Control;10.8‰) and depleted (Pos. A./H; 8.0‰) individuals, and old adults (n=11) (51+ 
years old) exhibit a 3.2‰ difference between the most isotopically enriched (Control; 
11.6‰) and depleted (Diseased; 8.4‰) individuals.  
A difference of 3.2‰ in δ13C values is noted between the most isotopically enriched 
and depleted rib samples (Appendix I). As with the disparate δ15N values, it is not possible to 
exclude age (i.e. age related dietary differences) as a factor, since the most depleted 
individual (Anemic; -21.3‰) is estimated to be ~3-4 years old while the most enriched 
individual (Pos. A./H; -18.1‰) is estimated to be ~18 to <25 years old (Appendix A, I). 
Overall, infants exhibit a difference of 3.1‰ between the most isotopically enriched 
(Anemic; -18.2‰) and depleted (Anemic; -21.3‰) individuals, while young adults exhibit a 
difference of 1.2‰ between the most isotopically enriched (Pos. A./H; -18.1‰) and depleted 
(Pos. A./H. and Control; -19.3‰) individuals. As with the young adults, middle adults only 
exhibit a difference of 1.1‰ between the most enriched (Control; -18.6‰) and depleted 
   158 
 
(Control; -19.7‰) individuals, while old adults exhibit a 0.7‰ difference between the most 
enriched (Diseased; -18.6‰) and depleted (Control; -19.4‰) individuals  
3.2. Cohort-Wide Analyses:  
Mean δ13C and δ15N bone collagen values for each cohort (i.e. Anemic, Pos.A./H., 
Diseased, and Control) are reported in Appendix I.  
3.2.1. Intra-Cohort Analyses: δ15N Bone Collagen Values 
Overall, Anemics (n=10) exhibit the greatest degree of intra-cohort variation in δ15N 
values, with a 4.6‰ per mil difference between the most isotopically depleted (9‰; aged 
between two years +/-8 months and four years old) and enriched (13.6‰; aged at two years 
+/- 8 months) rib samples (fig. 44) (Appendix I). A one-way ANOVA was used to assess the 
degree of intra-cohort variation between rib samples (n=8), and between total bone collagen 
(n=10) (i.e. all bone samples, including non-rib elements) δ15N values.  The test demonstrates 
that Anemics exhibit a significant amount of intra-cohort variation (rib samples: p=0.01; 
F=33.9;, df=1; total bone collagen: p=<0.001; F=44.147; df=1) which cannot be explained 
by age57 (Pearson: p=0.742, R2=0.020) or the state of pitting58 (Pearson: p=0.813, R2=0.032)   
A difference of 4.0‰ is noted between the most isotopically enriched (12.0‰; aged 
between ~18 years and <25 years old) and depleted (8.0‰; aged between 35 and 50 years 
old) rib samples in the Pos. A./H. cohort (fig. 44) (Appendix I). A one-way ANOVA 
demonstrates a significant amount of intra-cohort variation in δ15N values, both when only rib 
samples (n=9) are analysed (p=<0.000; F=38.615; df=1) and when total bone collagen 
(n=10) is analysed (p=<0.000; F=33.95; df=1). Age is not considered a significant factor in 
the degree of intra-cohort variation (Pearson: p=0.646; R2=0.031).  
The Diseased cohort exhibits a 2.1‰ difference between the most isotopically 
enriched (10.5‰; aged >50 years old) and depleted (8.4‰; aged >50 years) individuals (fig. 
44) (Appendix I). A one-way ANOVA demonstrates a significant amount of intra-cohort 
variation in δ15N values, both when only rib samples (n=10) are analysed (p=0.008; 
F=12.510; df=1) and when total bone collagen (n=12) is analysed (p=0.001; F=19.433; 
                                                          
57 Using youngest estimated age range in analysis 
58 Active micropitting, healed micropitting, active and healed micropitting 
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df=1). Age is not considered a significant factor in the variation noted (Pearson: p=0.969; 
R2=<0.000).  
The Control cohort exhibited a difference of 2.7‰ between the most isotopically 
enriched (11.6‰; aged >50 years old) and depleted (8.9‰; aged ~four years old) individuals 
(fig. 44) (Appendix I).  When age was taken into consideration (i.e. the infant omitted), a 
difference of 2.3‰ was noted between the most isotopically enriched and depleted (9.3‰; 
aged >35 years old) adults. A one-way ANOVA demonstrates a significant amount of intra-
cohort variation in δ15N values, both when only rib samples (n=11) are analysed (p=0.001; 
F=21.016; df=1) and when total bone collagen (n=13) is analysed (p=<0.000, F=35.713, 
df=1). Age is not considered a significant factor in the degree of intra-cohort variation noted 
(Pearson: 0.062; R2 =0.336). 
3.2.2. Intra-Cohort Analyses: δ13C Bone Collagen Values: 
As with the δ15N values, Anemics exhibit the greatest degree of variation in δ13C 
values, with a 3.1‰ difference between the most isotopically enriched (-18.2‰; aged 
between two years +/-8 months and four years old) and depleted (-21.3‰; aged between 
Fig. 44: Plot of δ15N bone collagen values for all rib and non-rib samples, per cohort (Carroll 2015) 
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three and four years old) individuals (Appendix I). Despite the relatively large difference in 
δ13C values between the two individuals, however a one-way ANOVA demonstrates no 
significant intra-cohort variation, either when just rib samples (n=8) are analysed (p=0.985; 
F=<0.000; df=1;) or when total bone collagen (n=10) (p=0.782; F=0.082; df=1) is 
analysed.  This is not entirely unexpected since the most depleted sample is a clear outlier, 
and a difference of just 1.2‰ is noted between the most isotopically depleted (-19.38‰; aged 
between 2 years +/-8 months and 4 years old) and enriched samples if that individual is not 
considered.  
The Pos. A./H. cohort exhibits a difference of 1.2‰ between the most enriched (-
18.1‰; aged between 18 years and <25 years old) and depleted samples (-19.3‰; aged 
between 18 months +/- 6 months and two years +/- 8 months) (Appendix I). Even when age 
is taken into consideration, the difference between the most enriched and depleted samples 
remains at 1.0‰. Significant intra-cohort variation is only noted when total bone collagen 
(n=10) is analysed (p=0.033; F=6.640; df=1; Ribs (n=9): p=0.086, F=5.920, df=1). 
A difference of 0.6‰ is noted between the most isotopically enriched (-18.7‰; aged 
>50 years old) and depleted individuals (-19.3‰; aged 35-50 years old) within the Diseased 
cohort (Appendix I). No significant intra-cohort variation is noted when either rib collagen 
(n=10) (p=0.958; F=0.003; df=1) or total bone collagen (n=12) (p=0.001; F=19.433; df=1) 
is analysed using a one-way ANOVA.  
Similar to the Pos. A./H. cohort, the Control cohort exhibits a difference of 1.1‰ 
between the most enriched (-18.6‰;  aged >35 years old) and depleted (-19.7‰; aged >35 
years old) individuals (Appendix I). Unlike all other cohorts, the Controls exhibit a 
significant amount of intra-cohort variation in rib collagen (n=11) (ANOVA: p=0.021; 
F=7.838; df=1) and total bone collagen (n=13) (ANOVA: p=0.003; F=13.735; df=1) δ13C 
values. Age is not considered a factor for the variation noted (Pearson: p=0.881; R2=0.002) 
3.2.3. Inter-cohort Statistical Analyses: δ15N and δ13C Bone Collagen Values: 
Parametric statistical analyses were conducted to assess the relationship between 
δ15N values and cohort status, as the data was normally distributed. A one-way ANOVA 
determined that cohorts have significantly different δ15N values, both when only rib bone 
collagen (n=38) is analysed (p=0.012; F=4.226; df=3, 34), and when all bone samples 
(n=45) are analysed (p=0.047; F=2.888; df=3). This was supported by a Scheffe post-hoc 
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test, which demonstrates that Anemic rib δ15N values are significantly different than the 
Diseased cohort (p=0.026) and the Control cohort (p=0.014), but not the Pos. A./H. cohort 
(p=0.195). While statistically significant, the partial Eta squared value (d=0.272) indicates 
that the clinical significance is low (see Chapter 8, section 5). No statistical difference is 
noted between the Pos. A/H. and the Diseased cohort (ribs: p=0.810; All: p=0.925), Pos. 
A./H. and Control cohort (ribs: p=0.902; All: p=0.826), or between the Diseased and Control 
cohorts (Ribs: p=0.996; All: p=0.997). Thus, it is clearly the Anemic cohort which is 
distinctive.  
Non-parametric statistical analyses were conducted to assess the relationship between 
δ13C values and cohort status, as a Shapiro-Wilk test of normality indicated the dataset (as a 
whole) was non-normally distributed. A Levene’s test and non-parametric Levene’s test of 
homogeneity indicated non-equality of variance. A Kruskal-Wallis test determined that there 
is no significant differences in bone collagen δ13C values between groups (p=0.230, df=3; 
χ2= 4.313). A Wilcoxon Mann-Whitney U test was conducted between Anemics and Control 
cohorts, and supports that no significant inter-group difference exists (p=0.198; Z=-1.322). 
Two cohorts (Anemics and Controls) had normally distributed data, and thus a one-way 
ANOVA and independent t-tests were used for comparison. No significant inter-group 
differences in rib bone collagen δ13C values (ANOVA: p=0.604; F=0.624, df= 3, 34; t-test: 
p= 0.712; df=17; t=0.375), or total bone collagen values (i.e. when all bone samples are 
analysed) (ANOVA: p=0.703; F=0.473; df=3) were noted.  
Overall, the only statistically significant inter-cohort difference in the isotopic 
composition of bone collagen is between the δ15N values of Anemic and Control cohorts. 
This means that the difference in bone collagen δ15N values between the two groups is 
definitively not related to chance, and that some other factor is responsible for the differences 
between the two groups. A Pearson’s correlation test was used to assess the relationship 
between cohort status (Anemic or Control) and δ15N values, as well as between age59 and 
δ15N values in the two groups. The results demonstrate that a significant relationship does 
exist between cohort status and δ15N values (p=0.014, R2= 0.308) as well as between age and 
δ15N values (p=0.013, R2= 0.310). In other words, 31% of the variation noted in δ15N 
between individuals can be attributed to age. Likewise, 31% of the variation in bone collagen 
δ15N can be attributed to cohort status, however, it is not possible to determine whether this 
                                                          
59 Categorized into one of the following; 18 months +/- 6 months to 4 years, 2 years +/- 8 months, 2 years +/- 8 months to 4 years, 3 years to 4 
years, young adult, mddle adult, old adult.  
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actually reflects states of physiology (i.e. Anemic or non-Anemic) or whether this is another 
reflection of the relationship between δ15N and age, since the Anemic cohort contains only 
infants while the Control cohort contains mostly adults (with the exception of one infant) 
(Appendix A).  
3.2.4. Non-Rib Bone Collagen Samples:  
A one-way ANOVA was conducted on all non-rib samples to determine whether 
their δ13C and δ15N values varied significantly between, and within, cohorts. The test 
determined that inter-cohort δ13C values do not vary significantly (p=0.339; df=3; F=9.559), 
although intra-cohorts δ13C values do (p=0.035; df=4; F=9.559). A Scheffe post-hoc 
analyses and t-tests revealed that Anemic non-rib samples vary significantly from the Control 
cohort (Scheffe: p=0.038; t-test: p=0.054; df=2; t=-4.136), but not from the Pos. A./H. 
(Sheffe: p=0.959) or Diseased (Scheffe: p=0.728; t-test: 0.280; df=2; t=-1.467) cohorts. 
Since the δ13C values are not statistically different between Pos. A./H. and Control cohorts 
(Scheffe: p=0.056; t-test: p=0.066; df=2; t=3.682), the Pos. A./H. and the Diseased cohorts 
(Scheffe: p=0.934; t-test: p=0.508; df=2; t=-0.800), or the Diseased and Control cohorts 
(Scheffe: p=0.091; t-test: p=0.122; df=2; t=2.591), it can be concluded that the difference 
between Anemic and Control cohorts is not actually significant (i.e. if the Anemic cohorts is 
statistically analogous to the Pos. A./H. and Diseased cohorts, and those two cohorts are 
statistically analogous to the Control cohort, Anemic and Control cohorts cannot be 
significantly different). Since the p value for anemic-Control comparison is 0.054 (and 
statistical significance is set at 0.05), and the one-way ANOVA demonstrates no significant 
inter-group differences in δ13C values, Anemics and Control non-rib samples will not be 
considered significantly different.  
A one-way ANOVA confirms that no significant variation in non-rib δ15N values 
exists between the groups (p=0251, F=2.342, df=3). This is supported by the Scheffe post-
hoc analysis.  
3.2.5. States of Pathology:  
Stable isotope ratios superficially appear to vary between states of pathology. For 
example, while thickened cranial vaults (n=2) exhibit similar δ15N and δ13C (0.03‰ and 
0.3‰ difference, respectively) values, vaults with new lamellar bone growth (n=2) exhibit 
relatively larger discrepancies between δ15N and δ13C values (0.58‰ and 0.81‰ 
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respectively). Similarly, rib samples with active micropitting appear to exhibit the lightest 
δ13C values (-21.3‰; -19.4‰), while rib samples with healed micropitting appear to exhibit 
the heaviest (-18.9‰; -18.8‰). Despite this, a one-way ANOVA indicates that no significant 
differences in δ13C values exists between states of porosity (p=0.186; d=1; F=3.111) or 
between states of cranial thickness (p=0.826; df=2; F=0.249). The same test also indicates 
no significant differences in δ15N values between states of porosity (ANOVA: p=0.560, df=1, 
F=0.479), or cranial thickness (ANOVA: p=0.327; df=2; F=1.286). The small sample sizes 
are likely to be contributing to this lack of significance.   
4. Enamel Apatite: δ13C and δ18O Values 
Appendix J contains all stable carbon and oxygen isotope data for accepted enamel 
apatite samples (n=45).  
           Mean δ13C values for permanent first (n=9), second (n=6) and third molars (n=24), as 
well as deciduous second molars (n=3) are -11.2‰ (+/- 1.1‰), -11.5‰ (+/- 0.8‰,), -11.2‰ 
(+/- 1.3‰) and -10.3‰ (+/-1.4‰), respectively. Mean δ13O values are -4.6‰ (+/- 1.3‰), -
4.5‰ (+/- 2.1‰), -4.7‰ (+/- 1.4‰), and -4.3‰ (+/- 0.1‰) for permanent first, second and 
third molars and deciduous second molars, respectively.  
4.1. Inter-tooth variation 
           One-way ANOVA and Kruskal-Wallis statistical analyses are used to compare δ13C 
and δ18O values between molars (M1, M2, M3, m2). A Lavene’s test of homogeneity 
confirmed equal variance between tooth types, however, a Shapiro-Wilk’s test demonstrated 
a mix of normally and non-normally distributed data amongst the groups. 
          One-way ANOVA60, Scheffe post-hoc61, and Kruskal-Wallis62 analyses all found that 
there is no significant difference in δ13C or δ18O values between m2s, M1s, M2s, and M3s, or 
between any of the tooth types63 (m1, m2, C, M1, M2, M3)64. A one-way ANOVA was also 
                                                          
60 One-way Anova; Test: Relationship between δ13C values and molars: p=0.5261; F=0.756; df=3. Conclusion: No statistical differences in δ13C 
values between m2s, M1s, M2, and M3s. Test: Relationship between δ18O values and molars: p=0.980; F=0.061; df=3. Conclusion: No statistical 
differences in δ18O values between m2s, M1s, M2s, and M3s 
61 Scheffe Post-Hoc: δ13C values: M1-M2: p=0.985; M1-M3: p=1.00; M1-m2: p=0.677; M2-M3: p=0.979; M2-m2: p=0.554; M3-m2: p=0.609. 
Conclusion: No statistical differences in δ13C values m2s, M1s, M2s, and M3s. δ18O values: M1-M2: p=1.00; M1-M3: p=0.999; M1-m2: p=0.994; 
M2-M3: p=0.997; M2-m2: p=0.998; M3-m2: p=0.984. Conclusion: No statistical differences in δ18O values between tooth types.  
62 Kruskal-Wallis: δ13C: p=0.381; df=3; X2 = 3.072; δ18O: p=0.462, df3; X2 = 2.575. Conclusion: No statistical differences in δ18O or δ13C values 
between m2s, M1s, M2s, and M3s 
63 Relationship between δ13C values and tooth types: p=0.907; F=0.252; df=4; Conclusion: No statistical differences in δ13C values between any 
of the teeth. Relationship between δ18O values and tooth type: p=0.643; F=0.631; df=4 Conclusion: No statistical differences in δ18O or δ13C 
values between tooth types 
64 In order to ensure that sample size wasn’t a factor, it was deemed appropriate to run statistical tests on all the teeth together, and then just on 
m2s, M1, M2s, and M3s, because only one canine and one deciduous first molar were sampled.  
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conducted to assess the relationship between δ13C and δ18O values in the deciduous molar 
(n=4) and permanent canine (n=1) dentition. It determined that no significant differences in 
δ13C or δ18O values exists between deciduous first molars, deciduous second molars and 
permanent canines (Carbon: p=0.877; F=0.220; df=3; Oxygen: p=0.081; F=81.754, df=3). 
Small sample size is likely contributing to this lack of significance.   
                 Given the fact that infants generally have heavier δ18O values than adults (by ~1‰ 
due to the enrichment of breastmilk compared to drinking water; Wright and Schwarcz 1998) 
an independent t-test was used to assess the isotopic differences between deciduous molars 
and third permanent molars. No significant differences are noted in δ13C or δ18O values 
between the permanent and deciduous molar dentition (Oxygen: p=0.524; df =23; t=-0.647; 
Carbon: p=0.594; df=23; t= 0.540). As mentioned, small sample size is likely contributing to 
this lack of significance.  
               Despite the lack of significant differences in δ13C and δ18O values between tooth 
types, when the mean isotopic 
values are plotted on a line graph, it 
demonstrates that second deciduous 
molars have the heaviest δ18O 
values, while the first deciduous 
molar has the lightest (fig.45). The 
permanent dentition exhibit a greater 
degree of similarity in mean δ18O 
values. Conversely, the first 
deciduous molar exhibits the 
heaviest δ13C value, while the canine 
exhibits the lightest (fig. 45). There 
appears to be a greater degree of 
inter-tooth variability in δ13C values, 
however, as mentioned, the 
differences are not significant.  
 
Fig. 45: Plot of mean δ13C and δ18O enamel 
apatite values for permanent and deciduous 
dentition (Carroll 2015). 
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4.2. Intra-tooth Variation:  
 
Differences in the isotopic composition between the most isotopically enriched and 
depleted dental samples, per tooth type, are noted in Table 3. Third (n=24) permanent molars 
exhibit the greatest degree of intra-tooth variation in δ13C values, while second permanent 
molars exhibit the least (Table 3). Second and third permanent molars exhibit the greatest 
degree of intra-tooth variation in δ18O values, and second deciduous molars showcase the 
least (Table 3). In both cases, sample size is likely a contributing factor.    
 Table 4 summarizes the differences in isotopic values between the most isotopically 
enriched and depleted dental samples, if cohort status is taken into account. The third 
permanent molars of the Pos. A./H. cohort (n=5) exhibit the greatest degree of intra-tooth 
variation in δ13C values, while the second permanent molars of the Control cohort (n=5) 
exhibit the least (Table 4). Conversely, the second permanent molars of the Control cohort 
exhibit the greatest degree of intra-tooth variation in δ18O values, while the third permanent 
molars of the Pos. A./H. cohort exhibit the least (Table 4).  
To determine the relationship between cohort status and the δ13C and δ18O values of 
permanent first molars (fig.46), one-way ANOVA and Kruskal-Wallis statistical parametric 
and non-parametric tests were used. A Shapiro-Wilk’s test of normality determined that 
stable carbon values are normally distributed among cohorts (Anemics: p=0.654; Pos. A.H.: 
p=0.837), and a Levene’s test confirmed equal variance between data (p=0.446). As such, a 
one-way ANOVA was used. The test determined that there is no significant differences in 
δ13C values between cohorts (p=0.387; F=1.115; df=2). Data for δ18O values are non-
normally distributed (Anemics: p=0.005; Pos. A.H.: p=0.004), and therefore a Kruskal-
Wallis test was employed. It determined that there is no significant differences in δ18O values 
between cohorts (p=0.134, df=2, χ2=4.018) (n= 5 Anemics=5; Pos. A./H.=3; Control=1). 
This was supported using Mann-Whitney U tests (Anemic to Pos. A./H.: p=0.071; Z=-1.938; 
Anemics to Control: p=0.667; Z=-0.878; Pos.A.H. to Control: p=1.000; Z=-0.447). There 
are no significant outliers for either δ18O or δ13C values.  
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Data for second permanent molars (fig. 47) is normally distributed (Carbon: 
p=0.617; Oxygen: p= 0.64), and exhibits equal variance (Carbon: p= 0.142; Oxygen: p= 
0.269), as demonstrated by a Shapiro-Wilk and Levene’s test. Due to the small sample size 
(n=1 Pos. A./H. and 4 Control) however, inferential statistics could not be performed. The 
degree of inter-cohort variation is therefore unknown.  
Data for third permanent molars (fig. 48) is normally distributed for both carbon and 
oxygen data. A Levene’s test demonstrates equal variance in oxygen data (p=0.096), but non-
equal variance in carbon data (p=<0.000). A one-way ANOVA demonstrates that no 
significant difference exists between cohort status and δ13C values (p=0.095; F=2.632, df- 2, 
32), which is supported using a post-hoc Sheffe test. Despite this, significant inter-group 
differences in δ18O values (p=0.034; F=3.998; df= 2, 21) was noted using the same one-way 
ANOVA technique. Independent t-tests conclude that δ18O values are significantly different 
between Pos. A./H. and Diseased cohorts (p=-0.004; df=13; t=-3.551) and between Diseased 
and Control cohorts (p=0.054, df=17; t=2.073), but not between Pos. A./H. and Control 
cohorts (p=0..628; df=12; t=-0.497).  
Fig. 46: Plot of δ13C and δ18O enamel apatite values for all permanent first molar samples collected from Écija, Spain. 
Standard deviations (+/-) for population δ13C values is shown horizontally, while standard deviations for δ18O values are 
shown vertically (Carroll, 2015). 
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Three individuals are considered to be outliers, two Pos. A./H., and one Control (fig. 
48). Independent t-tests confirm that the outlier Control has significantly different δ18O 
values (p=0.001; t=4.743, df=3), and that both Pos. A./H. have significantly different δ13C 
values (ID 7968 vs. Controls: p=0.001, t=-10.261, df=4; ID 12063 vs. Pos. A./H.: 
p=<0.000; t=-15.252, df=4) than the rest of the M3 population.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 47: Plot of δ13C and δ18O enamel apatite values for all permanent second molar samples collected from Écija, 
Spain. Standard deviations (+/-) for population δ13C values is shown horizontally, while standard deviations for δ18O 
values are shown vertically (Carroll, 2015). 
 
Fig. 48: Plot of δ13C and δ18O enamel apatite values for all permanent third molar samples collected from Écija, 
Spain. Standard deviations (+/-) for population δ13C values is shown horizontally, while standard deviations for 
δ18O values are shown vertically plot (Carroll, 2015). 
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5. Faunal Samples:  
 
5.1. Bone Collagen: 
The only accepted faunal bone collagen sample (Bos; mandible) yielded a δ15N value 
of 4.1‰, and a δ13C value of -20.6‰. The sample’s δ13C and δ15N values are statistically 
analogous to Bos Taurus (δ13C: p=0.420; df=4; t=0.899; δ15N: p=0.096, df=4, t=2.171), 
Gallus (δ13C: p=0.160, df=3, t=1.858; δ15N: p=0.897; df=3; t= -0.141) and ovicaprid (δ13C: 
p=0.418, df=3, t=0.938; δ15N: p=0.988, df=7, t=0.016) δ13C and δ15N values from Gandia, 
Spain, a 13th-16th century township in Valencia (Alexander et al. 2015) (Table 5, fig. 49). The 
sample’s δ15N value is also statistically analogous to the Bos Tarus (p=0.096, df=4, t=2.171) 
and ovicaprid (p=0.988, df=7, t=0.016) values (from the same site) (Alexander et al. 2015) 
(Table 5, fig.49).  As such, while only one faunal sample could be used as a non-human 
control, it is considered to be representative of organisms consuming a mainly C3, plant-
based, diet (fig. 49).  
 
 
 
 
 
 
 
 
 
 
 
 
Table 5: Results of the stable isotpe analyses of animal bone 
collagen from Gandia, Spain (Alexander et al. 2015, 266)  
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Independent T-tests confirm that all human cohorts, with the exception of the 
Anemic cohort, have significantly different δ13C value than the bovine sample (Bovine vs. 
Anemic: p=0.171, df=7; t=-1.527. Faunal vs. Pos. AH: p=0.006. df=7; t= -3.664. Faunal vs. 
Diseased: p= <0.000; df=9; t=-6.800. Faunal vs. Control p= 0.001; df=10; t=-4.625) (fig. 
49). All cohorts exhibit significantly different δ15N values (Faunal vs. Anemic: 0.007; df=7; 
t=-3.811. Faunal vs. Pos. AH: p=0.003, df=8; t= -4.269. Faunal vs. Diseased: p=<0.000; 
df=9; t=-7.517. Faunal vs. Control: p=<0.000; df=10; t=-6.055), as is expected (fig. 49).  
5.2. Enamel Apatite: 
Three faunal enamel apatite samples were considered sufficiently intact for analyses; 
one bovine and two equine molars (fig.50). Independent T-tests determined that the bovine 
sample has a statistically analogous δ13C value to all human cohorts (Bovine to Anemic: 
p=0.091; df=7; t=1.955; Bovine to Pos A./H.: p=0.123; df=9; t=1.703; Bovine to Diseased: 
p=0.231; df=12; t=1.276; Bovine to Control: p=0.248; df=12; t=1.209). Its δ18O value, 
however, is significantly different than the Diseased (p=0.009; df=10; t=3.227) and the 
Control (p=0.004; df=13; t=3.495) cohorts (Bovine to Anemic; p= 0.362; df=7; t=0.976; 
Bovine to Pos A./H: p=0.624; df=9; t=0.508). Given the different isotopic values obtained 
from the equine samples, they were analysed separately. Independent T-tests determined that 
the first equine sample (ID # 9.02) has statistically analogous δ18O and δ13C values to all 
human cohorts (Equine to Anemic: δ13C: p=0.686; df=7; t=0.422; δ15N: p=0.684; df=7; t=-
0.425; Equine to Pos A./H: δ13C: p=0.800; df=9; t=0.261; δ15N: p=0.784; t=-0.282; Equine 
to Diseased: δ13C: p=0.729; df=10; t=-0.357; δ15N: p=0.657; df=10; t=0.457; Equine to 
Control: δ13C: p=0.869; df=13; t=0.168; δ15N: p=0.619; df=13; t=0.510. All human cohorts 
and the second equine sample (ID # 9.07) exhibit analogous δ13C values (Equine to Anemic: 
p=0.982; df=7; t-0.023; Equine to Pos: p=0.977; df=9; t=-0.030; Equine to diseased: 
p=0.209; df=10; t=1.342; Equine to Control: p=0.167; df=13; t=1.463), but differ 
significantly in δ18O values (Equine to Anemic: p=0.001, df=7, t=-5.436; Equine to Pos: 
p=0.001; df=9; t=-5.251; Equine to diseased: p=<0.000; df=10; t=-6.596; Equine to Control: 
p=0.002; df=13). 
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Summary:  
The results of the isotopic analyses conducted on the bone collagen and enamel 
apatite samples obtained from Écija, Spain, are as follows;  
Pearson’s correlations tests indicate that a significant relationship exists between 
δ13C and δ15N bone collagen values, when all human and faunal bone collagen samples are 
analysed together. When cohorts are examined independently, however, it is revealed that 
δ13C and δ15N values are only significantly correlated in the Control group, and that a 
significant relationship between δ13C and δ15N values does not exist in the other groups. It 
was also determined that enamel apatite δ13C and δ18O values, as well as bone collagen and 
enamel apatite δ13C values, are not strongly correlated.  
All cohorts exhibit a significant amount of intra-cohort variation in bone collagen 
δ15N values. A Pearson’s correlation test was conducted to determine if, and to what extent, 
δ15N values and age were correlated. The test indicated that no significant relationship exists 
Fig. 50: Plot of δ13C and δ18O enamel apatite values for all human and faunal samples from Écija, Spain (Carroll, 2015); 
Legend: + = equine; X = bovine; red diamond= Anemic M1; purple diamond = Pos. A./H. M1; black diamond = Control 
M1; green square= Pos. A./H. M2; blue square = Control M2; green circle = Pos. A./H M3; pink circle = Diseased M3; 
yellow circle = Control M3; white triangle = Diseased C; red triangle = Pos. A./H. m2; purple triangle = Anemic m2; green 
triangle = Anemic m1. M1= first permanent molar; M2= second permanent molar; M3= third permanent molar; C= 
permanent canine; m1= deciduous first molar; m2= deciduous second molar (Carroll 2015). 
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between age and δ15N values in any of the groups, suggesting that intra-cohort variation in 
δ15N values is related to some other exogenous (e.g. dietary) or internal (e.g. physiological) 
factors. Only the Pos. A./H. and Control cohort exhibit a significant amount of intra-cohort 
variation in bone collagen δ15N values, however, only the Control group exhibits this 
variation when both rib collagen and total bone collagen is analysed.  
Parametric and non-parametric analyses on bone collagen samples indicate that 
Anemic δ15N values are significantly different from both the Diseased and Control cohorts, 
but not the Pos.A./H. cohort. No statistical differences were noted in δ15N values between the 
Pos. A/H. and the Diseased cohort, the Pos. A./H. and Control cohort, or between the 
Diseased and Control cohorts. There is no significant inter-cohort differences in bone 
collagen δ13C values. While pathology superficially appears to affect bone collagen δ13C and 
δ15N values, there is no significant differences between ribs with different types of pitting, or 
cranial vaults with different types of new bone growth.  
Parametric and non-parametric analyses on enamel apatite samples indicates that 
there is no significant difference in δ13C or δ18O values between tooth types. In other words, 
deciduous dentition exhibits the same mean isotopic values as permanent dentition, 
regardless of cohort status. Despite the low inter-group variation in isotopic values, a degree 
of intra-group (tooth types) variation does exists. This is particularly notable within Pos.A./H. 
permanent third molars, and Control permanent second molars, both of which exhibit a >5‰ 
difference between the most isotopically enriched and depleted samples.  
Statistical analyses indicates that the δ13C value of first and third permanent molars, 
as well as deciduous second molars do not vary significantly between cohorts. Second 
permanent molars show a statistically and clinically significant amount of inter-cohort 
variation in δ13C values, however, sample size is likely a factor. Independent T-tests conclude 
that the δ18O values of third permanent molars is significantly different between Pos. A./H. 
and Diseased cohorts, and between Diseased and Control cohorts, but not between Pos. A./H. 
and Control cohorts. In other words, Control and Pos.A./H. groups have statistically similar 
δ18O values, which is non-analogous to the δ18O values from the Diseased cohort. The δ18O 
value of first and second permanent molars, as well as deciduous second molars do not vary 
significantly between cohorts. 
Finally, it was determined that all human bone collagen samples, regardless of their 
cohort, have significantly more enriched δ15N values than the bovine sample. With the 
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exception of the Anemic group, all cohorts also exhibit statistically different δ13C bone 
collagen values than that of the bovine. Statistical analyses conducted between faunal and 
human enamel apatite samples indicate that δ13C values are analogous between the faunal and 
human dentition, regardless of cohort status. δ18O values are significantly different between 
bovine and Diseased cohorts, and bovine and Control cohorts. Anemics and Pos. A./H. 
exhibit statistically similar δ18O values to the bovine sample. One equine sample produced 
statistically identical δ13Cand δ18O values to all of the cohorts, while one was significantly 
different from them all.  
Results are interpreted in the proceeding chapter.  
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CHAPTER TEN 
                Discussion  
The primary purpose of this thesis was to evaluate whether the pathophysiology of sickle 
cell and/or thalassemia anemia significantly affects the assimilation, diffusion and/or 
metabolization of stable carbon, oxygen and nitrogen isotopes and, if so, whether these alterations 
could be assessed archaeologically using bone collagen and enamel apatite as indicators. At the 
beginning of this thesis, five research questions were posited; (a) Does functionally abnormal 
hemoglobin and/or the secondary effects of sickle cell and/or thalassemia affect the rate at which 
stable oxygen, carbon and nitrogen isotopes are incorporated into skeletal and dental tissues?; (b) 
If the pathophysiology of sickle cell and/or thalassemia does affect the fractionation of stable 
oxygen, carbon, and nitrogen isotopes, is it significant enough to differentiate sicklic and/or 
thalassemic individuals from healthy non-anemics?; (c) If the δ13C, δ18O  and/or δ15N values of 
those with sickle cell and/or thalassemia are significantly different from healthy, non-anemic 
individuals, is it also possible to differentiate individuals who are homozygotic for the anemia 
gene, and those who are heterozygotic?; (d) Is stable isotope analysis a viable method for 
diagnosing and/or differentiating sickle cell and thalassemia in the archaeological record?, and; 
(e) If stable isotope analysis proves to be a viable method for diagnosing genetic anemias in 
skeletal populations, is it necessary to re-evaluate current dietary, weaning and migration studies 
in populations where sickle cell and/or thalassemia are endemic?  In an attempt to answer these 
questions, a multi-component approach to palaeopathology was undertaken; one that included 
macroscopic skeletal analysis, stable isotope studies, and the amalgamation and critical 
assessment of current archaeological and clinical data. The following sections presents an in-
depth evaluation of the aforementioned investigations, and answer the research questions. 
 
 Sections one and two discuss some of the flaws inherent within this research, and 
attempts to reconcile these issues with the results. In addition, both sections outlines future 
considerations, and avenues of research such that additional studies have a more solid 
theoretically and functional framework within which to construct their own research guidelines. 
The third and fourth section present a summary of this research, and answers the five research 
questions forming the basis of this thesis.   
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1. Assumptions and Requirements: Interpreting the Results in Light of Non-
Genetically Diagnosed Individuals:  
 
      In order to assess the validity of the results obtained throughout the course of this 
study it is necessary to address, and consider the impact of all possible points of contention. 
One of the major flaws inherit within this research is the fact that none of the individuals 
could be genetically diagnosed as having sickle cell and/or thalassemia. In order to mediate 
this issue three factors were taken into consideration; the presence and distribution of 
characteristic osteological lesions, the contemporary distribution of sicklic and thalassemic 
mutations, and the geographic distribution of malaria, which is known to influence the 
geographic distribution of sicklic and thalassemic hemoglobinopathies (see Chapter 3). Based 
on these lines of evidence, β-thalassemia was considered to be the most likely cause of the 
skeletal lesions noted, with sickle cell and/or α-thalassemia the most likely differentials (see 
Chapter 3, section 5.1 to 5.3). In addition to these conditions, however, several other 
differential diagnoses were postulated and could not be ruled out as underlying mechanisms, 
or the primary cause of the lesions noted (see Chapter 3, section 5.1).  As such, while an 
educated diagnosis of β-thalassemia can be made (at least for the Anemic cohort), all isotopic 
results are predicated upon comparisons between individuals with unknown genetic and 
disease backgrounds. The results, therefore, reflect the following assumptions; (a) that all 
individuals within the Anemic and Pos. A./H. cohorts have chronically symptomatic sickle 
cell or thalassemia, and that the diffusion, fixation and metabolization of stable isotopes was 
congenitally non-analogous to those of the other cohorts; (b) that all individuals within the 
Control cohort were healthy non-Anemics who did not experience chronic 
pathophysiological alterations to stable isotopic fractionation; (c) that none of the individuals 
had persistent HbF and/or HbA2, or co-inherited sickle cell and thalassemia anemia; (d) that 
all of the individuals were consuming analogous diets and were from the same region.  
1.1 Assumption #1: Chronically, Congenitally Symptomatic Anemics:  
The first two factors are relatively self-explanatory; in order for appropriate 
comparisons, one group must be definitively anemic while the other must be definitively 
healthy and non-anemic. Even if we assume that all of the individuals classified as Anemic 
did have β-thalassemia or sickle cell, the first assumption/requirement is not met. As noted 
throughout Chapter 3 (sections 2.2 and 3), while β-thalassemia and sickle cell anemia are 
congenital conditions, symptoms are mediated by the presence of HbF, which increases the 
saturation capacity of affected RBCs due to the high affinity of oxygen molecules towards ɣ-
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polypeptides (Chui and Wayne 1998; Thein et al. 2009). While the production of HbF 
steadily declines throughout the first six to 24 months of age (Oliverier and Weatherall 1998; 
Thein et al. 2009; Sarnaik 2005), its presence within affected RBCs is known to reduce the 
effects of sickle cell and thalassemia by decreasing the rate at which vaso-occlusion and 
hemolysis (etc.) occurs (see Chapter 3, section 4) (Bookchin et al. 1974; Charache 1990; 
Clarke and Higgins 2000; Conley et al. 1963; Edoh et al. 2006; Olivieri and Weatherall 1998; 
Powers et al. 1984). Clinical research has shown that children do not regularly begin to 
exhibit the deleterious effects of sickle cell or thalassemia until enough hemoglobin with ɣ-
polypeptides (HbF) has been replaced by hemoglobin with ineffectual β-polypeptides (HbS-, 
HbSS, HbB0, HbB+) (Charache 1990; Clarke and Higgins 2000; Conley et al. 1963; Edoh et 
al. 2006; Olivieri and Weatherall 1998; Powers et al. 1984). This may occur as early as four 
months postpartum, however, certain individuals may not experience symptoms until much 
later (~1-3 years old) (Charache 1990; Clarke and Higgins 2000; Conley et al. 1963; Edoh et 
al. 006; Olivieri and Weatherall 1998; Powers et al. 1984). This means that even though the 
Anemics exhibited severe osteological (and thus, soft tissue) complications, the aberrant 
fractionation of stable isotopes may not have been chronic enough to significantly alter the 
isotopic value of bone collagen and/or enamel apatite, since both are reflective of the average 
accumulation of stable isotopes over time (which should be similar or analogous to healthy 
infants up until HbSS, HbB0, HbB+ production exceeded that of HbF). This may be why the 
δ13C values of Anemic bone collagen, and the δ18O value of Anemic enamel apatite are 
statistically analogous to that of the Control cohort. In other words, because the Anemics died 
between the ages of two years (+/- 8 months) and four years, they may have only recently 
begun to exhibit the types of chronic, systemic catabolic/anabolic/oxidative issues needed to 
induce the pathophysiological fractionation of stable isotopes; dying before those effects 
could more significantly alter the average isotopic value of their collagenous and apatite 
tissues, and therefore making them appear as ‘isotopically healthy’. The differences in δ15N 
values between Anemics and Controls may be related to chronic states of hypermetabolism or 
alterations in rates of bone turnover (see Chapter 6, section 2), which are known to occur in 
Anemics even in the absence of other severe complications. It is, however, not possible to 
exclude the influence of breastfeeding, or ignore the fact that pathological bone is known to 
influence isotopic signatures (Katzeberg and Lovell 1999; Olsen et al. 2013; see Chapter 6, 
section 3). Since all of the Anemics exhibited pathological lesions on the samples analysed, 
and many of the Control samples did not (see Appendix D), the differences in δ15N values 
may be reflecting local states of pathology (i.e. pitting, new bone growth etc.) and not 
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systemic pathophysiological differences (i.e. a genetic anemia).  
        As mentioned throughout Chapter 4, the rate at which oxygen is diffused, fixated 
and metabolized in Anemics is mediated by a number of factors; (1) the production of nitric 
oxide (see section 2.3 and 4.2) and carbon monoxide (see section 4.1), which is influenced by 
the rate and severity of inflammation and hemolysis; (2) the development and severity of 
blood clots and vaso-occlusive crises (see section 4.1); (3) the development of sequelae, such 
as Acute Chest Syndrome, tachycardia, and pulmonary hypo/hypertension (see section 5); 
and (4) the type, severity and chronicity of the physiological compensation mechanisms used 
to counter-balance states of hypoxia and hypoxemia (see section 5). These factors may have 
deleterious or positive effects on states of oxygenation (and therefore levels of carbon dioxide 
and nitric oxide), a feature which varies both intra and inter-individually. As such, even if all 
the individuals included in the Anemic cohort had sickle cell or thalassemia, and lived long 
enough to develop symptoms, it is possible that their isotopic values will exhibit significant 
intra-cohort variation as a result of different underlying compensations and sequalae (see 
section 1.4.1). This makes the use of stable isotope analysis as a diagnostic technique 
somewhat unreliable, since, unlike pathologies such as osteomyelitis and osteological 
wasting (etc.), which consistently produce heavier or lighter then average isotopic values 
(Katzenberg and Lovell 1999; Olsen et al. 2014) (see Chapter 6, section 3), sickle cell and 
thalassemia may not affect individuals the same way, and therefore may not induce the same 
types of long-term fractionation effects. This is particularly significant in archaeological 
contexts, since individuals with sickle cell or thalassemia anemia (or more severe 
manifestations of the heterozygotic states, such as β-thalassemia intermedia) are likely to 
have died in infancy, and therefore any outlier isotopic values may be disregarded as 
individual differences in breastfeeding practices (i.e. the extension of breastfeeding or early 
weaning, depending on the isotopic values) as opposed to differences in physiology (see 
section 1.4). In other words, due to the inherently complex nature of sickle cell and/or 
thalassemia, it is unlikely that affected (non-medically controlled) individuals will form the 
type of ‘diagnostic cluster’ needed to conclusively differentiate Anemics from non-anemics, 
and Anemics from infants with different dietary histories.  
     This is a somewhat different conclusion then those garnered from the biomedical 
investigations, all of which demonstrate that ‘anemics’ consistently manifest lighter stable 
oxygen isotope values (fig. 51) (Epstein and Zeiri 1988; Heller et al. 1994; Reitsema and 
Crews 2011) (see Chapter 5). The difference between these studies, and those which would 
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be conducted for archaeological 
purposes is that the aforementioned 
biomedical investigations were 
conducted on individuals who had 
life-long access to modern health 
care; their symptoms controlled, 
and thereby (presumably) less 
erratic and variable than the 
symptoms which may have been 
experienced by archaeological 
individuals without access to 
contemporary medications. In this 
way, the isotopic values of 
contemporary anemics may be 
more consistently dictated by inhibited 
oxygen fixation mechanisms and/or 
increased rates of metabolic 
fractionation (with medical and dietary 
interventions reducing the symptoms 
and effects of other Anemia-related 
complications, such as Acute Chest 
Syndrome, dietary deficiencies etc.), while the isotopic values of archaeological Anemics 
may be dictated by inhibited oxygen fixation, inhibited oxygen diffusion, inhibited oxygen 
diffusion and fixation processes, increased rates of metabolic fractionation and/or rates of 
carbohydrate oxidation (see chapters 4 to 6) depending on the individual and the nature of 
their condition, sequalae and compensations. Additionally, the results obtained from Epstein 
and Zeiri (1988) and Heller et al. (1994) were based on the expired air of non-HbF persistent 
adults. As mentioned, in archaeological cases the majority of individuals with sickle cell or 
thalassemia anemia are likely to have died during infancy/childhood and therefore may still 
have HbF mediated δ18O (and possibly δ13C and δ15N) values.  
 
 
Fig. 51: Relationship between δ18O values and the quality and 
quantity of hemoglobin, as demonstrated by Reitsema and Crews 
(2011:496) (left), Epstein and Zeiri (1988: 1730) (right) and 
Heller et al. (1994: 756) (bottom). Hb = hemoglobin 
concentration; δIE = fractionation effect between inspired and 
expired gas; δIU = overall fractionation effect of respiration; δIUn 
= overall fractionation effect of respiration, normalized for 
variations in ventilator conditions; Z= δ18O signature; Mouse 
figure: Tests conducted on transgenically modified mice; Human 
figure: tests conducted on humans (Carroll 2015, with figures 
from Epstein and Zeiri 1988, Heller et al. 1994 and Reitsema and 
Crews 2011). 
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  This research evaluated the enamel apatite δ18O values of individuals classified as 
Anemic, Pos. A./H., Diseased and Control. While the results do indicate that Anemic M1s 
have the lightest δ18O values (Anemic mean: -5.3‰; n=5; Pos. A./H. mean: -3.8‰; n=3; 
Control mean: -3.6‰; n=1), statistical analyses indicate that there are no significant inter-
cohort differences. Small sample size (see section 2) is likely a contributing factor to the lack 
of significance, and therefore more research should be conducted. Additional research should 
also be conducted on bone bioapatite (as per Reitsema and Crews 2011) and on bone collagen 
since enamel may be a poor choice for identifying anemics due to the presence of HbF in the 
system when deciduous dentition and first permanent molars are being formed/calcifying. 
Overall, the results of this research are inconsistent with those obtained by Epstein and Zeiri 
(1988), Heller et al. (1994) and Reitsema and Crews (2011), suggesting that either the 
individuals did not have a genetic anemia, that the Control cohort was not an effective proxy 
for healthy non-anemics, and/or that other exogenous and internal conditions were 
influencing the overall isotopic values of the individuals, diluting the effects of Anemia on 
enamel apatite δ18O values.  
1.2: Assumption #2: Healthy, Non-Anemic Controls:  
Archaeologically, it is difficult to ensure that any Control cohort is ‘healthy’ given 
the fact that, out of necessity, most control groups are comprised of individuals who died 
from a pathophysiological condition (as opposed to a traumatic injury). This means that, even 
if the Control cohort is definitively non-anemic, they may not be definitively non-
pathological. This complicates the second assumption/requirement. It has been repeatedly 
demonstrated that factors such as pulmonary function, carbohydrate oxidation, hemoglobin 
concentration and states of metabolism affects the fractionation of stable isotopes, at least in 
certain tissues and tissue by-products (Barstow et al. 1989; Epstein and Zeiri 1988; Feldman 
et al. 1959;  Heller et al. 1994; Heller et al. 1996; Lane and Dole 1956; Massicotte et al. 
1992; Panteleeriv et al. 1999; Reitsema and Crews 2011; Romijn et al. 1992; Schoeller et al. 
1984, Wolfe 1984; Zanconato et al. 1992) (see chapters 5 and 6). If chronic cardiovascular 
and/or pulmonary conditions were the leading cause of death, as is the case in contemporary 
populations (Ferri et al. 2012; Gorina et al. 2004; Sahyou et al. 2001), then the Control 
cohort may also be expressing aberrant fractionation patterns. This may also be the case if the 
cause of death was chronic organ failure, systemic infection, gastrointestinal disorders or 
nutritional deficiencies, since, as noted in Chapter 4 and 6, nutritional and metabolic status, 
as well as inflammation, may alter the rate at which stable oxygen, carbon and nitrogen 
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isotopes are diffused, fixated and metabolized by the body. Additionally, any non-anemic 
condition which may have affected the overall concentration of hemoglobin, such as 
leukemia, cirrhosis, lymphoma, porphyria, hypothyroidism etc.(Biecker 2013; Iddah et al. 
2013; Salmeron et al. 2013; Teuffel et al. 2008; Trier et al. 2013) should also affect the 
fractionation of stable isotopes in the same manner as it would affect anemia-related isotopic 
fractionation, potentially making those conditions isotopically indistinguishable from sickle 
cell and thalassemia.  
Since the rate at which TR occurs is mediated by factors such as cardiac output, 
respiration rate and blood pressure (see Chapter 4), and numerous chronic pathologies (i.e. 
those commonly experienced in the elderly, and which are a leading cause of death within 
adult populations) disrupt the rate at which one or any of these factors occur, it is difficult (if 
not impossible) to find an accurate archaeological control population with which to compare 
isotopic values. In other words, because cause of death is often unknown archaeologically, 
and not all soft tissue conditions induce a hard tissue response, it is difficult to ensure that 
Controls are actually expressing normal, healthy rates of isotopic fractionation. Therefore, 
comparisons may actually be between two pathological populations, as opposed to a healthy 
and diseased population. If this is the case, then analysing δ15N values may be the best way to 
differentiate Anemics from non-anemics, since pathological rates of protein turnover and 
hypermetabolism are more consistently noted in those with sickle cell and thalassemia, and 
less commonly so in those with heart disease, pneumonia, COPD and malnutrition (Badaloo 
et al. 1989; Barden et al. 2000; Borel et al. 1998ab; Buchowski et al. 2000; Gozashti et al. 
2014; Myfanwy et al. 1998; Salman et al. 1996; Shetty 1984 )(see Chapter 6). This may 
explain why the δ15N values of Anemics and Pos. A./H. are statistically analogous, but 
different from both the Diseased and Control cohorts.  
1.2.1. Socio-Cultural Factors:  
In addition to states of health, various socio-cultural practices must also be taken into 
consideration when attempting to locate a genuine Control population. Research by Epstein 
and Zeiri (1988) indicate that smoking may affect δ18O values, at least within respiratory 
gases. If chronic smoking habits do induce a fractionation effect within adults (bone collagen 
or bone bioapatite), then their δ18O values may be significantly altered and therefore a poor 
proxy for ‘healthy’ fractionation patterns. This may also affect enamel apatite δ18O values if 
children are smoking, or if they are raised in households with in-door fire-pits/hearths and a 
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lack of ventilation (thereby simulating a smoking effect). To the best of the author’s 
knowledge, there is no such research investigating these effects on isotopic values in 
archaeological contexts, or in non-respiratory gases (i.e. bone collagen, enamel apatite, bone 
bioapatite). In terms of this research, it is not hypothesized that any of the enamel apatite 
δ18O values are affected by tobacco smoking, since tobacco was only introduced to Spain in 
the 15th century (Doll 1998).  
Overall, additional research on a more strictly controlled population should be 
conducted. As it is, however, the use of stable isotope analysis as a tool for diagnosing sickle 
cell and thalassemia in the archaeological record is much too far in its infancy to be the only 
reliable method of diagnosing, and differentiating between, sickle cell and thalassemia 
anemia, especially since a multitude of other physiological and socio-cultural factors induce 
the same types of pathophysiological fractionation patterns, and cannot always be excluded 
as an underlying cause of outlier values. In other words, as it is right now, stable isotope 
analysis does not appear capable of assessing the functional and phenotypical properties of 
hemoglobin, nor can it elucidate how hemoglobin concentration affects isotopic values in 
bone collagen and/or enamel apatite.  
1.3. Assumption #3: Ameliorating Factors:   
        As mentioned in the first caveat, HbF is known to ameliorate the effects of sickle 
cell and thalassemia. This is also true for increased levels of HbA2 (Higgins et al. 2009; Qu 
et al. 2011; Verhovsek et al. 2012), and the co-inheritance of sickle cell and thalassemia 
(Embury et al. 1984; Saleh-Gohari and Mohammadi-Anaie 2012; Rahim et al. 2013; 
Rumaney et al. 2014; Wambua et al. 2006) (see Chapter 3, section 4). It can be assumed that 
the Anemic cohort did not express persistent HbF or HbA2 hemoglobin, nor did they co-
inherit sicklic and thalassemic mutations, based on the severity of their lesions and their age 
at death (which is consistent with the arrested synthesis of HbF around 6-24 months of age, 
and the production and proliferation of defective β-globin chains). The hemoglobin and 
genetic status of the other cohorts, however, is unknown. This presents two major issues; 
given that the hemoglobin status of the Controls is unknown, it is possible that some of the 
younger adults defined as Controls had sickle cell and/or thalassemia, but their symptoms 
were mediated by the presence of increased levels of non-anemic hemoglobin or other 
ameliorating factors, and they were mistakenly labelled as non-anemic due to their age and 
lack of osteological symptoms. As such, it is possible that Anemics were being compared to 
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‘Control’ Anemics, thereby diluting the differences in isotopic fractionation between the two 
groups. The second issue is the fact that, if Anemics with ameliorated sickle cell and 
thalassemia are ‘invisible’ (i.e. indistinguishable from the Controls) in the archaeological 
record (osteologically and isotopically), the application of stable isotopes as a diagnostic 
method may be helpful, but will never be representative of the true scale of sickle cell and/or 
thalassemia in the past and, like with macroscopic examinations alone, will dilute the social, 
environmental and evolutionary significance of the conditions, and falsely represent the range 
of hemoglobinopathic conditions within any given society.   
1.4. Assumption #4: Dietary Factors: Socio-Cultural and Physiological Unknowns 
     This thesis concerned itself with the fractionation of stable isotopes as a result of 
factors such as TR, rates of protein turnover, and states of hypermetabolism (see Chapters 4 
and 6). It was acknowledged, however, that stable carbon, nitrogen and oxygen isotopes are 
fractionated during other physiological and metabolic processes, such as those associated 
with diet, breastfeeding practices and migration (DeNiro and Epstein 1978; DeNiro 1985; 
Schoeninger 1985; Schoeninger and DeNiro 1984; van der Merwe and Vogel 1978; Vogel 
and van de Merwe 1977) (see Chapter 2, section 4.1). It was hypothesized, however, that one 
of the primary, systemic fractionation differences between healthy non-anemics and those 
with sickle cell and thalassemia (in statistically analogous socio-cultural groups/subsets) was 
the rate at which stable isotopes are diffused through pulmonary membranes, fixated by 
RBCs, metabolized during CR, and/or catabolized/anabolized by the body. In other words, 
this thesis was predicated upon the hypothesis that significant differences in isotopic values 
between healthy and genetically anemic individuals, within the same cultural groups, would 
be related to pathophysiological differences and not dietary ones.  
1.4.1. Breastfeeding and Weaning:  
    In order to ensure that diets were analogous between cohorts, isotopic analyses were 
conducted on a Muslim population, since Islamic socio-religious norms prescribes and 
proscribes certain dietary customs (see Chapter 7). While this may be true, at least in its 
strictest sense, archaeologically it is difficult to determine if socio-cultural perceptions of 
illness influenced dietary practices (in this, and other populations), and whether genetically 
anemic individuals really had the same base-diet as healthy non-anemics.  
   The Qur’an suggests that children should be breastfed for at least two years, with six 
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months of weaning to follow, barring failure to thrive (Qur’an 2:233, 31:14, 46:15)(see 
Chapter 7). Typically, exclusively breastfed infants are one trophic level higher than that of 
their mothers, given the enrichment in stable isotopes between consumers (infants) and 
producers (mothers). On average, the δ15N value of breastfeeding infants is enriched by ~2 to 
3‰ (Fogel et al., 1989; Fuller et al. 2006; Millard 2000; Tsutaya and Yoneda 2015), while 
δ18O values are enriched by ~0.7‰ (White et al. 2004; Wright and Schwarcz 1998, 1999). 
The δ15N values of the Anemic cohort (all infants) exhibit a significant amount of intra-
cohort variation, with seven individuals showcasing what can be described as the 
aforementioned trophic shift. Four of the individuals, however, exhibit δ15N values which are 
consistent with those of the adult Control cohort. In other words, their isotopic values are 
equal to, or more depleted than the adults, indicating no trophic level increase. This 
dichotomy could be the result of one of five factors; (1) that the four depleted infants were 
not conventionally breastfed, thus not imbibing the ‘breastfeeding signature’ into their 
collagenous tissues; (2) that the four depleted infants were weaned earlier than their similarly 
aged cohorts; (3) that the four depleted infants are showcasing a pathophysiological 
fractionation effect, which negates the trophic level increase associated with breastfeeding 
and imbibes a lighter isotopic signature into their collagenous tissues; (4) that the five 
enriched individuals are exhibiting signs of extended breastfeeding compared to their 
similarly aged cohorts; or (5) that the five enriched individuals were weaned within the 
prescribed two year time frame, and their heavier isotopic values are the result of a 
pathophysiological process such as hypermetabolism (see Chapter 6, section 2). In order to 
make stable isotope analysis a viable method of diagnosing, and differentiating between, 
sickle cell and thalassemia it is necessary to determine whether shifts in isotopic values are 
indicative of a pathophysiological effect (such as hypermetabolism, inhibited oxygen 
fixation, vaso-occlusion etc.) or whether they are reflective of socio-cultural responses to a 
severely ill infant. This is crucial, since socio-cultural responses to illness vary from society 
to society (and even family to family) and if outlier values are only reflective of societal 
customs then there will be no consistent diagnostic feature (i.e. consistently heavier or lighter 
isotopic values) with which to diagnose sickle cell or thalassemia anemia across populations.  
   In terms of this research, the first two possibilities are inconsistent with Islamic 
doctrine, which prescribes at least two years of breastfeeding even if the mother is deceased 
(i.e. it is customary to adopt a nursemaid), and which dictates the extension of breastfeeding 
as opposed to the early weaning of sick infants (Qur’an 2:233, 31:14, 46:15). The enamel 
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apatite δ18O values of the δ15N depleted Anemics are enriched compared to that of the 
Control (Anemic: n=3, mean δ18O= -5.77‰; Control: n=1, δ18O= -3.61‰), and are 
statistically analogous to the similarly aged δ15N enriched Anemics (δ18O= -5.9‰)65. This 
may suggest that all of the Anemics were breastfed for longer than their similarly aged 
Controls, which, given the fact that all of the Anemics exhibited hair-on-end trabeculae and a 
host of other osteological responses is consistent with the Qur’an’s suggestion that weaning 
should be postponed for sick infants. If this is the case, then it can be hypothesized that the 
depleted δ15N values are indicative of a pathophysiological response (e.g. pulmonary vaso-
occlusion etc.) experienced by the four δ15N depleted individuals, but not by the five δ15N 
enriched individuals. This, again, is consistent with the range of inter-individual 
pathophysiological variation commonly noted in sickle cell and thalassemia anemia, its 
compensations and sequelae. More analyses should be conducted however, since the 
hypothesis that all Anemics were breastfed for a similar period of time (which was longer 
than healthy children) is based off of limited dental evidence (i.e. only one Control molar).  
1.4.2 Pilgrimage:  
One of the fundamental frameworks associated with this thesis is, as mentioned, the 
hypothesis that all individuals would have analogous dietary backgrounds. While the Qur’an, 
and non-canonical Islamic teachings dictate what types of foods are halal and haram (see 
Chapter 7, section 2.1), it is not possible to ensure that every individual within this study had 
consistently analogous diets. One of the obstacles to this assumption (and one which can not 
be resolved at this time) is the practice of Pilgrimage (see Chapter 7).  
Islam considers pilgrimage to be a Pillar of the Faith, and as such it is difficult to 
determine whether the isotopic values of certain individuals were influenced by the 
consummation of ‘travel foods’. As demonstrated in Chapter 7 (section 2.1, fig. 32), Mecca 
is, at minimum, 5728 kms away from Écija, if traveling by foot across the northern coast of 
Africa. It is over 7000 kms if travelling north through Spain, across the southeastern 
European coast (fig. 32).  Even if the average person can feasibly walk 50 kms a day, it 
would take over 114 days to reach Mecca by way of Africa and ~140 days to reach it by 
walking across Europe. Even if travel times were ameliorated through the use of boats and 
horses (etc.), the average Meccan pilgrimage would have taken approximately one year. In 
this time, ‘base-diets’ (i.e. the diet regularly consumed in Écija) may have been adapted to 
                                                          
65 Only one tooth available, as the rest of the Anemic 2-3 year olds were not sampled - 
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include more fish (especially if travelling by the coast) or C4 breads, which could alter 
average bone collagen δ15N and δ13C values. Pilgrimage would also necessitate the 
consumption of non-Écijan water sources, which may have had different δ18O values 
(Ehleringer and Rundell 1988; Pollard 1993; Saurer et al. 1997; Schulting 1998; Schoeninger 
et al. 1983; Vogel 1993) (see Chapter 2, section 2.1, fig. 11). If an individual made his or her 
pilgrimage to Mecca during sub-adulthood, then these ‘aberrant’ δ18O values may have been 
imbibed within their enamel apatite matrices, altering their average isotopic values.  
In terms of this research, none of the cohorts (with the exception of one Anemic 
sample) exhibit outlying (population based) bone collagen δ15N or δ13C values (Chapter 9, 
fig. 49), reducing the likelihood that any of the individuals included in this study went on a 
Meccan pilgrimage witin the last ~7 years of their life. With this in mind, however, it is likely 
not possible to differentiate Pilgrimage-based (i.e. dietary and/or migratory) bone collagen 
δ15N or δ13C values fom pathophysiologically-based δ15N or δ13C values, since the 
consumption of fish (or other higher trophic level foods) or more C4 foods may mimic 
pathologies such osteomyelitis or periostitis (in terms of δ15N values) and/or bone atrophy (in 
terms of δ13C values), and a decrease in high-trophic level foods may do the same (i.e. mimic 
conditions such as bone atrophy in terms of δ15N values)(Katzenberg and Lovell 1999). This 
highlights an issue within both dietary and pathophysiologically based stable isotope 
analyses; if pathology can alter average (local) δ13C and δ15N values (Katzenberg and Lovell 
1999), is it possible to distinguish individuals with different/mixed dietary backgrounds from 
those with local and/or systemic conditions? At this point in time, this research suggests it is 
not possible due to the large number of unknowns, and the fact that differences in diet and 
pathology may mimic, or cause, one another.  More research distinguishing between the two 
is required.  
Three Pos. A./H. individuals (one permanent first molar, two permanent second 
molar) exhibit outlying (population based) enamel apatite δ13C values, when compared to the 
rest of the population (i.e. all dental elements) (see Chapter 9, section 4.2, third molars; and 
figure 50). As previously mentioned, it is not possible to determine whether these values 
represent differences in diet (i.e. the consumption of ‘travel foods’, the consumption of ‘sick’ 
foods, social status differenes in types of foods available etc.), or whether these three 
individuals were pathologically fractionating stable carbon isotopes as subadults (i.e. due to 
differences in rates of carbohydrate oxidation, vitamin and mineral deficiencies etc.).  
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One individual (Control; permanent second molar) exhibits outlying (population 
based) enamel apatite δ18O values (see Chapter 9, figure 50). It can be hypothesized that the 
differences in δ18O values is representative of a different migratory history than the rest of the 
population, which is consistent with the influx of North Africans and other Muslims during 
the Umayyad period (Chapter 7). With this in mind, however, it is also possible that between 
the ages of 2.5 and eight years old (the time during which second permanent molars calcify; 
Hillson 2005), the individual experienced a pathological condition which was chronic enough 
to alter the average δ18O value of their enamel apatite. While the former appears more likely, 
it re-iterates the issue of distinguishing between immigration and pathophysiology, and 
highlights the fact that non-pathologically based conclusions are generally chosen over 
pathological ones, even when no physical evidence exists for either assumption.  
Overall, there are too many exogenous and internal factors mediating the 
fractionation of stable isotopes to make the current state of isotopic diagnostic techniques 
viable, as is. More archaeologically and biomedically based stable isotope research is 
required in order to determine if, and to what extent, bone collagen, bone bioapatite and 
enamel apatite are affected by the pathophysiological fractionation of stable isotopes, and to 
determine the feasibility of differentiating between diet, pathophysiology and migration 
based isotopic signatures.   
2. Sampling and Chemical Procedures 
2.1: Cohort Creation: Effects on Bone Collagen Results: 
As mentioned, the creation of an accurate control cohort is always an issue for this 
type of research, given the fact that osteological lesions do not always manifest in chronically 
diseased individuals, as well as the fact that most deceased individuals die as a result of a 
fatal (potentially chronic) illness. Ordinarily this research would have benefitted from the 
inclusion of infants as Controls, since it is not necessarily appropriate to compare the bone 
collagen of Anemic infants to that of healthy, Control adults given non-analogous rates of 
bone/protein turnover (Hedges et al. 2007; Schweissing and Grupe 2003; White and Folkens 
2005), as well as differences in subsistence patterns (i.e. the trophic level effect experienced 
by infants as a result of breastfeeding). The use of infant Controls, however, is also not 
entirely appropriate given the aforementioned issues with locating a truly ‘healthy’, dead 
infant. The use of bone collagen, therefore, is perhaps best suited to understanding local, intra 
and inter-individual variations in isotopic values brought on by sicklic and/or thalassemic 
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sequelae and comorbidities, and linking the presence and severity of those alterations to a 
broader socio-pathological framework. For instance, bone collagen could be useful for 
determining which Anemic infants experienced complications that increased isotopic 
fractionation, and which experienced complications which decreased isotopic fractionation, 
and then comparing those values to the types, frequency, and severity of osteological lesions 
noted. Additionally, it could be used to narrow down the age at which sicklic or thalassemic 
symptoms and sequelae appear in an individual, and then comparing those to other factors 
such as the development of Harris lines, linear enamel hypoplasias, and patterns of growth. In 
doing so, a more systemic understanding of the skeletal manifestations of sickle cell and/or 
thalassemia may be possible, and more disease-specific patterns (i.e. distribution and severity 
of osteological lesions, range of dental defects etc.) may be visible. This, in turn, would make 
macroscopic diagnoses more accurate since (to date) neither condition is known to produce 
pathognomonic lesions or distribution patterns, causing both to be easily misdiagnosed (see 
Chapter 1 and 3).  
2.2. Cohort Creation: Effects on Enamel Apatite Results: 
All bone collagen and enamel apatite samples were selected prior to dividing the 
individuals into Anemic, Pos.A./H., Diseased and Control cohorts, a factor which proved 
problematic. Initially, only two categories existed, Pos. A./H. and Control. At this stage, it 
was deemed appropriate to sample an array of teeth in order to obtain a more diachronic 
understanding of the pathophysiological effects of homozygotic and heterozygotic 
expressions of anemia. After careful consideration however, it was determined that only a 
select number of individuals showcased clear signs of sickle cell or thalassemia anemia, and 
that the rest should be reclassified as Pos. A./H. or Diseased, based on the lack of clear 
evidence to the contrary. In doing so, categories became unbalanced, making it difficult to 
make statistically significant comparisons and realistic inferences. Unfortunately, this was 
largely unavoidable given the fact that the macroscopic analyses and documentation of all 
lesions occurred over the course of three days, with a more dedicated approach to classifying 
individuals occurring at a later date, based off of the photographic evidence, field notes and 
the guidelines set forth by publicized examples of archaeologically diagnosed cases of sickle 
cell or thalassemia anemia (e.g. Angel 1964, 1966, 1967, 1971, 1977; Stuart-Macadam 1989, 
1992). This highlights another issue; the cateogorization of individuals as Pos. A./H. or 
Diseased. Upon a final review, the differences in skeletal pathology between the two groups 
seems to overlap, sometimes quite considerable. This may have affected some of the results, 
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however, the comparisons between the Anemic and Control cohort should remain the same 
since those categories had stricter guidelines. Future analyses should be conducted in order to 
rectify the aforementioned issue, and to ensure that the results achieved herewithin are 
accurate.  
Unlike bone collagen, the use of enamel apatite may provide a more effective way to 
compare adult Controls to infant Anemics, since enamel is reflective of the isotopic values 
imbibed during its formation, and therefore acts as a proxy for subadult values regardless of 
age at death (see Chapter 2). The use of dental enamel comes with its own set of issues 
however. To start, first permanent molar crowns are known to reflect the average isotopic 
values assimilated from birth to approximately three years of age (Hillson 2005; Reid and 
Dean 2006). If enamel is significantly affected by the state of the hemoglobin molecule, all 
first permanent molar crowns will reflect the combined activity of HbF (and possibly HbA), 
because HbF production continues until ~six to 24 months of age, depending on the 
individual (Cao and Galanello 2010; Galanello and Origa 2010; Oliverier and Weatherall 
1998; Perisano et al. 2012; Sarnaik 2005; Yochum and Rowe 2005). If the anemic mutation 
only affects the production β-globin chains, as seen in those with β-thalassemia and sickle 
cell, then sampling the entire tooth crown could bias the results, as individuals are generally 
asymptomatic until HbF molecules are outnumbered by defective HbS-, HbSS, HbB0, HbB+ 
molecules (see Chapter 3). As such, a sampling procedure which takes this factor into 
account could be more useful, but only if those sicklic and/or thalassemic individuals do not 
have persistent HbF, or chronically increased HbA2 production, factors which can only be 
determined through genetic testing (making the use of stable isotope analysis as a diagnostic 
aid redundant). Sampling the entire permanent second molar crown may also prove useful, as 
non-persistent HbF and HbA2 production will (theoretically) have ceased prior to the initial 
calcification of that tooth, and the entire crown should therefore be only reflective of sicklic 
and thalassemic hemoglobin. Archaeologically, however, this may prove difficult as those 
with homozygotic expression of sickle cell or thalassemia anemia are likely to have died 
prior to their complete calcification. If this is the case, implementing an incremental sampling 
strategy for Control teeth and comparing those results to what is available from the Anemics 
could provide more accurate results, and methods of comparison.  
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2.3. Bone Collagen Chemical Procedures: NaOH:  
During the creation of the collagen pseudomorphs, several of the samples (n= 3 
Anemics; 1 Pos. A./H. and 1 control) exhibited signs of poor collagen preservation and were 
therefore not placed in NaOH (see Appendix E). Research has demonstrated that this can 
increase δ13C values by, on average, 0.3 ‰ (Jorkov et al. 2007; Sealy et al. 2014). The 
majority of the samples which skipped the NaOH protocol were omitted from the final 
analyses due to poor quality control indicators (see Appendix H). A correction of 0.3‰ was 
made to the affected samples which were retained, however, these corrections did not alter 
the significance of the final results and as such, their original (non-corrected) values are those 
reported.  
Despite the fact that δ13C values were not significantly altered by the lack of the NaOH 
bath, futue studies should consider the compromised (i.e. poorly preserved) state of Anemic 
and bone collagen and factor this into their sampling strategies. The poor collagen 
preservation in Anemic samples may be related to the extensive micropitting seen throughout 
them, or may be indicative of pathological rates of collagen turnover (see Chapter 6, section 
2). It is not thought to be related to differences in burial environment, or post-excavation 
techniques since, if this were the case, more non-Anemic samples would have been affected.  
 3. Stable Carbon and Oxygen Values: Interpreting the Results  
The results demonstrate that no significant differences in enamel apatite or bone 
collagen δ13C values exists between cohorts/dental elements. In terms of pathophysiological 
analyses, the analogous δ13C values between cohorts is unsurprising, since bone collagen and 
enamel apatite are considered more representative of dietary carbon (DeNiro 1985; DeNiro 
and Epstein 1978; Schoeninger 1985; Schoeninger and DeNiro 1984; van der Merwe and 
Vogel 1978; Vogel and van de Merwe 1977), than the dissolved gaseous carbon circulating 
throughout the pulmonary and venous systems. As mentioned throughout Chapter 4, sicklic 
and thalassemic mutations do not affect the binding sites for carbon dioxide and as such, the 
vascular fractionation of isotopic carbon is more or less dictated by the diffusion, fixation and 
metabolization of oxygen (Epstein and Zeiri 1988; Heller et al. 1994; Reitsema and Crews 
2011), and the rate at which stable carbon isotopes are fractionated during the conversion of 
bicarbonates to gaseous carbon dioxide (Panteleev et al. 1999). Even if these processes are 
chronically non-analogous between those with sickle cell and/or thalassemia, and healthy 
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non-anemics, it is unlikely that they will significantly alter the isotopic composition of bone 
collagen or enamel apatite because they are generally acute, and any process which could 
feasibly be severe enough to counteract the dietary signature of those tissues would likely 
also be fatal, and thus not incorporated into bone or enamel tissue.  
In addition to the fact that the bone collagen and enamel apatite δ13C values do not 
suggest any chronic, severe differences in rates of pulmonary and/or vascular stable carbon 
isotope fractionation, it also suggests that Anemics did not experience any significant, 
chronic differences in carbohydrate oxidation or basal nutrient metabolism when compared to 
the other cohorts. In other words, the rate at which Anemics metabolized and fractionated 
dietary carbons (found within glucose, starches, lipids, proteins etc.) appears to be analogous 
to the rate at which Pos. A./H., Diseased and Control cohorts fractionated dietary carbons, at 
least in this sample population. An analysis of specific amino acids may provide more 
conclusive details, however. Overall, it appears as though all individuals (regardless of age or 
health status) were consuming a mainly C3 terrestrial diet, similar (in δ13C values) to the diets 
consumed by herbivorous domestics (i.e. cattle, sheep and horses). This is supported by a 
range of historical (Islamic and non-Islamic) documents, which indicate that rice, barley, rye, 
lentils, pulses and bread made from unrefined wheat were commonly eaten by Spanish 
Muslims, and used as animal fodder (Alexnder et al. 2005; de Castro 1993; Marsilla 1993; 
Sanchez 1995).  
The statistically analogous enamel apatite δ18O values between tooth-types reinforces 
the idea that individuals were consuming a homogeneous type of diet and were residents of 
Écija, at least from birth until 16 years of age (when the third permanent molar finishes 
mineralizing, and therefore ceases to imbibe stable isotopes). The results also imply that 
mothers have analogous dietary/migratory of diets as subadults (at least while pregnant), 
since the deciduous dentition (which begins to mineralize in-utero and therefore reflects fetal 
isotopic values, which is largely influenced by maternal values) are not significantly different 
from the other tooth-types.  
The similarity in enamel apatite δ18O values between Anemic dentition (m2s and 
M1s) and Control dentition (M1s, M2s, M3s) is not altogether surprising, since (as 
mentioned) enamel formed in-utero and within the first six to 24 months of age should be 
influenced by the presence of Hbf, and therefore anamolous rates of fractionation may not 
have had enough time to alter the average, ‘healthy’ isotopic value of the tooth. The results 
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may have been different if Anemic M2s and/or M3s had been sampled, since their isotopic 
values would (presumably) not be influenced by Hbf, therefore increasing the likelihood that 
the tooth imbibed Anemic δ18O values.  
Despite the lack of inter-tooth type variation, a significant amount of intra-tooth type 
variation was noted within the third permanent molars. The results indicate significant 
fractionation differences between Pos. A./H.s and Diseased cohorts and between Diseased 
and Control cohorts, but not between Pos. A./H.s and Control cohorts. This suggests that 
either hemoglobin concentration does not significantly affect δ18O enamel apatite values, 
since those with (presumably) poor quality and quantities of hemoglobin do not exhibit any 
differences from those with (presumably) healthy hemoglobin concentrations and 
phenotypes, or that the Pos.A./H cohort only experienced acute symptoms which were not 
registered in the enamel apatite. The latter may explain why the δ18O values of the Diseased 
cohort are significantly different from the Pos. A./H and Control cohorts. In other words, 
those within the Diseased cohorts may have experienced the types of long term fractionation 
effects required to alter the isotopic values of enamel apatite, a feature which is 
uncharacteristic of heterozygotic expressions of sickle cell and thalassemia. This issue could 
be elucidated more thoroughly by examining the enamel apatite δ18O values of Anemics, 
and/or by determining which disease(s) the Diseased cohort had (in order to determine 
whether the symptoms are generally more acute, or more chronic than those experienced by 
anemic heterozygotes). Unfortunately, the small sample size of Anemic dentition precludes 
such investigations, and the diagnosis of non-Anemic conditions was outside of the purvue of 
this research.  
 In terms of social contracts, the statistically comparable enamel apatite δ18O values, 
coupled with the analogous δ13C values noted between cohorts implies that Pos. A./Hs. were 
not seen as ‘other’66 by the community, and that their subjective and/or objective suffering 
did not significantly alter their state of personhood, or their dietary patterns.   
4. Correlations: δ13C and δ18O Values 
As mentioned in Chapter 6 (section 1.1.), the isotopic value of bone collagen is 
highly reflective of dietary sources of stable isotopes, with tissue recycling more heavily 
influencing δ15N than δ13C values. The effects of tissue recycling on bone collagen δ15N 
                                                          
66 Individuals who are different than, or apart from, the rest of the community specifically because of their health status and/or their inability to 
contribute significantly to the group 
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values may be why only the Control group exhibits a significant relationship between δ13C 
and δ15N values (see Chapter 9, section 2). In other words, it is possible that the ‘healthy’ 
relationship between δ13C and δ15N values is somehow disrupted in individuals/samples with 
macroscopic manifestations of pathology (Anemic or otherwise). It is possible that all non-
Controls were experiencing increased rates of tissue anabolism and/or catabolism, altering 
the dietary signature of bone collagen to a dietary-recycling signature, and destabalizing the 
‘normal’ relationship between carbon and nitrogen. Despite this, however, only the Anemic 
cohort exhibits significantly different δ15N values from the Control cohort, and stastical 
analyses could not determine whether this was due to age, or due to physiology. More 
research should be conducted, with stricter controls in place.  
5.  Conclusions 
 
 Stable isotope analysis has proven to be a viable method of diagnosing select 
metabolic and pathophysiological processes in living populations, however, its use in 
archaeological populations seems fraught with difficulty, at least at this point in time. Until 
more concerted research has been conducted, on more strictly controlled populations, stable 
isotope analysis is not able to differentiate anamolous dietary practices or migration histories 
from pathophysiological processes. As such, the extent to which hemoglobin concentration 
affects δ13C, δ18O and δ15N remains larelgy unknown, and can therefore not be used as a 
method for diagnosing, or differentiating between, sickle cell and thalassemia.  
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CHAPTER ELEVEN 
        Summary and Conclusions 
The final chapter of this thesis presents a concise summary of the results obtained 
from the isotopic analysis of the bone collagen (δ13C and δ15N) and enamel apatite (δ13C and 
δ18O values) samples collected from Écija, Spain, and provides several concluding remarks as 
to the efficacy of stable isotope analysis as a diagnostic aid in archaeological contexts. 
Primarily, its purpose is to provide a systematic overview of this research, and to answer the 
five research questions originally posited in Chapter one (section 5).  
1. Summary 
Since the 1950 and 60’s, when the link between porotic hyperostosis and ‘anemia’ 
was established both clinically (Aksoy et al. 1966; Britton et al. 1960; Burko et al. 1961; Eng 
1958; Jelliffe and Blackman 1962; Mosley 1974) and archaeologically (Angel 1964; 1966; 
1967; 1984), the term ‘anemia’ has become somewhat of a default diagnosis; an umbrella 
under which a multitude of etiologically and pathophysiologically distinct hemoglobinopathic 
and red blood cell disorders are meant to reside.  This is problematic since bioarchaeologists 
endeavor not only to diagnose disease, but to link them to the socio-cultural and 
environmental framework within which they are inherently and inseparably entrenched. A 
method for more accurately diagnosing, and possibly even differentiating between, anemias 
is therefore a crucial step towards more accurately understanding the relationship between 
individuals, their bodies, and their world.  
The purpose of this thesis was to determine if, and how, the pathophysiology of 
sickle cell and/or thalassemia affects the assimilation, diffusion and/or metabolization of 
stable carbon, oxygen and nitrogen isotopes, using bone collagen and enamel apatite as 
indicators. Biomedically, there is ample evidence which attests to the link between isotopic 
fractionation and (patho)physiology (Barstow et al. 1989; Butz et al. 2014; Epstein and Zeiri 
1988; Feldman et al. 1959; Lane and Dole 1956; Heller et al. 1994; Heller et al. 1996; 
Luijendijk et al. 2007; Panteleev et al. 1999; Pflug and Schuster 1989; Romijn et al. 1992; 
Schoeller et al. 1984; Schuster et al. 1994; Wolfe 1984; Zanconato et al. 1992). 
Archaeologically, however, the relationship between the two is often overlooked, possibly 
due to the fact that soft tissue physiology is not only complex, but often difficult (if not 
impossible) to determine through the macroscopic examination of human skeletal remains 
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alone. As such, stable isotope analysis has primarily been used for dietary and migration 
studies, with only a select number of researchers attempting to elucidate the dynamic 
relationship between isotopic values and systemic pathological conditions. To the best of the 
author’s knowledge, this research represents the first extensive isotopic study of sickle cell 
and/or thalassemia in the archaeological record, as well as the first to amalgamate and 
critically assess the relevant biomedical research surrounding the pathophysiological 
fractionation of stable isotopes in anemics.  
Originally, it was hypothesized that, because anemics are in a state of homeostatic 
disequilibrium due to chronically inhibited oxygen fixation mechanisms, their bodies would 
attempt to compensate by altering rates of TR and/or basal metabolism, which in turn would 
affect the rate at which stable oxygen, nitrogen and carbon isotopes are diffused, fixated, 
and/or metabolized. Since sickle cell and thalassemia anemia are chronic conditions, it was 
hypthosized that these physiological alterations would be chronic enough to affect the rate of 
isotopic fractionation, making Anemics appear isotopically distinct from healthy non-
anemics. More specifically, it was hypothesized that individuals with sickle cell and/or 
thalassemia anemia would exhibit the lightest enamel apatite δ18O and heaviest bone collagen 
δ15N values, when compared to heterozygotes and healthy non-anemics, due to factors such 
as chronic hypermetabolism, differences in rates of carbohydrate oxidation and nutritional 
status, decreases in physical activity and rates of oxygen fixation, and increases in rates of 
vaso-occlusion and organ failure (to name a few); all factors which are known to affect the 
rate at which stable oxygen and nitrogen isotopes are fractionated. It was also hypothesized 
that enamel apatite and bone collagen δ13C values would not differ significantly between 
Anemics, heterozygotes, and healthy non-anemics because bone collagen δ13C values are 
more representative of dietary carbons (DeNiro 1985; DeNiro and Epstein 1978; Schoeninger 
1985; Schoeninger and DeNiro 1984; van der Merwe and Vogel 1978; Vogel and van de 
Merwe 1977) than the dissolved carbons circulating throughout the pulmonary and vascular 
systems. It was thought that any differences in δ13C values between Anemics and healthy 
non-anemics would be related to aberrant dietary practices, and not tp pathophysiological 
differences. In other words, it was hypothesized that shifts in δ13C values would be indicative 
of an illness narrative whereby the chronically ill (i.e. the Anemic) are fed different diets than 
the rest of the population, either in an attempt to cure them or to further separate them from 
society. Finally, it was hypothesized that, for the most part, heterozygotes would be 
isotopically indistinguishable from healthy non-anemics because heterozygotes generally 
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experience more acute symptoms, which would be unlikely to alter the average isotopic 
values of their skeletal matrices.  
In order to evaluate the significance of sicklic and/or thalassemic fractionation 
mechanisms, stable isotopic analyses were conducted on the organic (bone collagen) and 
inorganic (enamel apatite) matrices of archaeological Muslims from el Plaza de Espana in 
Écija Spain, all of which were posited to be on an anemia gradient. In other words, samples 
were taken from individuals with lesions characteristic of β-thalassemia major, sickle cell 
anemia, and/or α-thalassemia major, from individuals who exhibited osteological symptoms of 
heterozygotic α  and/or β-thalassemia (i.e. α-thalassemia minor, β-thalassemia intermedia, β-
thalassemia minor) or sickle cell disease/trait, from individuals with unknown pathological 
conditions, and finally, from individuals without any macroscopic evidence of pathology. It was 
hypothesized that pathophysiological fractionation patterns could be assessed using an 
Islamic population, since both the Qur’an and Islamic socio-cultural norms and mores 
prescribe and proscribe certain dietary customs (i.e. which types of food should and should 
not be eaten). As such, while diet is a known source of isotopic fractionation, it was 
hypothesized that the primary, systemic fractionation difference between healthy non-
anemics and those with sickle cell and/or thalassemia (in statistically analogous socio-cultural 
groups/subsets) would be the rate at which stable isotopes are diffused through pulmonary 
membranes, fixated by RBCs, metabolized during CR, and/or catabolized/anabolized by the 
body.  
  The results indicate that, as expected, there are no significant differences in enamel 
apatite or bone collagen δ13C values between cohorts or tooth types, suggesting that Anemics 
and Pos. A./Hs  consumed the same C3 terrestrial based diets as healthy individuals (and 
individuals with various other pathological conditions) despite differences in health status. 
This implies that sicklic and/or thalassemic infants and children were not seen as “other’, and 
were integrated members of the family and community despite their subjective and objective 
experiences with Anemia. The analogous δ13C values also imply that rates of carbohydrate 
oxidation and basal nutrient metabolism were not significantly, chronically different between 
Anemics and Pos. A./Hs, and non-anemics (at least up until the point of death).  
 Parametric and non-parametric statistical analyses on enamel apatite also indicate no 
significant differences in δ18O values between tooth types, reinforcing the hypothesis that all 
subadults consumed the same base-diet. No differences in δ18O values were noted between 
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Anemic dentition (m2s and M1s) and Control dentition (M1s, M2s, and M3s), however, this 
may be due to small sample size and/or the fact that the presence of Hbf during enamel 
formation may have precluded the development of an ‘Anemic’ signature. Likewise, no 
significant differences were noted in the third permanent molars of Pos. A./Hs and Controls, 
suggesting that hemoglobin either does not significantly affect enamel apatite values, or that 
Pos. A./Hs only exhibited acute pathophysiological fractionation effects. More research on 
both fronts is required.  
 Finally, the results indicate that Anemics exhibit a significant amount of inter and 
intra-cohort variation in bone collagen δ15N values, the exact reasons for which remain 
unclear. Additional research, on a more strictly controlled population, is required.     
2. Conclusions 
  At the beginning of this thesis, five research questions were considered; (1) Does 
functionally abnormal hemoglobin and/or the secondary effects of sickle cell and/or thalassemia 
affect the rate at which stable oxygen, carbon and nitrogen isotopes are incorporated into skeletal 
and dental tissues?; (2) If the pathophysiology of sickle cell and/or thalassemia does affect the 
fractionation of stable oxygen, carbon, and nitrogen isotopes, is it significant enough to 
differentiate sicklic and/or thalassemic individuals from healthy non-anemics?; (3) If the δ13C, 
δ18O  and/or δ15N values of those with sickle cell and/or thalassemia are significantly different 
from healthy, non-anemic individuals, is it also possible to differentiate individuals who are 
homozygotic for the anemia gene, and those who are heterozygotic?; (4) Is stable isotope analysis 
a viable method for diagnosing and/or differentiating sickle cell and thalassemia in the 
archaeological record?, and; (5) If stable isotope analysis proves to be a viable method for 
diagnosing genetic anemias in skeletal populations, is it necessary to re-evaluate current dietary, 
weaning and migration studies in populations where sickle cell and/or thalassemia are endemic?   
 As is often the case, this research leaves more questions then answers. It seems as though 
the pathophysiology and secondary effects of sickle cell and thalassemia do in fact alter the rate at 
which stable isotopes are fractionated. This has been noted numerous times in biomedical 
literature (Epstein and Zeiri 1988; Heller et al. 1994; Reitsema and Crews 2011). 
Archaeologically however, the diagnosis and differentiation of hemoglobinopathic disorders does 
not appear to be as straight forward; numerous uncontrollable, and often unknowable, exogenous 
and internal factors complicate the situation. As such, the answer to the first question is yes, but 
more research is required to fully understand pathophysiological fractionation patterns in sickle 
cell and thalassemia, as well as in the countless other conditions which may also affect the rate at 
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which stable isotopes are diffused, fixated and metabolized. Simiarly, more research is required to 
differeniate pathophysiological fractionation patterns from dietary and migratory ones. As of right 
now, it seems unlikely to be able to differentiate between homozygotic and heterozygotic 
expressions of sickle cell and/or thalassemia, or between heterozygotes and healthy non-anemics 
using stable isotope analysis alone. With this in mind however, archaeological stable isotope 
analysis may prove to be a viable method for diagnosing chronic, systemic diseases if used in 
conjunction with other methods, and if more research is conducted in order to refine the methods 
used, and to define the types of fractionation effects expected of various diease processes. In all 
cases, disease should be considered a factor in the fractionation of stable isotopes, however, at this 
moment in time, more research needs to be conducted in order to assess its affects on current 
dietary and migraton studies. This is crucial, since as mentioned in Chapter 10, 
pathophysiological alterations in the isotopic composition of bone collagen (and likely other 
tissues) can mimic dietary or migratory differences, and the three are often interlinked--changes in 
diet or immigration promoting disease and vice versa.  
In terms of this research specifically, it is considered worthwhile to reassess the 
individuals using a more refined sampling strategy (i.e. incremental isotopic analyses of the 
dentition, the use of M2s to ensure HbF is not affecting the results, stricter cohort inclusion 
guidelines, more infant ‘controls’ etc.), and taking the century of death into consideration (i.e. not 
comparing individuals from the 8th century to those from the 12th). Additionally, the analyses of 
bone bioapatite may also help elucidate pathophysiological fractionation patterns associated with 
sickle cell or thalassemia anemia, since previous biomedical research has proven successful in 
identifying hemoglobin dependant fractionation effects within osteological apatite tissues 
(Reitsema and Crews 2011). Overall, it is not possible to conclusively state that sickle cell and/or 
thalassemia anemia affects the isotopic values of bone collagen or enamel apatite, however, 
several significant alterations to the methods and materials used throughout this thesis may prove 
more effective, and may produce the types of results originally hypothesized.  
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              ABSTRACT 
Since the 1950 and 60’s, when the link between porotic hyperostosis and ‘anemia’ 
was established both clinically and archaeologically, the term ‘anemia’ has become 
somewhat of a default diagnosis; an umbrella under which a multitude of etiologically and 
pathophysiologically distinct hemoglobinopathic and red blood cell disorders are meant to 
reside. This is problematic since bioarchaeologists endeavor not only to diagnose disease, but 
to link them to the socio-cultural and environmental framework within which they are 
inherently and inseparably entrenched. A method for more accurately diagnosing, and 
possibly even differentiating between, ‘anemias’ is therefore a crucial step towards more 
accurately understanding the relationship between individuals, their bodies, and their world. 
The purpose of this thesis was to determine if, and how, the pathophysiology of homozygotic 
and heterozygotic sickle cell and/or thalassemia affects the assimilation, diffusion and/or 
metabolization of stable carbon (δ13C), oxygen (δ18O) and nitrogen (δ15N) isotopes, using 
bone collagen and enamel apatite as indicators. To the best of the author’s knowledge, this 
research represents the first extensive isotopic study of sickle cell and/or thalassemia in the 
archaeological record, as well as the first to amalgamate and critically assess the relevant 
biomedical research surrounding the pathophysiological fractionation of stable isotopes in 
‘anemics’. Results, obtained from 45 individuals from el Plaza de Espana (8th-12th centuries 
A.D.) in Écija, Spain, suggests that bone collagen δ15N values are significantly different 
between Anemic and Control groups, however, breastfeeding could not be conclusively ruled 
out as the cause of the trophic level shift. No significant differences in bone collagen or 
enamel apatite δ13C values were noted between cohorts or tooth types, however, sample size 
is considered to be a contributing factor to the lack of significance. There were no significant 
differences in enamel apatite δ18O between tooth types, however, significant differences were 
noted between cohorts. Overall, while disease should be considered an underlying cause of 
local and systemic isotopic fractionation, more research is required prior to the adoption of 
stable isotope analysis as a palaeopathological diagnostic method.  
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Appendix B: Anemic Profiles: 
 
Individual 11321; Phase 2:  
 
Completeness 50 -75% complete 
Preservation good 
Note: Incomplete skull.  
 
Pathologies:  
 Extensive and severe active and healed porotic 
hyperostosis on the occipital, parietals, temporals and 
frontal bones. Hair on end trabecula.  
 Bilateral active and severe cribra orbitalia, macropitting 
on the superior orbital surfaces. Other orbital surfaces 
not available for examination.  
 Extensive and severe NWBG and micropitting on both 
zygomatics, mandible, maxillae, palate, and on the 
vertebral lamina. Micropitting not related to growth. 
o Zygomatics: All surfaces 
o Mandible: Concentrated along the right 
mandibular ramus (left ramus absent) and 
throughout the anterior surface of the 
mandibular body (surrounding the menal eminence).  
o Maxilla: All surfaces 
o Vertebrae: Cervical to sacrum. Concentrated 
primarily on the lamina.  
 Micro and macropitting of the anterior vertebral bodies. 
Possibly related to growth, but appears outside normal range 
of variation.  
 Micropitting on all rib surfaces 
 Flared metaphyses, lower long bones. Flared rib ends. 
 NWBG on the shafts of all long bones. At least partially 
related to growth.  
 
Age:   
 First permanent molars erupted, roots ¼ complete. 2 yrs +/- 
8 mths as per Ubelaker 1989.  
 Vertebral neural arches partially fused. Age of fusion 1-4 
yrs. Less than 4 yrs, as per Buikstra and Ubelaker 1994.   
 Neural arches not fused to centrums. Age of fusion. 3-7 
yrs. Less than 7 yrs.  
 No epiphyseal fusion of the long bones, as per Buikstra 
and Ubelaker 1994. 
 Estimated age range: 2 yrs +/- 8 months, to 4 yrs based 
primarily on dental development and fusion of the 
vertebral lamina and centra. 
Diagnosis: 
 β-thalassemia major; Anemia Differential: Sickle Cell 
Anemia, α-thalassemia major 
 
Fig. 1a: Ectocranial hair-on-end 
trabeculae ID 11321 (Carroll 2015, 
taken with permission from the 
Municipal Museum of Écija Spain). 
 
Fig. 2a: Severe macropitting and 
on the zygomatic ID 11321 
(Carroll 2015, taken with 
permission from the Municipal 
Museum of Écija Spain). 
 
Fig. 3a: Extensive NWBG on the 
zygomatic (Carroll 2015, taken with 
permission from the Municipal 
Museum of Écija Spain). 
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Individual 2134; Phase 2: 
 
Completeness: 25-50 % complete 
Preservation: Good 
 
Pathologies:  
 
Dental:  
 No dentition recovered 
 
Skeletal:  
 
 Extensive, severe macro and 
micropitting throughout the 
cranium and post-cranium.  
o Particularly severe on the vertebrae (lamina 
and vertebral bodies), ribs (all surfaces), and 
cranium (endo and ectocranium).  
o Micropitting on all long bones, located 
primarily at the metaphyseal and diaphyseal 
surfaces.  
 Extensive, severe active NWBG on the 
endocranium, on all long bones (not related to 
growth), vertebrae (lamina, vertebral bodies), and 
ribs (all surfaces).  
 Extensive, severe porotic hyperostosis on the 
parietals and frontal bones.  
 Osteochondrosis of the long bone epiphyses. 
Possibly related to ischemic/aseptic necrosis or other 
degenerative/regenerative mechanisms.  
 No orbits visible--presence/degree of cribra orbitalia 
unknown.  
 Flaring of the rib ends 
 
Age Estimate:  
 No dentition recovered.  
 Vertebral neural arches fused 
together, but not to the centrum 
(Buikstra and Ubelaker 1994:43)  
 No epiphyseal fusion of other 
primary ossification centers.  
o Possibly related to 
epiphyseal plate pathologies.  
 Estimated Age: ~3-4 years old 
 
 
Diagnosis: 
 β-thalassemia major; Anemia 
Differential: Sickle Cell Anemia, α-
thalassemia major 
 
Fig. 4a: Severe macropitting on the ectocranial surface of 
the cranium ID 2134 (Carroll 2015, taken with permission 
from the Municipal Museum of Écija Spain). 
 
Fig. 6a: Micro and macropitting on the vertebral 
lamina ID 2134 (Carroll 2015, taken with permission 
from the Municipal Museum of Écija Spain) 
 
Fig. 5a: Severe macropitting on 
the ectocranial surface of the 
cranium ID 2134 (Carroll 2015, 
taken with permission from the 
Municipal Museum of Écija 
Spain). 
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Individual 2030; Phase 2: 
 
Completeness: >75% complete 
Preservation: Good 
 
Pathologies:  
 
Dental:  
 No LEH 
 
Skeletal:  
 Extensive, severe active and healed 
endocranial and ectocranial lesions (hair 
on end trabeculae) on the occipital and 
parietal bones.  
 Active and healed porotic hyperostosis 
(micro and macropitting) on the ectocranium. 
Less severe than individual 2134 or 11321, but 
with similar distribution pattern (frontal, 
parietals, temporals, occipital) 
 Micropitting of the zygomatics. All surfaces.  
 Micropitting of the pars basilaris (occipital). 
Unfused.  
 Extensive, severe active cribra orbitalia (hair on 
end trabeculae) along the superior border of the 
orbits.  
 Vertebral micropitting, mostly on the thoracic 
vertebrae lamina. Some pitting on the long 
bones, but it is very diffuse.  
 No evidence of pathological NWBG in the post-
crania  
Age:  
 Permanent first molar crowns complete, no root 
formation. Min age. 2 yrs +/- 8 mnths, 
based on Ubelaker 1994.  
 Vertebral neural arches fused together 
(age range: 1-4 yrs), but not to centrum 
(fusion commences between 3-7 yrs). 
Based on Buikstra and Ubelaker 1994:43.  
 Pars basilaris unfused (age of fusion 2yrs-
8 yrs, based on Buikstra and Ubelaker 
1994:43).  
 No epiphyseal fusion of other primary 
ossification centers.  
 Estimated age range: 2 yrs (+/-8 mnths), 
based on epiphyseal fusion of the vertebrae 
and pars basilaris and dental development. 
Buikstra and Ubelaker 1994:43 and Ubelaker 1989.  
Diagnosis: 
 β-thalassemia major; Anemia Differential: Sickle Cell Anemia, α-thalassemia major 
 
Fig. 7a: Orbital hair-on-end trabeculae ID 2030 
(Carroll 2015, taken with permission from the 
Municipal Museum of Écija Spain) 
 
Fig. 8a: Endocranial hair-on-end 
trabeculae ID 2030(Carroll 2015, taken 
with permission from the Municipal 
Museum of Écija Spain) 
 
Fig. 9a: Micropitting on the basilar bone of 
the occipital ID 2030 (Carroll 2015, taken 
with permission from the Municipal Museum 
of Écija Spain) 
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Individual 4238; Phase 5:  
Completeness: >75% 
Preservation: good 
 
Pathologies:  
 Active and healed cribra orbitalia (bilateral), located primarily along the superior 
orbital borders.  
 Active and healed porotic hyperostosis (frontal, parietals, temporals, occipital) 
 NWBG and micropitting on the palate. Not related to growth.  
 Hair-on-end trabeculae on the endocranium, not as severe as 2030 
 Slight flaring of the rib ends, and possibly the long bone metaphyses. Needs x-ray.  
 Possible enlargement of the maxillae (maxillary gnathopathy), however it is not 
extreme and possibly within range of normal variation.  
 
Dental:  
 No LEH noted. 
 
Age:  
 Second deciduous molar crowns complete, with roots ¼ formed. Age range: 18 mths 
+/- 6 mths 
 First permanent molar crown (unknown stage), and lateral permanent incisor crown 
(at least half complete) visible. Age range: At least 1 yrs +/- 4 months.  
 Vertebral lamina partially fused (cervical only). Age range: 1-4 yrs.  
 Vertebral lamina not fused to centra. Age of fusion: 2-8 yrs.  
 Estimated age range: 18 mths +/- 6 months to 4 yrs old.  
 
Diagnosis: 
 β-thalassemia major; Anemia Differential: Sickle Cell Anemia, α-thalassemia major, 
iron-deficiency anemia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10a: Active and healed cribra 
orbitalia ID 4238 (Carroll 2015, taken 
with permission from the Municipal 
Museum of Écija Spain). 
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Individual 11989; Phase Unknown:  
 
Completeness: >75% complete 
Preservation: Excellent 
 
Pathologies:  
 Severe active bilateral cribra orbitalia, located 
along the superior orbital border. New woven 
bone growth present. Slight hair-on-end 
trabeculae. Not as severe as 2030.  
 Extensive and severe endocranial lesions 
(paritels, frontal) -- hair on end trabeculae 
 Active and healed porotic hyperostosis 
(frontal, parietals, occipital)  
 NWBG with macro and micropitting on the 
greater wings of the sphenoid. Possibly 
thickened. x-rays required.  
 Micropitting of the nasal cavity, on the floor of 
the maxilla and throughout the ribs.  
 Extensive micropitting of both zygomatics.  
 Post-cranial long bone cortices appear thinned, 
but x-rays required to confirm 
 No pathological micropitting seen on the post-
crania  
 Flaring of the ulnar metaphyses. X-ray needed 
to confirm 
 
Age:  
 Second deciduous molar crowns complete, with 
roots ½ formed. 2 yrs +/-8 mnths.  
 Pars basilaris unfused. Age of fusion: 1-4 yrs 
old.  
 All long bone epiphyses unfused.  
 Vertebral lamina partially fused (cervical). 
Age range: 1-4 yrs.  
 Estimated age range: 2 yrs +/- 8 mnths to <4 
yrs.  
 
Diagnosis: 
β-thalassemia major; Anemia Differential: Sickle Cell 
Anemia, α-thalassemia major 
 
 
 
 
 
Fig. 11s: Endocranial lesions, with 
possible hair-on-end trabeculae ID 
11989 (Carroll 2015, taken with 
permission from the Municipal Museum 
of Écija Spain) 
 
Fig. 12a: Cribra orbitalia with possible hair-
on-end trabeculae ID 11989 (Carroll 2015, 
taken with permission from the Municipal 
Museum of Écija Spain) 
 
Fig. 13a: Flaring of the ulnar metaphysis ID 
11989 (Carroll 2015, taken with permission 
from the Municipal Museum of Écija Spain) 
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Individual 4776; Phase Unknown: 
 
Completeness: >75% 
Preservation: Excellent  
 
Pathologies:  
 
 Extensive and severe active porotic hyperostosis 
(hair on end trabeculae) on the pterion, and 
endocranial surface of the occipital bone.  
 Active porotic hyperostosis on the ectocranial 
surface of the crania (temporals and occipital), 
and bilaterally on the zygomatics, nasal bones, 
and ascending mandibular rami.  
 Active and healed cribra orbitalia on the superior 
orbital margins  
 Flared rib ends (vertebral and sternal), with 
active and healed micro and macropitting on all 
surfaces. New woven bone growth along the 
metaphyseal surfaces (vertebral and sternal) 
(possibly related to growth).  
 Metaphyseal surfaces of both tibias (proximal 
end) appear expanded (x-rays needed to 
confirm).  
o Marrow hyperplasia  
o Growth 
 Micropitting and new woven bone along the metaphyseal surfaces of all long bones.  
o Possibly pathological, but may be within normal range of variation for growth  
 The diaphyseal surfaces of both femurs 
and tibias are striated  
o Healed periostosis 
 No linear enamel hypoplasias 
 
Age:  
 Permanent first molar crowns complete, 
molar ¼ complete. Min age. 2 yrs +/- 8 
mnths, based on Ubelaker 1994.  
 Vertebral neural arches fused together 
(age range: 1-4 yrs), but not to centrum 
(fusion commences between 3-7 yrs). 
Based on Buikstra and Ubelaker 1994:43.  
 Pars basilaris unfused (age of fusion 2yrs-
8 yrs, based on Buikstra and Ubelaker 
1994:43). 
 No epiphyseal fusion of long bone 
primary ossification centers. 
 Estimated age range: 2 yrs (+/-8 mnths) to 4 yrs (+/- 12 mths), based on epiphyseal 
fusion of the vertebrae and pars basilaris and dental development. Buikstra and Ubelaker 
1994:43 and Ubelaker 1989.  
 
Diagnosis: 
 β-thalassemia major; Anemia Differential: Sickle Cell Anemia, α-thalassemia major 
Fig. 14a: Ectocranial hair-on-end trabeculae 
ID 4776 (Carroll 2015, taken with permission 
from the Municipal Museum of Écija Spain). 
 
Fig. 15a: Macropitting on the zygomatic ID 4776 
(Carroll 2015, taken with permission from the 
Municipal Museum of Écija Spain). 
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Individual 12283; Phase Unknown 
Completeness: >75% 
Preservation: good 
 
Pathologies:  
 Active and healed cribra orbitalia 
(bilateral), located primarily along the 
superior orbital borders.  
 Active and healed porotic hyperostosis 
(frontal, parietals, temporals, occipital) 
 Hair-on-end trabeculae on the 
ectocranium, mild.  
 Slight flaring of the rib ends and 
metaphyses.  
 Waxy new (lamellar) bone growth on the 
ectocranium.  
 Diffuse pitting and NWBG throughout 
the post-crania, but likely more related to 
growth as opposed to an Anemic 
response.  
 No LEH noted. 
 
Age:  
 Second deciduous molar crowns complete, with roots ¼ formed. Age range: 18 mths 
+/- 6 mths 
 Vertebral neural arches fused together, but not to the centrum (Buikstra and Ubelaker 
1994:43)  
 No epiphyseal fusion of other primary ossification centers.  
 Estimated Age: ~3-4 years old 
 
Diagnosis: 
 β-thalassemia major; Anemia Differential: Sickle Cell Anemia, α-thalassemia major 
 
Individual 2772; Phase Unknown: 
Completeness: <50% 
Preservation: Poor 
Note: No bone collected 
 
Pathologies:  
 Active cribra orbitalia (bilateral), located primarily along the superior orbital borders.  
 Active porotic hyperostosis (frontal, parietals, temporals, occipital) 
 Hair-on-end trabeculae on the ectocranium, mild 
 Slight flaring of the rib ends and metaphyses.  
 Diffuse pitting and NWBG throughout the post-crania, but likely more related to 
growth as opposed to an Anemic response.  
 No LEH noted. 
 
Age:  
Fig. 16a: Waxy new bone growth on the 
ectocranium ID 12283(Carroll 2015, taken with 
permission from the Municipal Museum of Écija 
Spain). 
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 Second deciduous molar crowns complete, with roots ¼ formed. Age range: 18 mths 
+/- 6 mths 
 Vertebral neural arches fused together, but not to the centrum (Buikstra and Ubelaker 
1994:43)  
 No epiphyseal fusion of other primary ossification centers.  
o Possibly related to epiphyseal plate pathologies.  
 Estimated Age: 18 mths (+/- 6 mths)-4 yrs 
 
Diagnosis: 
 β-thalassemia major; Anemia Differential: Sickle Cell Anemia, α-thalassemia major 
 
Individual 5255; Phase Unknown: 
Completeness: >75% 
Preservation: Good 
 
Pathologies:  
 Severe cribra orbitalia (bilateral), with 
possible hair-on-end trabeculae  
 Active and healed porotic hyperostosis 
(frontal, parietals) 
 Hair-on-end trabeculae on the 
endocranium, mild.  
 Flaring of the rib ends and 
metaphyses.  
 Waxy new bone growth on the 
ectocranium, diploe appears thickened 
(lack of pneumatisation)   
 Waxy new bone growth on the ribs (ventral and dorsal surface) 
 Diffuse pitting and NWBG throughout the post-crania, but likely more related to 
growth as opposed to an Anemic response.  
 No LEH noted. 
 
Age:  
 Vertebral neural arches fused 
together, but not to the centrum 
(Buikstra and Ubelaker 1994:43)  
 No epiphyseal fusion of other 
primary ossification centers.  
 Estimated Age: ~3-4 years old 
 
Diagnosis: 
 β-thalassemia major; Anemia 
Differential: Sickle Cell Anemia, α-
thalassemia major 
 
 
Fig. 18a: Example of the waxy new bone growth noted on 
the ribs ID 5255 (Carroll 2015, (Carroll 2015, taken with 
permission from the Municipal Museum of Écija Spain) 
 
Fig. 17a: Cribra orbitalia, with possible hair-on-end 
trabeculae ID 5255 (Carroll 2015, (Carroll 2015, taken 
with permission from the Municipal Museum of Écija 
Spain). 
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Appendix C: Pos. A./H. Profiles: 
 
Individual 5920; Phase 4:  
Completeness: >75% complete 
Preservation: Good 
 
Pathologies:  
 Active and healed porotic hyperostosis 
(frontal, parietals, occipital) on the ecto 
cranium. Endocranial surface not visible.  
 Active and healed cribra orbitalia, 
concentrated primarily along the superior 
orbital borders.  
 Extensive, severe macroporosity on both 
dorsal and ventral surfaces of the 
sternum and manubrium. 
 Extensive, severe macroporosity of the 
anterior vertebral bodies (expansion of 
the vascular canals) 
 New lamellar bone growth on the 
dorsal surfaces of the ribs. Midshaft 
only.  
 Micropitting throughout the post-cranial 
skeleton, particularly on the pelvis and 
vertebrae. 
 One lumbar vertebrae exhibits a large 
macropit/foramin on the anterior surface 
of the vertebral body. Edges are smooth, 
with no NWBG surroduning the 
foramen.  
 Squaring/towering of the lower thoracic 
and upper lumbar vertebrae 
 osteophytic lipping around the left 
acetabulum. All other joints are non-
pathological.  
 Circular enamel defect, LM3.  
 
Age:  
 All third molars erupted, and roots 
complete. Age range 18+ yrs  
 Superior and inferior cervical-lumbar 
vertebral epiphyses (centra) partially fused. Age of fusion 17-24 yrs (lumbar) old.  
 Unfused clavicular epiphyses. Age of fusion 18-36 yrs as per Buikstra and Ubelaker 
1994:43.  
 Estimated age range: 18-24 yrs. Young adult. 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: Sickle Cell Disease 
Fig. 20a: Severe macropitting on the ventral surface 
of the manubrium ID 5920 (Carroll 2015, taken with 
permission from the Municipal Museum of Écija 
Spain) 
 
Fig. 19a: Expansion of the vertebral vascular canals 
ID 5920(Carroll 2015, taken with permission from the 
Municipal Museum of Écija Spain) 
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Individual 2527; Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good 
 
Pathologies:  
 
 Extensive bilateral NWBG on the mandible, maxillae, zygomatics and in the orbits. 
Severe (75% coverage) 
o Mandible: Located on the ventral (lingual) surfaces of both ascending ramii, 
and along the dorsal (buccal) and ventral (lingual) surfaces of the mandibular 
body.  
o Maxilla: Located along the anterior surface of both maxilla, extending past 
the canine fossa and into the surface near the frontal maxillary process.  
o Zygomatics: Located on all all surfaces.  
o Orbits: Located along the superior borders of the orbits, descending onto the 
greater wings of the sphenoid, and along the orbital surface of the zygomatic. 
Accompanied by micro and macropitting (cribra orbitalia). 
 Extensive, severe active and healed endocranial lesions (hair on end trabeculae) on 
the occipital and parietal bones.   
 Active and healed porotic hyperostosis (micro and macropitting) of the ectocranium 
(frontal, parietals, temporals, occipital) 
 Micropitting of the pars basilaris (occipital). Unfused.  
 Flaring of the proximal metaphysis of the left ulna. X-rays needed to confirm.  
 Flaring of the sternal rib ends.  
 Active osteolytic lesion on the left femur. 
 No LEH noted 
 
Age:  
 
 Deciduous second molar crowns fully developed, roots ¼ complete. Min. age: 18 
mnths +/- 6 mnths, based on Ubelaker 1989.  
 Vertebral neural arches fused together (age range: 1-4 yrs), but not to centrum 
(fusion commences between 3-7 yrs). Based on Buikstra and Ubelaker 1994:43.  
 Pars basilaris unfused (age of fusion 2yrs-8 yrs, based on Buikstra and Ubelaker 
1994:43). 
 No epiphyseal fusion of other primary ossification centers. 
 Estimated age range: 18 months (+/-6 months) to 2 yrs (+/- 8 months) based 
primarily on dental (root) development. Buikstra and Ubelaker 1994:43 and Ubelaker 
1989.  
 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: Sickle Cell Disease 
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Individual 6795: Phase 2   
 
Completeness <75% complete 
Preservation good-excellent 
Sampled: Lamina (thoracic), rib (midshaft) 
 
Pathologies:  
 Extensive and severe healed porotic 
hyperostosis of the ectocranium (frontal, 
parietals, occipital). Endocranium not visible.  
 Active and healed cribra orbitalia. Bilateral.  
 Extensive and severe micro and macropitting 
on the vertebrae, ribs, pelvis, and mandibular 
ramus.  
o Vertebrae: Cervical to sacrum, 
concetrated on the lamina and 
vertebral bodies. Superior and inferior 
vertebral body surfaces appear within 
normal range (i.e-non- 
o pathological in appearance) 
o Ribs: Pitting on all surfaces, with the most 
severe pitting located at the midshafts 
(ventral and dorsal surfaces).  
o Pelvis: Macropitting throughout the ventral 
and dorsal surfaces, with the highest 
concentration of macropitting surrounding the acetabulum.  
o Mandible: Only one mandibular condyle/ramus intact. Micropitting 
concentrated beneath the mandibular condyle. 
o NWBG on the vertebrae, ribs and in the acetabulum 
o Vertebrae: concentrated primarily on the thoracic lamina  
o Ribs: 
concentrated 
primarily at the 
mid-shaft 
 Lamellar bone growth on 
the ribs, concentrated 
primarily at the mid-
shaft, and in both 
acetabulum.  
 Bilateral acetabular 
lesions 
o New woven bone 
and lamellar 
bone growth on 
all surfaces. 
o Micropitting 
Fig. 21a: New bone growth in the 
acetabular fossa ID 6795(Carroll 
2015, taken with permission from 
the Municipal Museum of Écija 
Spain). 
 
Fig. 22a: New bone growth, acetabular osteochondrosis, and pitting in 
the acetabular fossa ID 6795(Carroll 2015, taken with permission from 
the Municipal Museum of Écija Spain). 
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 Acetabular osteochondrosis 
 ischemic necrosis of the femoral heads.  
 Disordered resorption/reparative mechanisms.  
 Linear enamel hypoplasias 
 
Sex:  
 Male, based on the appearance of the pelvis, sacrum and cranium, as per Buikstra and 
Ubelaker 1994.  
Age:  
 All permanent third molar crowns complete and erupted. Age range 17-21 yrs, as per 
Ubelaker 1989 and QUOTE. 
 Minimal occlusal wear to M3s. Suggestive of a YA age range.  
 M3 roots experienced taphonomic damage, so completion phase is unknown. Roots 
at least ¾ length complete. 17 yrs +.  
 Medial clavicular epicondyle only partially fused. Age of fusion between `18-30 yrs, 
as per Buikstra and Ubelaker 1994. Age range <30. 
 Femoral head and lesser trochanter completely fused. Age of fusion between 17-23 
yrs old.  
 Radial distal epiphysis fused. Age of fusion between 17 and 20 yrs old.   
 Spheno-occipital synchondrosis unfused. Age of fusion 19-25 yrs, as per Buikstra 
and Ubelaker 1994.  . Age range <25.  
 Estimated age range: 17 yrs to <25 yrs, based primarily on dental development and 
epiphyseal fusion.  
 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: Sickle Cell Disease 
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Individual 5757: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Excellent 
 
Pathologies:  
 
 Active and healed porotic hyperostosis and 
cribra orbitalia 
 Possible H-shaped vertebrae (cervical to 
lumbar); may also be age related degeneration 
 New woven bone growth throughout the 
pelvis, sacrum and sternum 
 Pitting throughout the post-cranial skeleton, 
most severe on the manubrium, sacrum 
thoracic spine and along the inferior scapular 
borders 
 Patellar exostosis, IVD, neural pitting 
 No LEH noted 
 
Age:  
 Middle Adult  
 
Diagnosis: β-thalassemia minor; Anemia 
Differential: Sickle Cell Disease/trait, iron-
deficiency anemia 
 
 
 
 
Fig. 23a: Possible H-shaping of the lumbar 
vertebrae ID 5757 (Carroll 2015, taken with 
permission from the Municipal Museum of 
Écija Spain) 
 
Fig. 24a: Patellar exostosis ID 5757 
(Carroll 2015, taken with permission 
from the Municipal Museum of Écija 
Spain). 
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Individual 11916: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Excellent 
 
Pathologies:  
 
 Active, severe porotic hyperostosis and cribra 
orbitalia 
 Extensive micro and macropitting throughout the 
entire skeleton; most severe on the sacrum, pelvis, 
vertebrae sternum and calcanei 
 New woven bone growth throughout the skeleton, 
not related to growth. 
 Flared rib ends and metaphyses, possible flaring of 
the femoral and tibial metaphyses. X-ray required.  
 No LEH noted, no hair-on-end trabeculae 
 
Age:  
 
 Sternum remains unfused, 
vertebral lamina are not fused to 
the centrum. 
 Deciduous dentition only, m2s 
still in crypt 
 Age estimation: 18mths (+/- 6 
mths) to 2 yrs (+/- 8 mths) 
 
Diagnosis: β-thalassemia major (but 
did not categorize as such, due to the 
lack of hair-on-end trabeculae); 
Anemia Differential: Sickle Cell 
Anemia, β-thalassemia intermedia.  
 
 
 
 
Fig. 26a: Severe micro and macropitting of the sacral vertebrae, 
with NWBG ID 11916 (Carroll 2015, taken with permission from 
the Municipal Museum of Écija Spain) 
 
Fig. 27a: Severe macropitting of the sternal 
bodies ID 11916 (Carroll 2015, taken with 
permission from the Municipal Museum of Écija 
Spain) 
 
Fig. 28a: Severe 
micropitting of the 
calcaneous ID 11916 
(Carroll 2015, taken 
with permission from 
the Municipal 
Museum of Écija 
Spain) 
 
Fig. 25a: Cribra orbitalia ID 11916 
(Carroll 2015, taken with permission from 
the Municipal Museum of Écija Spain) 
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Individual 10326: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good-excellent 
 
Pathologies:  
 
 Active cribra orbitalia; active and healed porotic 
hyperostosis 
 Possible avascular necrosis of the humeral head; 
left humerus is significantly shorter than the right 
 Pitting throughout the post-cranial skeleton.  
 Expansion of the meningeal grooves/vascular 
canals (endocranium). A single large pit is located 
superior to one of the canal expansions.  
 Significant size disparity between the inferior 
auricular surfaces of C1, and superior auricular 
surfaces of C2.  
 Degenerative changes (IVD, micropitting) noted 
in the vertebral column (cervical to lumbar) 
 Arthritic alterations (rheumatic) to the distal foot 
phalanges 
 
Age:  
 Middle Adult; all dentition erupted. Epiphyseal 
fusion of the clavicle, humerus, sacrum, 
acetabulum etc. 
 
Diagnosis: 
 β-thalassemia minor; Anemia Differential: Sickle Cell Disease/trait, iron-deficiency 
anemia 
 
 
 
 
 
 
Fig. 29a: Expansion of the meningeal 
groove, and evidence of macropiting  ID 
10326 (Carroll 2015, taken with 
permission from the Municipal Museum 
of Écija Spain) 
 
Fig. 30a: Possible avascular necrosis of 
the humeral head ID 10326 (Carroll 2015, 
taken with permission from the Municipal 
Museum of Écija Spain) 
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Individual 12063: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good-excellent 
 
Pathologies:  
 
 Active and healed cribra orbitalia; 
healed porotic hyperostosis (frontal) 
 Waxy new lamellar bone growth 
throughout the ribs, and the occipital 
base 
 Active and healed micropitting 
throughout the ribs, and along the 
occipital base 
 Flared rib ends.  
 
Age:  
 Third molar cusp developed, root not 
completely developed. Estimated age: 18-
<25 yrs.  
 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: β-thalassemia major, sickle cell 
anemia, iron-deficiency anemia. 
Individual 4574: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good-excellent 
 
Pathologies:  
 
 Active and healed cribra orbitalia and porotic hyperostosis  
 Active and healed micropitting throughout the post-cranial; most severe in the ribs, 
and vertebral column.  
 Flared rib ends. Possible flaring of the long bone metaphyses. Need x-ray. 
 Cortices appear thinned. Need x-ray. 
Age:  
 First molar cusp only, root formation not complete. 
 Vertebral lamina are fused, but not to centrum.  
 Age Estimation: ~3-4 yrs.  
 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: β-thalassemia major, sickle cell 
anemia, iron-deficiency anemia.  
Fig. 31a: Waxy new lamellar bone growth and  
maropitting on the occipital base ID 12063 (Carroll 
2015, taken with permission from the Municipal 
Museum of Écija Spain). 
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Individual 10021: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good-excellent 
 
Pathologies:  
 
 Active and healed cribra orbitalia and porotic 
hyperostosis (frontal, occipital, parietals) 
 New woven bone growth on the endocranial 
surface 
 Cranial diploe lacks normal pneumatisation  
 Active and healed micropitting throughout the 
ribs 
 Infraorbital foramen appear expanded compared 
to the rest of the population; possibly still within 
normal range of variation 
 Skull appears more prognathic than the rest of 
the population; possible gnathopathy, possibly of 
African origin (no nasal guttering noted, 
however) 
 New woven bone growth and micropitting throughout the ribs and vertebral column 
(cervical-lumbar) 
 Slight flaring of the rib ends and metaphyses 
 Dental diastemas 
 No LEH noted 
 
Age:  
 Young adult (third molar roots not fully developed;  18 yrs - <25 yrs) 
 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: Sickle Cell Disease, β-thalassemia 
minor, iron deficiency anemia.  
 
 
 
 
Fig. 32a: New bone growth on the 
endocranial surface ID 10021 (Carroll 
2015, taken with permission from the 
Municipal Museum of Écija Spain) 
 
Fig. 33a: Active micropitting on 
the dorsal surface of the rib ID 
10021 (Carroll 2015, taken with 
permission from the Municipal 
Museum of Écija Spain). 
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Individual 7968: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good-excellent 
 
Pathologies:  
 
 Active and healed cribra orbitalia and porotic hyperostosis (frontal, occipital, 
parietals) 
 Rib flaring, new woven bone growth at the vertebral epiphyses, small depostis of 
New lamellar bone growth throughout the ventral and doral surfaces of the ribs 
 Extensive micropitting throughout the vertebrae, most severe on the vertebral lamina 
(cervical to lumbar) 
 Linear enamel hypoplasia (incisors, canine, premolars; maxillary and mandibular) 
 
Age:  
 Young adult (third molar crowns formed, root apex open) 
 
Diagnosis: 
 β-thalassemia intermedia; Anemia Differential: Sickle Cell Disease, β-thalassemia 
minor, iron deficiency anemia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 34a: Rib flaring, with new woven 
bone growth at the vertebral epiphysis 
and small deposits of lamellar bone 
growth on the body ID 7968 (Carroll 
2015, taken with permission from the 
Municipal Museum of Écija Spain) 
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Individual 5093: Phase Unknown: 
 
Completeness: >75% complete 
Preservation: Good-excellent 
 
Pathologies:  
 
 Active and healed cribra orbitalia and porotic hyperostosis (frontal, occipital, 
parietals) 
 Extensive micropitting throughout the vertebral lamina 
 Healed LBG with active and healed and micropitting on the on the pleural and dorsal 
surfaces of the rib shafts. 
o Cannot exclude pulmonary conditions as the cause of the healed LBG on the 
rib midshafts.  
 Lack of woven bone suggests the condition was not active and/or 
was not severe enough to affect osteological tissues at/near the time 
of death.   
 **Pulmonary conditions may affect the ratio of stable oxygen 
isotope within the system due to inspiratory/expiratory fractionation 
processes.**  
Age:  
 Young adult; third molar crowns formed, root apex open. <16 yrs->25 yrs 
 
Diagnosis: 
 β-thalassemia minor Anemia Differential: Sickle Cell Disease, iron deficiency 
anemia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 35a: Healed new lamellar bone 
growth on the dorsal surface of the rib ID 
5093 (Carroll 2015, taken with permission 
from the Municipal Museum of Écija 
Spain)  
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Appendix D: Pathological and Taphonomic Alterations Noted in Each of the 
Human Osteological Samples Analysed Isotopically (Carroll 2015) 
 
NBG New bone growth 
MiP Micropitting 
MaP Macropitting 
TMiP Taphonomic Micropitting 
TMaP Taphonomic Macropitting 
B Both surfaces 
P Pleural surface 
D Dorsal surface 
X Active 
H Healed 
 
ID # Type Sample Pitting NBG Notes 
(A) 
11321 Anemic Rib HMIP? A Possible healed micropitting on dorsal surface 
(B) 
11321 Anemic R. zygo XHMIP X (b) 
Active bone growth throughout, active and 
healed micropitting 
(A) 
2134 Anemic Rib 
X/HMI
P (B) 
X/H 
(B) 
Active and healed micropitting on both 
surfaces, but mainly on pleural surface, active 
and healed NBG (woven) on both surfaces. 
Black staining on both surfaces. 
(B) 
2134 Anemic Vault 
MIP/M
AP 
Y 
(X/H) 
Active macro and micropitting on the 
endocranial surface, micropitting on the 
ectocranial surface 
2030 Anemic Rib 
XMIP/T
MIP A 
Active micropitting along inferior border. 
Taphonomic damage throughout. 
4238 Anemic Rib TMIP A Taphonomic micropitting both surfaces 
11989 Anemic Rib XMIP A Active pitting on pleural surface 
4776 Anemic Rib 
X/HMI
P A 
Active and healed micropitting on both 
surfaces. 
(A) 
12283 Anemic Rib 
HMIP 
(d) A Healed micropitting on dorsal surface 
(B) 
12283 Anemic Vault HMIP A Healed micropitting throughout both surfaces 
2772 Anemic Rib TMIP A Brown staining 
(A) 
5255 Anemic Rib XHMIP A Active and healed micropitting throughout 
 
Micropit 
Small pit in the bone 
which is less thaen 
0.50mm in diameter 
Macropit 
Pit in the bone which 
is more then 0.50mm 
in diameter  
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(B) 
5255 Anemic Vault XHMIP A 
Active and healed micropitting on both 
surfaces 
ID # Type Sample Pitting NBG Notes 
5920 
Pos. 
A./H. Rib 
XMIP/T
MIP H (d)? 
Micropitting on both surfaces, taphonomic 
cracking. Possible healed NBG on dorsal 
surface (roughened), possibly taphonomic. 
(A) 
11916 
Pos. 
A./H. Rib 
Tmip/x
mip (p) A 
Healed mpitting on the pleural surface. 
Minor. 
(E) 
11916 
Pos. 
A./H. Rib 
Tmip/X
HMIP 
(B) A 
Active and healed mpitting on both surfaces. 
Some taph damage. 
2527 
Pos. 
A./H. Rib XMIP A Active micropitting on both surfaces 
(A) 
5757 
Pos. 
A./H. Rib A H ? Possible healed NBG on dorsal surface. 
(B) 
5757 
Pos. 
A./H. Lamina 
XMIP/T
MIP A Active and taphonomic micropitting 
(A) 
6795 
Pos. 
A./H. Rib 
XHMIP
/TMAP
?AMAP
? A 
Active and healed micropitting on both 
surfaces. Macropits along the inferior border, 
possibly taphonomic/pathological. 
(B) 
6795 
Pos. 
A./H. Lamina 
XHMIP
/MAP A 
Active and healed micro and macropitting 
throughout. Sclerosis of the auricular surface 
10326 
Pos. 
A./H. Rib 
HMIP 
(B) X 
Healed micropitting on both surfaces, healed 
NBG on the dorsal surface. 
(A) 
12063 
Pos. 
A./H. Rib 
HMIP/T
MIP A 
Micropitting throughout, possibly 
taphonomic. 
(E) 
12063 
Pos. 
A./H. Rib ? ? ? 
(A) 
10021 
Pos. 
A./H. Rib 
XHMIP
/TMIP H (P)? 
Active and healed micropitting throughout, 
possible patch of healed NBG on pleural 
surface. 
(B) 
10021 
Pos. 
A./H. Vault A 
XH 
(b) 
Active new bone growth endocranial, healed 
NBG ectocranially 
5093 
Pos. 
A./H. Rib XHMIP A 
Active and healed micropitting on both 
surfaces. brown staining 
7968 
Pos. 
A./H. Rib A X Possible healed NBG on superior border 
(A) 
4574 
Pos. 
A./H. Rib TMIP A N/A 
(B) 
4574 
Pos. 
A./H. Rib A A N/A 
ID # Type Sample Pitting NBG Notes 
9247 Diseased Rib 
TMip, 
TMap, 
XMip A Healed micropitting on the dorsal surface. 
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(E) 
9247 Diseased Rib Tmip X(p) Possibly healed NBG on the pleural surface. 
(A) 
9027 Diseased Rib 
TMIP, 
TMAP A N/A 
(B) 
9027 Diseased Vault A A Some taph damage 
2817 Diseased Rib XHMIP H (B) 
Active and healed micropitting on both 
surfaces, healed NBG throughout 
11681 Diseased Rib 
XMIP, 
TMAP A 
Healed micropitting on the dorsal surface. 
Taph damage 
11837 Diseased Rib TMip A Minor taph damage 
(A) 
12895 Diseased Rib 
TMIP/T
MAP A Taphonomic changes only 
(B) 
12895 Diseased Vault A A N/A 
10957 Diseased Rib 
TMIP/H
MIP (D) X (b) 
Slight pitting, and healed new bone growth on 
both surfaces 
(A) 
3863 Diseased Rib A A N/A 
(B) 
3863 Diseased Scapula XMIP H 
Micropitting throughout, potentially within 
normal range. Healed new bone growth on 
dorsal surface 
12271 Diseased Rib 
TMIP/T
MAP A Taph damage 
(E) 
12271 Diseased Rib HMIP A 
Healed micropitting on dorsal surface, taph 
damage throught 
(A) 
6855 Diseased Rib A H (d)? 
Possible healed new bone growth on dorsal 
surface 
(E) 
6855 Diseased Rib 
HMIP/T
MIP H (d)? 
Healed and taphonomic micropitting 
throughout, possible healed NBG on dorsal 
surface 
(A) 
509 Diseased Rib 
XHMIP
/XMAP A 
Active and healed micro/macropitting on both 
surfaces, possible healed periostosis on the 
dosal surface 
(B) 
509 Diseased Vault 
XMAP 
? A 
Possible healed pitting on the end and 
ectocranial surface, possibly taphonomic. 
Brown staining. Thickened diploe . 
ID # Type Sample Pitting NBG Notes 
492 Control Rib 
XHMIP
/XHMA
P X (P) 
Active and healed micro and macropitting on 
both surfaces, healed bone on pleural surface. 
Brown staining throughout both surfaces. 
3801 Control Rib TMIP A Taph damage on both surfaces 
(A) 
3697 Control Rib 
XMIP/T
MIP H 
Taphonomic pitting, with some active 
micropitting (within normal range) healed 
NBG on dorsal surface 
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(B) 
3697 Control Lamina 
XMIP/T
MIP P 
Active and taphonomic micropitting. New 
bone growth on the auricular surface. 
4421 Control Rib MIP (P) A 
Slight pitting of the inferior pleural border. 
W/in normal range 
(A) 
12677 Control Rib A A N/A 
(B) 
12677 Control Lamina A A Sclerotic bone on auricular surface 
(E) 
12677 Control Rib A A N/A 
10027 Control Rib A X (b) 
Healed new bone growth on pleural surface 
and superior border. Possible healed 
periostosis. 
12601 Control Rib HMIP A 
Healed micropitting on the dorsal surface, 
taphonomic pitting on pleural surface 
11873 Control Rib A X (P) 
Possible healed NBG on the pleural surface. 
Roughened in appearance. 
11752 Control Rib A A N/A 
12286 Control Rib A X (b) 
Healed NBG on both surfaces, but mainly on 
the inferior border of the pleural surface 
532 Control N/A N/A N/A N/A 
2561 Control N/A N/A N/A N/A 
5902 Control Rib A 
Bleach
ed 
white N/A 
12577 Control N/A N/A N/A N/A 
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Appendix E: Concise Report of all Bone Collagen Chemical Procedures 
Conducted Prior to Isotopic Analyses (Carroll 2015) 
ID # Type Sample 
x 
Sonica
tion 
Water 
Color 
Pre-
treatment 
Sample 
Weight (g) 
Days 
in HCl 
1% 
Hours 
in 
NaOH 
NaOH 
color 
Tissue 
color 
(A) 
11321 Anemic Rib 7x5 Clear 0.8468 5 22 
Light 
brown 
Tissue 
white. 
(B) 
11321 Anemic R. Zygo 7x5 Clear 0.4911 3 23 Clear 
Tissue 
brown 
(A) 
2134 Anemic Rib 8x5 Clear 0.4335 4 21 Clear 
Tissue 
white-
brown. 
(B) 
2134 Anemic Vault 8x5 Clear 0.3172 3 0 N/A 
Tissue 
brown 
2030 Anemic Rib 10x5 Clear 0.8238 7 19 Clear 
Tissue 
white 
4238 Anemic Rib 8x5 Clear 0.3375 4 21 Clear 
Tissue 
white 
11989 Anemic Rib 5x5 Clear 0.7675 7 19 Clear 
Tissue 
white 
4776 Anemic Rib 7x5 Clear 1.1769 9 19 Clear 
Tissue 
white 
(A) 
12283 Anemic Rib 8x5 Clear 1.0663 14 0 N/A 
Tissue 
white 
(B) 
12283 Anemic Vault 7x5 Clear 0.7688 4 0 N/A 
Tissue 
brown 
2772 Anemic Rib 10x5 Clear 0.5153 4 21 Clear 
Tissue 
white 
(A) 
5255 Anemic Rib 10x5 Clear 1.0808 
3 
(B)/6(
A) 20 
Light 
brown 
Tissue 
white-
brown. 
(B) 
5255 Anemic Vault 15x5 Cloudy 0.7864 2 20 Clear 
Tissue 
clear 
ID # Type Sample 
x 
Sonica
tion 
Water 
Color 
Sample 
Weight (g) 
Days 
in HCl 
1% 
Hours 
in 
NaOH 
NaOH 
solutio
n color 
Tissue 
color 
5920 Pos. A./H. Rib 8x5 Clear 1.3627 9 19 Clear 
Tissue 
white 
11916 Pos. A./H. Rib 8x5 Clear 0.5528 4B/7A 19 Clear 
Tissue 
white 
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2527 Pos. A./H. Rib 12x5 Cloudy 0.2609 4 21 Clear 
Tissue 
white 
(A) 
5757 Pos. A./H. Rib 8x5 Clear 1.0588 5 22 
Light 
brown 
Tissue 
white 
(B) 
5757 Pos. A./H. Lamina 12x5 Cloudy 0.4628 4 
No 
NaOH 
No 
NaOH 
Tissue 
brown 
(A) 
6795 Pos. A./H. Rib 11x5 Clear 1.3806 13 21 
Light 
brown 
Tissue 
white 
(B) 
6795 Pos. A./H. Lamina 8x5 Clear 0.791 6 20 Clear 
Tissue 
white-
brown 
10326 Pos. A./H. Rib 10x5 Clear 1.234 8 20 
Dark 
brown 
Tissue 
brown 
12063 Pos. A./H. Rib 7x5 Clear 0.9148 6 0 N/A Dissolved. 
(A) 
10021 Pos. A./H. Rib 13x5 Cloudy 0.7251 6 20 
Light 
brown 
Tissue 
white-
brown 
(B) 
10021 Pos. A./H. Vault 6x5 Clear 1.3336 9 0  
Tissue 
white 
5093 Pos. A./H. Rib 8x5 Clear 1.1654 6 20 
Light 
brown 
Tissue 
white 
7968 Pos. A./H. Rib 8x5 Clear 0.3035 3 23 Clear 
Tissue 
white 
4574 Pos. A./H. Rib 10x5 Clear 1.0316 6 20 
Light 
brown 
Tissue 
brown 
ID # Type Sample 
x 
Sonica
tion 
Water 
Color 
Sample 
Weight (g) 
Days 
in HCl 
1% 
Hours 
in 
NaOH 
NaOH 
solutio
n color 
Tissue 
color 
9247 Diseased Rib 10x5 Clear 1(0)284 8 20 
Light 
brown 
Tissue 
white-
brown 
(A) 
9027 Diseased Rib 8x5 Clear 1.1212 6 20 
Dark 
brown 
Tissue 
white-
brown 
(B) 
9027 Diseased Vault 5x5 Clear 0.6892 6 20 Clear 
Tissue 
clear 
2817 Diseased Rib 15x5 Cloudy 1.5657 9 19 Clear 
Tissue 
white 
11681 Diseased Rib 9x5 Clear 1.0379 9 20 Clear 
Tissue 
white 
11837 Diseased Rib 8x5 Clear 1.7324 9 19 Clear 
Tissue 
white 
10957 Diseased Rib 7x5 Clear 1.1148 8 20 
Light 
brown 
Tissue 
brown 
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(A) 
12895 Diseased Rib 14x5 Clear 1.5784 9 19 Clear 
Tissue 
white 
(B) 
12895 Diseased Vault 5x5 Clear 0.9385 8 20 Clear 
Tissue 
white 
(A) 
3863 Diseased Rib 12x5 Cloudy 0.4935 4 21 Clear 
Tissue 
clear 
(B) 
3863 Diseased Scapula 7x5 Clear 1.1178 9 20 
Light 
brown 
Tissue 
white-
brown 
12271 Diseased Rib 9x5 Clear 1.5845 8 20 
Dark 
brown 
Tissue 
brown 
6855 Diseased Rib 10 x5 Cloudy 1.5049 9 19 Clear 
Tissue 
white 
(A) 
509 Diseased Rib 10x5 Clear 1.3924 
2 B/9 
A 19 Clear 
Tissue 
white 
(B) 
509 Diseased Vault 8x5 Clear 3.7194 14 0  
Tissue 
white 
ID # Type Sample 
x 
Sonica
tion 
Water 
Color 
Sample 
Weight (g) 
Days 
in HCl 
1% 
Hours 
in 
NaOH 
NaOH 
solutio
n color 
Tissue 
color 
492 Control Rib 8x5 Clear 1.2041 8 20 Clear 
Tissue 
white-
brown 
3801 Control Rib 8x5 Clear 1.6834 10   
Tissue 
white 
(A) 
3697 Control Rib 8x5 Clear 1.1526 6 20 
Dark 
brown 
Tissue 
brown 
(B) 
3697 Control Lamina 10x5 Clear 1.6235 13 0  
Tissue 
white 
4421 Control Rib 8x5 Clear 0.707 3 21 Clear 
Tissue 
brown 
(A) 
12677 Control Rib 15x5 Clear 1.8991 9 20 
Light 
brown 
Tissue 
white 
(B) 
12677 Control Lamina 12x5 Cloudy 0.8442 5 22 Clear 
Tissue 
white 
10027 Control Rib 8x5 Clear 1.1429 5 22 
Light 
brown 
Tissue 
white/brow
n 
12601 Control Rib 8x5 Clear 1.8504 11 0 Clear 
Tissue 
white 
11873 Control Rib 9x5 Clear 0.9916 12 21 
Light 
brown 
Tissue 
white 
11752 Control Rib 9x5 Clear 1.3744 9 20 Clear 
Tissue 
white 
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12286 Control Rib 10 x5 Cloudy 1.1464 9 20 Clear 
Tissue 
white 
532 Control N/A N/A N/A N/A N/A N/A N/A 
N/A 
2561 Control N/A N/A N/A N/A N/A N/A N/A 
N/A 
5902 Control Rib 8x5 Clear 1.245 6 20 Clear 
Tissue 
white 
12577 Control N/A N/A N/A N/A N/A N/A N/A N/A 
ID # Type Sample 
x 
Sonica
tion 
Water 
Color 
Sample 
Weight (g) 
Days 
in HCl 
1% 
Hours 
in 
NaOH 
NaOH 
solutio
n color 
Tissue 
color 
3989 Faunal 
Sheep 
mandible 8x5 Clear 1.0198 8 20 Clear 
Tissue 
white 
8062 Faunal 
Cow 
mandible 15x5 Clear 2.0005 10 20 
Light 
brown 
Tissue 
white 
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Appendix F: Raw δ13C and δ15N Values for all Bone Collagen and Laboratory Control 
Standards (Carroll 2015) 
    Nitrogen Carbon     
Amount 
Identifier 
1 
Area 
28 
∂15N (‰ 
vs Nair) 
N 
(mg) 
Area 
44 
∂13C 
(‰ vs 
VPDB) 
Carbon 
(mg) 
C/N 
(g/g) 
C/N 
(mol/mol) 
0.515 USGS40 42.36 -4.52 0.05 57.93 -26.19 0.21 4.03   
0.507 USGS40 40.87 -4.48 0.05 57.71 -26.38 0.20 4.16   
0.493 USGS40 39.73 -4.50 0.05 56.39 -26.39 0.20 4.18   
0.519 USGS41 42.60 47.59 0.05 60.59 37.68 0.21 4.19   
0.505 USGS41 41.41 47.58 0.05 59.00 37.46 0.21 4.20   
0.497 USGS41 40.86 47.63 0.05 58.30 37.73 0.21 4.20   
0.439 USGS42 56.15 7.89 0.07 55.16 -21.40 0.20 2.92 3.41 
0.427 USGS42 53.35 8.04 0.06 52.49 -21.27 0.19 2.93 3.42 
0.432 USGS42 54.10 7.80 0.06 53.27 -21.15 0.19 2.93 3.42 
0.185 Glysine 27.87 2.79 0.03 15.90 -40.58 0.06 1.72 2.00 
0.409 Glysine 64.47 2.61 0.08 36.65 -40.07 0.13 1.71 2.00 
0.596 Glysine 94.24 2.67 0.11 53.51 -40.10 0.19 1.71 2.00 
0.786 Glysine 124.42 2.62 0.15 70.80 -39.83 0.25 1.71 2.00 
0.488 
LAMINA 
5757B 37.70 11.30 0.05 38.36 -19.89 0.14 3.01 3.51 
0.512 5757 RIB 45.44 10.79 0.05 42.84 -19.29 0.15 2.80 3.27 
0.492 
509 B 
CRANIA 60.67 10.25 0.07 55.83 -19.56 0.20 2.74 3.20 
0.516 509 RIB 60.69 9.51 0.07 55.62 -19.22 0.20 2.73 3.19 
0.482 
3697 B 
LAMINA 57.06 10.79 0.07 52.70 -18.50 0.19 2.75 3.21 
0.519 3697 RIB 62.78 10.84 0.07 57.57 -18.61 0.20 2.74 3.19 
0.495 
2134 B 
VAULT 4.97 14.62 0.01 10.31 -23.82 0.04 5.15 6.01 
0.504 2134 RIB                 
0.497 
10021 B 
VAULT 81.63 9.80 0.10 77.39 -18.82 0.27 2.83 3.31 
0.508 
10021 
RIB 50.60 9.84 0.06 48.92 -19.35 0.17 2.88 3.36 
0.421 USGS42 53.25 7.82 0.06 52.45 -21.39 0.19 2.93 3.42 
0.455 USGS42 58.17 7.80 0.07 57.09 -21.05 0.20 2.92 3.41 
0.485 
6795 B 
LAMINA 55.78 9.94 0.07 51.84 -19.53 0.18 2.77 3.23 
0.494 6795 RIB 59.63 9.73 0.07 54.29 -19.33 0.19 2.72 3.17 
0.504 
9027 B 
VAULT 59.11 10.22 0.07 54.61 -19.26 0.19 2.75 3.21 
0.498 9027 RIB 60.68 10.07 0.07 55.74 -18.95 0.20 2.74 3.20 
0.516 
8062 
MAND 53.71 4.07 0.06 50.05 -20.62 0.18 2.78 3.24 
0.492 
12677 
RIB 49.33 10.31 0.06 45.72 -19.29 0.16 2.76 3.22 
0.504 
11752 
RIB 63.20 9.62 0.08 57.53 -19.06 0.20 2.72 3.17 
0.509 
11916 
RIB 59.43 9.17 0.07 54.57 -19.16 0.19 2.74 3.19 
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0.506 
11681 
RIB 59.75 9.89 0.07 54.79 -19.18 0.19 2.73 3.19 
0.519 
3989 
MAND                 
0.453 USGS42 74.72 7.31 0.09 75.93 -20.84 0.27 3.03 3.54 
0.426 USGS42 54.04 7.89 0.06 52.98 -21.35 0.19 2.92 3.40 
0.488 
11873 
RIB 56.61 9.25 0.07 52.01 -19.28 0.18 2.74 3.20 
0.506 4776 RIB 62.52 9.83 0.07 56.91 -18.84 0.20 2.72 3.17 
0.494 
11837 
RIB 40.46 9.91 0.05 38.49 -19.43 0.14 2.82 3.29 
0.436 
12063 
RIB 4.33 7.71 0.01 7.70 -24.11 0.03 4.37 5.10 
0.511 
11989 
RIB 61.43 11.99 0.07 57.34 -18.22 0.20 2.78 3.25 
0.496 2030 RIB 61.29 13.56 0.07 55.98 -18.63 0.20 2.72 3.18 
0.494 492 RIB 52.04 9.37 0.06 50.53 -19.66 0.18 2.89 3.37 
0.511 
12601 
RIB 62.42 9.74 0.07 57.08 -19.27 0.20 2.73 3.18 
0.499 2817 RIB 51.32 9.36 0.06 48.57 -18.94 0.17 2.82 3.29 
0.486 3801 RIB 60.35 9.36 0.07 55.52 -19.27 0.20 2.74 3.20 
0.489 USGS42 61.78 7.89 0.07 60.57 -21.10 0.21 2.92 3.41 
0.441 USGS42 55.96 8.06 0.07 54.78 -21.23 0.19 2.91 3.40 
  Nitrogen Carbon   
Amount 
Identifier 
1 
Area 
28 
∂15N (‰ 
vs Nair) 
N 
(mg) 
Area 
44 
∂13C 
(‰ vs 
VPDB) 
Carbon 
(mg) 
C/N 
(g/g) 
C/N 
(mol/mol) 
0.504 USGS40 39.94 -4.55 0.05 55.02 -26.35 0.20 4.20   
0.488 USGS40 39.15 -4.38 0.05 54.62 -26.42 0.20 4.26   
0.494 USGS40 39.68 -4.57 0.05 55.45 -26.39 0.20 4.27   
0.507 USGS41 41.74 47.72 0.05 58.19 37.68 0.21 4.26   
0.503 USGS41 41.21 47.55 0.05 57.72 37.51 0.21 4.28   
0.517 USGS41 42.48 47.53 0.05 59.13 37.69 0.21 4.25   
0.459 USGS42 58.16 7.74 0.07 56.00 -21.02 0.20 2.95 3.44 
0.462 USGS42 58.09 7.76 0.07 55.85 -21.11 0.20 2.94 3.43 
0.428 USGS42 53.53 7.64 0.06 51.64 -20.99 0.19 2.95 3.45 
0.203 Glysine 31.73 2.51 0.04 17.73 -39.74 0.06 1.71 2.00 
0.408 Glysine 64.15 2.42 0.08 35.81 -40.01 0.13 1.71 2.00 
0.599 Glysine 94.58 2.44 0.11 52.72 -39.97 0.19 1.71 2.00 
0.807 Glysine 127.32 2.35 0.15 71.01 -40.11 0.26 1.71 2.00 
0.508 
12286 
RIB 63.70 9.86 0.08 56.92 -19.34 0.21 2.74 3.19 
0.514 5255 RIB 58.09 9.53 0.07 52.43 -18.94 0.19 2.76 3.22 
0.505 9247 RIB 60.39 10.60 0.07 55.53 -18.58 0.20 2.82 3.29 
0.497 5093 RIB 58.93 11.43 0.07 53.30 -18.88 0.19 2.77 3.23 
0.509 5902 RIB 56.56 11.64 0.07 53.67 -18.68 0.19 2.91 3.39 
0.498 
10027 
RIB 57.48 8.42 0.07 52.07 -19.24 0.19 2.77 3.24 
0.486 3863 RIB 61.04 8.73 0.07 54.58 -18.82 0.20 2.74 3.20 
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0.5 
10957 
RIB 57.55 9.50 0.07 53.19 -18.85 0.19 2.83 3.30 
0.513 6855 RIB 55.15 8.39 0.07 51.07 -19.10 0.19 2.84 3.31 
0.49 2527 RIB 56.74 9.51 0.07 52.25 -19.28 0.19 2.82 3.29 
0.456 USGS42 58.01 7.59 0.07 55.98 -20.98 0.20 2.95 3.45 
0.455 USGS42 58.14 7.67 0.07 56.05 -21.09 0.20 2.95 3.44 
0.5 
10326 
RIB 62.54 8.02 0.07 56.01 -19.07 0.20 2.74 3.20 
0.485 
12271 
RIB 57.68 10.53 0.07 51.85 -18.74 0.19 2.75 3.21 
0.494 
12283 
RIB 61.29 13.44 0.07 57.45 -21.29 0.21 2.87 3.35 
0.517 5929 RIB 59.82 9.18 0.07 54.94 -18.72 0.20 2.81 3.28 
0.485 4574 RIB 53.82 10.98 0.06 49.17 -19.08 0.18 2.80 3.26 
0.485 
11321 
RIB 52.87 9.00 0.06 47.92 -19.38 0.17 2.77 3.24 
0.493 7968 RIB 61.30 11.56 0.07 55.34 -18.06 0.20 2.77 3.23 
0.512 4238 RIB 57.92 13.07 0.07 54.21 -18.49 0.20 2.87 3.34 
0.515 
12895 
RIB 53.54 9.64 0.06 49.31 -19.31 0.18 2.82 3.29 
0.511 4421 RIB 62.03 8.93 0.07 57.27 -19.25 0.21 2.83 3.30 
0.49 USGS42 59.84 7.74 0.07 59.96 -21.09 0.22 3.07 3.58 
0.46 USGS42 55.14 7.92 0.07 56.31 -21.01 0.20 3.13 3.65 
0.507 
12677 B 
LAMINA 49.04 11.49 0.06 47.65 -18.94 0.17 2.97 3.47 
0.501 2772RIB 57.49 11.57 0.07 54.67 -18.71 0.20 2.91 3.40 
0.465 USGS42 55.31 30.89 0.07 57.35 -20.81 0.21 3.17 3.70 
0.436 USGS42 51.85 180.17 0.06 53.15 -20.51 0.19 3.14 3.66 
0.478 USGS42 57.13 313.48 0.07 58.48 -20.29 0.21 3.13 3.66 
0.508 
11321 
2490B 50.22 9.27 0.06 45.88 -19.63 0.16 2.61 3.04 
0.51 
3863 
SCAP B                 
0.493 
12283 
VAULT 
B 72.55 10.38 0.09 71.57 -19.63 0.25 2.85 3.33 
0.496 
5255 
VAULT 
B 5.77 14.19 0.01 8.31 -23.50 0.02 3.34 3.90 
0.454 USGS42 57.43 7.98 0.07 55.79 -21.05 0.19 2.79 3.26 
0.424 USGS42 53.13 8.09 0.06 51.60 -21.01 0.18 2.78 3.25 
 
 
Tray 1    Tray 2   
 Mean Mean   Mean Mean 
USG 40 -4.5 +/- 0.1 -26.3 +/- 0.1  USG 40 -4.5 +/- 0.1 -26.4 +/- 0.03 
USG 41 -47.6 +/- 0.2 37.6 +/- 0.1  USG 41 47.6 +/- 0.1 37.6 +/- 0.1 
USG 42 8.0 +/- 0.4 -21.2 +/- 0.1  USG 42 7.7 +/- 0.1 -21.2 +/- 0.1 
Glysine 2.7 +/- 0.1 -40.0 +/- 0.3  Glysine 2.4 +/- 0.1 -40.0 +/- 0.3 
Red=Omitted 
Blue=Warning, 
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Appendix G: Raw δ13C and δ18O Values for all Bone Collagen and Laboratory Control 
Standards (Carroll 2015, Laffoon 2015) 
 
Identifier 
1 ∂13C (‰ vs VPDB) 
∂18O (‰ vs 
VPDB) 
Ampl  
44 
  Average SD Average SD   
2772 -8.76 0.11 -4.22 0.10 2417 
2030 -11.70 0.10 -3.32 0.14 1486 
4238 -11.97 0.09 -3.77 0.06 2844 
4421 -11.56 0.20 -3.61 0.28 1015 
5757 -12.00 0.11 -5.15 0.24 978 
10326 -13.12 0.11 -3.07 0.11 1214 
12283 -9.43 0.25 -5.90 0.32 527 
12286 -12.30 0.10 -2.54 0.08 1460 
2817 -11.90 0.17 -3.52 0.16 1951 
11837 -11.22 0.10 -4.97 0.12 1620 
12271 -11.35 0.15 -4.76 0.16 1447 
11681 -11.26 0.13 -3.64 0.15 2590 
11989 -11.51 0.15 -4.33 0.17 1459 
2527 -10.35 0.12 -4.46 0.15 987 
11321 -10.71 0.12 -5.95 0.15 1297 
5255 -10.62 0.13 -5.51 0.12 1365 
4574 -10.49 0.19 -3.12 0.14 1221 
4776 -11.36 0.14 -5.85 0.18 991 
492 -11.36 0.08 -8.29 0.07 2855 
12677 -11.94 0.09 -5.53 0.10 2110 
532 -10.95 0.18 -4.31 0.17 1558 
2561 -12.01 0.10 -3.04 0.32 2373 
6795 -12.39 0.17 -5.74 0.13 1447 
5920 -12.14 0.24 -6.24 0.17 967 
7968 -8.22 0.16 -5.22 0.13 1620 
10021 -11.24 0.14 -4.64 0.19 983 
3697 -11.37 0.08 -6.24 0.14 1937 
509 -10.89 0.09 -3.77 0.10 2253 
10027 -11.36 0.07 -5.25 0.15 1854 
9027 -11.56 0.06 -3.87 0.13 3523 
5902 -12.07 0.05 -2.80 0.05 6227 
12577 -12.28 0.13 -5.39 0.14 1629 
12063 -6.44 0.16 -5.79 0.18 1243 
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11916 -10.27 0.09 -3.50 0.07 2434 
3801 -11.11 0.20 -6.34 0.13 1313 
3863 -11.91 0.15 -4.67 0.14 1110 
12895 -12.97 0.10 -2.46 0.10 2194 
10957 -11.14 0.11 -4.67 0.17 1347 
12601 -10.39 0.14 -4.06 0.14 1361 
11873 -11.28 0.11 -3.63 0.13 2005 
11752 -11.84 0.09 -4.21 0.10 2011 
9247 -11.79 0.19 -2.26 0.18 1250 
6855 -11.05 0.08 -5.43 0.08 1893 
8062 -9.58 0.27 -2.65 0.14 976 
9.02 -11.27 0.15 -4.38 0.09 2711 
9.03 -8.81 0.07 0.59 0.08 3162 
9.07 -10.73 0.09 -10.99 0.09 2333 
9.13 -109.52 2.70 -206.17 4.09 12665 
 
Control standard    
 d13C d18O  
IAEA-CO1 2.76 -2.30 8017 
IAEA-CO1 2.56 -2.45 6024 
IAEA-CO1 2.54 -2.45 3860 
IAEA-CO1 2.59 -2.40 5903 
IAEA-CO1 2.40 -2.40 3280 
IAEA-CO1 2.89 -2.26 8973 
IAEA-CO1 2.54 -2.42 2967 
IAEA-CO1 2.85 -2.34 8810 
IAEA-CO1 2.63 -2.33 4572 
    
IAEA-CO1    
 d13C d18O  
Average 2.61 -2.38  
SD 0.16 0.07  
 
 
 
 
 
 
Red=Omitted 
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Appendix H: Complete Report of all Bone Collagen Quality Control Indicators and List 
of Samples Retained for Analyses (Carroll 2015)  
 
  Possible Contamination/Degradation 
  Outside Accepted Range 
  Possible Post-Mortem Organic Carbon Contamination 
  
Possible Post-Mortem Peat or Humic Acid 
Contamination  
N/A Equipment/Procedural Error  
N/A Not Sampled for Bone Collagen 
XXXX Omitted from Study 
 
Cohort ID 
Collagen 
Yields 
C:N 
(mol/mol) %N wt %C wt 
Anemic 2030 Rib 2.9 3.2 14.1 40.3 
Anemic 2134 Rib 2.9 N/A N/A N/A 
Anemic 
2134 
C.Vault N/A 6.0 14.1 8.1 
Anemic 2772 Rib 2.0 3.4 13.9 39.9 
Anemic 4238 Rib 1.4 3.3 13.7 39.1 
Anemic 4776 Rib N/A 3.2 13.8 39.5 
Anemic 5255 Rib 3.6 3.2 13.6 40.0 
Anemic 
5255 
C.Vault 3.2 3.9 2.0 40.0 
Anemic 11321 Rib 4.4 3.2 12.4 35.1 
Anemic 
11321 
Zygomatic 6.2 3.0 11.8 31.5 
Anemic 11989 Rib 2.9 3.3 13.7 39.1 
Anemic 
12283 
Rib* 2.0 3.4 14.2 42.5 
Anemic 
12283 
C.Vault N/A 3.3 18.3 50.7 
Pos. A./H.  2527 Rib 4.3 3.3 14.3 38.8 
Pos. A./H.  4574 Rib 3.5 3.3 12.4 37.1 
Pos. A./H.  5093 Rib 2.9 3.2 14.1 38.2 
Pos. 
A./H.  5757 Rib 4.0 3.3 9.8 29.3 
Pos. 
A./H.  
5757 
Lamina 0.3 3.6 10.3 28.7 
Pos. A./H.  5920 Rib N/A 3.3 13.8 37.3 
Pos. A./H.  6795 Rib 2.0 3.2 14.2 38.5 
Pos. A./H.  
6795 
Lamina 1.0 3.2 14.4 37.1 
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Pos. A./H.  7968 Rib 4.8 3.2 14.2 40.6 
Pos. A./H.  10021 Rib 2.0 3.2 11.8 33.5 
Pos. 
A./H.  
10021 
C.Vault 4.0 3.2 20.1 54.3 
Pos. A./H.  10326 Rib 2.1 3.2 14.0 40.0 
Pos. A./H.  11916 Rib 5.6 3.2 13.8 37.3 
Pos. 
A./H.  12063 Rib 0.1 5.1 2.3 6.9 
Diseased 509 Rib 5.6 3.2 13.6 38.8 
Diseased 
509 
C.Vault 0.2 3.2 14.2 40.7 
Diseased 2817 Rib 2.5 3.3 12.0 34.1 
Diseased 3863 Rib 2.5 3.2 14.4 41.2 
Diseased 
3863 
Scapula 2.5 N/A N/A N/A 
Diseased 6855 Rib N/A 3.3 13.7 37.0 
Diseased 9027 Rib 4.5 3.2 14.1 40.2 
Diseased 
9027 
C.Vault 0.7 3.2 13.9 37.7 
Diseased 9247 Rib 5.3 3.3 13.9 39.6 
Diseased 10957 Rib 4.2 3.3 14.0 38.0 
Diseased 11681 Rib 7.8 3.2 13.8 37.6 
Diseased 11837 Rib 7.3 3.3 10.1 28.3 
Diseased 12271 Rib 4.6 3.2 14.4 39.2 
Diseased 12895 Rib 2.8 3.3 11.7 35.0 
Control 532 N/A N/A N/A N/A 
Control 2561 N/A N/A N/A N/A 
Control 492 Rib N/A 3.4 12.2 36.4 
Control 3697 Rib 7.2 3.2 13.5 39.2 
Control 
3697 
Lamina 1.4 3.2 14.5 39.4 
Control 3801 Rib 4.7 3.2 14.4 41.2 
Control 4421 Rib 2.1 3.3 13.7 41.1 
Control 5902 Rib 2.1 3.4 13.8 37.3 
Control 10027 Rib 4.5 3.2 14.1 38.2 
Control 11752 Rib 10.1 3.2 15.9 39.7 
Control 11873 Rib 5.4 3.2 14.3 36.9 
Control 12577 N/A N/A N/A N/A 
Control 12286 Rib 6.1 3.2 15.8 41.3 
Control 12601 Rib 4.8 3.2 13.7 39.1 
Control 12677 Rib 4.4 3.2 12.2 32.5 
Control 
12677 
Lamina 1.0 3.5 11.8 33.5 
Faunal 
8062 
Bovine 12.4 3.2 11.6 34.9 
Faunal 
3989 
Ovicaprid 0.6 N/A N/A N/A 
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Appendix I: Complete Report of all Bone Collagen δ13C and δ15N Values from Well-
Preserved Samples (Carroll 2015)  
Cohort 
 ID ∂15N (‰ vs N/Air) ∂13C (‰ vs VPDB) 
Anemic 2030 Rib 13.6 -18.6 
Anemic 2772 Rib 11.6 -18.7 
Anemic 4238 Rib 13.1 -18.5 
Anemic 4776 Rib 9.8 -18.8 
Anemic 5255 Rib 9.5 -18.9 
Anemic 11321 Rib 9.0 -19.4 
Anemic 11321 Zygo 9.3 -19.6 
Anemic 11989 Rib 12.0 -18.2 
Anemic 12283 Rib 13.4 -21.3 
Anemic 
12283 C. 
Vault  10.4 -19.6 
  
RIB MEAN 
(n=8) 11.5 +/- 2.0 -19.1 +/- 1.0 
  
Total Mean 
(n=10) 11.2 +/- 0.6 -19.1 +/- 0.5 
  
Intra-
Cohort 
Variation 
(‰) 4.6 3.1 
Pos. 
A./H.  2527 Rib 9.5 -19.3 
Pos. 
A./H.  4574 Rib 11.0 -19.1 
Pos. 
A./H.  5093 Rib 11.4 -18.9 
Pos. 
A./H.  5920 Rib 9.2 -18.7 
Pos. 
A./H.  6795 Rib 9.7 -19.3 
Pos. 
A/H 
6795 
Lamina 9.9 -19.5 
Pos. 
A./H.  7968 Rib 11.6 -18.1 
Pos. 
A./H.  10021 Rib 12.0 -18.2 
Pos. 
A./H.  10326 Rib 8.0 -19.1 
Pos. 
A./H.  11916 Rib 9.2 -19.2 
  
RIB MEAN 
(n=9):  10.2 +/- 1.4 -18.9 +/- 0.5 
   280 
 
  
Total Mean 
(n=10) 10.2 +/-1.3 -18.9 +/- 0.5 
  
Intra-
Cohort 
Variation 
(‰) 4.0 1.2 
Diseased 509 Rib 9.5 -19.2 
Disease 509 C. Vault 10.3 -19.6 
Diseased 2817 Rib 9.4 -18.9 
Diseased 3863 Rib 8.7 -18.8 
Diseased 6855 Rib 8.4 -19.1 
Diseased 9027 Rib 10.1 -19.0 
Disease 
9027 C. 
Vault 10.2 -19.3 
Diseased 9247 Rib 10.6 -18.6 
Diseased 10957 Rib 9.5 -18.9 
Diseased 11681 Rib 9.9 -19.2 
Diseased 12271 Rib 10.5 -18.7 
Diseased 12895 Rib 9.6 -19.3 
  
RIB MEAN 
(n=10):  9.6 +/- 1.0 -19.0 +/- 0.2 
  
Total Mean 
(n=12) 9.7 +/- 0.7 -19.0 +/- 0.3 
  
Intra-
Cohort 
Variation 
(‰) 2.1 0.6 
Control 492 Rib 9.4 -19.7 
Control 3697 Rib 10.8 -18.6 
Control 
3697 
Lamina 10.8 -18.5 
Control 3801 Rib 9.4 -19.3 
Control 4421 Rib 8.9 -19.3 
Control 5902 Rib 11.6 -18.7 
Control 10027 Rib 8.4 -19.2 
Control 11752 Rib 9.6 -19.1 
Control 11873 Rib 9.3 -19.3 
Control 12286 Rib 9.9 -19.3 
Control 12601 Rib 9.7 -19.3 
Control 12677 Rib 10.3 -19.3 
Control 
12677 
Lamina 11.5 -18.9 
  
RIB MEAN 
(n=11):  9.8 +/- 1.3 -19.2 +/- 0.3 
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Total Mean 
(n=14) 10.0 +/- 1.0 -19.1 +/- 0.3 
  
Intra-
Cohort 
Variation 
(‰) 2.7 1.1 
        
  
Population 
Rib Mean 
(n=38) 10.2 +/- 1.4 -19.0 +/- 0.6 
  
Population 
Total Mean 
(n=46)  10.2 +/- 1.3 -19.1 +/- 1.3 
Faunal 8062 Bovine 4.1 -20.6 
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Appendix J: Complete Report of all Bone Collagen δ13C and δ15N Values from Well-
Preserved Samples (Carroll 2015)  
Cohort ID 
Tooth 
Type 
∂13C (‰ vs 
VPDB) SD 
∂18O (‰ vs 
VPDB) SD (+/-) 
Anemic 2030 RM1 max -11.7 0.1 -3.3 0.1 
Anemic 4776 RM1 man -11.4 0.1 -5.9 0.2 
Anemic 5255 LM1 man -10.6 0.1 -5.5 0.1 
Anemic 11321 LM1 man -10.7 0.1 -6.0 0.2 
Anemic 12283 LM1 max -9.4 0.3 -5.9 0.3 
Pos. 
A/H 4574 LM1 man -10.5 0.2 -3.1 0.1 
Pos. 
A/H 5757 RM1 max -12.0 0.1 -5.2 0.2 
Pos. 
A/H 10326 LM1 max -13.1 0.1 -3.1 0.1 
Control 4421 RM1 max -11.6 0.2 -3.6 0.3 
    MEAN: -11.2 +/- 1.1   -4.6 +/- 1.3   
Cohort ID 
Tooth 
Type 
∂13C (‰ vs 
VPDB) SD 
∂18O (‰ vs 
VPDB) SD (+/-) 
Pos. 
A/H 11916 RM2 man -10.3 0.1 -3.5 0.1 
Control 12677 LM2 man -11.9 0.1 -5.5 0.1 
Control 12286 RM2 max -12.3 0.1 -2.5 0.1 
Control 492 LM2 man -11.4 0.1 -8.3 0.1 
Control 532 LM2 man -11.0 0.2 -4.3 0.2 
Control 2561 LM2 man -12.0 0.1 -3.0 0.3 
    MEAN: -11.5 +/-0.8   -4.5 +/- 2.1   
Cohort ID 
Tooth 
Type 
∂13C (‰ vs 
VPDB) SD 
∂18O (‰ vs 
VPDB) SD (+/-) 
Pos. 
A/H 3 LM3 -12.1 0.2 -6.2 0.2 
Pos. 
A/H 6795 LM3 man -12.4 0.2 -5.7 0.1 
Pos. 
A/H 7968 LM3 man -8.2 0.2 -5.2 0.1 
Pos. 
A/H 10021 LM3 man -11.2 0.1 -4.6 0.2 
Pos. 
A/H 12063 RM3 man -6.4 0.2 -5.8 0.2 
Diseased 509 LM3 man -10.9 0.1 -3.8 0.1 
Diseased 2817 RM3 max -11.9 0.2 -3.5 0.2 
Diseased 3863 RM3 man -11.9 0.2 -4.7 0.1 
Diseased 9027 LM3 man -11.6 0.1 -3.9 0.1 
Diseased 9247 RM3 man -11.8 0.2 -2.3 0.2 
Diseased 10957 RM3 man -11.1 0.1 -4.7 0.2 
   283 
 
Diseased 11681 LM3 max -11.3 0.1 -3.6 0.2 
Diseased 11837 RM3 max -11.2 0.1 -5.0 0.1 
Diseased 12271 RM3 max -11.4 0.2 -4.8 0.2 
Diseased 12895 RM3 man -13.0 0.1 -2.5 0.1 
Control 3697 LM3 man -11.4 0.1 -6.2 0.1 
Control 10027 LM3 man -11.4 0.1 -5.3 0.2 
Control 12601 RM3 man -10.4 0.1 -4.1 0.1 
Control 11873 RM3 man -11.3 0.1 -3.6 0.1 
Control 11752 RM3 man -11.8 0.1 -4.2 0.1 
Control 5902 LM3 man -12.1 0.1 -2.8 0.1 
Control 492 LM2 man -11.4 0.1 -8.3 0.1 
Control 3801 RM3 man -11.1 0.2 -6.3 0.1 
Control 12577 LM3 man -12.3 0.1 -5.4 0.1 
    MEAN: -11.2 +/- 1.3   -4.7 +/- 1.4   
Cohort ID 
Tooth 
Type 
∂13C (‰ vs 
VPDB) SD 
∂18O (‰ vs 
VPDB) SD (+/-) 
Diseased 6855 LC man -11.1 0.1 -5.4 0.1 
Pos. 
A/H 2527 rm2 man -10.4 0.1 -4.5 0.2 
Anemic 2772 lm2 max -8.8 0.1 -4.2 0.1 
Anemic 4238 lm1 max -12.0 0.1 -3.8 0.1 
Anemic 11989 lm2 man -11.5 0.2 -4.3 0.2 
 
 
 
 
 
 
 
 
 
 
 
 
